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Fundamental scientific understanding of oral diseases associated with tissue-contacting dental and
medical devices is primordial to facilitate pathways for their translation to clinical use. The interaction
of bacteria with biomaterials’ surfaces has critical clinical implications due to biofilm formation and
biofouling. Although biofilms play an important positive role in various ecosystems, they also have
many adverse effects, including biofilm-related infections in medical and dental settings.
Biofilms account for up to 80% of the total number of bacteria-related infections, including endocarditis,
cystic fibrosis, secondary dental caries, periodontitis, rhinosinusitis, osteomyelitis, non-healing chronic
wounds, meningitis, kidney infections, and prosthesis- and implantable device-related infections.
Worldwide, populations of all ages suffer from oral biofilm-trigged diseases, such as dental
caries and tooth surrounding tissue infections impacting the human body. New dental materials and
biomaterials, currently being introduced, under development, or proposed, are expected to benefit the
oral health status. These materials will provide a wide range of diverse functions, from promoting
osteogenesis to bacterial biofilm formation inhibition.
In the Special Issue “Bacterial Interactions with Dental and Medical Materials,” encouraging findings
on tissue-contacting biomaterials to control biofilms and susceptibility to bacterial colonization and
understand mechanisms, clinical perspectives beneficial to healthcare were discussed.
As cariogenic bacterial grows inside the mouth due to lack of caries disease management,
the tooth–material interface continues to degrade by bacterial acids leading to increasing premature
failure of tooth filling. Bienek et al. [1], Mena Silva et al. [2], Yaghmoor et al. [3], Lu and Jin [4],
Lygidakis et al. [5], and Mitwalli et al. [6] investigated the application of polymerizable antibacterial
monomers based on di-imidazolium or quaternary ammonium compounds as an antibacterial strategy
for resin-based materials in efforts toward caries-related biofilm control.
Looking for the control of and reduction in oral biofilm formation, initiated by bacterial species
living in polymicrobial, pathogenic colonies at or below the gingival margin, Mortazavian et al. [7],
Afonso Camargo et al. [8], and Torres and Bienek [9] presented antibiofilm strategies targeting adhesion
to a substrate via brush-like structures of highly packed polymer chains and silicon carbide coating
that could physically repel bacteria to result in a significant reduction in attached bacteria.
The search for new bioactive compounds to prevent dental caries development and progression has
led researchers to focus their attention on the use of nanotechnologies, especially hydroxyapatite (HAp),
metals, and metal oxide nanoparticles. Garcia et al. [10] investigate the effects of different loadings of cerium
dioxide on their radiopacity and degree of conversion of dental adhesives. Nanotechnology applications
have offered the opportunity to modulate the formation of dental biofilms using nanoparticles with
bioactive effects. Luong et al. [11] have assessed novel nanohydroxyapatite-based desensitizer and its
effect on dental adhesives’ bond strength.
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Ionescu et al. [12] have looked to the synergistic antibacterial performance of toothpaste containing
nano-hydroxyapatite substituted with metal ions. Shimabukuro et al. [13] have investigated both
the durability of the antibacterial effect and the surface change of Ag- and Cu-incorporated porous
titanium dioxide (TiO2) layer; silver (Ag) and copper (Cu) have been incorporated into the titanium
(Ti) surface to realize their antibacterial properties. Ag- and Cu-incorporated TiO2 layers were formed
by micro-arc oxidation (MAO) treatment using the electrolyte with Ag and Cu ions. Their collective
findings indicated the importance of the time-transient effects of Ag and Cu. This knowledge will help
design antibacterial implants based on Ag and Cu’s surface changes. Paterson et al. [14] incorporate
silver-doped nano-hydroxyapatite into electrospun scaffolds for applications in bone repair.
Papynov et al. [15] have developed a combination of calcium monosilicate, β-wollastonite (CaSiO3),
and hydroxyapatite (HAp), which is a complete analog of a living bone. This approach can pave the way
to the fabrication of biocompatible ceramics for bone tissue engineering; thus, contributing another flexible
strategy for the synthesis of biomaterials with broad intended applications in traumatology, orthopedics,
dentistry, maxillofacial surgery, and other areas of medicine for the recovery, replacement, and reconstruction
of the damaged tissue.
As we observe an increasing number of investigations addressing new antibacterial materials
and devices, we also face a significant challenge in evaluating the new materials. There is a limited
understanding of the mechanisms involved in bacteria–materials interactions in the oral environment.
The gaps in the development and application of reliable methodological approaches for the characterization
of this new generation of antibacterial materials require considering the complexity and heterogeneity of
the disease process investigated.
Garcia-gareta et al. [16] developed a live ex vivo model of persistent infection that can be used
for pre-screening biomaterials intended for treating chronic wounds for their antimicrobial and
angiogenic potential. This model is relatively simple, quick, and low-cost and mimics the in vivo
situation more closely than traditionally used antimicrobial tests using agar plates and dilution assays.
Additionally, keeping under the principles of the National Centre for the Replacement Refinement and
Reduction of Animals in Research, this model does not require administrative procedures for obtaining
ethics committee approval for animal experimentation.
In this Special Issue, there are 16 papers by authors from 9 countries in Asia, Europe, and Latin
and North America. Their investigations represent a wide range of aspects related to the current
scenario on bacteria interactions with biomaterial surfaces and give timely examples of research
activities that can be observed around the globe. We hope that this work will be inspirational for
further research on understanding oral diseases associated with tissue-contacting dental and medical
devices, new antibiofilm agents, and the relevance of assessing the material using clinically significant
biofilm models.
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Abstract: White spot lesions (WSLs) can develop quickly and compromise the successful outcome of
the orthodontic treatment. Orthodontic bonding cement with the capability to prevent or mitigate
WSLs could be beneficial, especially for patients with high risk of caries. This study explored novel
mono- and di-imidazolium-based polymerizable antibacterial monomers and evaluated orthodontic
cement compositions comprising such novel monomers. Their antibacterial potentials, mechanical
properties, and shear bond strength (SBS) to bovine enamel were investigated. Statistical tests were
applied to SBS and mechanical tests (one-way ANOVA and Tukey’s test). For antibacterial resins C
(ABR-C) and E (ABR-E), their minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) against cariogenic Streptococcus mutans bacterial strain UA159 were found to
be 4 μg/mL and 8 μg /mL, respectively. The loss of dry mass from completely demineralized dentin
beams in buffer solutions pre-dipped into ABR-C and ABR-E resins is much less than that in control
buffer (artificial saliva) only. For unfilled resins comprising up to 12 wt % ABR-C, no significant
decreases in flexural strength or modulus were observed. For experimental cements incorporating
1–4 wt % ABR-C, there was no drastic compromise to the SBS to enamel except for 3 wt % ABR-C.
Furthermore, their SBS was all comparable to the commercially available orthodontic cements.
The ISO-22196 antimicrobial test against S. aureus showed significant levels of antibacterial effects—up
to over 5 logs of microorganism reduction exhibited by ABR-C-containing experimental cements.
The imidazolium-based polymerizable monomers could be utilized to functionalize orthodontic
bonding cement with steady antibacterial activity and develop a potential strategy to counteract WSLs.
Keywords: white spot lesions; antibacterial; biofilms; dental; orthodontic
1. Introduction
Beyond just straightening teeth and achieving better esthetics, proper orthodontic intervention
can result in greatly improved oral and psychological health [1,2]. A major undesirable outcome
during orthodontic treatment is the development of white spot lesions (WSLs) around orthodontic
brackets, especially near the gingival margin [3–6]. The boosted accumulation of biofilms around the
brackets further lowers pH around these sites. Despite advancements in patient education, WSLs can
still develop rapidly and could compromise the successful outcome of the treatment, even resulting in
premature termination of treatment in severe cases [7–9]. It has been reported that between roughly
26% and 70% of patients using fixed orthodontic appliances exhibited various levels of WSLs during
the orthodontic treatment [4,6,7]. In another study, the prevalence of WSLs was reported to be 38% in
the 6-month group, whereas it was 46% in the 12-month group [9].
Due to the more retentive, complicated surfaces around brackets and higher occurrences for
plaque or biofilm adherence, it has become quite challenging to maintain good oral hygiene, especially
for less compliant patient groups [8,10–12]. It has been reported that fixed orthodontic appliances can
J. Funct. Biomater. 2020, 11, 75; doi:10.3390/jfb11040075 www.mdpi.com/journal/jfb5
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affect the self-cleansing capabilities of the intraoral system, owing to the interactions of saliva and
teeth surfaces. Even for patients with clear aligners, wearing aligners 20~22 h daily could limit the
natural cleansing and neutralizing effects of saliva [13]. The fixed orthodontic appliances can even
alter the oral microflora and increase the levels of acidogenic plaque bacteria, i.e., Streptococcus mutans
(S. mutans), and lactobacilli in saliva and dental biofilm during active wearing of such appliances
throughout lengthy orthodontic treatment procedures, with an average duration around two to three
years [14–19] .
The interface between tooth and orthodontic bonding adhesive or cement, many of them
based on (meth)acrylate chemistry, could also become the victim of bacterial attack and subsequent
degradation [20,21]. Finer et al.’s findings revealed increased degradation of resin-based composite
and bonding agent by S. mutans UA159 vs. control. Esterase activities at levels that could degrade
adhesives and resin composite have also been linked to S. mutans [20]. While bonding the irregularly
shaped orthodontic appliances onto the tooth surface, the residual excess of orthodontic cements can
also stimulate the extra accumulation of dental biofilm around brackets. The biofilm degradation
of this important tooth–cement–bracket interface may contribute to the premature debonding of the
brackets, especially given the compounding interactions with the microorganisms that could lead to
biocorrosion on the surfaces of metal-based brackets and appliances [22].
Given the extensive prevalence of WSLs occurring during orthodontic treatments, various
strategies have been utilized to prevent or mediate demineralization and occurrence of WSL formation.
The use of fluoride via various forms, i.e., mouth rinse, gel, topical varnish, toothpaste, etc., has been
the predominant remedy applied and studied [7,14,23,24]. Fluoride ions have been well documented
to enhance remineralization of enamel and mitigate mineral loss during acid dissolution, by replacing
the hydroxyl groups in hydroxyapatite and forming more acid-resistant fluorapatite [25]. The findings
consolidated by Bergstrand and Twetman concluded that the use of topical fluoride varnish along with
fluoride toothpaste has been the best evidence-based approach to prevent WSLs. The mean prevented
portion based on six clinical trials was 42.5% with a range from 4% to 73% [23]. These studies provided
convincing support for routine professional applications of fluoride varnish around the bracket base
during orthodontic treatment [24–28].
The application of quaternary ammonium compound (QAC) has been actively investigated to
introduce antibacterial activity into the orthodontic bonding system. A unique type of antimicrobial
polymer is demonstrated by incorporating quaternary ammonium polyethyleneimine (QPEI)
nanoparticles. QPEI nanoparticle-containing composites have been reported to exhibit antibacterial
activity against salivary bacteria and in vivo antibiofilm activity [29]. Experimental orthodontic bonding
cements with 1% incorporated insoluble QPEI and polycationic polyethyleneimine nanoparticles were
reported to exhibit stable, long-lasting antibacterial properties against S. mutans [30,31]. A variety
of QAC-containing functional monomers have been systematically studied, including the widely
studied methacryloyloxydodecylpyridinium bromide (MDPB) [32,33] ; dimethylaminohexadecyl
methacrylate (DMAHDM), a mono-methacrylate QAC with an alkyl chain length of 16 [34,35];
dimethylaminododedecyl methacrylate (DMADDM), a mono-methacrylate QAC with an alkyl chain
length of 12 [36–38]; and 2-methacryloxylethyl hexadecyl methyl ammonium bromide (MAE-HB),
a crosslinkable, di-methacrylate QAC with an alkyl chain length of 16 [39,40]. Significant antibacterial
activities and biofilm reductions have been demonstrated.
Recently, a series of polymerizable imidazolium-based antibacterial resins (ABRs) were successfully
designed in our laboratory [41,42]. To the best of our knowledge, no such novel crosslinkable
imidazolium-based monomers have been investigated for their application towards an orthodontic
bonding system with the potential to prevent and mitigate WSLs. The aims of this study were
to investigate imidazolium-based ABR’s antibacterial activities and impacts on the adhesive and
mechanical properties of experimental orthodontic bonding cement formulations.
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2. Results
By coupling with different mono-ols, diols, polyols (such as triols), monoamines, diamines, and/or
polyamines, a range of methacrylate resins with (poly)imidazole moieties were prepared. During
the processes of synthesizing imidazolium-based polymerizable resins from imidazole-containing
monomers, a facile process based on imidazole and (meth)acrylated resins was developed.
As demonstrated in Schemes 1 and 2, a variety of imidazole-containing polymerizable monomers were
able to be prepared accordingly.
Scheme 1. Isosorbide-based bisimidazole–dimethacrylate resins.
The polymerizable imidazole-based resins were further converted into polymerizable
imidazolium-based monomers by reacting them with a variety of halogenated alkyls. A variety
of polymerizable imidazolium-based antibacterial resins (ABRs) were successfully synthesized as
exhibited in Schemes 3 and 4. The primary evaluations of these novel ABRs’ antibacterial activity
include the determination of minimum inhibitory concentration (MIC) and minimum bactericidal
concentration (MBC) against cariogenic S. mutans bacterial strain UA159.
7
J. Funct. Biomater. 2020, 11, 75
Scheme 2. Various polymerizable mono-imidazole monomers synthesized.
Scheme 3. Polymerizable alkylimidazoliumbromide–dimethacrylate monomer, antibacterial resin
C (ABR-C).
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Scheme 4. Polymerizable alkylimidazoliumbromide–methacrylate monomer ABR-E.
Table 1 presents the results of MIC and MBC for representative ABR resins and SDR Resin (a
proprietary dimethacrylate monomer, without imidazole moiety, synthesized by Dentsply Sirona) in
comparison to frequently used controls, namely chlorhexidine (CHX) as wide-spectrum antimicrobial
agent and triethylene glycol dimethacrylate (TEGDMA). TEGDMA was chosen as control monomer
because it is widely used in the composition of resins for dental-related applications, including but
not limited to restorative, adhesive, and orthodontic compositions. In addition, it was not known to
have antibacterial potencies against common cariogenic oral bacteria strains. Furthermore, by using
a modified JIS Z 2801 test method, a preliminary antibacterial test against S. mutans strain UA159
was used to evaluate the antibacterial effectiveness for such formulated compositions. After 24 h
contact, a bacterial reduction of 99.88% was exhibited by test sample containing ABR-E (Scheme 4),
as compared to control. This indicated that imidazolium-based polymerizable resin could be highly
effective in suppressing the growth of bacteria such as S. mutans.
Table 1. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of
novel antibacterial resins ABR-E and ABR-C against Streptococcus mutans strain UA159, as compared to
SDR Resin, triethylene glycol dimethacrylate (TEGDMA), and chlorhexidine.




ABR-E 2.5% 0–0.1% 9 × 107 4 μg/mL(0.0004%)
8 μg/mL
(0.0008%)
ABR-C 1% 0–0.1% 9 × 107 4 μg/mL(0.0004%)
8 μg/mL
(0.0008%)
SDR Resin 0.25% 0–0.1% 9 × 107 No bacterial growth inhibition
TEGDMA 100% 0–0.1% 9 × 107 No bacterial growth inhibition
Chlorhexidine 2.5 mg/mL 0–125 mg/mL 9 × 107 2 mg/mL 4 mg/mL
The loss of dry mass from completely demineralized dentin beams (2 mm × 1 mm × 6 mm) in
buffer solutions pre-dipped into ABR-C and ABR-E resins, versus in control buffer (artificial saliva)
without pre-dip, was studied. The amount of soluble collagen in these demineralized dentin beams
was measured after 7 days of incubation at 37 ◦C. As Figure 1 indicates, dentin beams without pre-dip
lost about 15.5% of their dry mass due to degradations of endogenous matrix metalloproteinases
(MMPs) and cathepsins. When the dentin beams were pre-dipped in 1–4% of imidazolium-based
ABR resins (ABR-C, ABR-E) for 30 s and then dropped in incubation medium, the dentin beams only
lost about 3.5–5% of their dry mass. Furthermore, the hydroxyproline (HYP), an amino acid unique
to collagen, content in the medium was also measured. The collagen peptide fragments that were
solubilized by the endogenous proteases of the dentin matrix were hydrolyzed to amino acids in
6N HCl and then analyzed for hydroxyproline. In the control group, the proteases released about
10.5 μg HYP/mg dry dentin after 7 days; beams pre-dipped in 1% or 4% of ABR-C released less than
half as much hydroxyproline and the beam treated with ABR-E yielded a similar result.
As the designed imidazolium-based resin still comprises a methacrylate functional group,
no compatibility or copolymerization issues were found when mixed with typical dimethacrylate-type
dental resins, such as 1,6-bis[methacryloyloxyethoxycarbonylamino]-2,4,4-trimethylhexane (UDMA),
ethoxylated bisphenol A dimethacrylate (EBPADMA), and TEGDMA. Even with 16 wt % loading of
ABR-C into the control orthodontic resin, no mixability issue was observed and the resulting resin
mixture was found uniform. The 3-point bending flexural strength and modulus of unfilled orthodontic
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resins containing 4~16 wt% ABR-C, along with control, were measured following ISO-4049 method
and the results are presented in Table 2.
 
Figure 1. Effect of pre-dipping in antibacterial resins ABR-C and ABR-E on loss of dry mass of
demineralized dentin beams after incubation for 7 days at 37 ◦C.
Table 2. Flexural strength and flexural modulus of exp. orthodontic resins (unfilled) that contain
various concentrations of imidazolium-based polymerizable antibacterial monomer ABR-C.
Resin Sample Control 4%_ABR-C 8%_ABR-C 12%_ABR-C 16%_ABR-C
Antibacterial Monomer in Resin 0 4 wt% 8 wt% 12 wt% 16 wt%
Flexural Strength, MPa (s.d.) 97 (8) A 88 (5) A,B 91 (4) A 95 (3) A 81 (4) B
Flexural Modulus, MPa (s.d.) 2443 (87) a 2388 (183) a 2394 (139) a 2293 (82) a,b 2125 (125) b
Within the same row, means that do not share the same superscript(s) are significantly different (α = 0.05).
The 75 wt % filled experimental orthodontic cements incorporating various concentrations of
antibacterial monomer ABR-C were also studied. The current investigation examined flexural and
compressive strengths, flexural modulus, ambient light sensitivity, and notched-edge shear bond
strength (NE-SBS) to bovine enamel. Results along with statistical analysis are presented in Table 3.
For reference, the shear bond strength to bovine enamel, using the same NE-SBS method, and ambient
light sensitivity of five commercially available orthodontic bonding cements were also evaluated,
as presented in Figures 2 and 3, respectively.
Antibacterial testing was also conducted at an independent and good laboratory practice (GLP)
complied testing institution. As shown in Table 4, for orthodontic cement paste formulations that
incorporated imidazolium-based dimethacrylate antibacterial monomer (ABR-C), the ISO-22196
antimicrobial testing results against ATCC 6538 showed significant levels of antibacterial effects—up
to over 5 logs of microorganism reduction—when compared with control. Such highly effective
bactericidal effects for the imidazolium-based polymerizable resins were promising due to a relatively
low-level loading and significantly reduced probability of leaching out owing to the dimethacrylate
functional groups.
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Table 3. Adhesive and physical properties of orthodontic cements (filled with 75% inorganic filler) that
contain various concentrations of imidazolium-based polymerizable antibacterial monomer ABR-C.
Orthodontic Cement Control 1%_ABR-C 2%_ABR-C 3%_ABR-C 4%_ABR-C
Antibacterial Monomer in Cement 0 1 wt% 2 wt% 3 wt% 4 wt%
Resin Conc. 25.0% 25.0% 25.0% 25.0% 25.0%
Ambient Light Sensitivity 2:35" 2:00" 2:05" 2:00" 2:15"
Compressive Strength, MPa (s.d.) 373 (25) A 361 (12) A,B 346 (10) B 352 (5) A,B 307 (15) C
Flexural Strength, MPa (s.d.) 150 (14) A 139 (6) A 114 (10) B 114 (10) B 88 (7) C
Flexural Modulus, MPa (s.d.) 11165 (531) a 10848 (383) a,b 10319 (549) a,b 10607 (629) a,b 10066 (445) b
NE-SBS to Etched Enamel, MPa (s.d.) 32.8 (2.7) A,B 36.7 (4.5) A 28.8 (4.3) B,C 25.4 (3.5) C 31.0 (5.8) A,B,C
SBS to Enamel Range, MPa 29.5 ~ 37.2 31.9 ~ 43.4 21.9 ~ 32.7 21.5 ~ 29.5 23.1 ~ 38.0
SBS to Enamel C.V. 8.1% 12.1% 14.8% 14.0% 18.7%
Within the same row, means that do not share the same superscript(s) are significantly different (α = 0.05).
 
Figure 2. Notched-edge shear bond strength to bovine enamel of commercial orthodontic cements.
Values that do not share the same superscript(s) are significantly different (α = 0.05).
Figure 3. Ambient light sensitivity of commercial orthodontic cements. Values that do not share the
same superscript are significantly different (α = 0.05).
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Table 4. ISO-22196 antimicrobial test of orthodontic cements (filled with 75 wt % inorganic filler) that
contain various concentrations of imidazolium-based polymerizable antibacterial monomer using










to Control at Contact Time
Log10 Reduction Compared to
Control at Contact Time
S. aureus
6538
Time Zero Control 0 1.00 × 106 N/A
24 h
ATL Control 0 8.50 × 105
2%_ABR-C 2 wt% 1.00 × 10 99.9988% 4.93
4%_ABR-C 4 wt% 1.50 × 10 99.998% 4.75
1%_ABR-C 1 wt% 4.72 × 103 99.44% 2.26
3%_ABR-C 3 wt% <5.00 > 99.9994% > 5.23
3. Discussion
As demonstrated by MIC and MBC test results reported in Table 1, ABR-C and ABR-E displayed
distinct antibacterial activities against cariogenic S. mutans cells. Not surprisingly, the MIC values of
ABR-C and ABR-E were higher than that of benchmark wide-spectrum bactericidal chlorhexidine,
which is also highly leachable and does not offer sustained antibacterial activity once leached out. Also
as expected, the 8 μg/mL MBC of ABR-C and ABR-E is higher than CHX’s MBC of 4 μg/mL, whereas
no bactericidal activities were observed at all for SDR Resin and TEGDMA. It has been shown that,
for an organic QAS compound, 10~14 carbon atoms for the N-alkyl group are associated with higher
antimicrobial activity [43,44]. Another study also showed that imidazolium’s N-alkyl’s chain length
can play a critical role in antitumor activity and cytotoxicity; C-12 was found exhibiting high antitumor
activity against ~60 tumor cell lines as well as low cytotoxicity in most cases. Longer chain length could
improve antitumor potency but also increase imidazolium’s cytotoxicity [45]. As demonstrated in their
chemical structures in Schemes 3 and 4, respectively, both ABR-C and ABR-E have a 12-carbon atom
chain length on their N-alkyl group, which helps in explaining their identical MIC and MBC values.
The dentin mass loss results (Figure 1) indicate that the ABR resins, even at low concentrations,
are effective against matrix metalloproteinases (MMPs) for minimizing the collagen degradation.
MMPs belong to a larger group of proteases known as the metzincin superfamily. These collagenases
are capable of degrading triple-helical fibrillary collagens, such as those in dentin, into distinctive
fragments. More specifically, certain MMPs are considered to contribute to the gradual degradation of
collagen fibrils in hybrid layers established during dentin bonding. A wide range of MMPs, including
MMP-2, MMP-8, MMP-9, and MMP-20, have been detected in the human dentin matrix [46]. It is
well reported that CHX has broad anti-MMP activity in addition to antimicrobial capability. However,
the long-term in vivo anti-MMP activity of CHX may not be as effective, which has been attributed to
possible leaching out of the CHX [47,48]. It has also been reported that cationic quaternary ammonium
methacrylates may exhibit dentin MMP inhibition comparable with that of CHX but that higher
concentrations were required [49].
The synthetic strategy in this investigation focused on covalently linking antibacterial compounds
that contain functional groups with strong antibacterial activities to a variety of backbones and
polymerizable groups compatible with conventional dental resin systems. The antibacterial capability
of the active compound could be either enhanced or reduced by polymerization. This depends on how
the compound eradicates bacteria, either by disrupting bacterial membrane or via depleting the bacterial
food supply. In order for an antibacterial resin to be a viable option for industrial-scale production
and application, there are several essential requirements that need to be fulfilled: (1) synthesis of
ABR should be straightforward and not cost-prohibitive; ideally, well-established synthetic routes are
preferred; (2) ABR should have good storage stability (sufficient shelf life); (3) end products that contain
ABR should be able to maintain their antibacterial activities through recurrent bacterial challenges;
(4) ideally, the antibacterial effect can be achieved with relatively small dosing and minimum bacterial
resistance in the target pathogenic microorganisms; (5) no drastic compromises to the other vital
properties should be introduced by ABR. As shown in Table 2, even at up to 12 wt % loading level,
there are no significant decreases in flexural strength or flexural modulus with the incorporation of the
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imidazole-based polymerizable antibacterial monomer ABR-C, as compared to control. The flexural
strength of the resin mixture with 16 wt % antibacterial monomer showed lower flexural strength,
but flexural modulus still retained 84% value as compared to control.
During this investigation, it was found that a group of polymethacrylate resins containing at least
one imidazole moiety could be readily prepared via appropriate hybrid methacrylate–acrylate resins or
polyacrylate resins with proper control of the conversion of the imidazole addition. This is an effective
approach to incorporating an imidazole moiety into a polymerizable resin as novel acid-free functional
resins. Moreover, such imidazole-containing polymerizable resins may be further chemically modified
by reacting with a variety of halogenated alkyls to form polymerizable resins with ionic moiety of
imidazolium, which results in a unique class of polymerizable ionic liquid resins.
Sufficient mechanical properties of the orthodontic bonding cement are important as the bending
force and torque during teeth straightening and aligning could be quite significant. There is a slight
reduction of flexural strength with a higher loading amount of ABR-C; however, flexural modulus can
be maintained with up to 3 wt % of ABR-C loading (Table 3). A similar trend was also observed for
compressive strength. Ambient light sensitivity (ALS) is another important property for light curable
orthodontic cement or adhesive, as adequate ALS is needed for the bracket to be carefully placed and
aligned at the correct position and angle, before it is light cured. As also exhibited in Table 3, the ALS
values of ABR-C-containing orthodontic cements are all at 2 min or higher, which compared well with
commercially available orthodontic cements, as shown in Figure 3.
Orthodontic cement with the capability to prevent the development of WSLs without
compromising enamel bond strength would be desirable. Orthodontic treatments last an average
of two to three years, during which time orthodontic cement must be capable of bonding to the
enamel with high bond strength in order to resist masticatory loads. As demonstrated in Table 3,
for experimental orthodontic cements incorporating 1–4 wt % ABR-C, there is no drastic compromise
to the SBS to enamel except for 3 wt % ABR-C. More importantly, their SBS values are all comparable to
those of the commercially available orthodontic cements products (Figure 2), with mean SBS ranging
from 20.1 MPa to 36.0 MPa. However, this bond strength to enamel should not be too high either,
to prevent damages to the enamel while removing the bracket.
The strong effectiveness in eradicating bacteria for the imidazolium-based polymerizable resins
was further demonstrated by the formulated experimental orthodontic cements. As exhibited in Table 4,
even at a low-level loading (1 wt %) of such imidazolium-based polymerizable monomer, a reduction
of over 2 logs of microorganisms can be achieved by ABR-C. When the loading level of ABR-C was
increased from 2 wt % to 4 wt %, reductions of around 5 logs or higher were observed. Moreover,
with optimized compositions, not only can a highly effective antibacterial capability be achieved,
but balanced mechanical properties can also be maintained (Table 3). The potent antibacterial property
of this novel polymerizable imidazolium resin offers another crucial benefit—no severe cytotoxicity
was introduced [50]. Conventional QAS-based polymerizable resins, on the other hand, could be less
effective and a high dose loading (up to 30 wt %) is needed, which frequently leads to significant drops
in mechanical properties and elevated cytotoxicity [51,52].
Effective antimicrobial agents are expected to regulate the oral biofilm at levels compatible
with good oral health while not sacrificing the beneficial properties of the resident oral microflora.
Compounds comprising imidazolium moieties have exhibited various antibacterial, antioxidant, and
antifungal properties; imidazolium salts’ overall mechanism of antibacterial function is similar to
that of QAS—mainly by disturbing the planktonic cell membrane [52]. Nonetheless, comprehensive
studies by Koo et al. have shown that ABR-MC (ABR-modified composite) impaired biofilm initiation
by disrupting bacterial accumulation, cell colonization, and subsequent biofilm development, if left
unintervened [50]. The anti-biofilm properties of ABR-MC were assessed using an EPS-matrix
producing S. mutans in an experimental biofilm model. Using high-resolution confocal fluorescence
imaging and biophysical methods, they observed severely reduced biomass, remarkable disruption of
bacterial accumulation, and defective 3D matrix structure on the surface of ABR-MC. Mechanism-wise,
13
J. Funct. Biomater. 2020, 11, 75
it was speculated that the distinct difference in the basicity between N-substitute imidazole (pKaH
of 7.20 for 1-methylimidazole) and aliphatic tertiary amine (pKaH of 10.7 for triethylamine) might
be the major contributor to the increased polarity and higher potential in its charged conjugated
moiety (imidazolium). However, the exact mechanism contributing to the much more pronounced
bactericidal effects as compared to conventional QAS compounds will require further investigation.
Other areas of relevant investigation include the further study of the hydrolytical stability of these
antibacterial monomers.
4. Materials and Methods
4.1. Materials
Antibacterial resins (ABR-C and ABR-E) were prepared in house; the detailed preparation route
can be found in a previous paper [50]. SDR Resin and adhesion-promoting resin (APR, Dentsply
proprietary resin) were supplied by Dentsply Sirona’s internal production (Milford, DE, USA). Other
conventional dental resins and ingredients used in formulations were purchased from commercial
sources, including 1,6-bis [methacryloyloxyethoxycarbonylamino]-2,4,4-trimethylhexane (UDMA),
ethoxylated bisphenol A dimethacrylate (EBPADMA), trimethylolpropane trimethacrylate (TMPTMA),
camphorquinone (CQ), dimethylaminobenzonitrile (DMABN), diphenyl (2,4,6-trimethylbenzoyl)
phosphine oxide (TPO), and butylated hydroxytoluene (BHT). Inorganic fillers were milled and silanated
in house, including barium fluoroalumino borosilicate glass (BFBG), bariumalumino borosilicate glass
(BABG), and AEROSIL fumed silica OX-50 (silanated OX-50). All fillers were surface treated by
γ-methacryloxypropyl-trimethoxysilane.
Commercially available orthodontic cements studied include the following: Prime Master (Sun
Medical Co., Shiga, Japan), Light Bond (Reliance Orthodontic Products, Alsip, IL, USA), Transbond
XT (3M Unitek, Monrovia, CA, USA), NeoBond (Dentsply Sirona, Milford, DE, USA), and Grengloo
(Ormco, Glendora, CA, USA).
Preparation of experimental orthodontic resin and cement. Experimental dental resin mixture
with various concentrations of polymerizable antibacterial resin (0 (control), 4, 8, 12, 16 wt %) was
mixed with other resins, namely UDMA (28~34 wt %), EBPADMA (20~26 wt %), APR (28~32 wt %),
TMPTMA (6~8 wt %), CQ (~0.1 wt %), DMABN (~0.2 wt %), and BHT (~0.07 wt %), to a uniform
resin blend at 55 ◦C using an overhead mechanical stirrer (Fisher Scientific, Pittsburgh, PA, USA).
Experimental orthodontic cements were compounded with 75 wt % of inorganic filler mixture using a
Ross double planetary mixer at 55 ◦C to a uniform paste (Ross Mixer, Charles Ross & Son Company,
Hauppauge, NY, USA). The inorganic filler used in this study consists of three types of fillers in the
filler blend: ~33 wt % BABG, ~65 wt % BFBG-2, and ~2 wt % silanated OX-50.
4.2. Evaluation Methods
MIC and MBC Testing. Three monomers were tested against controls, i.e., ABR-E, ABR-C, and
SDR Resin (a proprietary dimethacrylate monomer, without imidazole moiety, synthesized by Dentsply
Sirona). The monomers were diluted in UltraPure distilled water (Gibco, Gaithersburg, MD, USA)
before use. Different concentrations of the three tested monomers, along with two controls, i.e.,
wide-spectrum antimicrobial agent chlorhexidine (CHX) and conventional monomer TEGDMA, were
incubated statically with the cariogenic organism S. mutans strain UA159 using mid-exponential cells
for 48 h at 37 ◦C in the presence of 5% CO2. A fixed initial inoculum size of 9 × 107 CFU/mL of bacterial
cells was inoculated per well and 2-fold dilutions of the experimental monomers, CHX, and TEGDMA
were added. The following concentrations were tested: 0 to 125 μg/mL for CHX; 0 to 0.1% for the
experimental monomers ABR-E, ABR-C, SDR Resin, and the control monomer TEGDMA. The MIC
was determined as the lowest test concentration needed to ensure that culture did not grow over 10%
of the relative cell, as determined by visual inspection of the growth inhibition of each well compared
to that of the control well (without test compounds). For the MBC test, cells were serially diluted and
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spot-plated on agar plates; MBC values were determined by using the actual reduction of the bacterial
viable cell counts. The MBC was determined as the lowest concentration that allows less than 0.1% of
the original inoculum to survive.
Dentin Mass Loss. Completely demineralized dentin beams (2 mm× 1 mm× 6 mm) were prepared.
Dentin beams were obtained from extracted molars after removing the enamel and superficial dentin.
The beams were then submerged in 10% phosphoric acid for 18 h at 25 ◦C to completely demineralize
the dentin. They were incubated in a control buffer (artificial saliva) to see how much of the insoluble
collagen in demineralized dentin could be solubilized in 7 days of incubation at 37 ◦C. The loss of
dry mass from completely demineralized dentin beams (2 mm × 1 mm × 6 mm) in buffer solutions
pre-dipped into ABR-C and ABR-E resins for 30 s, versus in control buffer (artificial saliva) without
pre-dip, was studied. The amount of soluble collagen in these demineralized dentin beams was
measured after 7 days of incubation at 37 ◦C.
Flexural Strength. Specimens were prepared based on ISO 4049:2019. Samples were carefully
injected into 25 mm × 2 mm × 2 mm stainless steel molds, then covered by Mylar film and cured
with a Spectrum 800® (Dentsply Sirona, Milford, DE, USA ) halogen lamp uniformly across the entire
length of the specimen, using an irradiance of 850 mW/cm2 for 5 × 20 s. After curing, specimens
were immersed in DI water for 24 h at 37 ◦C prior to the 3-pt bending flexural test. Flexural test was
performed on an Instron Universal Tester (Model 4400R, Norwood, MA, USA countr using a crosshead
speed of 0.75 mm/min. Six specimens per sample set were prepared and tested.
Compressive Strength. Samples were carefully injected into ∅4 mm × 7 mm stainless steel
molds, sandwiched between two Mylar films. Light curing of the specimen was carried out with a
Spectrum 800® (Dentsply Sirona) halogen lamp at an irradiance of 850 mW/cm2 for 20 s on both ends.
After curing, specimens were immersed in DI water for 24 h at 37 ◦C, before being polished to ∅4 mm
× 6 mm specimen size with 600 grit sand paper. The compression test was performed on an Instron
Universal Tester (Model 4400R) using a crosshead speed of 5 mm/min. Six specimens per sample set
were prepared and tested.
Ambient Light Sensitivity (ALS). ALS was tested on a Suntest unit (model CPS 56007014,
Heraeus Noblelight, Buford, GA, USA ) with a UV filter that was calibrated to provide illuminance
of 8000 ± 1000 lux tested by a Lux Meter HD400 (Extech, Nashua, NH, USA ). A spheroidal mass of
approximately 0.03 gm of the material was weighed to be tested on a glass microscope slide, and the
slide was positioned with a matte black cover on top of the cell with a UV filter in place. The Suntest
light was turned on, and one should wait at least 10 s until the light output has stabilized. The matte
black cover was removed and the timer was started simultaneously. After exposure, the slide with the
sample was removed and the second microscope slide was immediately pressed against the material
with a slight shearing action to produce a thin layer. The material was visually inspected to see
whether it was physically homogeneous. If the material has begun to set, clefts and voids appear in the
specimen when the thin layer is being produced. The time was recorded when the sample started to
set and appeared physically non-homogeneous. In all, 3 runs were conducted for each sample.
Notched-Edge Shear Bond Strength. Caries-free and freshly extracted bovine incisors were
carefully sectioned longitudinally through the distal, occlusal, and mesial surfaces using a precision
low speed saw (TechCut 4™, Allied High Tech Products, Rancho Dominguez, CA, USA). The sectioned
bovine incisors, with buccal surface exposed, were then mounted in a cylindrical block using cold-cure
acrylics. The exposed surface was then coarse ground on a model trimmer until a flat enamel surface
was exposed, followed by wet ground on a grinding wheel under running water using 120-grit
and 320-grit SiC sanding papers until the surface was even and smooth when visually inspected.
Enamel was acid etched using 34% phosphoric etching gel for 15 s, then thoroughly rinsed for 20 s.
The notched-edge bonding jig contained a cylindrical plastic mold, resulting in samples with a defined
bonding area (diameter of 2.38 mm). The antibacterial orthodontic cement restorative composite was
then carefully placed into the center of the mold and good contact with the substrate was ensured.
After light curing with a Spectrum 800® (Dentsply Sirona) halogen lamp at 850 mW/cm2 for 20 s,
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the specimen was then carefully removed from the mold. Specimens were stored in DI water for 24 h
at 37 ◦C prior to SBS testing. The SBS test was performed on an Instron Universal Tester (Model 4400R)
using a crosshead speed of 1 mm/min. Seven specimens per sample set were prepared and tested.
JIS Z 2801. This test was conducted at Antimicrobial Test Laboratories (ATL, Round Rock, TX,
USA), an independent and GLP complied testing institution. JIS Z 2801 was adopted as ISO standard
(ISO-22196). This test is designed to quantitatively test the ability of hard surfaces to inhibit the growth
of microorganisms over a 24-h period of contact. The test microorganism selected for this test was
Streptococcus mutans (S mutans, ATCC® 25175). The following protocol was used by ATL: (1) test
microorganism S mutans, ATCC® 25175 was prepared by growth in tryptic soy broth for 24 h; (2)
the suspension of the test microorganism was standardized by dilution in a Dey-Engley neutralizing
broth (D/E Broth) at 0.9 mL blanks; (3) control and test surfaces were inoculated with microorganisms,
and then the microbial inoculum was covered with a thin sterile film; (4) microbial concentrations were
determined at “time zero” by elution followed by dilution and plating to tryptic soy agar (Difco); (5) a
control was run to verify that the neutralization/elution method effectively neutralized the antimicrobial
agent in the antimicrobial surface being tested; (6) the inoculated covered control and antimicrobial test
surfaces were allowed to incubate undisturbed in a humid environment for 24 h at 36 ± 1 ◦C; and (7)
after incubation, microbial concentrations were determined and the reduction of microorganisms
relative to the control surface was calculated as follows:
R (Average Log Reduction) = Log (B/C), (1)
where
B = Average number of viable cells on the control pieces after 24 h.
C = Average number of viable cells on the test pieces after 24 h.
ISO-22196 Antimicrobial Test. This test was conducted at Antimicrobial Test Laboratories (ATL,
Round Rock, TX, USA), an independent and GLP complied testing institution. ISO method 22196 is a
quantitative test designed to assess the performance of materials’ antimicrobial capabilities on hard
non-porous surfaces. The method can be conducted using contact times ranging from 10 minutes up to
24 h. For the ISO 22196 test, non-antimicrobial control surfaces are used as the baseline for calculations
of microbial reduction. The test microorganism selected for this test was Staphylococcus aureus
6538 (S. aureus 6538). This bacterium is a Gram-positive, spherical-shaped, facultative anaerobe.
Staphylococcus species are known to demonstrate resistance to antibiotics such as methicillin and is
commonly used in standard test methods as a model for Gram-positive bacteria. S. aureus pathogenicity
can range from commensal skin colonization to more severe diseases such as pneumonia and toxic
shock syndrome (TSS). The following protocol was used by ATL: (1) S. aureus 6538 prepared by growth
in tryptic soy broth for 18 h and the suspension of the test microorganism was standardized by dilution
in broth at 1:500 by volume; (2) control and test surfaces were inoculated with microorganisms, and
then the microbial inoculum was covered with a sterile thin film; (3) microbial concentrations were
determined at “time zero” by elution, followed by dilution and plating to tryptic soy agar; (4) a control
was run to verify that the neutralization/elution method effectively neutralized the antimicrobial agent
in the antimicrobial surface being tested; (5) the inoculated covered control and test surfaces were
allowed to incubate undisturbed in a humid environment at 36 ± 1 ◦C for 24 h; and (6) after incubation,
microbial concentrations were determined and the reduction of microorganisms relative to the control
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B = Number of viable test microorganisms on the control carriers after the contact time.
A = Number of viable test microorganisms on the test carriers after the contact time.
Statistical Analysis. Statistical analysis was conducted with Minitab 17 Statistical Software
(Minitab®, State College, PA, USA). Normality of data was checked using the Anderson–Darling test.
Mechanical properties and shear bond strength data were analyzed with one-way analysis of variance
(ANOVA) and Tukey’s test. Significance levels of 0.05 were used for ANOVA and Tukey’s tests.
5. Conclusions
This study explored the potential of incorporating unique imidazolium-based polymerizable
antibacterial monomers into orthodontic bonding cements. For unfilled resins comprising up to 12 wt
% ABR-C, no significant decreases in flexural strength or modulus were observed. For experimental
cements incorporating 1–4 wt % ABR-C, there is no drastic compromise to the SBS to enamel except for
3 wt % ABR-C; moreover, their SBS values are all comparable to those of the commercially available
orthodontic cements. The ISO-22196 antimicrobial test against S. aureus showed significant levels of
antibacterial effects—up to over 5 logs of microorganism reduction exhibited by ABR-C-containing
experimental cements. Although MIC and MBC were identified, and a range of antibacterial activities
of imidazolium-based orthodontic cements were demonstrated, clinical and long-term studies are still
important to validate the efficacy of this unique series of imidazolium resins towards preventing and
mitigating WSLs for patients.
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Abstract: Preventing the development of osteomyelitis while enhancing bone regeneration is
challenging, with relatively little progress to date in translating promising technologies to the clinic.
Nanoscale hydroxyapatite (nHA) has been employed as a bone graft substitute, and recent work has
shown that it may be modified with silver to introduce antimicrobial activity against known pathogens.
The aim of this study was to incorporate silver-doped nHA into electrospun scaffolds for applications
in bone repair. Silver-doped nHA was produced using a modified, rapid mixing, wet precipitation
method at 2, 5, 10 mol.% silver. The silver-doped nHA was added at 20 wt.% to a polycaprolactone
solution for electrospinning. Bacteria studies demonstrated reduced bacterial presence, with Escherichia
coli and Staphylococcus aureus undetectable after 96 h of exposure. Mesenchymal stem cells (MSCs)
were used to study both toxicity and osteogenicity of the scaffolds using PrestoBlue® and alkaline
phosphatase (ALP) assays. Innovative silver nHA scaffolds significantly reduced E. coli and S. aureus
bacterial populations while maintaining cytocompatibility with mammalian cells and enhancing
the differentiation of MSCs into osteoblasts. It was concluded that silver-doped nHA containing
scaffolds have the potential to act as an antimicrobial device while supporting bone tissue healing for
applications in orthopedic and dental bone surgery.
Keywords: electrospinning; antimicrobial; nano-hydroxyapatite; silver; toxicity; bone regeneration
1. Introduction
Preventing deep bone infections after surgery and enhancing bone regeneration reduces the time
required for patient recovery and the costs associated with long hospital stays. Deep bone infections
are very challenging to treat once established due to the difficulty of achieving a suitable antibiotic
concentration in the affected area and ensuring all bacteria have been removed. Bacteria such as
Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli) are responsible for causing bone infections
post-surgery [1,2], and the application of excessive antibiotics can lead to antimicrobial resistance.
Antibacterial poly(methyl methacrylate) beads have been used routinely for treating infections in
a reactive manner with additional disadvantages of requiring surgical removal after the treatment
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ends [3]. Silver has often been used to successfully treat bacterial and fungal infections [4,5] and can be
delivered in a localized area. Metallic implants coated with silver have been investigated to prevent
infections [6]. However, silver by itself does not enhance wound healing and can have a toxic effect on
mammalian cells at higher concentrations [7,8].
To facilitate bone healing, surgeons currently employ hydroxyapatite in granular or paste form to
stimulate bone regrowth. Hydroxyapatite is the mineral component of bone and can be manufactured
synthetically and has been demonstrated to aid in bone regeneration [9]. Nanoscale hydroxyapatite
(nHA) is an increasingly popular biomaterial due to its similarity to the hydroxyapatite in human bone
and tooth enamel. Our group recently produced a bioinspired nHA material through a rapid mix
preparation, which is slightly calcium deficient to better mimic biological apatite [10]. Using nHA-based
medical devices to increase the regeneration rate of the bone after surgery could greatly decrease
patient healing times. Unfortunately, despite its success in aiding bone regeneration, hydroxyapatite
has no innate antimicrobial properties to prevent infection. Moreover, the implantation of medical
devices provides an increased risk of bacterial colonization and eventual biofilm formation if left
untreated [11]. Once a biofilm has been established it is very difficult to treat using antibiotics and
even surgical intervention involves a high risk of reoccurrence [12].
There is growing interest in using a combination of silver and hydroxyapatite to produce a material
with both antimicrobial/antifungal [13,14] and bone-regenerating properties [15–18]. Jiang et al. [19]
produced foamed polyurethane scaffolds containing up to 40 wt.% silver phosphate particles (Ag3PO4)
and nHA. These mold-formed scaffolds were porous and eluted silver for up to 22 days without
toxic effects on the human osteosarcoma cell line MG63. Saravanan et al. [20] produced scaffolds
using the freeze-drying technique incorporating nano-hydroxyapatite with nanoparticles of silver.
Wilcock et al. [21] developed a novel, rapid mixing, wet precipitation method of producing bioinspired,
nanoscale hydroxyapatite crystals doped with silver for antimicrobial action. A degradable scaffold
could be placed against existing implants or used to hold packed bone substitutes (e.g., bone chips)
into a bone defect.
The biomaterials’ research community has been keenly interested in using electrospinning as a
containment system for ceramic-derived materials including hydroxyapatite [22]. Electrospinning
is a technique for producing fibrous scaffolds that roughly resemble the body’s extracellular matrix.
These can be made porous to allow cell thoroughfare or nanoscale to act as a barrier to cells, fulfilling a
wide variety of applications. Ciraldo et al. [23] investigated three different manufacturing approaches
using mesoporous glasses containing silver. These were glass coatings prepared using electrospraying,
sol-gel methods, and directly spinning with polycaprolactone (PCL). For electrospinning, the authors
were limited to 5% mesoporous glasses in PCL but did not investigate antimicrobial action. However,
a recent paper by the same group demonstrated that the mesoporous glasses loaded with silver were
antimicrobial [24]. Anjaneyulu et al. [25] manufactured doped hydroxyapatite through the sol-gel
method and electrospun with poly(vinyl alcohol). Schneider et al. [26] electrospun tricalcium phosphate
nanoparticles into poly(lactic-co-glycolic acid) (PLGA) scaffolds, looking at a single concentration of
silver, but did not investigate mammalian toxicity of the scaffold. Furtos et al. [27] electrospun a PCL
scaffold to contain both nHA and amoxicillin, which they tested against four bacterial strains and
found that increasing the nHA content reduced the loading efficiency of the antibiotic.
A variety of polymers and calcium compounds have been used for producing these antimicrobial
scaffolds. Different manufacturing technologies have also been employed to produce these as scaffolds.
A relatively small number of the above publications have reported testing their material with primary
mesenchymal stem cells (MSCs), which are key to understanding bone-healing mechanisms. Few of
the published reports have investigated microbiological testing beyond agar diffusion assays with no
time course elution antimicrobial testing.
Here we present the fabrication of novel, dual-function scaffolds that combine silver to impart
antimicrobial properties and hydroxyapatite to enhance bone regeneration. Our laboratory previously
developed a silver-doped nano-hydroxyapatite material formed by the wet precipitation method [21].
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Here we show the incorporation of this innovative material into an electrospun scaffold alongside a
thorough investigation of metal ion release, antimicrobial activity against clinically relevant bacterial
strains, and in vitro biocompatibility using cultured mammalian MSCs. This research has provided
an important proof-of-concept study that has the potential to underpin the development of a new
generation of dual-action medical devices to address the growing challenges of deep bone infection
and antimicrobial resistance.
2. Materials and Methods
2.1. Silver Nano-Hydroxyapatite (Ca10(PO4)6(OH)2) Manufacture via Wet Precipitation
This was based on our previously published methods [10,21]. In brief, calcium hydroxide (Sigma
Aldrich, Dorset, UK) (50 mmol) was suspended in 500 mL deionized water (dH2O) into which 0, 1,
2.5, or 5 mmol silver nitrate (Sigma Aldrich, UK) (corresponding to 0, 2, 5, or 10 mol%, respectively)
was added and stirred at 400 rpm for 1 h on a hotplate (Fisher Scientific, Loughborough, UK) at
90 ◦C. Phosphoric acid (Sigma Aldrich, UK) (30 mmol) was dissolved in 250 mL dH2O, poured into
the calcium and silver preparation, and stirred for a further hour. The suspension was left to settle
overnight, after which the supernatant was poured off and the silver-doped nHA suspension was
washed with dH2O (3 × 500 mL). The silver-doped nHA suspensions were dried at 60 ◦C and ground
in an agate mortar and pestle.
2.2. Imaging the Silver Nano-Hydroxyapatite and Electrospun Fibers Using SEM
Dried nHA powder or a 5 × 5 mm section of electrospun scaffold was attached to a carbon tab and
sputter gold coated and then imaged using a TESCAN VEGA3 SEM (Tescan, Brno, Czech Republic)
with an accelerating voltage of 15 kV.
2.3. Imaging the Silver Nano-Hydroxyapatite Using Transmission Electron Microscopy (TEM) and
Energy-Dispersive X-Ray Spectroscopy (EDX)
The nHA powder (0.1 g) was dispersed in ethanol in an ultrasonic bath (ThermoFisher, Shanghai,
China) for 1 h and a drop was placed onto a copper mounting grid with carbon film and allowed to dry
under ambient conditions. Samples were then imaged on a transmission electron microscope (Tecnai
G2 F30, ThermoFisher, Shanghai, China) under standard imaging and EDX detecting elements Ca, P,
Ag, and O. EDX settings used were 20 kV, takeoff 14.8, amp time 7 μs, and 126.5 eV resolution.
2.4. Analyzing Crystal Phases Present Using X-Ray Diffraction (XRD)
Phase analysis was performed on powdered samples using XRD (STOE IP, Darmstadt, Germany)
with Cu Kα λ = 1.5418 Å radiation to determine the crystal structure of the materials. The diffractometer
was operated at 40 kV and 35 mA, with a 2θ range of 20–50◦. The following The International Centre
for Diffraction Data Powder Diffraction (ICDD-PDF) cards were used for phase identification: 9-432
hydroxyapatite, 6-505 silver phosphate.
2.5. Electrospinning Polycaprolactone (PCL) and Incorporating the Ag–nHA
Polycaprolactone (average 80,000 Mn, Sigma, UK) was dissolved in a specific solvent and then
propelled by an electric field onto a collector where polymer fibers formed as the solvent evaporated.
Adding both the silver-doped and undoped nHA powder to the solution at 20 wt.% allowed it to be
incorporated into the electrospun scaffold. PCL (1.5 g) was dissolved into a solvent mixture (90%
Dichloromethane [DCM], 10% Dimethylformamide [DMF]) (Sigma Aldrich, UK) and stirred using a
magnetic stirrer bar (5 mm bar, Sigma Aldrich, UK) for 2 h. The nHA powders were incorporated at
20 wt.% of the PCL component and added into the dissolved PCL solution. The polymer-ceramic-solvent
mixtures were placed in an ultrasonic bath for 30 min, before stirring using a magnetic stirrer bar for
30 min to ensure even distribution of powder in the solution. A 1-mL Luer-Lok syringe (BD, EU) was
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loaded with 1 mL of the PCL/nHA solution and this was electrospun using a custom electrospinning
rig described previously [28]. In total, 2 mL of solution at 1 mL/hr was used to fabricate each scaffold
at 17 kV with a spinning gap between the needle and collector of 20 cm.
2.6. Accelerated Degradation Study of Electrospun Scaffolds and Release Profile
To investigate the rate at which nHA was released during scaffold degradation, an accelerated
degradation study was performed over 30 days. Samples were weighed and added to a 5-mL solution
of 0.1 M NaOH (Sigma Aldrich, UK) in dH2O and placed in an oven at 37 ◦C. At each time point (days
0, 1, 7, 14, 21, and 28) material was also weighed and 0.5 mL of solution was removed, which was
replaced with fresh solution. The solutions obtained were diluted to 5 mL using dH2O.
2.7. Inductively Coupled Plasma (ICP) Measurement of Material and Degradation Product
To ascertain the presence and abundance of various elements within the sample, ICP was utilized.
Solid samples (e.g., 0.25 g–0.5 g) were weighed into a glass tube and 9 mL of concentrated hydrochloric
acid (Sigma Aldrich, UK) added and 3 mL of concentrated nitric acid (Sigma Aldrich, UK) added.
The samples were then placed into the heating block and the temperature was gradually raised to 150 ◦C
and maintained at this temperature for 30 min. After removal from the block and cooling, the samples
were diluted to 50 mL with 1% nitric acid. Samples were diluted down to 1 in 100 for analysis. Samples
were analyzed using an ICP-OES (Spectro-Ciros-Vision Optical Emission Spectrometer (Spectro, Kleve,
Germany) using a procedure with a detection limit of at least 10 ppm.
2.8. Scaffold Preparation for Cell Culture
Disks of each electrospun scaffold were prepared and sterilized prior to culture with cells. Using
a 13 mm cork borer, disks (13 mm) of each scaffold were punched out of the primary collector sheet.
On the day of use, the culture scaffolds were disinfected with 70% ethanol (Sigma Aldrich, UK) in
dH2O for 30 min and then washed three times in dH2O for 5 min.
2.9. Contact Bacterial Toxicity Test
Antimicrobial activity was investigated using a classical diffusion agar assay. Isolates of E. coli
and S. aureus were purchased from the China Center of Industrial Culture Collection (CICC, Beijing,
China): E. coli, CICC23657 and S. aureus, CICC10384. The bacterial suspensions at stationary phase
were firstly obtained by culture in LB (Luria-Bertani) medium overnight at 37 ◦C in a 120-rpm shaker.
Then 1 mL of the E. coli and S. aureus suspensions were pipetted from the overnight phase into another
100-mL flask containing 50 mL of fresh LB. The mixture was then cultured at 37 ◦C for another 6 h
to obtain bacterial suspensions at exponential growth phase. After that, the bacterial suspension
was centrifuged at 8000 rpm, washed, and resuspended in sterilized physiological saline to reach a
concentration of 1 × 107 colony forming units (CFU)/mL. Then, 0.1 mL of the bacteria suspension with
1 × 107 CFU/mL was pipetted and plated on the agar plate uniformly. Three disks of the electrospun
material (12 mm diameter) were placed on each Petri dish. These were incubated at 37 ◦C for 24 h.
The zone of inhibition ring around the electrospun scaffolds was measured.
2.10. Antimicrobial Diffusion Toxicity Test
A disk of the electrospun scaffold (12 mm diameter) was immersed into the bacteria suspension
(10 mL) containing 1 mL 107 CFU/mL and 9 mL sterile physiological saline in a 15-mL falcon tube.
The falcon tubes were placed on a carousel (IKA, Staufen, Germany) and rotated 360◦ in the z axis
at 30 rpm in an incubator at 37 ◦C. At the time points 3, 18, 24, 48, 72, and 96 h, 200 μL of phosphate
buffered saline (PBS) was removed and serially diluted to 10−7 before 100 μL of diluted solutions were
added to an agar plate and incubated for 24 h before imaging. The CFUs on plates were counted using
the dilution, which was the highest with all bacterial colonies visible as single entities.
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2.11. Rat Mesenchymal Stem Cell (MSC) Isolation and Passage
MSCs were isolated from four 4–5-week-old male Wistar rat femurs following the method
previously described in literature [29,30]. Briefly, the femur was removed from the rats, opened at
both ends, and flushed with media. This was then cultured to collect adherent cells, cells from all
rats were intermixed, and cells were passaged twice before use. Cells were cultured in minimum
essential medium (αMEM) supplemented with 10 U/mL penicillin (Sigma Aldrich, UK), 0.1 mg/mL
streptomycin (Sigma Aldrich, UK), 20 mM alanyl-glutamine (Sigma Aldrich, UK), and 10% v/v
fetal bovine serum (FBS; Biosera, Heathfield, UK). Cells were passaged 1:5 using trypsin-EDTA
(ethylenediaminetetraacetic acid, Sigma Aldrich) and used below passage 10 for toxicity studies and
below passage 5 for differentiation studies.
2.12. Noncontact Mammalian Cell Toxicity Study
Toxicity of elution from the electrospun scaffolds was measured by suspending the material over
on cultured cells for 24 h. Both primary rat MSCs and the established fibroblast 3T3 cell line were used
to test this material. Both cell lines were treated the same in the experiment apart from the rat MSCs
were cultured in αMEM as described above and the 3T3 cells were cultured in high-glucose Dulbecco’s
Modified Eagle Medium (DMEM) with 10% FBS, both supplemented with 20 mM alanyl-glutamine
(Sigma Aldrich, UK) and 0.1 mg/mL of streptomycin (Sigma Aldrich, UK). Cells were trypsinized
and added to a 24-well plate (ThermoFisher, Loughborough, UK) at 30,000 cells per well in 1 mL of
respective media. The cells were cultured for 24 h in an incubator at 37 ◦C and 5% CO2. Media was
replaced and a Transwell® insert (Millicell Hanging Cell Culture Insert, polyethylene terephthalate
(PET) 0.4 μm, 24-well) was added to each well containing cells. In triplicate, the following were added
to the Transwell® inserts: No scaffold (positive), 1 mL 70% industrial methylated spirit (IMS) (negative),
0% Ag nHA scaffold, 5% Ag nHA scaffold, and 10% Ag nHA scaffold. One mL of media was added to
each Transwell® insert and plates were incubated for 48 h at 37 ◦C and 5% CO2. After 48 h the cells
within the wells were imaged and metabolic activity was assessed using PrestoBlue™ (ThermoFisher,
UK). Media was removed and 700 μL of PrestoBlue™ (10% in complete media) was added to each well
and the well plate was incubated for two hours. From the wells, 200 μL of PrestoBlue™ was added in
triplicate to a 96-well plate. The fluorescence of the solutions was measured using a plate reader (FLx
800 Bio-Tek Instruments; Thermo Fisher Scientific, UK) with an excitation wavelength of 535 nm and
an emission wavelength of 590 nm. The experiment was repeated four times (N = 4, n = 3).
2.13. Contact Biocompatibility Study on Rat MSCs
A direct-contact biocompatibility study was used to assess the toxicity of the scaffolds on cells
over 21 days. Rat MSCs were used for this study. Disks of each scaffold were added in triplicate to a
24-well plate and 1 mL of media was added to each for 30 min (including a tissue culture plastic [TCP]
control). Cells were trypsinized, suspended in media, and then 30,000 cells were added to each well.
Well plates were agitated to aid even cell-seeding across the scaffold. Well plates were incubated for
24 h before cell metabolic activity was measured using PrestoBlue™. The scaffolds were transferred to
a new well plate before PrestoBlue™ to avoid interference of cells growing on the tissue culture plastic
surrounding the scaffold. PrestoBlue™was measured at 4, 7, 14, and 21 days in culture. N = 2, n = 3.
2.14. Live and Dead Cell Staining
Cells were stained with two dyes to identify if the cell was alive or if the cell scaffold was disrupted
(dead). Cells were stained using the LIVE/DEAD™ Viability/Cytotoxicity Kit (Thermofisher, UK) as
per the instructions. In brief, cells were washed in PBS and then Calcien and Ethidium homodimer-1
(both at 5 μM concentration) were incubated with cells in media for 30 min. Samples were imaged
using a fluorescent microscope (Axioplan 2, Zeiss, Jena, Germany) using the built-in filters for FITC
(calcein) and TRITC (Ethidium homodimer-1).
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2.15. Total Sample DNA and Alkaline Phosphatase Production Measurements
Alkaline phosphatase (ALP) is an early indicator of MSC differentiation to osteoblasts and can
be measured using an ALP detection test. ALP was normalized to DNA to give a reading of alkaline
phosphatase activity per cell regardless of cell number. Media was removed and samples washed
three times with PBS. Cell digestion buffer was made up using deionized water and 1% triton X-100
(Sigma, UK). Samples were incubated at 4 ◦C for 1 h in the cell digestion buffer. The samples were then
subjected to two freeze–thaw cycles (–20 ◦C to room temperature), which included solution agitation
by pipetting when thawed to ensure thorough lysis of cells. After the second freeze–thaw cycle, an
alkaline phosphatase diethanolamine detection kit was used to assess the alkaline phosphatase activity
of the cultures. Then, 40 μL of cell culture lysate solution was placed in a 96-well plate in triplicate
with 210 μL alkaline phosphatase reaction buffer. A standard curve of para-nitrophenyl (pNP) product
was prepared with concentrations of 250, 100, 50, 10, and 0 nmole.ml−1 pNP in the alkaline phosphate
reaction buffer. Then, 250 μL of the standard solutions were added in triplicate to the 96-well plate.
The para-nitrophenylphosphate (pNPP) substrate solution was prepared by dissolving 6.6 mg pNPP
per 1 mL of dH2O. Then, 10 μL substrate was then added to each well using a multichannel pipette
and the plate was incubated in the dark at 37 ◦C. The plate was monitored for color change and, at an
appropriate time point, the absorbance at 405 nm was read, ensuring that the readings were within the
range provided by the standard solutions. The amount of pNP in the sample wells was then calculated
using the standard curve and used as a measure of ALP activity.
After a further freeze–thaw cycle, Quant-iT™ PicoGreen® dsDNA assay (ThermoFisher, UK) was
used in accordance with the manufacturer’s instructions to quantify the DNA content of the cultures.
In detail, 50 μL of cell culture lysate was placed in a 96-well plate in triplicate along with 50 μL dH2O.
A standard curve of DNA was also prepared in triplicate with final concentrations of 1000, 500, 100, 50,
10, 5, and 0 ng.mL−1 when 100 μL of PicoGreen reagent was added to the 100 μL of standard solution
in each well. Then, 100 μL of freshly made PicoGreen reagent was added to all the wells using a
multichannel pipette. The plate was incubated in the dark for 4 min, after which the fluorescence was
read using an excitation wavelength of 485 nm and an emission wavelength of 528 nm. The standard
curve was plotted and used to convert the fluorescence units of the wells into the DNA content of the
original cultures.
2.16. Statistical Methodology
Statistical analysis was conducted using ANOVA run with multiple comparisons using GraphPad
Prism 8 (GraphPad Software, Inc., San Diego, CA, USA) with significance indicated with * when
p < 0.05. No demarcation of lower p values was used as all were tested with p = 0.05.
3. Results
3.1. Analysis of Prepared Nanoscale Hydroxyapatite
Nano-hydroxyapatite was prepared via the rapid mixing technique previously published [10].
Using TEM, the nanoscale hydroxyapatite particles were visualized and contained crystalline and
amorphous regions, typically less than 100 nm in size. Silver was found within the nanoscale
hydroxyapatite particles, with the visible formation of nanoparticles of silver. Both materials showed
the peaks associated with hydroxyapatite in XRD patterns. XRD showed the presence of silver
phosphate peaks but only for the 10 mol.% silver-containing material (Figure 1a). Despite this, in both
materials silver nanoparticles were visible under TEM; EDX confirmed that the darker regions found
under the TEM contained silver. See Supplementary Figure S1 for EDX mapping of all elements found
in sample Figure 1e. The size distribution of particles’ diameter between nHA and nHA with 10 mol.%
silver substituted in was found to be similar, with an average of 37 and 40 nm, respectively (Figure 1f).
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Figure 1. Evaluation of silver-containing nanoscale hydroxyapatite (a) XRD patterns of 5 and
10 mol.% silver doped nanoscale hydroxyapatite (Ag nHA), identifying peaks for hydroxyapatite
Ca10(PO4)6(OH)2 and silver phosphate (Ag3PO4) phases within the sample. Silver phosphate was only
identified in the 10 mol.% silver-containing material. Plot line 1 (blue) is 10 mol.% Ag nHA and plot line
2 (green) is 5 mol.% Ag nHA; (b) TEM image of nHA sample containing 5 mol.% silver. Silver deposits
visible and highlighted by black arrows; (c) TEM at higher magnification on one of the silver deposit
areas; (d) TEM image of nHA sample containing 10 mol.% silver. Larger silver deposit noted by black
arrow; (e) Spatial EDX map of location of silver, mapped over the same location as that boxed in (d);
(f) Particle diameter comparison between nHA and nHA with 10 mol.% silver shown as a Tukey box
plot, ns = not significant; (g) TEM micrograph of nHA nanoscale particles.
3.2. Ensuring Encapsulation of nHA by Electrospun Fibers
Both silver and nondoped nHA were electrospun into polycaprolactone (PCL) scaffolds with a
thickness of between 150 and 200 μm. SEM images showed incorporation of large particles in the
fibers that were not observed in plain PCL scaffolds (Figure 2a). When digested, ICP analysis showed
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that plain PCL had very low levels of elements found within Ag-nHA (Figure 2b). The electrospun
nHA showed the presence of calcium and phosphorus but not silver. Both electrospun scaffolds with
silver-containing nHA showed the presence of silver alongside calcium and phosphorus (Figure 2b).
This demonstrated that nHA was successfully incorporated into the electrospun fibers.
Figure 2. Scaffold fibers containing nHA (a) SEM micrographs of electrospun scaffold.
Top: Polycaprolactone (PCL) scaffold. Middle: PCL scaffold containing nHA. Bottom: PCL scaffold
containing 10 mol.% Ag nHA. Different magnifications were used to visualize encapsulation of nHA
particles into the electrospun scaffold; (b) Inductively coupled plasma (ICP) analysis of dissolved
electrospun scaffolds showing mg/kg of elements present. All % Ag materials are in mol.%.
3.3. Investigation of Silver Release and Scaffold Loss in Accelerated Degradation Study
An accelerated degradation assay was performed using sodium hydroxide at 37 ◦C to understand
the degradation profile of the electrospun scaffolds and to observe release profiles (Figure 3). All scaffolds
degraded at the same rate with the presence of nHA having no apparent effect on degradation profile
(Figure 3a). Cumulative release of silver was observed for the full 30 days (Figure 3b). The plot
of release rate (Figure 3c) indicated that in the early period of days 1 to 5 the release was from
surface-bound origins, whereas from days 7 onwards the release was from silver within the polymer
that was then released through degradation. Mass loss from degradation was nonexistent in the 1- to
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7-day period and then rapidly degraded from there, which reinforced the conclusions drawn from the
silver release rate.
Figure 3. Accelerated degradation study of electrospun scaffolds containing nHA, over a 28-day period
in 0.1 M sodium hydroxide. (a) Remaining weight over degradation time of different mol.% silver
scaffolds; (b) Release profile of silver from an electrospun scaffold containing 10 mol.% Ag nHA over a
28-day period; (c) Plot of the silver release rate per day. All % Ag materials are in mol.%.
3.4. Antimicrobial Impact of Scaffolds
Both silver-containing scaffolds showed an antibacterial effect on both agar diffusion and on
bacterial suspensions. PCL-only scaffolds and those with undoped nHA showed no innate antimicrobial
action. Scaffolds containing silver of any concentration showed an antimicrobial response on agar
diffusion (Figure 4a,b). Bacterial suspension cultures in PBS exposed to scaffolds for 24 h demonstrated
the antimicrobial properties of the scaffolds containing silver. The 10 mol.% silver nHA was studied
in a time course assay against bacteria and this showed a significant reduction in bacteria over time
(Figure 4e,f). The scaffold reduced the viable bacteria count to undetectable levels by 48 h for E. coli
and 96 h for S. aureus.
29
J. Funct. Biomater. 2020, 11, 58
Figure 4. Antibacterial studies on E. coli and S. aureus bacteria using the electrospun scaffold. (a) Agar
diffusion test using disks of the electrospun samples against E. coli bacteria. Graph displaying individual
data plots with a line demarking the mean value; (b) Agar diffusion test using disks of the electrospun
samples against S. aureus; (c) Disks of electrospun samples suspended in PBS containing bacteria,
measuring viable colonies after 24 h; (d) Optical images of the area of inhibition ring surrounding a
12-mm disk of scaffold containing either 10 mol.% silver or plain PCL and tested against S. aureus
and E. coli; (e) Bacteria count after E. coli are suspended in PBS and exposed to a disk of electrospun
10 mol.% silver nHA for 3, 18, 24, 48, 72, and 96 h; (f) Same as (e) but using S. aureus bacteria. All graphs
show mean ± standard deviation. All % Ag materials are in mol.%.
3.5. Antimicrobial Impact of Scaffolds
Indirect toxicity assays found that higher silver concentrations were more toxic to both cell types
while a longer, 21-day direct growth experiment showed a reduced toxic impact of these high silver
samples on cells over time. When tested using fibroblast 3T3 cells, all scaffolds had a significantly
higher viability than the negative (cytotoxic) control (Figure 5a). However, the scaffold containing
10 mol.% silver was also significantly different to the cell-only positive control, indicating some toxic
impact. When the materials were tested on primary rat MSCs the toxic impact was more pronounced.
The scaffold with 10 mol.% silver was significantly different to the cell-only positive control, but no
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statistical difference was found with the negative cell death control (Figure 5b). All the remaining
materials were statistically different to the negative cell death controls. A longer, 21-day direct growth
experiment found that cell metabolic activity for 5 mol.% silver-containing scaffolds were significantly
increased compared to the PCL-only scaffolds (Figure 5c). The 10 mol.% silver-containing scaffolds
reduced the metabolic activity when compared to 5 mol.% silver but did not show a toxic impact when
compared to the PCL-only scaffold. Live cell morphology can be observed from live fluorescent images
(Figure 5d) along with the proportion of live to dead cells. Cells appeared to have a more spread out
morphology on the nHA silver-containing material than in the PCL-only control.
Figure 5. Cell toxicity from the electrospun scaffold with different concentrations of silver nHA assessed
by cell metabolic activity via PrestoBlue™ assay. (a) A 48-h noncontact toxicity test with the scaffold
in the media above a monolayer of 3T3 cells. Graph displaying individual data plots with a line
demarking the mean value. Dotted line contains each scaffold under it to be compared to another
condition; (b) A 48-h noncontact toxicity test with the scaffold in the media above a monolayer of
primary rat MSCs. Graph displaying individual data plots with a line demarking the mean value.
Dotted line without star contains each scaffold to be compare to another condition; (c) Cell metabolism
after 21 days of direct culture with the cells seeded on top of the scaffold using metabolic activity at
each time point. Statistics (ANOVA) conducted on the day 21 measurements; (d) Live/dead staining of
MSCs cultured on electrospun scaffolds after 21 days.
3.6. MSC Osteogenic Differentiation Study by ALP Quantification
The impact of silver on the differentiation of primary MSCs down the osteoblast linage
was measured after 21 days in culture by quantifying ALP content per unit of DNA (Figure 6).
ANOVA showed a significant difference with 5 mol.% and the lower silver concentrations in regard to
ALP production. Scaffolds with 10 mol.% silver are not significantly different to 5 mol.% silver scaffolds.
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Figure 6. Cell differentiation potential of scaffolds containing different silver contents regarding ALP
presence per unit of DNA after 21 days in culture with primary MSCs. Cells were cultured on top of
the scaffolds. Graph displaying mean value ± standard deviation. N = 2, n = 3.
4. Discussion
Electrospun scaffolds with incorporated silver nano-hydroxyapatite are nontoxic to cells at a
concentration that was antimicrobial, making them suitable for use as antimicrobial bone implants.
In 2017, Anjaneyulu et al. [25] published a study looking into nanoscale electrospun fibers containing
silver-doped hydroxyapatite and its hemocompatibility. Our study took a different direction, producing
scaffolds with fibers to allow ingrowth of cells with larger pore sizes having positive impact on osteoblast
cell growth [31]. Our study also included an in-depth microbiology study looking at both contact
and noncontact tests. Investigating the impact of the scaffolds on bone regeneration via analyzing the
toxicity on primary MSCs, for relevant cell toxicity, and 3T3 fibroblasts allowed toxicity comparison
between labs.
The rapid manufacturing of nHA pioneered by Wilcock et al. [10] was replicated to produce
silver-doped nHA powder. The characterization of nanoscale hydroxyapatite indicated it was
comparable to that produced in previous studies. We were able to go one step further by confirming
via TEM XRD that the denser (black) areas on the TEM contained silver. This had been hypothesized
by the previous paper but not directly confirmed [21]. Under XRD we confirmed that the material
was both hydroxyapatite and that it contained silver. TEM analysis showed that the nHA was in a
nanoscale particulate form. The lack of an XRD-measurable silver phosphate phase in the 5 mol.% Ag
nHA demonstrated that the silver had been incorporated into the nHA, either by substitution of silver
into the HA crystal lattice for calcium or by doping of the silver ions onto the HA structure (i.e., not
replacing the ions of the HA crystal). This result was expected for our method as our previous reports
demonstrated a pure hydroxyapatite phase precipitated at 5 mol.% using this reaction [21].
The silver-doped nHA was successfully electrospun into PCL scaffolds. PCL is a popular material
used in bone-related applications as its long-term degradation profile is suited to the slower healing
rate of bone compared to soft tissues. Incorporating silver-containing tricalcium phosphate was
reported by Schneider et al. [26], who found it effective against E. coli but did not test against the
more common bone infection-related pathogen S. aureus. Jiang et al. [19] assessed antibacterial activity
using both of these bacteria with a scaffold formed by in situ foaming, which allowed inclusion of
silver/nHA up to 40% of total weight. This technique does not produce scaffolds, however, instead
producing a monolithic block that would need to be carved to dimensions required during theater.
Anjaneyulu et al. [25] investigated using both bacteria types and manufactured formed scaffolds but
did not assess bone cell biocompatibility.
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Our scaffolds degraded in an accelerated degradation study and showed a two-phase silver
release system. Initially, a rapid burst of silver was released, decreasing in rate until day 7. During the
same initial period of degradation, the polymer had not lost any mass. This rapid silver release is likely
to arise from surface- (or near surface-) bound material. After the initial 7 days, the material lost mass
and silver was released for the remainder of the experiment. Rothstein et al. described this in a model
of an initial surface erosion system, which then transitions into bulk erosion [32]. The combination of
the two allows for a rapid release when first implanted to clear immediate microorganisms and then a
slower sustained release of the remainder of the implant life to prevent colonization from opportunistic
bacteria, which may later attach to the device through a hematogenous route. Liu et al. [15] used
electrochemical deposition of silver onto their electrospun fibers to provide an initial burst of silver over
two days instead of a continual release. This would help prevent potential buildup of silver toxicity but
would not prevent later infections from occurring. A continuous release of calcium and phosphorus was
detected using ICP, which has been widely reported to stimulate bone regeneration [33]. An implanted
material can act as a desirable location for bacteria to colonize with an infection requiring far fewer
bacteria to start than in a normal tissue [34]. A continuous silver release would prevent opportunistic
bacteria from infecting the implant at a later date. Due to the limited nature of our degradation method
we cannot report on the exact amount of silver released per unit of time in vivo, as physiological
conditions would impose a more complicated environment that may impact silver release. Despite
not knowing the exact amount released, we showed that it is sufficient to prevent bacteria growth in
non-accelerated studies.
Antimicrobial tests using both Gram-positive and Gram-negative bacteria showed that an
antimicrobial response was found for 2, 5, and 10 mol.% incorporated silver-doped nHA. In a contact
agar diffusion assay, both the silver-containing materials were found to produce an area of inhibition,
whereas hydroxyapatite by itself does not [35]. Looking at the reduction of bacteria in solution, both
bacteria were reduced beyond detection within 96 h. In our study we found silver was far more
effective against S. aureus than against the E. coli bacteria. This was unexpected, as the thicker wall
of the Gram-positive S. aureus is arguably better defended against the uptake of silver particles than
thinner Gram-negative cell walls [36]. Resistance to silver can be acquired by bacteria [37], although it
is a relatively broad spectrum medicant. This is significant, as S. aureus is among the most common
pathogens found in bone infections [1,2]. Recent studies have shown that treating the motile S. aureus
in an infected 3D tissue model is more challenging than treating a monolayer bacteria assay [38].
Therefore, this would be the logical progression for the testing of this material. One side effect of silver
is that it can also be toxic to mammalian cells at elevated concentrations, which we investigated with
our scaffolds.
The toxicity of the scaffolds was related to both the silver concentration and on the cell type being
tested. Against the standard cell line of mouse fibroblast 3T3 cells there was a small indication of
toxicity with scaffolds containing 10 mol.% silver. When using a primary rat MSCs there was clear
toxicity detected with this highest concentration of silver. This shows the importance of not just using
a single cell line to determine toxicity of a material but also of the correct choice of relevant cells. For a
more in-depth review of the different modes of action of silver nanoparticles on various cell types,
see Zhang et al. [39]. Using 3T3 cells is a useful method of comparing relative toxicities between
different laboratories as they are well known and utilized in international standards for cytotoxicity
(ISO 10993-5). The primary MSCs are more difficult to standardize between labs and are, therefore,
harder to use to compare toxicity. They do give a more realistic insight on what levels of toxicity
might be harmful in the environment the medical device is intended for. From the results presented,
5 mol.% silver-doped material at 20 wt. mol.% to PCL had an antimicrobial impact without being toxic
to mammalian MSCs.
Using a longer study of 21 days, the 10 mol.% silver nHA scaffolds maintained a viable and
growing cell population on par with the plain PCL material. Hydroxyapatite appeared to boost the
metabolic activity of the MSCs by day 21 with the combination of 5 mol.% silver and hydroxyapatite,
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resulting in even higher levels of cell activity. Increasing the amount of silver to 10 mol.% did not
increase the trend of increased proliferation. The initial high release rate from the material was
potentially too toxic for the cells early on but, once the release level had fallen to a consistent 50 mol.%,
surviving cells would then have been able to proliferate. After this period, the metabolic activity of cell
on the 10 mol.% silver nHA scaffold increased at a similar growth rate to other materials. This is highly
advantageous in a wound-healing application as it would allow an initially high burst to clear bacteria,
which then lowers to allow the mammalian cells to begin the healing process.
Hydroxyapatite is widely reported to increase MSC differentiation into osteoblasts [40–42] so
we focused on investigating the impact of silver on this process showing increased ALP production.
Huge disparity can be found in the literature on whether silver has a significant impact on
differentiation of MSCs. Some authors find that silver nanoparticles have no impact on MSC
differentiation [43,44]. Other papers report on an impact of silver nanoparticles on MSC differentiation
down the osteogenic lineage [45,46]. Conversely, some authors argue that silver particles can cause
adipogenic differentiation [47] of MSCs, whereas others have found no impact at all on adipogenic
differentiation [48]. One aspect that varies between these papers is the size of the silver nanoparticles,
which might be a reason between the widely different reporting of the impact of silver on differentiation.
Powers et al. found impact on neurodevelopment from silver on zebrafish PC12 cells, which was very
dependent on both silver composition and silver nanoparticle size [49]. Another variation between
papers is the wide range of different MSCs that are tested for differentiation, from both different tissue
and animal origins. As even MSCs from different tissue origins vary in behavior, it is not surprising that
different conclusions have been reported by multiple studies [50]. We found that 5 mol.% silver had
the highest ALP production at day 21, although there was no significant difference to 10 mol.% silver.
It is possible that either diminishing returns or an already reached optimum concentration of silver is
the reason for no further increase at 10 mol.% silver. Another explanation is that the slightly more
toxic impact of 10 mol.% silver offsets any additional osteogenic stimulation. Our study demonstrated
that silver-doped nHA incorporated into PCL scaffolds may have a positive effect regarding MSC
differentiation along an osteoblastic lineage due to increased levels of ALP production.
Limitations to the study include no mapping of elements within the electrospun membrane
containing nHA. However, Figure 2b does show evidence that the material is present within the
electrospun membranes but the precise location of the nHA is not known. Another limitation is that,
while using bacteria typical of infections in bone, neither of the isolates was taken from a patient bone
infection. Another limitation on the microbiology side is the simple nature of the tests used; it should be
considered that (along with other disparities) osteomyelitis is associated with a hypoxic environment,
which was not reflected by our experiments. Further work is needed to address these issues, including
the use of a bone infection model to more accurately reproduce the conditions found in vivo. In a
recent study we found that a material with antimicrobial impact on planktonic bacteria and simple
biofilm models was then not effective on P. aeruginosa in tissue-engineered skin models, believed to be
due to the bacteria motility [24]. This is something we intend to investigate in future work.
This research found that silver nHA containing scaffolds has the potential to act as an antimicrobial
scaffold while stimulating bone tissue regeneration. The scaffolds degrade slowly and release a
continuous amount of silver into the local environment over time. They are nontoxic to mammalian
cells at a concentration that is toxic to both Gram-negative and Gram-positive bacterial strains.
Investigating the impact of silver on MSC differentiation has suggested that higher values of silver
promote MSC differentiation.
5. Conclusions
Silver-doped nanoscale hydroxyapatite may be incorporated into electrospun PCL scaffolds to
fabricate a device that is both nontoxic to cultured mammalian cells and capable of inhibiting the
growth of pathogenic microorganisms. The scaffold demonstrated antibacterial activity against both
Gram-positive and Gram-negative bacterial strains commonly found in bone infections. The material
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was shown to release silver in an initial burst followed by a more sustained bulk degradation
release. Silver appeared to enhance MSC differentiation down an osteogenic path when used in
nontoxic concentrations. Silver-doped nHA containing scaffolds exhibited antimicrobial activity while
stimulating bone tissue regeneration, which shows promise as a dual-action medical device to address
unmet clinical needs in orthopedic and dental bone surgery.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-4983/11/3/58/s1,
Figure S1: EDX elemental mapping of 10 Ag mol.% samples detecting oxygen, phosphorus, calcium and silver.
TEM image of the analysed material is also shown for comparison along with an overlay image of all elements in a
single frame.
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Abstract: Continuing cariogenic bacterial growth demineralizing dentine beneath a composite filling
is the most common cause of tooth restoration failure. Novel composites with antibacterial polylysine
(PLS) (0, 4, 6, or 8 wt%) in its filler phase were therefore produced. Remineralising monocalcium
phosphate was also included at double the PLS weight. Antibacterial studies involved set composite
disc placement in 1% sucrose-supplemented broth containing Streptococcus mutans (UA159). Relative
surface bacterial biofilm mass (n = 4) after 24 h was determined by crystal violet-binding. Live/dead
bacteria and biofilm thickness (n = 3) were assessed using confocal laser scanning microscopy (CLSM).
To understand results and model possible in vivo benefits, cumulative PLS release from discs into
water (n = 3) was determined by a ninhydrin assay. Results showed biofilm mass and thickness
decreased linearly by 28% and 33%, respectively, upon increasing PLS from 0% to 8%. With 4, 6,
and 8 wt% PLS, respectively, biofilm dead bacterial percentages and PLS release at 24 h were 20%, 60%,
and 80% and 85, 163, and 241 μg/disc. Furthermore, initial PLS release was proportional to the square
root of time and levelled after 1, 2, and 3 months at 13%, 28%, and 42%. This suggested diffusion
controlled release from water-exposed composite surface layers of 65, 140, and 210 μm thickness,
respectively. In conclusion, increasing PLS release initially in any gaps under the restoration to kill
residual bacteria or longer-term following composite/tooth interface damage might help prevent
recurrent caries.
Keywords: dental composite; antibacterial; antibiofilm; polylysine
1. Introduction
Dental caries is a main public health issue worldwide [1]. In Europe, it affects almost 100% of
adults and 20–90% of 6-year-old children [2]. Mercury silver amalgam was for nearly 200 years the
most commonly used permanent direct dental filling material in the EU. European legislation, however,
in July 2018, aligned with the Minamata convention on mercury reduction to ban the use of dental
amalgam for children under 15 years old and pregnant or breastfeeding women. Complete dental
amalgam phase out is planned for 2030 [3]. Mercury concerns in combination with growing demand
for more conservative and aesthetic restorations have made the resin composite the new main direct
long-term restorative of choice [4,5]. Composites, however, have higher failure rate with the most
common cause being recurrent (secondary) caries [5–8]. This is largely due to the tendency of resin
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composite to accumulate bacterial biofilms more than amalgam, which is not only responsible for
recurrent caries but also periodontal problems [9].
Dental plaque biofilms consist of microorganisms in an exopolymer matrix (EPM) [10].
These biofilms are three dimensional, spatially-organized microbial communities that show properties
as a unit [11]. Metagenomics studies revealed that up to 19,000 bacterial species could be found in a
mature dental plaque biofilm [12,13]. Shift in composition of the dental biofilm towards more acidogenic
and aciduric bacteria leads to caries. Dentinal caries lesions contain primarily acid-producing and
Gram-positive species, with Streptococcus mutans being particularly high [14,15]. Their lowering of pH
enhances solubility and dissolution of apatite in enamel [16]. Subsequent demineralization of dentine
activates enzymes that, over time, slowly hydrolyze remaining collagen [16].
Previously, tooth restoration involved removal of the soft, highly-infected as well as the underlying
harder, acid-affected dentine through drilling. Tooth restoration became a major problem during the
global SARS-Cov-2 pandemic in 2020, as drilling increases aerosol production that could spread the
viral infection [17,18]. Additionally, acid-affected dentine is remineralizable [19]. Furthermore, current
recommendations for management of cavitated caries advocate controlling the lesion [19]. This could
be better achieved through minimally invasive treatment and bacterial inactivation instead of total
demineralized dentine removal [19]. This would reduce the need for drilling, which both dentists and
patients consider a major benefit [20].
Bacterial inactivation by composite restorations can be achieved by cavity sealing reducing
nutrient ingress [19]. Composite shrinkage during placement or long-term cyclical loading, however,
can damage this seal. Residual bacteria or bacterial leakage from surface plaque with sugars from
food would then enable biofilm formation in gaps at the composite/tooth interface. Immediate
release of antibacterial agents in response to interface damage could potentially reduce this risk.
In combination with remineralising agents to seal any gaps, this could provide the time required for
the tooth to self-heal.
(Poly-ε-lysine) (ε-PL) (PLS) is a naturally created antibacterial homopolypeptide of 25–30 L-lysine
residues that is stable in basic and acidic environments as well as at high temperatures [21,22].
Moreover, it is biodegradable, water-soluble, edible, non-toxic, and has broad-spectrum antibacterial
properties [21,23]. Polylysine has therefore recently been incorporated into resin composites with
remineralising agents [22,24]. Chemical setting kinetics, volumetric stability, polylysine release kinetics,
remineralising features, mechanical properties, and wear have already been investigated [22,24].
One recent study has also studied material effects on bacteria [25]. This previous investigation,
however, was restricted to formulations with low PLS concentrations and planktonic S. mutans with
none of the sucrose required for biofilm maturation [25]. Biofilms, in general, have been shown to
be more resistant to antimicrobial agents compared to the same bacterium growing in planktonic
culture [26].
The aim of this new study was to evaluate if higher levels of PLS and remineralising agents within
composites have the potential to prevent residual bacteria in cavities depositing and forming biofilms
early on the composite surface. This is achieved through investigation of new composites incubated
with S. mutans and sucrose. PLS release kinetics are also provided to help explain the observations.
2. Materials and Methods
2.1. Composite Components
Resin-composite formulations were prepared as in previous studies [25] but with higher
antibacterial and remineralising agents by combining two phases: liquid and powder. Liquid
components included urethane dimethacrylate (UDMA) as the main base monomer and the initiator
camphorquinone (CQ). Both were from DMG (Hamburg, Germany). Poly (propylene glycol)
dimethacrylate (PPGDMA) was added to improve fluidity and polymerization kinetics. This and the
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adhesion promoting monomer, 4-methacryloyloxyethyl trimellitic anhydride (4-META), were from
Polysciences (PA, Warrington, UK) [25].
The filler consisted primarily of silane-treated radiopaque strontium aluminosilicate glass filler of
7 and 0.7 μm from DMG. These were combined with silica nano-glass particles (Azelis, Hertford, UK).
Monocalcium phosphate monohydrate (MCPM) (Himed, Old Bethpage, NY, USA) and polylysine
(PLS) (Handary, Brussels, Belgium) were added as remineralising and antibacterial agents, respectively.
Particle SEM images are provided in a previous work [24].
2.2. Paste and Solid Sample Disc Composition and Preparation
Four semi-fluid paste formulations were prepared using a powder to liquid weight ratio of 3:1.
The clear liquid phase consisted of UDMA (72 wt%), PPGDMA, (24 wt%), 4-META (3 wt%), and CQ
(1 wt%). This monomer system polymerizes effectively upon light activation without need of an amine
activator [24]. Then, 7 μm glass, 0.7 μm glass, and silica were combined in the weight ratio 6:3:1 [24].
This maximized particle packing and provided flow and material handling characteristics approved by
clinical focus groups. MCPM (0, 8, 12, and 16 wt%) and PLS (0, 4, 6, and 8 wt%) were added to this
powder with the MCPM:PLS weight ratio fixed at 2:1.
Clear liquids were prepared by completely dissolving solid 4-META and CQ in PPGDMA followed
by UDMA addition. The powder components were mixed first at 3500 rpm for 10 s using a Speedmixer
(DAC600.2 CM51, Synergy Devices Ltd., High Wycombe, UK). Monomers and powders were then
mixed at 3500 rpm for 40 s.
To prepare solid disc specimens (1 mm thick, 9.4 mm diameter, and mass 0.13 g), pastes were
pressed within metal circlips sandwiched between two acetate sheets then light cured. Each surface
was cured using a light-emitting diode (LED) with a wavelength of 450–470 nm and power of
1100–1300 mW/cm2 (Demi Plus, Kerr Dental, Bioggio, Switzerland) in contact with the acetate sheet
with 4 overlapping irradiation cycles according to ISO:4049 [27]. Then, 40 s per cycle was used to
ensure maximum room temperature monomer conversion of 72% [24]. After curing, composite discs
were removed from the moulds, and excess composite was trimmed.
2.3. Biofilm Formation on Composite Discs
S. mutans (UA159) was cultured on brain heart infusion (BHI) Agar (CM1136 by OXOID, Thermo
Fisher Scientific, Loughborough, UK) at 37 ◦C in an atmosphere of air enriched with 5% CO2 for 72 h.
A single colony was inoculated into 10 mL BHI broth (CM1135 by OXOID) and allowed to grow for 18 h
at 37 ◦C in air enriched with 5% CO2. This was diluted to obtain a bacterial density of 8 × 107 CFU/mL,
which was confirmed by colony forming unit (CFU) counting and calibrated optical density (caused by
absorbance and light scatter) at 595 nm (OD595). The OD595 was measured using a spectrophotometer
(Biochrom WPA CO8000, Cambridge, UK).
Specimen discs were placed randomly in 24 well plates (Greiner bio-one, Cellstar, Kremsmunster,
Austria) and sterilized through top and bottom surface exposure to UV light for 40 min. Biofilms were
grown on each composite disc by adding 25 μL of 8 × 107 CFU/mL inoculum (containing 2 × 106 CFU)
with 1 mL BHI broth (OXOID) containing 1% (w/v) sucrose. The well plate was incubated at 37 ◦C
statically in air enriched with 5% CO2. After 24 h, the medium was carefully removed. The resultant
biofilms were washed twice with 1 mL of sterile phosphate buffered saline (PBS) and fixed by exposure
to 1 mL methanol during 15 min.
2.4. Crystal Violet (CV) Biofilm Assay
A crystal violet (CV) assay was used to evaluate relative biofilm mass on composite surfaces [28].
Biofilms were produced on 4 separate days; 3 composite discs per formula were tested each day
requiring 12 discs per formula in total.
The procedure involved addition of 1 mL of aqueous 0.1% CV (Pro-Lab Diagnostics, Bromborough,
UK) to each disc for 5 min then washing with 1 mL of PBS twice. After drying, bound CV was
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solubilized in 1 mL of 30% aqueous acetic acid. Once fully dissolved, the resultant CV solutions were
diluted to enable absorbance (OD595) determination, and the OD595 of the undiluted solutions were
calculated and reported.
2.5. Live/Dead and Biofilm Thickness Assessment
Live/dead assay and biofilm thickness were assessed using confocal laser scanning microscopy
(CLSM, Lasersharp 2000) (Radiance 2100, Biorad, Hercules, CA, USA) with a 40×magnification wet
lens. Biofilms were prepared and examined on different days in 3 independent assays with one disc
per formulation each day.
Then, 20 μL of LIVE/DEAD stain (Viability Kit, Thermofisher Scientific, Loughborough, UK)
and 10 mL of PBS were added to the biofilms on discs within wells. Green and red images of live
versus dead bacteria were obtained from near the biofilm centre (260 × 260 μm2). In the following,
red and green images are shown overlapped. For analysis, the individual red or green images were
converted to black (background) and white (stained bacteria), and the percentage area that was white
was determined using ImageJ software. The ratio of live/dead bacteria was obtained by dividing the
percentage of white areas from the green versus red images; this was then converted to percentages.
Additionally, movement of the microscope stage in the z direction enabled determination of biofilm
thickness. Average results at three random points within the image area were obtained. Normalised
thickness was obtained by dividing biofilm thickness by that for the control with no PLS on each
given day.
2.6. Polylysine Release
To quantify kinetics of PLS release, 6 composite discs of each formulation of known total mass
were stored in plastic pots containing 5 mL of deionized water at room temperature (RT). A total
of 2 discs per pot enabled sufficient release for ease of detection and a sample repetition number of
n = 3. The discs were transferred to new plastic containers with fresh 5 mL of deionized water at the
following time points: 6 h, 24 h, 3 days, and at 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 12, 14, and 18 weeks.
The concentration of PLS that had leached into the deionized water was determined using a
ninhydrin assay that was modified from previously published work [29]. It involved adding 1 mL of
0.5% ethanolic Ninhydrin (Sigma-Aldrich, Gillingham, UK) solution to boiling tubes containing 4 mL of
sample storage solution or aqueous polylysine solutions of known concentration. After vortex-mixing
for 10 s, 1.5 g (± 0.1) of marble chips (BDH, Poole, England, UK) were added to each tube. All tubes
were covered with aluminium foil and placed in a boiling water bath to accelerate a ninhydrin/PLS
reaction. After 15 min, reactions were quenched by rapid cooling to RT.
Following sedimentation, supernatant liquids were analysed using a spectrophotometer (Thermo
Spectronic Unicam UV 500 Spectrophotometer, Loughborough, England with Vision proTM software).
The absorbance was recorded between 400–700 nm to ensure curves were consistent and free of
background scattering (for example due to residual non sedimented marble chips). Absorbances at
570 nm (A570) for known polylysine concentrations of 0, 4, 10, 16, 20, 40, 60, 80, and 100 ppm were
used to establish a calibration graph (A570 = 0.023/ppm, Pearson correlation coefficient, RSQ = 0.96).
This was then used to determine polylysine concentration in each storage solution and cumulative
release in μg/disc versus time. Cumulative PLS (%) was also calculated using:






where Rt is the amount of released PLS (g) at time t, wc is the amount of PLS (g) in the composite disc.
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2.7. Statistical Analysis
The 95% confidence intervals (95%CI) (equal to 2 SD/SQRT(n) where SD and SQRT are standard
deviation and square root) are provided as error bars in Figures. Average percentage standard deviations
(%SD) were 7%, 9%, and 15% and sample numbers n = 4, 3, and 3 for crystal violet (CV) absorbance,
normalised biofilm thickness, and PLS release studies, respectively. Significance (p < 0.05) was determined
using one-way Analysis of Variance (ANOVA) followed by pairwise comparisons (Kruskal–Wallis test).
Excel was used for curve fitting and to calculate the Pearson correlation coefficient (RSQ).
3. Results
3.1. Biofilm Mass
CV adsorption and subsequent absorbance indicated an inverse relationship between the amount
of biofilm mass and the concentration of PLS in composite formulations (Figure 1). All PLS-containing
formulations (4, 6, and 8 wt%) had biofilms with significantly less CV adsorption than the control
formula with no PLS. In addition, the formula containing 8% PLS had significantly less CV adsorption
compared to the material containing 4% PLS.
 
Figure 1. Mean ± (95%CI, n = 4) absorbance (OD595) due to crystal violet (CV) adsorbed by biofilms
on the four composite formulations with 0, 4, 6, or 8 wt% polylysine (PLS) in filler phase (error bars
are for 4 repetitions on different days with an average result of 3 specimens per formulation each
day). The absorbance values were 10 times those measured in the spectrometer to account for dilution.
Composite formulations with the same uppercase letter/s above the bars were not significantly different
at p < 0.05.
3.2. Live/Dead S.Mutans
Confocal microscopy images showed primarily dead bacteria with 8% PLS but live bacteria with
0% and 4% PLS levels. The 6% PLS samples had both live and dead bacteria (Figure 2). Quantification
of live versus dead stain confirmed that formulae containing 6% and 8% PLS had significantly more
dead S. mutans and significantly less live S. mutans than the 4% and the control formulations (Figure 3).
Additionally, live and dead percentages gave linear trends versus concentration between 4% and
8% PLS (Figure 3). Additionally, live and dead percentages gave linear trends versus concentration
between 4% and 8% PLS (Figure 3).
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Figure 2. Example confocal microscopy images of live/dead stained biofilms formed on composite
formulations containing different percentages of PLS added to the filler phase. Live bacteria stain green
whereas dead bacteria are red.
 
Figure 3. Mean ± (95%CI, n = 3) percentage of live and dead S. mutans in biofilm formed on discs of
the four composite formulations with 0, 4, 6, or 8 wt% PLS in filler phase at 24 h (error bars are for
3 repetitions on different days with 1 specimen per formulation per day). Composite formulations with
the same uppercase/lowercase letter/s were not significantly different at p < 0.05.
3.3. Biofilm Thickness
Due to the variability in biofilm thickness arising from day to day, the data were normalised
by biofilm thickness of the control on the given day. All PLS-containing formulations (4, 6, and 8%)
then showed significantly reduced normalised biofilm thickness compared to the control (Figure 4).
In addition, the formula containing 8% PLS had significantly less biofilm thickness compared to that
containing 4% PLS. Additionally, a linear decline in biofilm thickness was observed with increasing
PLS concentration (Figure 4).
When biofilm mass and biofilm thickness were both normalised by results for the control, the data
within experimental error overlapped. Additionally, both showed a linear decline in normalised mean
with increasing PLS concentration (Figure 4). Linear declines of up to 28% and 33% in the biofilm
mass and the biofilm thickness, respectively, were observed with increasing PLS concentration to 8%
(Figure 4).
44
J. Funct. Biomater. 2020, 11, 55
 
Figure 4. Scatter graph showing the relationship between normalised mean ± (95%CI) biofilm thickness
(n = 3) and biofilm mass (n = 4) (Y-axis) for different composite formulations (X-axis). For biofilm mass
and thickness, the formulations with the same uppercase letters above and lowercase letters below the
bars, respectively, were not significantly different at p < 0.05.
3.4. Polylysine Release
Percentage PLS release was proportional to the square root of time up to 1, 2, or 3 months with 4%,
6%, and 8% PLS, respectively, but then levelled (Figure 5). The overall general linear model revealed a
significant difference in the percentage of PLS released between different composite formulations at
every time point. Cumulative release in μg/disc at 24 h and final percentage release both increased
with raising the PLS filler content (Figure 6). Within error, final percentage release was 60/350 times the
24 h μg/disc release for all formulations (Figure 6). Final percentage releases were 42%, 28%, and 13%
with 8%, 6%, and 4% PLS in the filler phase, respectively. Release at 24 h was 241, 163 and 85 μg/disc,
respectively (Figure 6). At 6 h, the release was half these values.
 
Figure 5. Scatter graph of mean ± (95%CI, n = 3) percentage PLS release (Y-axis) versus the square root
of time/hours (X-axis) for each composite formula up to 18 weeks (the legend shows the composite
filler PLS %). All final release values were significantly different for different PLS levels at p < 0.05.
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Figure 6. Scatter graph of mean ± (95%CI, n = 3) cumulative percentage PLS release at 18 weeks
(left Y-axis) and mean ± (95%CI) cumulative PLS release in (μg/disc) at 24 h (right Y-axis) for different
composite formulations (X-axis). The formulations with the same uppercase letter/s above or lowercase
letter/s below the bars that indicate 18 week and 24 h data, respectively, were not significantly different
at p < 0.05.
4. Discussion
In the current study, the antibacterial effects of composites formulated with simultaneously
increasing levels of antibacterial PLS and remineralising MCPM was evaluated. MCPM/PLS weight
ratio was fixed at 2. From relative densities and molecular weights, this gave approximately comparable
volumes of the two components and the moles of MCPM and the lysine monomer units in all
formulations. Previous studies have shown that, in composites, these may work synergistically at
promoting surface mineralizing properties [22]. The aim of this study, however, was to assess how
formulations with these two components affect S. mutans biofilm deposition and survival on the
composite surface. Subsequent polylysine release rates were used to explain the large differences
observed between materials with different PLS and MCPM levels.
Polylysine is effective against a wide range of bacteria, although concentrations required tend
to be much higher than for conventional antibiotics or agents such as chlorhexidine. A recent study
showed that increase in PLS concentration above 250 ppm caused reduction in survival rate, enzymatic
activity, and adenosine triphosphate (ATP) levels of Staphylococcus aureus. It also increased cell collapse
and membrane permeability. Additionally, it destroyed the peptidoglycan component of the cell wall
and caused changes in the levels of several metabolites [23]. Another study compared the action of
PLS of 750 and 74 ppm on Gram-positive and Gram-negative bacteria, Listeria innocua, and E. coli,
respectively. In both cases, PLS exerted its activity by binding to negatively charged phospholipid head
groups in the lipid bilayer of bacterial membranes and destabilized them, thus increasing permeability.
In the case of E. coli, PLS also binds to and destroys the lipopolysaccharide component of the outer
membrane [30].
The minimum inhibitory concentration of PLS against S. mutans with the standard initial inoculum
level of 5.5 × 105 CFU/mL was found to be 20 μg/mL [31], but this increases with the higher bacterial
levels seen in the oral cavity. S. mutans is a Gram-positive facultative anaerobic bacterium that was
first identified as a cariogenic bacterium in 1924 [32]. A previous longitudinal study reported that
96.6% of patients aged between 6–30 have S. mutans present in their oral cavity [33]. In a recent study,
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composite formulations that released 93 ppm PLS upon the first 24 h of water immersion were able to
reduce an initial inoculum level of 8 × 105 CFU/mL down to 102 CFU/mL [25]. In this present study,
the formulation with 4% PLS with a similar level of PLS release, however, was unable to prevent S.
mutans biofilm growth. This was likely due to the addition of sucrose enhancing the rate of bacterial
growth in addition to enabling production of a protective extracellular matrix (ECM) [34]. The observed
linear decline in biofilm mass with increasing PLS suggests it may have been causing a linear decline
in the numbers of viable bacteria in the surrounding medium. Alternatively, this effect could have
been independent of PLS bactericidal activity and due instead to biofilm matrix disruption caused by
PLS [35].
Since CV may stain the ECM in addition to the bacterial cell wall, it provides a measure of the
combined live and dead bacteria. In the present study, a live/dead stain was additionally used to
determine the fraction of the bacterial population that were live. In regard to the live/dead stain,
propidium iodide staining (red) revealed a damaged cell membrane. A statistically significant increase
in the percentage of dead S. mutans was apparent with the composites containing 6% and 8% PLS
compared to the 4% and the control formulations. This study, in conjunction with the previous
work [25], suggests that the concentrations of PLS and MCPM in the filler need to be increased
significantly to be effective when sucrose is added.
Considerable variation in biofilm thickness detected by confocal microscopy was observed
between experiments, although this was not apparent in the biofilm mass measured by CV staining.
This may reflect differences in biofilm structural organization between experiments. Nonetheless,
when the data were normalised to the control in individual experiments, a consistent decline in both
biofilm mass and thickness with increasing PLS concentration was evident.
The most widely used antibacterial agent in dental composites has been chlorhexidine (CHX).
Previous studies, however, showed development of antibacterial resistance toward CHX [36] as well as
severe [37] and sometimes fatal hypersensitivity reactions [38]. Furthermore, release from hydrophobic
composites [39,40] can be restricted and can require addition of hydrophilic components to promote
water sorption, which decreases strength. Whilst, in standard tests, minimum inhibitory concentrations
of PLS are generally much higher (20 ppm) [31] than those of CHX (<1 ppm), the new studies suggest
its very much higher aqueous solubility enables faster release from the composite surface.
In order to quantify the kinetics of PLS release from each formulation, a ninhydrin assay was
used. Ninhydrin is used for the detection of ammonia, primary or secondary amines, amino acids,
peptides, and proteins [41]. The reaction between NH2-group present in protein, peptide, or amino acid
with ninhydrin (originally yellow color) produces a coloured ninhydrin chromophore (deep purple
colour) (Ruhemann’s purple λmax 570 nm) [41]. PLS is one of the peptides that can be detected by the
ninhydrin reaction. Under appropriate conditions, the intensity of the purple colour is proportional to
the NH2-group (PLS concentration). Ninhydrin reaction is extremely sensitive to low concentrations of
protein, peptide, or amino acid [41].
Unlike previous studies [22], there was no initial burst release of PLS in this new study. This
may have been a consequence of higher filler content in the earlier work (80 wt%) leading to particles
making more direct contact with the surface. In the current study, the percentage of PLS released was
instead proportional to the square root of time. This is expected from the Higuchi equation for drug










Pt and P∞ are the percentage PLS release at time t and at infinity, respectively. D is a diffusion coefficient
and L the thickness of the layer top and bottom of the sample from which the drug is released. If all the
PLS is released from this layer but none is released from the remaining material bulk, layer thickness
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where h is half the sample thickness and is equal to 0.5 mm. As maximum percentage polylysine
releases are 13%, 28%, and 42%, the top and the bottom surface layers depleted of PLS are expected
from this expression to be 65, 140 and 210 μm with 4%, 6%, and 8% PLS in the filler, respectively. These
are approximately 2, 4, and 6 times the diameters of the PLS and the MCPM particles. The increase in
thickness is likely due to higher levels of these hydrophilic components upon their release, generating
pores in the surface that enable PLS release from deeper within the specimens. Doubling the
concentration of PLS in the filler therefore more than doubles the release from the composite.
























w24 and wc are the weight of PLS released at 24 h in micrograms and total PLS in the composite disc. m,
c, and f are mass of disc in grams (0.13 g), percentage of PLS in the filler, and filler fraction (0.75) in
the composite. This equation shows that, upon doubling the PLS concentration in the filler, the early
release in micrograms more than doubles. h, m, and f are all constants. Comparing Equations (5) and
(6) therefore suggests that, upon increasing c, the diffusion coefficient for PLS increases, enabling faster
release. This may be a consequence of higher c increasing PLS, MCPM, and water sorption. Further
studies would be required to separate the effects of PLS and MCPM variables. The results, however,
show that doubling both PLS and MCPM filler content more than doubles early PLS release mass.
When the composite is in direct contact with the dentine, release of PLS would be restricted.
Release could occur, however, upon composite/dentine interface damage creating a water filled gap.
These gaps may occur due poor bonding technique generated through composite shrinkage upon
placement or formed at a later time due to cyclic stress on the bond. Rapid release of PLS into this gap
could help to prevent biofilm formation initiating recurrent caries. The caries could, at early times after
restoration, arise due to residual bacteria, or, if the gap is larger than a few microns, may be initiated by
bacteria penetrating from the oral cavity. Additional diffusion of nutrients from the oral cavity would
accelerate the bacterial growth within the gap.
If release of PLS is sufficiently fast to enable the minimum inhibitory concentration to be reached
in the medium before exponential bacterial growth, then biofilm formation should be prevented.
Alternatively, as occurred in this study, if release is not sufficiently fast to prevent biofilm initiation,
longer-term release may kill the bacteria that are adherent on the composite surface. This study
suggests that higher MCPM and PLS are required to achieve this mechanism of biofilm destruction.
This antibacterial action would enable reduced risk with partial caries removal and possibly allow less
affected dental hard tissue removal. In addition, it might increase the survival rate of the restoration
and decrease the prevalence of recurrent caries. Excessive release of surface PLS, however, would have
a negative effect on the top surface roughness and hardness. High levels could additionally reduce
mechanical properties. This, however, could be addressed through use of the composite with high
levels of MCPM and PLS beneath the control composite. This would likely block release of PLS from
the top surface into the oral cavity.
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5. Conclusions
Composites were prepared with PLS added to the filler phase at levels of 0, 4, 6, and 8 wt% and with
monocalcium phosphate added simultaneously at double these levels. Upon incubating set composite
discs with S. mutans and sucrose, a linear decline in surface biofilm mass and thickness occurred with
increasing PLS level. Conversely, an abrupt increase in dead bacteria within the biofilm was observed
with PLS levels above 4 wt%. Release studies suggest this was a consequence of 24 h PLS release
needing to be above a critical level to kill bacteria within the surface biofilms. Early PLS release from
the composite was proportional to the square root of time, as expected for a diffusion controlled process.
Release levelled below 100%, suggesting it was from surface layers, which increased in thickness
with raising PLS level. Upon damage of the composite restoration/tooth interface, either through
polymerization shrinkage during placement or upon cyclic loading, a new composite surface was
generated that was in contact with fluid. With rapid and sufficient PLS release from this new surface,
risk of recurrent caries within the microgaps formed could potentially be reduced.
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Abstract: An advancement in preventing secondary caries has been the incorporation of quaternary
ammonium containing (QAC) compounds into a composite resin mixture. The permanent positive
charge on the monomers allows for electrostatic-based killing of bacteria. Spontaneous adsorption
of salivary proteins onto restorations dampens the antimicrobial capabilities of QAC compounds.
Protein-repellent monomers can work with QAC restorations to achieve the technology’s full potential.
We discuss the theory behind macromolecular adsorption, direct and indirect characterization methods,
and advances of protein repellent dental materials. The translation of protein adsorption to microbial
colonization is covered, and the concerns and fallbacks of the state-of-the-art protein-resistant
monomers are addressed. Last, we present new and exciting avenues for protein repellent monomer
design that have yet to be explored in dental materials.
Keywords: protein repellent; restorations; zwitterionic polymers; dental materials; antimicrobial;
antifouling
1. Introduction
Tooth decay, also known as dental caries, is one of the most prevalent infections globally that
afflicts both the developed and developing world. It affects young and old at large percentages,
while being a preventable disease. Due to the high incidence of patient affliction, the economic toll is
large in the US, approximately $442 billion [1]. To combat caries, clinicians remove the decayed tissue
and replace with restorative materials. These composite materials consist of a stiff polymeric matrix
(e.g., bisphenol A-glycidyl methacrylate (BisGMA) [2], urethane dimethacrylate [3], or methacryl
polyhedral oligomeric silsesquioxane [4,5]) and inorganic filler components (i.e., amorphous calcium
phosphate nanoparticles [6], borosilicate microparticles [7], and hydroxyapatite [8]). Additional
problems arise from secondary caries, subsequent infections beneath or in the micro-cracks of the
composite [9]. This occurs up to 44% for all adult patients and could be mitigated by antimicrobial
technologies [10].
Integration of polymerizable antimicrobial methacrylates in dental resin offers the benefit of
providing lasting antimicrobial activity, while being chemically stable. Specifically, quaternary
ammonium containing (QAC) monomers have been incorporated into dental resins, to enable
contact-killing of microorganisms. This concept was first introduced in 1993 by Imazato et al. [11].
Briefly, a quaternary ammonium compound, 12-methacryloyloxydodecylpyridinium bromide (MDPB),
was incorporated into a resin, to formulate an antimicrobial composite [12]. Reports have indicated that
QAC compounds destroy bacterial cell membrane integrity and eventually lead to cell death [13–15].
The design of these monomers has been heavily studied to optimize antimicrobial capabilities and
elucidate the mechanism of bacterial killing [16]. For example, Li and coworkers synthesized QAC
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monomers with varying carbon lengths, following the positive quaternary amine, to enhance the
insertion of the dangling monomer into the Streptococcus mutans membrane [17]. Another strategy has
been to investigate monomers with varying degrees of flexibility, for improved incorporation into the
bacterial membrane. The effect of alkyl chain length on antimicrobial properties of monomethacrylate
monomers suggested a rise in antibacterial activity with the increasing alkyl chain [18,19]. However,
the antimicrobial efficacy–structure relationships are not strictly linear. For instance, the longer chain
length of novel adhesive methacrylate dental monomers had a less marked effect on reducing S. mutans
biofilms [20]. Furthermore, when drawing conclusions about chain length, it is important to consider
that antimicrobial functionality is also affected by molecular mass, spacer rigidity, hydrophobicity,
charge density, and charge distribution [21,22]. Since the first Imazato and coworkers’ QAC resin
manuscript, advances have been made in synthesizing QAC monomers with dual functionality, such as
increased shear bond strength [20,23,24] and silane-coupling capabilities [25–27]. Similarly, other
antimicrobial approaches have been studied in dentistry, including metallic nanoparticles with inherent
bactericidal properties [28] and are not discussed in this review.
While previous studies on QAC dental materials are significant, their impact has been dampened
by the reduction in antimicrobial efficacy due to protein adsorption [29]. Salivary proteins form a
thin coating onto the enamel surface, called the pellicle [30]. The pellicle allows for the attachment
of early colonizing bacteria [31]. Many bacterial species possess surface structures (i.e., fimbriae and
fibrils), which facilitate their attachment [32]. In the early stages of biofilm formation, planktonic
bacteria directly attach to surfaces or indirectly bind to other bacteria that have already colonized [33].
Acidic and high-molecular-weight mucin fractions, acidic proline-rich proteins, and a multidomain
glycosylated protein of the salivary pellicle are reported to bind bacteria and adhere to the non-native
surface, to support biofilm attachment at the composite–adhesive–tooth interfaces [34]. The proteins
and pathogens (and their interactions) attributing to failure at the composite–tooth interfaces have been
presented in an elegant review [35]. After attachment, the bacterial cells proliferate, form microcolonies,
and mature. Generally, biofilms can be morphologically heterogeneous 3D structures with the shape
affected by spatiotemporal stress [36]. The 3D biofilm structures can be interspersed with bacteria-free
channels used as diffusion pathways [32]. Dental caries and periodontal disease are a net result of the
cross-talk between pathogenic dental-plaque biofilm and the host-tissue response [36]. While clinical
examination and X-rays are commonly used to diagnose oral disease, advancement of salivary
biomarkers and metaproteomic analyses of the oral microbiota may be exploited for future diagnosis
of opportunistic and infectious disease [37].
To improve the antimicrobial properties of QAC monomers, protein-repellent functionality
should be incorporated to prevent the extent of adsorption that current restorations experience
(Figure 1). To accomplish this, the dental-material community has implemented approaches from the
surface-science and blood-contacting material literature. Much of the recent literature has focused on
2-methacryloyloxyethyl phosphorylcholine (MPC), a commercially available and U.S. Food and Drug
Administration-cleared zwitterionic polymer with well-studied protein-repellent capability.
The objective of this review is to focus on (1) the theoretical and practical considerations of protein
adsorption; (2) methods to quantify protein adsorption; and (3) protein repelling functionality in dental
restoratives and mouthwash technologies. Moreover, we also identify challenges with commonly used
protein repellants and consider the potential of developing novel monomers.
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Figure 1. Dual functional dental materials enable contact-killing of cariogenic microorganisms by
repelling proteins and disrupting bacterial membranes via charged interactions. (A) Salivary proteins
adsorb to quaternary ammonium-containing (QAC) monomers, inhibiting their long-term antimicrobial
properties. (B) Protein-repellent molecules work with QAC monomers to disrupt the formation
of biofilms.
2. Theoretical and Practical Considerations for Protein Adsorption
Protein adsorption is a spontaneous process arising from a contribution of electrostatic and
hydrophobic interactions, or hydrogen bonding [38]. Net charges on proteins can electrostatically bond
with surfaces that are oppositely charged. This process can be reversed as the pH is altered, owing to
the proteins pKa [39]. Additionally, hydrophobic regions of proteins can unravel (face outward) to
bond with hydrophobic surfaces, minimizing the interactions between water and salivary proteins
and between the surface and salivary proteins [40]. Lastly, both proteins and dental materials can
participate in hydrogen bonding with each other if that is more favorable than surface solvation
interactions [41].
Understanding the mechanisms of adsorption has led to the development of design principles
for protein-repellent materials. The Whitesides group in 1993 reported a method for fabricating
self-assembled monolayers (SAMs) as a tool to study protein adsorption [42]. These SAMs consisted
of densely packed alkylthiol molecules that aligned parallel with one another on the surface of gold
substrates. The tail end of the alkylthiol molecules were terminated with a functional group that could
be covalently bonded to a chemical group of interest. Surface Plasmon Resonance (SPR) was coupled
with a SAMs device to quantify the adsorption, observed as a change in frequency of the plasmon
resonance. Their group subsequently followed their initial article with a survey of chemical structure
relationship on adsorption, for which they reported four distinct rules for effective protein-repellent
surfaces: The surface exposed monomers should be (1) hydrophilic; (2) contain hydrogen bond
acceptors; (3) have no hydrogen bond donors; and (4) be electrically neutral [43–45]. Poly(ethylene
glycol) (PEG)-based polymers [46] and many zwitterions [47] fall into this set of criteria and have been
widely used for coatings in blood-contacting materials and implants.
In practice, additional considerations need to be taken into account to ensure effective protein
repelling. The findings of the Whitesides’ group can only translate if a critical density of antifouling
monomers is on the surface of the material. Surface-coating treatment of protein-repellent monomers
will not be as effective in dentistry, due to the formation of micro-cracks in composite materials
produced during polymerization shrinkage [3]. These cracks are susceptible to bacterial colonization
and consequently secondary caries, which are largely responsible for the failure of composite
fillings [10]. It is imperative that dental materials contain protein-repellent molecules on their
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surface and in the bulk without (or minor) effect on the mechanical properties. In the same vein,
researchers have developed hydrogels with protein-repellent monomers incorporated in the bulk and
surface [48–50]. Last, the QAC monomers have functional groups that inherently adsorb proteins
more readily. Specifically, the charged quaternary amine will participate in electrostatic interactions
with proteins, leading toward adsorption. The long alkyl chain in many QAC monomers will also
aid in hydrophobic–hydrophobic interactions, causing unfavorable adsorption. Therefore, dental
materials require sufficient coverage of protein-repellent monomers to minimize attractive forces
between proteins and QAC monomers.
3. Characterization Methods for Quantifying Protein Adsorption
Several techniques and assays have been developed to study the degree of protein coating on
material surfaces (Figure 2). These methods range in sensitivity and each have trade-offs and should
be considered for studying the adsorption of protein on dental materials. A comprehensive guide to
characterization techniques for protein adsorption can be found in a previous article [51].
The most sensitive techniques (able to detect 1 ng to 1 μg of protein) commonly utilized are SPR
or quartz crystal microbalance (QCM). Both analyze the surface of a small (<5 × 5 mm) substrate
that is functionalized with a protein repellent of interest. Samples are prepared by coating or
chemically functionalizing the surface with the protein repellent of interest. By preparing a thin
sample, the interactions between a protein solution and protein-repellent monomer can be probed. In a
typical SPR detection apparatus, a thin gold-coated slide is coated with the monomer of interest [42,52].
The slide is mounted, glass side down, onto a prism, and the functionalized side is used as part of a
microfluidic channel. A light source with narrow range emission is projected through the prism and
glass slide and reflected off the thin gold layer. A detector collects the angle of the reflected light, which
corresponds to the index of refraction of the functionalized gold layer. When a protein solution flows
onto the functionalized surface, the index of refraction increases, causing the angle of the reflected light
to change. This change can then be used to calculate the mass of protein on the surface of the substrate.
QCM devices implement a piezoelectric functionalized substrate [53–55]. When a current is
applied to the substrate, the material vibrates at a frequency proportional to its mass. The piezoelectric
material surface is coated or chemically bonded with a material of interest, to probe how much protein
adsorbs to the material surface. These substrates are incorporated into microfluidic devices that flow
protein solutions onto the substrate surface and are coupled with real-time sensing. When proteins
adsorb onto the substrate, the frequency at which it vibrates changes. This change in frequency is
converted to the mass of protein adsorbed to the substrate. QCM can be used to yield dynamic
properties of adsorbed proteins, such as revealing changes to the salivary pellicle on hydroxyapatite
surfaces when various detergents are flowed over the substrates [56]. In addition to monitoring protein
adsorption, QCM has been used to probe the formation of biofilms and bacterial death in a clinically
relevant microorganism model [57]. SPR and QCM techniques are useful for protein interactions
with high-density surfaces and are best for studying low adsorption, as they saturate with milligram
quantities of protein.
Dental composite materials exhibit polymerization stress, causing the composite to crack when
curing [3]. These cracks expose the bulk, leaving sites for adsorption without a surface-modified layer.
A more practical method for detection of protein adsorption is through colorimetric analysis of protein
solution surrounding a dental material. Biochemical assays such as the bicinchoninic acid (BCA),
Lowry protein, or Bradford assay utilize reagents that alter their visible-light absorbance upon reacting
with a protein in solution. In this regard, three protocol variations have been widely used by the dental
materials community. A material sample is submerged in a protein solution for a predetermined time.
(1) The material is rinsed with saline solution, to remove non-adsorbed proteins, and the adsorbed
protein is removed by rinsing the material with a sodium dodecyl sulfate (SDS) solution. This SDS
solution is then used in a colorimetric assay [58]. While this method is the most used in the dental
material literature, a comprehensive investigation determined that SDS rinsing does not adequately
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remove adsorbed proteins [59]. This may lead researchers to conclude a protein-repelling capacity that
is inaccurate. (2) In lieu of rinsing the material with SDS to remove the adsorbed protein, the protein
solution and material can be vortexed to remove non-adsorbed proteins, and the protein solution
surrounding the material is analyzed. This method yields quantification of the remaining solution
compared to the initial starting concentration. (3) A small sample of protein solution is placed on a flat,
clear, and polymerized dental resin. After the desired time, the non-adherent protein is removed by
rinsing with saline. The material is then submerged in the reagents of a colorimetric assay, allowing
the adsorbed proteins to react with the assay reagents. The optical density at the assays absorbance
wavelength is then performed to quantify the adsorbed proteins [60,61].
 
Figure 2. Characterization methods for quantifying protein adsorption on dental materials.
(A) A general Surface Plasmon Resonance (SPR) device setup. Protein solution is flowed through a
microfluidic channel and onto the material of interest bonded to a thin gold layer. Light is projected
through a prism and onto the gold layer to discern protein–material interactions. (B) A general quartz
crystal microbalance (QCM) device setup. The material of interest is fabricated onto a piezoelectric
sensor. As protein accumulates onto the material, the vibration frequency changes. (C) Colorimetric
methods for quantifying protein adsorption. (i) A disk with protein adsorbed to the surface is placed
into a sodium dodecyl sulfate (SDS) buffer, to remove the protein. This solution is then analyzed by
using an amino acid colorimetric reactive dye. (ii) A material of interest is placed in a protein solution
of known concentration. After some time, the material is removed, and the remaining solution is
analyzed. (iii) A material is placed in protein solution and is removed from the solution after a desired
time point. The material with adsorbed protein is placed in a solution with colorimetric reagents, and
the optical density is measured.
Topographical features and visualization of adsorption are important in understanding the growth
of biofilm formation on dental materials. Looking toward the future, dental materials researchers
should explore atomic force microscopy as a characterization tool. This technique probes the surface of
materials, using a cantilever tip (100 nm–100 μm) and a laser to gauge the position of the tip, producing
geometric information of a material [62]. Few dental material groups have explored the use of atomic
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force microscopy. to visualize protein adsorption on the surface [63]. Information that could be useful
to researchers include the homogeneity of the adsorption layer, thickness of the adsorption layer,
and force required to break bonds between the material surface and adsorbed proteins.
4. Dental Materials with Protein-Repellent Functionality
MPC is a methacrylate zwitterionic polymer that contains a negatively charged phosphorylcholine
and a positively charged quaternary ammonium head. It is the most investigated molecule for
protein-repelling dental materials [47,64,65]. It blends well into BisGMA/triethylene glycol methacrylate
(TEGMA) and other hydrophilic resins. It was first introduced in the dental material literature by the Xu
group in 2015 as an additive to a 50:50 BisGMA and TEGMA (BT) resin with dimethylaminohexyadecyl
methacrylate (DMAHDM) and barium boroaluminosilicate filler [58]. The authors found that, out
of various compositions investigated, a 3% (wt/wt) MPC and 1.5% (wt/wt) DMAHDM composite
demonstrated nine times less bovine serum albumin (BSA) adsorption (~1 μg/cm2), compared to the
commercial control. For this composition, the flexural strength decreased from 100 to 80 MPa and
elastic modulus from 6.7 to 6.5 MPa, compared to the resin without MPC. Oral biofilms, derived from
the saliva of human donors, were cultured on the composites, to assess the antimicrobial capabilities
of the MPC composites, with and without DMAHDM. Compared to the commercial control, a 3%
MPC composite exhibited an order of magnitude lower total microorganisms, while the 3% MPC +
1.5% DMAHDM exhibited a three order of magnitude decrease of total microorganisms. This result
demonstrated that the full potential of QAC resins could be realized with the addition of MPC.
The Xu lab continued their efforts into investigating the capability of MPC in many facets of
materials in dentistry. A subsequent article optimized the addition of MPC into BT resins to identify
a formulation with high protein repellency, without compromising the mechanical properties of the
material [66]. They demonstrated that the flexural strength and elastic modulus suffer with materials
containing 4.5% MPC and above. Specifically, the 4.5% MPC composite exhibited a flexural strength
decrease to ~60 MPa compared to ~85 MPa in the case of the control. Moreover, the elastic modulus
decreased to 5 MPa, compared to 6 MPa, as it was with the control. In a BSA adsorption assay,
the researchers reported that a 3% MPC sample decreased the amount adsorbed by 85%, as compared to
a polymerized BT sample. This same formulation also exhibited eight times fewer total microorganisms
compared to the BT control.
MPC was then incorporated into a dental primer, to establish whether it could be useful as a
restoration [67]. In conjunction with DMAHDM, MPC mixed into a commercial dental bond primer
(3M Scotchbond Multi-Purpose Adhesive and Primer). A 7.5% MPC composite demonstrated less
than 1 μg/cm2 of protein adsorption, nearly 10 times less than the control. The same formulation
had a comparable dentin shear bond strength, at ~27 MPa, compared to the control, at ~33 MPa.
The degree of conversion was minimally impacted in all the formulations tested, indicating that MPC
blends well with conventional dental resins. Last, the 7.5% MPC formulation was the most effective
at reducing the total microbial count, by four orders of magnitude lower than the primer control.
A follow-up investigation with amorphous calcium phosphate nanoparticles as the filler revealed
that the shear bond strength decreased from 30 to 22 MPa [68]. The addition of the particles did
decrease the shear bond strength to 25 from 30 MPa for a filler content of 30%, but did not alter the
protein-repelling effects or antimicrobial efficacy. Even in long-term water aging of 180 days, MPC
composites demonstrated closely similar protein-repelling and antimicrobial efficacy, likely due to the
high degree of conversion [69].
To probe whether MPC inhibited or enhanced the release of calcium and phosphate ions from
ACP particles, a 1:1 mixture of ethoxylated bisphenol A dimethacrylate (EBPADMA) and pyromellitic
dianhydride glycerol dimetrocralte (PMGDM) was used as the resin matrix, abbreviated to EBPM [70].
This resin formulation was found to allow for the release of calcium and phosphorous ions when
used with a ACP particle filler [71]. The combination of resin, MPC, and DMAHDM did not alter the
protein-repelling properties of a 3% MPC formulation. In a four-organism biofilm challenge, a 3% MPC
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+ 3% DMAHDM composite inhibited the colony count of Porphyromonas gingivalis and Aggregatibacter
actinomycetemcomitans by four orders of magnitude and Prevotella intermedia and Fusobacterium nucleatum
by three orders of magnitude, as compared to the resin alone [70]. The hydrophilicity of MPC caused
more swelling in the composites, leading to a higher release of calcium and phosphorous ions, compared
to the formulation without MPC [72]. By altering the amount of MPC, the amount of ions released
could be tuned [73].
Poly(methyl methacrylate) (PMMA) is a common biomaterial routinely used in dentures and
can be a breeding ground for oral microbes due to the heavy coating of salivary proteins it endures.
MPC was incorporated into a methyl methacrylate monomer mixture and thermally cured. A 3%
MPC formulation was enough to substantially decrease the amount of BSA adsorbed to ~2.0 μg/cm2
compared to bare PMMA (~12 μg/cm2) [74]. Computational modeling of surface interactions of MPC
grafted onto PMMA revealed that MPC forms a tight hydration layer and a network of hydrogen
bonding between adjacent MPC chains (in high-density grafting), which inhibits the adsorption of
proteins and the anchoring of bacteria to the material surface [75].
More recently, there has been an effort to understand how QAC composites affect the microbial
composition in biofilm models. MPC in QAC composites were shown to be more effective at decreasing
the microbial growth of a single species biofilm of P. gingivalis [76]. As the microbial diversity increased,
the composite was less effective at decreasing growth. Ultimately, the composite decreased the total
microbe count by three orders of magnitude, compared to the resin control. It is well-documented that
genetic information is shared between microbes in biofilm communities that act as a defense against
chemical agents [77]. These composites also have shown to decrease the S. mutans composition in
biofilms, leaving non-cariogenic species to thrive [78]. A summary of the protein repellent dental
material capabilities discussed can be found in Table 1.
5. Mouthwash Coating Technology
A potential solution to repetitive cariogenic bacterial attachment to dental tissue is through the
use of oral rinses with safe protein-repellent molecules that bind to enamel, root, or dentin surfaces.
Recently, this concept was tested in a small clinical study by evaluating the number of microbes in
dental plaque before and after rinsing with a solution of 5% MPC in saline [79]. Twenty patients had
oral samples collected via gargle immediately after and 5 h after brushing their teeth. Half of the
subjects were given a saline rinse as a control and the other half the MPC treatment. The patients
treated with MPC saw a microbial decrease of 45%, compared to the control, through electric counting
of the patients’ gargle, indicating that protein adsorption was lessened. The number of fusobacteria,
a mediator of bacterial aggregation and plague formation, was inhibited by this treatment. While no
chemical modification of the oral environment was mentioned, a more biologically compatible material
may be necessary for frequent rinses. In a separate study, a self-assembly approach was used to coat
the oral cavity with lysozyme aggregated particles tethered to PEG to repel proteins [53]. Lysozyme
was reduced with tris(2-carboxyethyl)phosphine (TCEP) to induce aggregation. These particles have a
high tendency to physically bond to many material surfaces, including dentin and enamel surfaces.
The particles densely pack at the surface, allowing for the formation of a tight hydration shell around
the outward facing PEG molecules, yielding an effective protein repellent monolayer. The authors
successfully tested their coatings against BSA, concanavalin A, fibronectin, saliva, fetal bovine serum,
milk, egg whites, and various polysaccharides. Importantly, the authors found they can overcome the
potential of esterase degradation by incorporating both positive and negative charges into the PEG
molecules to induce a zwitterion effect and increase protein repellency of esterases. These approaches
are novel and justify further investigations to determine feasibility and effect on the biofilm formation.
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6. Limitations of Existing Technologies
While MPC has gained attention in the dental material literature, it has several shortcomings:
(1) MPC contains an ester group connecting the zwitterionic component and the polymerizable
methacrylate group. It is well-documented that ester bonds can be cleaved by esterases in saliva via
hydrolysis [81]. (2) To achieve low levels of protein adsorption (ng/cm2), MPC concentrations ≥ 5%
need to be included into the bulk, which has a detrimental effect on the flexural strength, elastic
modulus, and hardness. (3) Currently, there is a paucity of information regarding the long-term
protein adsorption of dental resins containing MPC [82]. (4) Although, in theory, MPC meets many
design criteria for being the superior protein-repellent candidate, many groups have shown that other
conventional polymers outperform MPC in various experimental models [83–86]. New zwitterionic
polymers are needed to overcome some of the long-term concerns with MPC. In addition, the potential
clinical benefit needs to be confirmed, as MPC may have a deleterious effect on the remineralization
capacity of restoratives (i.e., possible binding of the re-mineralizing calcium ions by MPC).
Recently, a zwitterionic polymer was synthesized by oxidizing an acrylamide monomer with 50%
hydrogen peroxide, resulting in a permanently positive quaternary amine bonded to a permanently
negative oxygen atom [80]. The proximity of the two charged atoms forms a tight hydration layer in an
60
J. Funct. Biomater. 2020, 11, 54
aqueous environment, leading to high repellent efficacy (5 ng/cm2 by SPR). The polymer also exhibited
satisfactory cytotoxicity and immunogenicity in a mouse model and should be studied as a candidate
for protein repellency in dental materials. A separate group also synthesized amide-based mono-
and bi-functional monomers to create hydrogels, which also demonstrated excellent compatibility
in vivo and high protein repellency (4.3 ng/cm2 by SPR) [49,87]. Further investigations are warranted
to determine if these types of molecules can produce dental materials with satisfactory mixing with
resin monomers, mechanical properties, and degree of conversion.
7. Conclusions
Protein-repellent technology has the potential to decrease the global burden of dental caries.
When incorporated into composites alone or with QAC monomers, protein-repellent technology can
inhibit the adsorption of proteins onto dental materials and thus slow the formation of biofilm and
associated oral diseases. Many research groups have contributed to the understanding of protein
adsorption and material design, and it is now time for dental material researchers to make an
impact in the clinical setting. A concerted effort should be placed on understanding the long-term
effect on the oral microflora with protein-repellent restorations, as it is not ideal to remove “good”
bacteria from the oral cavity. New, more design-driven monomers should be explored to enhance the
stability and protein repellency of QAC restorations, to allow for prolonged antimicrobial properties.
Last, the dental material field should unify in using reliable protein-adsorption protocols, to ensure
consistent comparisons across different material platforms.
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Abstract: This in vitro study evaluated the effect of myristyltrimethylammonium bromide (MYTAB)
on the physical, chemical, and biological properties of an experimental dental resin. The resin was
formulated with dental dimetacrylate monomers and a photoinitiator/co-initiator system. MYTAB was
added at 0.5 (G0.5%), 1 (G1%), and 2 (G2%) wt %, and one group remained without MYTAB and
was used as the control (GCtrl). The resins were analyzed for the polymerization kinetics, degree
of conversion, ultimate tensile strength (UTS), antibacterial activity against Streptococcus mutans,
and cytotoxicity against human keratinocytes. Changes in the polymerization kinetics profiling were
observed, and the degree of conversion ranged from 57.36% (±2.50%) for G2% to 61.88% (±1.91%) for
G0.5%, without a statistically significant difference among groups (p > 0.05). The UTS values ranged
from 32.85 (±6.08) MPa for G0.5% to 35.12 (±5.74) MPa for GCtrl (p > 0.05). MYTAB groups showed
antibacterial activity against biofilm formation from 0.5 wt % (p < 0.05) and against planktonic bacteria
from 1 wt % (p < 0.05). The higher the MYTAB concentration, the higher the cytotoxic effect, without
differences between GCtrl e G0.5% (p > 0.05). In conclusion, the addition of 0.5 wt % of MYTAB did
not alter the physical and chemical properties of the dental resin and provided antibacterial activity
without cytotoxic effect.
Keywords: dental materials; dentistry; anti-bacterial agents; dental caries; biocompatible materials;
biofilms; quaternary ammonium compounds
1. Introduction
Dental caries-linked bacteria growing in biofilms play a pivotal role in the initial formation
and development of carious lesions. The demand for the development of antibacterial surfaces
has gained prominence in order to reduce patients’ susceptibility to new or repeated diseases [1–5].
In dentistry, dental materials have been developed with antibacterial agents to provide new preventive
and treatment dynamics for patients [6–9]. The antibacterial approach for dental materials relies on
biological interactions of the bacteria grown over the materials, and the contact with antibacterial
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agents presents in the surface or is released by the materials [10–13]. In this context, the achievement
of surfaces able to reduce caries-linked biofilm formation over dental tissues or restorative structures
has gained the attention of dental biomaterial researchers.
The current understanding of the dental caries disease process and the new advances in dental
materials promote the preservation of dental structure and the application of minimally invasive
techniques [14]. Under this framework, dental resins are the first option for the replacement of dental
hard tissues that were lost due to carious lesions [15,16]. Dental resins are materials cured by chemical
or physicochemical (via photo-activation) processes, and they present inorganic fillers depending on
their purpose. In areas where it is necessary to increase strength (occlusal/chewing surfaces of teeth),
a high amount of inorganic fillers is incorporated [17]. Dental resins with low viscosity can also be
successfully used to seal the biting surfaces of teeth, decreasing the incidence of caries lesions [18].
The oral environment provides many challenges to the physical and chemical stability of dental
resins, such as high humidity, temperature, and pH variations [19,20]. Likewise, acids leached by high
acidogenic caries-linked bacteria such as Streptococcus mutans, conjointly with a degradative attack
of enzymes, inherently present in the saliva, can jeopardize the materials’ properties over time [21].
More expressively, acidic attack from high acidogenic caries-linked bacteria is a crucial step in tooth
demineralization around the restorations [22]. On this basis, the search for long-lasting strategies
challenging biofilm accumulation on dental resins, as well as the consequent caries lesion development
around restorations, must be addressed.
Antibacterial surfaces with a bacteria-killing function have shown great promise in biological and
biomedical applications, in particular for dental resin-based materials. This approach employs the
incorporation of quaternary ammonium compounds (QACs) in the monomeric blend of the resin-based
material formulation [9,11,23]. QACs have facile synthesis, antibacterial property, and a lack of a
detrimental effect on the mechanical and physical properties when incorporated in concentrations.
Typically, QAS exhibits a positive charge, which confers the surface with the ability to attach and
kill bacteria efficiently. The killing effect is attributed to their electronically interaction and linking
to bacteria membrane and wall, along with their possible diffusion into the cytoplasmic membrane,
an increase of osmotic pressure, and the release of some cytoplasmic constituents [24,25].
Myristyltrimethylammonium bromide (MYTAB) is a QAC with an alkyl-chain length of 14 carbons
presenting a chemical structure of C17H38NBr, a molecular weight of 336.39, and a cationic polar head
group. Trimethyl alkylammonium compounds such as the MYTAB series can also strongly affect
bacterial membrane properties of a wide range of microorganisms, including changes in electrokinetic
potential as well as net surface charge [26]. A recent study has shown promising application for
the sealing of dental roots during endodontic treatment with expressive bacterial reduction of the
endodontic pathogen [27]. Additionally, the long-chain MYTAB presents the potential to act as a
useful endocytosis inhibitor for cell biology, inhibiting different forms of endocytosis in multiple cell
systems [26].
The present study aimed to evaluate the potential ability of MYTAB to impair bacterial reduction
when incorporated into dental resin at increasing concentrations. Its antibacterial effects against
S. mutans, a pivotal cariogenic pathogen presented in planktonic and biofilm stages, were assessed.
The cytotoxicity effect on human keratinocytes was investigated. The chemical and physical effects of
its incorporation on the materials were also explored.
2. Results
Figure 1 shows the results of polymerization kinetics (Figure 1a–c), degree of conversion
(Figure 1d), and ultimate tensile strength (UTS) (Figure 1e). The experimental dental resins had
different polymerization behavior throughout the 40 s of photoactivation. The degree of conversion
per time is shown in Figure 1a. The results (Figure 2d) ranged from 57.36% (±2.50%) for G2% to 61.88%
(±1.91%) for G0.5%, without statistical difference among groups (p > 0.05). Figure 1b indicates the results
of the polymerization rate per time, showing that the higher the concentration of MYTAB, the higher
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the delay in achieving the maximum polymerization rate. Moreover, the higher the concentration of
MYTAB, the lower the maximum polymerization rate. Figure 1c displays these differences, showing
that at the same degree of conversion among groups, the polymerization rate of GCtrl was higher than
G1% and G2% and lower than G0.5%. In Figure 1d, the degree of conversion revealed similar behavior
for the tested groups (p > 0.05). The mechanical property of the dental resins was evaluated under UTS
and expressed in MPa, as shown in Figure 1e. The UTS ranged from 32.85 (±6.08) MPa for G0.5% to
35.12 (±5.74) MPa for GCtrl. There was no statistical difference among groups (p > 0.05).
Figure 1. Comprehensive results of polymerization kinetics (a–c), degree of conversion after 40 s of
photoactivation (d), and ultimate tensile strength (UTS) (e). Same capital letters indicate no statistical
difference among groups (p > 0.05). The groups had different polymerization kinetics without statistical
difference for the degree of conversion and UTS.
Figure 2 shows the results of the antibacterial activity of the experimental dental resins
against biofilm formation of S. mutans and planktonic S. mutans, expressed by the log reduction
in colony-forming unit per milliliter. In the microbiological assessment against biofilm formation
(Figure 2a), the values ranged from 4.58 (±0.08) log CFU/mL for G2% to 7.21 (±0.08) log CFU/mL for
GCtrl (p < 0.05). A greater bacterial reduction (p < 0.05) was observed at the higher concentration of
MYTAB incorporated into the dental resin. In the test against planktonic bacteria (Figure 2b), the values
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ranged from 6.68 (±0.58) log CFU/mL for G2% to 8.28 (±0.05) log CFU/mL for GCtrl (p < 0.05). The group
presenting MYTAB concentration at 2% expressed the highest S. mutans bacterial reduction (p < 0.05).
Figure 2. Bacterial colony forming unit counting: (a) Streptococcus mutans biofilms and (b) planktonic
S. mutans that were in contact with the polymerized samples. Values indicated by different letters
indicate statistical differences among the groups (p < 0.05).
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Figure 3 presents the effects of MYTAB incorporated into a dental resin on normal human
keratinocytes (HaCaT) for cytotoxicity assessed by sulforhodamine B (SRB) assay. The percentage of
viability of the cells ranged from 45.26% (±14.11%) for G2% to 110.16% (±14.64%) for GCtrl (p < 0.05).
G0.5% (91.82% ± 12.17%) presented no statistical difference in comparison to GCtrl (p > 0.05) for
cytotoxicity against human keratinocytes.
Figure 3. Cytotoxicity evaluation of the experimental dental resins expressed by percentage of cell
viability: (a) structure of myristyltrimethylammonium bromide (MYTAB) and schematic drawing of
sulforhodamine B (SRB) assay; and (b) MYTAB cytotoxicity assessed in normal human keratinocytes
(HaCaT) line. Different capital letters indicate statistical differences among groups (p < 0.05).
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3. Discussion
Dental resins are reliable materials to restore teeth, and, when used as pit and fissure sealants,
could prevent new caries lesions [18,28,29]. Nevertheless, the formation of caries lesions around dental
resins is still a major concern due to biofilm accumulation [22,30]. In order to prevent this issue,
we investigated the effect of a cationic organic compound, MYTAB, in the properties of an experimental
dental resin. The formulated resin is a suitable material for dental restorative purposes.
The longevity of dental restorative materials is strongly related to material rates of polymerization.
High monomer conversion is essential for polymers to achieve reliable properties and stability [31].
The study of their polymerization behavior of modified formulations assists in understanding the
effects of the incorporation of the compound on the functional aspect of the restorative material. Here,
the formulated experimental dental resins showed different polymerization kinetics depending on the
concentration of MYTAB. The effects were more evident with the addition of 1 wt % of MYTAB in the
resin (Figure 2 A–C). From this concentration, the polymerization process was delayed, and the groups
reached the maximum polymerization rate later compared to GCtrl and G0.5%.
On the other hand, G0.5% showed a higher maximum polymerization rate compared to all groups
(Figure 2 B). The rationale for this may be attributed to different viscosities among groups [32]. It was
previously suggested that cationic surfactants could increase monomer chain mobility and modify
polymerization behavior [33]. The lower viscosity and the higher monomer chain mobility for G0.5%
may lead to a higher maximum polymerization rate. Nevertheless, by increasing MYTAB incorporation,
the spaces among monomer chains would be increased further, leading to a lower polymerization rate
for G1% and G2%. Despite these events, there was no difference in the degree of conversion among
groups, and they achieved high values of conversion, similar to commercial dental resins [34].
Even though all groups presented a reliable degree of conversion, the delay during the
polymerization kinetics observed for G1% and G2% could induce the formation of a more linear
polymer, with lower crosslinking density [35]. Therefore, the mechanical evaluation of the formulated
materials was essential in better understanding their performance. The specimens of dental resins were
submitted to tensile strength until fracture in a universal testing machine with no statistical difference
among groups. The UTS was a promising outcome because the incorporation of antibacterial agents
could lead to lower mechanical properties [36]. The dental resins formulated in this study may be used
in occlusal surfaces, where repetitive chewing stress is applied. The maintenance of resins’ mechanical
properties besides the antibacterial activity presented is essential in keeping the material in function.
In chewing sites, the experimental material proposed could be used not only for the prevention
of caries lesions [18] but also to treat teeth already affected by the disease [29]. Pits and fissures are
sites of difficult hygiene, favoring biofilm accumulation. Dental sealants successfully inhibit dental
caries due to their ability to seal the demineralized tissue and form a mechanical barrier, inhibiting
bacterial growth, hampering lesion progression, or preventing the demineralization of the sealed
area [18,37]. The use of dental sealants in children and adolescents decreases the susceptibility to
caries development in occlusal surfaces of permanent molars in comparison to people with no sealed
teeth. Even among the people with sealed teeth, there are around 18% who present new lesions over
time [18]. The composition of the sealants available in the market does not present antibacterial agents
in their composition, which could be a strategy to reduce this percentage.
The parental composite resin formulated had its viscosity manually accessed for friendly use in
clinical settings as a sealant. In the previous study with similar QAC, a high antibacterial effect of
myristyltrimethylammonium bromide against Enterococcus faecalis was observed [27]. In both cases,
these QACs have a long alkyl chain, which increases the QAC’s hydrophobicity [38]. Consequently,
when leached, these agents are more prone to penetrate bacterial walls and membranes [39].
With MYTAB, the higher its concentration in the dental resin, the lower the viability of S. mutans in
biofilm and in planktonic stages.
For the assessment of antibacterial property, discs of the polymerized dental resins entered
into contact with an enriched broth containing S. mutans as previously performed [13,33,40–42].
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This bacterium is Gram-positive, and it is present in intraoral multispecies biofilms [43]. S. mutans
group is the main bacteria associated with caries lesion development [44], and they can attach to dental
and material surfaces [1,21]. The samples were exposed to planktonic as well as biofilm stages. During
the contact with a dental resin containing MYTAB, planktonic bacteria reduction is suggested because
of the leaching of some MYTAB molecules for the broth. The lack of assessment of the long-term
antibacterial effect of the dental resins is a limitation of this study. Besides this, the quantities of MYTAB
released over time from the polymerized resin is not known. The knowledge about this event could be
valuable in order to understand the long-term behavior of the material and to assist in predicting the
in vivo outcomes. However, the main goal of this study was to investigate the potential adverse effects
of the addition of this compound into the composite to impart an antibacterial effect.
The cytotoxicity test was performed against human keratinocytes via the SRB method. Through
this method, proteins of viable cells are stained, indicating increased viability when higher optical
density is achieved [45]. The higher the incorporation of MYTAB, the higher the cytotoxic effect
observed. This result corroborates with previous studies, which showed that cationic compounds with
long-alkyl chains lead to high cytotoxic effects [46]. The International Organization for Standardization
(ISO) recommends that biomaterials must promote up to 70% of cells’ viability in order to not be
considered cytotoxic [47]. It is worth mentioning that, despite the lower values of viability found for 1
and 2 wt % of MYTAB, all groups were directly treated with the eluates from the samples. In other
words, we did not dilute the agent as other studies do [46], but we did somewhat increase the challenge
by using the eluates on human cells during 72 h of contact.
A similar compound to MYTAB, a quaternary ammounium compound called ATAB, has been
found to show antibacterial activity against Enterococcus faecalis, a relevant bacterium to endodontic
infections [48]. The main difference between MYTAB and ATAB is the presence of mixing of QACs
with different aliphatic chain lengths for ATAB, which does not occur in the case of MYTAB. In the
previous study, ATAB was associated with halloysite nanotubes (HNT) that were incorporated in
the sealer without the evaluation of ATAB alone [27], which might have repercussions for physical,
chemical, or biological properties. In the same study, there were no cytotoxic effects for pulp cells with
the incorporation of 10 wt % of ATAB/ halloysite nanotubes in the sealer, even when the proportion of
ATAB/ halloysite nanotubes was 2:1 [27]. Here, MYTAB was not carried out by another system because
we aimed to evaluate the QAC itself as a free drug, which may have increased the biological effects.
G0.5% showed no cytotoxicity in comparison to GCtrl, and both promoted viability higher than 70%.
Therefore, the addition of 0.5 wt % of MYTAB may be a promising method for providing antibacterial
activity for a dental resin without compromising its physical, chemical, and biological properties.
The material here formulated is an exciting approach to be further translated for clinical trials.
4. Materials and Methods
4.1. Study Design and Formulation of Dental Resins
The study design is described in the flowchart presented in Figure 4. All reagents of the
analytical grade for in vitro experiments were purchased from Sigma-Aldrich (Sigma-Aldrich Chemical
Company, St. Louis, MO, USA) if not otherwise specified. First, a parental resin was formulated
with two dimethacrylate monomers: bisphenol A glycol dimethacrylates (BisGMA) and triethylene
glycol dimethacrylate (TEGDMA), at the proportion of 1:1. As a photoinitiator/co-initiator system,
camphorquinone and ethyl 4-dimethylaminobenzoate were added to the resin at 1 mol % each.
Butylated hydroxytoluene was added at 0.01 wt % as a polymerization inhibitor. Calcium tungstate
(CaWO4) was added as inorganic filler at 30 wt %. Colloidal silicon dioxide (SiO2; Aerosil 200, Evonik,
Essen, Germany) was incorporated at 0.7 wt % to adjust the resin’s viscosity. After being hand-mixed
for 5 min, they were sonicated for 180 s and hand-mixed for 5 min.
MYTAB with a purity of > 99% was added to the parental dental resin formulation at an increased
double concentration of 0.5, 1, and 2% wt% mass fractions.
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Figure 4. Flowchart of the study design. Experimental dental resins were formulated with different
concentrations of a quaternary ammonium compound (MYTAB). Bisphenol A glycol dimethacrylates
(BisGMA) and triethylene glycol dimethacrylate (TEGDMA) were used for the monomeric blend.
The four experimental groups were evaluated for chemical, physical, and antibacterial properties,
alongside their effect against human keratinocytes.
4.2. Polymerization Kinetics and Degree of Conversion
Fourier transform infrared spectroscopy (FTIR, Vertex 70, Bruker Optics, Ettinger, Germany) was
used to evaluate the polymerization kinetics and the degree of conversion of the experimental dental
resin. For this test, three samples per group were analyzed by dispensing them on the attenuated
total reflectance (ATR) device in the polyvinylsiloxane matrix measuring 1 mm thickness and 4 mm in
diameter. To perform the photoactivation of each sample, the light-cured unit (Radii Cal, SDI, Australia;
1200 mW/cm2) was fixed using support to maintain 1 mm between the tip of the light-cured unit and
the top of each sample. During the 40 s of photoactivation, two spectra were obtained per second in
absorbance mode (10 kHz velocity, 4 cm−1 resolution; Opus 6.5 software, Bruker Optics, Ettlingen,
Germany) in the range of 4000 to 400 cm−1. The first spectrum obtained was used as “uncured resin
dental resin”, and the last spectrum as “cured resin dental resin” in the calculation of the degree of
conversion. The peak at 1610 cm−1 from aromatic carbon–carbon double bond was used as an internal
standard, and the peak at 1640 cm−1 was used as an aliphatic carbon–carbon double bond to calculate
the conversion in percentage (Equation (1)) [31]. The polymerization rate was calculated using the





peak height of cured aliphatic C=C/peak height of cured aromatic C=C
peak height of uncured aliphatic C=C/peak height of uncured aromatic C=C
) (1)
4.3. Ultimate Tensile Strength (UTS)
Ten samples per group with hourglass shape were prepared in a metallic matrix that was 8.0 mm
long, 2.0 mm wide, and of 1.0 mm thickness, with a cross-sectional area of ±1 mm2. Each uncured
sample was placed in the mold and photoactivated for 20 s on each side (bottom and top). The prepared
samples were stored in distilled water at 37 ◦C for 24 h. The samples were fixed in jigs with cyanoacrylate
resin, and they were submitted under tensile strength in a universal testing machine (EZ-SX Series,
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Shimadzu, Kyoto, Japan) at 1 mm/min until fracture. The maximum force value (Newtons, N) achieved
was divided by the constriction area of each sample, which was measured with a digital caliper
(Mitutoyo, Kawasaki, Kanagawa, Japan) to calculate the maximum value of tensile strength (Equation









Two in vitro assessments were performed to evaluate the antibacterial activity of the experimental
dental resin: (1) planktonic bacteria and (2) against biofilm formation on the polymerized samples.
The bacteria used in both tests were S. mutans (NCTC 10449). Three samples per group were prepared
for the biofilm test, and the other three samples per group were used in the test against planktonic
bacteria. S. mutans were prepared according to a previous study [13], and the initial inoculum used for
the tests was assessed by serial dilution method and colony counting, which indicated an inoculum at
7.8 × 107 CFU/mL.
To evaluate the antibacterial activity against biofilm formation, the polymerized samples (1 mm
thickness and 4 mm diameter) were fixed on Teflon specimens that were fixed on the cover of a 48-well
plate, and this assembly was sterilized with hydrogen peroxide plasma (58%, 48 min, 56 ◦C) [13,49].
From the initial inoculum, 100 μL was added in each well of a 48-well plate with 900 μL of brain–heart
infusion (BHI) broth with 1 wt % of sucrose. All reagents used in the antibacterial activity analysis
were purchased from Aldrich Chemical Company (St. Louis, MO, USA). The sterile set of cover and
samples was joined with this 48-well plate and kept for 24 h under 37 ◦C for biofilm formation on the
samples. After this period, each sample was detached from the cover and vortexed for 1 min in 1 mL
of sterile saline solution. The solution was serial diluted up to 10−6 mL and plated on Petri dishes





Avarage number of colonies x Dilution factor
Volume of culture plate
)
(3)
To evaluate the antibacterial activity against planktonic bacteria, the BHI broth that was in contact
with the polymerized samples along the 24 h mentioned above was used. From each well of the 48-well
plate, 100 μL was collected after the 24 h of bacteria–sample contact and was inserted into Eppendorf
tubes with 900 μL of saline solution to be vortexed, diluted until 10−6, and plated on BHI agar Petri
dishes. For this test, an additional group was added as a negative control. The negative control was
composed of BHI broth and S. mutans at the same proportion (10% of initial inoculum of bacteria
in each well) without samples’ contact. Colonies were visually counted, and the results were also
expressed in CFU/mL.
4.5. Cytotoxicity
To evaluate the possible cytotoxic effect of the experimental dental resin, human keratinocytes
(HaCaT, CLS Cell Lines Service GmbH, Eppelheim, Germany) were used in this test [40]. All reagents
used to evaluate the possible cytotoxicity of the dental resins were purchased from Aldrich Chemical
Company (St. Louis, MO, USA). The keratinocytes were kept in contact (5 × 103 cells/per well) with
100 μL of Dulbecco’s modified Eagle’s medium (DMEM) in 96-well plates for 24 h at 37 ◦C. On the same
day, five samples per group (1 mm thickness and 4 mm diameter) were placed separately in Eppendorf
tubes containing 1 mL of DMEM and kept for 24 h at 37 ◦C. Thus, eluates from possible leaching from
the samples were formed. These eluates (100 μL) were kept in contact with the keratinocytes in the
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96-well plates for 72 h at 37 ◦C. There was one group that was maintained without eluates with 100 μL
of pure DMEM that was used as a control for the test. In addition to using five samples per group,
the eluates were applied in five replications, totalizing 100 wells containing eluates from the samples.
After 72 h, 50 μL of trichloroacetic acid/distilled water solution (50:50) was added in each well and kept
at 4 ◦C for 1 hour to fix the cells on the bottom. Running water (30 s) was used to wash the 96-well
plates six times. The 96-well plates were kept at room temperature until drying.
Sulforhodamine B at 0.4% (50 μL) was added in each well, and the 96-well plates were kept at
room temperature for 30 min. The 96-well plates were washed four times with acetic acid at 1% and
kept at room temperature until drying. Trizma solution at 10 mM (100 μL) was added in each well,
and the 96-well plates were incubated for 1 hour at room temperature. The absorbance of plates’ wells
was analyzed at 560 nm, and the cell viability of the wells that contained eluates was compared to the
wells without eluates. The viability of the keratinocytes used was normalized against the viability of
cells without contact with eluates (negative control). The results were expressed in percentage using
the viability of negative control as 100%.
4.6. Statistical Analysis
Data normality was evaluated by the Shapiro–Wilk test. One-way ANOVA and Tukey’s post-hoc
test was used to compare groups for all tests at a level of 0.05 of significance.
5. Conclusions
The present study incorporated a not yet investigated quaternary ammonium MYTAB into a
dental resin, which achieved potent antibacterial effects against dental plaque microcosm biofilms for
the first time. The results showed that (1) MYTAB at 2% greatly decreased S. mutans in planktonic
and biofilm stages compared to GCtrl, (2) higher MYTAB mass fraction rendered the adhesive more
strongly antibacterial, (3) MYTAB at 1% mass fraction greatly reduced the cell viability, and (4) the
incorporation of MYTAB at a maximum concentration of 2% had no detrimental effect on the degree of
conversion and ultimate tensile strength. MYTAB-containing dental resin is a promising strategy for
dental applications.
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Abstract: (1) Background: The objective of this study was to develop a novel dental nanocomposite
containing dimethylaminohexadecyl methacrylate (DMAHDM), 2-methacryloyloxyethyl
phosphorylcholine (MPC), and nanoparticles of calcium fluoride (nCaF2) for preventing
recurrent caries via antibacterial, protein repellent and fluoride releasing capabilities. (2) Methods:
Composites were made by adding 3% MPC, 3% DMAHDM and 15% nCaF2 into bisphenol A
glycidyl dimethacrylate (Bis-GMA) and triethylene glycol dimethacrylate (TEGDMA) (denoted
BT). Calcium and fluoride ion releases were evaluated. Biofilms of human saliva were assessed.
(3) Results: nCaF2+DMAHDM+MPC composite had the lowest biofilm colony forming units (CFU)
and the greatest ion release; however, its mechanical properties were lower than commercial control
composite (p < 0.05). nCaF2+DMAHDM composite had similarly potent biofilm reduction, with
mechanical properties matching commercial control composite (p > 0.05). Fluoride and calcium ion
releases from nCaF2+DMAHDM were much more than commercial composite. Biofilm CFU on
composite was reduced by 4 logs (n = 9, p < 0.05). Biofilm metabolic activity and lactic acid were also
substantially reduced by nCaF2+DMAHDM, compared to commercial control composite (p < 0.05).
(4) Conclusions: The novel nanocomposite nCaF2+DMAHDM achieved strong antibacterial
and ion release capabilities, without compromising the mechanical properties. This bioactive
nanocomposite is promising to reduce biofilm acid production, inhibit recurrent caries, and increase
restoration longevity.
Keywords: dental nanocomposite; calcium fluoride nanoparticles; remineralization; antibacterial;
protein repellent; oral biofilm
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1. Introduction
Dental resin composites are an excellent material for direct restorations of anterior teeth and in
many cases posterior teeth due to their esthetics and ease of placement [1]. Nevertheless, composites
are known to accumulate more oral bacterial plaque and biofilm than other direct restorative materials,
which could expose the restored tooth to a higher risk for future recurrent caries [2]. Indeed, most failed
restorations due to secondary caries are restored with composites [3,4]. The formation of plaque
starts with the salivary-acquired pellicle formation. The glycoprotein found in the acquired pellicle
promotes bacterial cell adherence. The microbes in the biofilm then produce acids which lowers the
pH and lead to mineral loss over time resulting in dissolution of the tooth structure, the formation of
caries, and failure of the restoration [5–7]. Unfortunately, currently available commercial composites
lack antibacterial properties. Accordingly, efforts were made to overcome the presence of cariogenic
bacteria, in an effort to prevent recurrent caries [8].
The incorporation of calcium fluoride nanoparticles (nCaF2) into composites has the potential
to reduce demineralization [9]. Fluoride (F) ions work by stimulating the remineralization and
suppressing the oral microorganisms [10,11]. The presence of F ions in the event of demineralization
enhances the precipitation of calcium and phosphate ions and forms fluorapatite [Ca5(PO4)3F] to
protect the tooth surface [12–14]. Fluoride was also shown to have the advantage of reducing bacterial
acid production to reduce recurrent caries.
Designing a composite containing calcium fluoride nanoparticles would enhance the fluorapatite
deposition in the affected tooth structure. When the tooth structure is subjected to acidic attack by
the cariogenic pathogens, calcium and phosphate ions are lost from enamel. Using remineralization
approaches to restore the lost minerals is required to enforce and strengthen the tooth structure.
Therefore, the composite with calcium fluoride nanoparticles would enhance remineralization and
form fluorapatite that is able to resist future acidic challenges. Several studies have demonstrated
the ability of forming fluorapatite using nanotechnology [15,16]. In one study, they manufactured
fluorapatite nanoparticles and examined its doping with silver ion nanoparticles and evaluated its
physical and antimicrobial effects. The results showed 30% inhibition of bacterial growth after 4 h of
incubation while maintaining the natural morphology of fluorapatite [15]. In another study, fluorapatite
was incorporated into chitosan scaffolds. Fluorapatite maintained its structure, granted antimicrobial
effects, and showed osteoconductive capability [16].
Furthermore, the incorporation of antibacterial agents into composites have also been investigated.
Imazato et al. integrated 12-methacryloyloxydodecylpyridinium bromide (MDPB) into composites
and showed successful antibacterial effects [17–20]. The incorporation of quaternary ammonium
polyethylenimine (QPEI) into composites also produced a potent and wide-spectrum antimicrobial effect
against salivary microorganisms [21]. Antimicrobial peptides (AMPs) were also demonstrated to have
antimicrobial properties by bacterial membrane permeabilization and intracellular targeting [22].
Other studies developed antibacterial agents such as dimethylaminohexadecyl methacrylate
(DMAHDM) [23,24] and showed a strong antibiofilm activity without compromising the mechanical
properties [25].
Previous studies indicated that the salivary protein accumulation on composite surface could
lower the efficiency of “contact-killing” mechanisms [26,27]. Accordingly, efforts were made to
improve protein-repellent strategies including the addition of protein-repellent agents such as
(2-methacryloyloxyethyl phosphorylcholine, or MPC) into resins [28–30]. This method provided
resistance to protein adsorption and bacterial adhesion due to the hydrophilic characteristic of
MPC [29,30]. However, to date, there has been no report on the development of a novel bioactive
dental composite that contains nCaF2, DMAHDM, and MPC in combination.
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The objectives of this study were to develop a new composite consisting nCaF2, DMAHDM,
and MPC, and to investigate the mechanical, ion release and oral biofilm properties for the first time.
The following hypotheses were tested: (1) Adding DMAHDM and MPC into the nCaF2 composite
would have mechanical properties similar to a commercial control composite; (2) Adding DMAHDM
and MPC into the nCaF2 composite would not compromise the F and Ca ion release; and (3) The new
bioactive composite would have much less microorganisms, produce less biofilm acid, and have better
remineralizing properties than the commercial control composite.
2. Materials and Methods
2.1. Fabrication of Composites
The experimental resin consisted of bisphenol A glycidyl dimethacrylate (BisGMA, Esstech,
Essington, PA, USA), and triethylene glycol dimethacrylate (TEGDMA, Esstech) at 50:50 mass
ratio. Camphorquinone at 0.2% (Millipore Sigma, Burlington, MA, USA) and 0.8% ethyl 4-N,
N-diethylaminobenzoate (Millipore Sigma) were incorporated for photoactivation. The resin is referred
to as BT resin. MPC (Millipore Sigma) was added at a mass fraction of 3% and incorporated into the
BT resin with magnetic stirring bar at 150 rpm to be dissolved completely into the resin.
The synthesis of DMAHDM was performed using a modified Menschutkin reaction [31]. Briefly,
10 mmol of 2-(dimethylamino) ethyl methacrylate (Millipore Sigma), 10 mmol of 1-bromohexadecane
(TCI America, Portland, OR, USA), and 3 g of ethanol were combined in a reaction vessel and then
stirred for 24 h at 70 ◦C. After the evaporation of the solvent and removal of impurities, the DMADHM
was collected. DMAHDM was added into the BT resin at a mass fraction of 3% and was stirred using a
magnetic stirring bar at 150 rpm until it was completely dissolved into the resin.
The nCaF2 was manufactured using a spray-dry method as described in previous studies, yielding
a mean particle size of 32 nm [9,32–34]. The mass fraction of nCaF2 incorporated into BT resin was
15%, based on our preliminary study. A previous study tested different concentrations of nCaF2 in
composite and, after long-term water-aging, the composite with 20% nCaF2 had a flexural strength of
60 MPa [33]. In the present study, 15% nCaF2 was integrated into the resin to achieve good mechanical
strength. Silanized barium boroaluminosilicate glass particles with a mean size of 1.4 μm (Dentsply
Sirona, Milford, DE, USA) were incorporated into the BT resin for mechanical enhancement. As a
commercial control composite, Heliomolar (Ivoclar Vivadent, Mississauga, ON, Canada) was also
tested. Heliomolar contains 66.7% filler mass fraction of ytterbium-trifluoride and nanofillers of 40–200
nm of silica. The following groups were tested (Table 1 summarizes the materials used in the study):
1. Heliomolar (referred to as commercial control (CC));
2. BT Resin + 70% glass (referred to as experimental control (EC));
3. Remineralizing composite: BT + 15% nCaF2 + 55% glass (referred to as nCaF2);
4. Antibacterial and remineralizing composite: BT + 15% nCaF2 + 3% DMAHDM + 55% glass
(referred to as nCaF2+DMAHDM);
5. Protein-repellent and remineralizing composite: BT + 15% nCaF2 + 3% MPC + 55% glass (referred
to as nCaF2+MPC);
6. Antibacterial, protein-repellent, and remineralizing composite: BT + 15% nCaF2 + 3% DMAHDM
+ 3% MPC + 55% glass (referred to as nCaF2+DMAHDM+MPC).
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Table 1. Materials used in the study.
Formulation/Manufacturer Abbreviation Fluoride DMAHDM MPC
Heliomolar, Ivoclar Vivadent, Mississauga, ON, Canada
(Commercial control) CC + - -
30% BT+70% Glass (Experimental Control) EC - - -




DMAHDM + + -
27% BT+15% nCaF2+3% MPC +55% Glass nCaF2+MPC + - +
24% BT+15% nCaF2+3% DMAHDM
+3% MPC+55% Glass nCaF2+DMAHDM+MPC + + +
2.2. Characterization of nCaF2
Transmission electron microscopy (TEM, Tecnai T12, FEI, Hillsboro, OR, USA) was used to assess
the nanoparticles. Samples were prepared through placing nanoparticles on a perforated copper grid
coated by a carbon film. To avoid particle agglomeration, the sample was ultrasonicated for 5 min in
acetone prior to deposition. Particle size distribution was measured using a laser diffraction particle
size analyzer (SALD-2300, Shimadzu North America, Columbia, MD, USA).
2.3. Mechanical Properties Testing
Each composite paste was mixed in a disposable plastic container using a speed mixer (DAC 150.1
FVZ-K SpeedMixer™, FlackTec Inc., Landrum, SC, USA) at a speed of 2800 rpm for 1 min, and then
thoroughly mixed by hand on a plastic slab for 5 min. The paste was then placed in a rectangular mold
of 2 × 2 × 25 mm3. Mylar strips were placed on both sides, followed by two glass slides. The specimen
was light-cured using a curing unit at 1200 mW/cm2 (Labolight DUO, GC America, Alsip, IL, USA) on
each side for 1 min [35]. After demolding, the samples were stored in a 100% humidity chamber for
24 h at 37 ◦C. Flexural strength and elastic modulus were tested at a crosshead-speed of 1 mm/min with
a 10 mm span with a three-point flexural test using a computer-controlled universal testing system
(Insight 1, MTS, Eden Prairie, MN, USA) [36,37]. Flexural strength and elastic modulus were measured
after 24 h of specimen immersion in distilled water at 37 ◦C. Flexural strength: S = 3Pmax/L(2bh2),
where Pmax is the fracture load, L is span, b is sample width and h is thickness. Elastic modulus:
E = (P/d) (L3/[4bh3]), where load P was divided by displacement d which is the slope in the linear
elastic region. Six specimens were tested for each group (n = 6).
2.4. Ca and F Ion Release
The ion releases for all groups containing nCaF2 were tested. A solution of sodium chloride
(NaCl) (133 mmol/L) was buffered with 50 mmol/L HEPES to pH 7 [36,38]. Three specimens of 2 × 2
× 12 mm3 were placed into 50 mL of solution, accommodating a specimen volume/solution ratio of
3.0 mm3/mL, similar to those in previous studies [36,38,39]. The specimen’s F and Ca ions release were
measured at 1, 2, 4, 7, 14, 21, 28, 35, 42, 49, 56, 63, and 70 days. At every time point, aliquots of 2 mL
were collected and substituted by a fresh 2 mL solution of NaCl. The aliquots were investigated for Ca
ions by a colorimetric assay using a microplate reader (SpectraMax M5, Molecular Probes, San Jose,
CA, USA) as previously described, using known standard and calibration curves [36,38,39]. The F ion
release was tested with a F ion selective electrode (Orion, Cambridge, MA, USA). Fluoride standard
solutions were measured to form a standard curve. The standard curve was used to establish the F
concentration. The F ion concentration measurement was performed by combining 0.5 mL of sample
and 0.5 mL of undiluted TISAB solution (Fisher Scientific, Pittsburgh, PA, USA).
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2.5. Sample Preparation for Biofilm Tests
The cover of a 96 well plate was used to fabricate composite discs for microbiological experiments
yielding samples 0.5 mm in thickness and 8 mm in diameter [31]. Composite paste was placed at
each indent in the in 96-well plate cover then covered with Mylar strips and glass slides to form a
smooth surface. It was then light cured as described previously and then stored for 24 h at 37 ◦C.
The following day discs were magnetically stirred for 1 h at 100 rpm in distilled water to remove
uncured monomers [18,40,41]. The specimens were sterilized using ethylene oxide (Anprolene AN
74i, Andersen Products, Haw River, NC, USA) for 24 and allowed to de-gas for 7 days, following the
instructions of the manufacturer.
2.6. Saliva Collection and Dental Plaque Microcosm Biofilm Model
Saliva collection was conducted in accordance with the Declaration of Helsinki, and the protocol
was approved by the Institutional Review Board at the University of Maryland Baltimore (IRB
#: HP-00050407). The advantage of the dental plaque microcosm biofilm model is the use of an
inoculum of human saliva to mimic the heterogeneity and complexity of the bacteria that are present in
human dental plaque [18]. An equal amount of saliva was simultaneously gathered from ten healthy
contributors with normal dentition, free of active caries, and no antibiotic use within the prior 3 months.
Contributors were instructed not to brush their teeth 24 h preceding collection and not to eat or drink
2 h preceding the collection. Subsequently, the collected saliva from all participants was mixed and
diluted to 70% in sterile glycerol. Then the saliva–glycerol solution was stored at −80 ◦C until use [42].
For all biofilm experiments, McBain artificial saliva growth medium was used. McBain medium
contained 2.5 g/L Type II mucin (porcine, gastric, Millipore Sigma), 2.0 g/L bacteriological peptone
(Becton Dickinson, Sparks, MD, USA), 2.0 g/L tryptone (Becton Dickinson), 0.35 g/L NaCl, 1.0 g/L yeast
extract (Fisher Scientific), 0.2 g/L potassium chloride (Millipore Sigma), 0.1 g/L cysteine hydrochloride
(Millipore Sigma), 0.2 g/L calcium chloride (Millipore Sigma). The pH of the medium was adjusted
to 7 and autoclaved. After cooling the medium, 0.0002 g/L vitamin K1, 0.001 g/L hemin were added.
During biofilm experiments, 2% sucrose solution and the saliva–glycerol solution were used as an
inoculum at a ratio of 1:50. The sucrose and inoculum were added to the medium and 1.5 mL of the
medium was placed in each well of a 24-well plate containing a composite specimen from each groups.
Specimen were incubated in 5% CO2 at 37 ◦C for 8 h to permit biofilm growth on the samples. The same
procedure was repeated after 8 h without the addition of saliva and incubation occurred again for 16 h.
After 16 h the samples were moved to a new 24-well plate which contained fresh medium and sucrose,
and was further incubated for 24 h. Composites were exposed to bacterial culture for a total of 48 h,
which resulted in reasonably mature dental plaque microcosm biofilms on composites [25,43].
2.7. Biofilm Colony Forming Units (CFU) Counts
Nine discs were prepared for each group. Following the 48 h incubation, the disc samples
containing biofilm were transported into a vial filled with 1 mL of cysteine peptone water (CPW).
This was vortexed for 5 s then sonicated for 5 min and vortexed again to harvest the biofilm [29].
Serial dilutions of the suspensions of bacteria were prepared and transported to agar plates to grow.
The CFU were counted on three different agar plates. To determine total streptococci count, mitis
salivarius agar (MSA, Becton Dickinson, Sparks, MD, USA) were used. To determine the growth of
mutans streptococci, 0.2 units per mL bacitracin (Millipore Sigma) was added to the mitis salivarius
agar (MSB). To evaluate the growth of the total microorganisms, tryptic soy blood agar (TSBA) agar
plates were used by adding defibrinated sheep blood to tryptic soy agar (TSA, Becton Dickinson).
The agar plates were kept at 37 ◦C in a 5% CO2 incubator for 48 h. CFU calculation was based on the
colony number and multiplied by the dilution factor [29].
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2.8. Biofilms Metabolic Activity Evaluation (MTT)
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5- diphenyltetrazolium bromide) assay was performed
to investigate the biofilm metabolic activity. Following 48 h of incubation, the discs (n = 9) were
transferred into a clean 24-well plate, then 1 mL of tetrazolium dye was placed to every disc. The discs
were then incubated in an incubator of 5% CO2 at 37 ◦C. Discs were then transported to another
24-well plate, and 1 mL of dimethyl sulfoxide (DMSO) was added to every disc and incubated for
20 min in a dark room [29,44]. After incubation, 200 μL of the DMSO solution was collected and the
absorbance at 540 nm was measured [29,44] using a microplate reader (SpectraMax® M5, Molecular
Devices, San Jose, CA, USA).
2.9. Biofilms Lactic Acid Production
Following 48 h incubation, discs (n = 9) were moved to a different 24-well plate comprising 1.5 mL
buffered-peptone water (BPW) with 0.2% sucrose then incubated for 3 h in a 5% CO2 incubator at 37 ◦C
to release acids. After 3 h, the BPW solution lactic acid concentrations were measured by recording
the absorbance at 340 nm [29,44] using a microplate reader (SpectraMax® M5, Molecular Devices).
Standard curves were produced by means of lactic acid standards.
2.10. Scanning Electron Microscopy (SEM) of Biofilms
For biofilm visualization and confirmation of bacterial attachments on composite discs, biofilms
formed at 24 h, 48 h, and 96 h were sputter-coated with platinum. Scanning electron microscopy
(SEM, Quanta 200, FEI Company, Hillsboro, OR, USA) was used to examine the bacterial accumulation
(Figure 7).
3. Statistical Analysis
All data were evaluated with one-way analysis of variance (ANOVA), and post hoc multiple
comparison using Tukey’s honestly significant difference test was performed. All statistical analysis
was completed using the GraphPad Prism 8 software package (GraphPad Software, San Diego, CA,
USA) at 0.05 level of significance.
4. Results
A representative TEM image of calcium fluoride (nCaF2) nanoparticles is shown in Figure 1A.
The nanoparticle size distribution ranged from 22 nm to 57 nm, with a mean particle size of 32 nm and
is illustrated in Figure 1B.
Flexural strength and elastic modulus of the six composite groups (mean ± sd; n = 6) are shown in
Figure 2A,B, respectively. The flexural strength was measured after one day of immersion in water at
37 ◦C. The flexural strength was significantly higher in EC and nCaF2 composites, when compared to
the commercial Heliomolar control (p < 0.05). Flexural strength in groups with nCaF2+DMAHDM and
nCaF2+MPC matched those of Heliomolar control composite (p > 0.05). However, flexural strength in
nCaF2+DMAHDM+MPC was significantly lower than commercial Heliomolar control (p < 0.05).
The elastic modulus values of EC and nCaF2 were significantly greater than all other groups
(p < 0.05). Other groups had comparable elastic modulus values to Heliomolar control (p < 0.05).
The accumulative F ion release is shown in Figure 3. At 70 days, the composite nCaF2+MPC
had the highest F release of (0.40 ± 0.02) mmol/L (p < 0.05). Meanwhile, nCaF2+DMAHDM+MPC
had F release of (0.25 ± 0.03) mmol/L, nCaF2+DMAHDM had (0.20 ± 0.03) mmol/L, and nCaF2 had
(0.04 ± 0.01) mmol/L of fluoride ion release. Heliomolar control had the lowest F release of (0.004 ±
0.0003) mmol/L.
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Figure 1. (A) TEM of nanoparticles of CaF2 (nCaF2) synthesized in this study. (B) Particle size
distribution of nCaF2. The nCaF2 were synthesized via a spray-drying technique and collected using
an electrostatic precipitator.
Figure 2. Mechanical properties of composites: (A) Flexural strength, and (B) Elastic modulus (mean ±
sd; n = 6). The flexural strength was higher in experimental control (EC) and nCaF2 than commercial
Heliomolar control (p < 0.05). Flexural strength in nCaF2+DMAHDM and nCaF2+MPC matched
Heliomolar control (p > 0.05). However, the flexural strength in nCaF2+DMAHDM+MPC was reduced
(p < 0.05). The elastic modulus of the EC and nCaF2 were higher than Heliomolar control (p < 0.05).
All other groups had comparable elastic moduli to Heliomolar control after 1 day of immersion (p> 0.05).
In each plot, different letters (a, b, c) indicate values that are significantly different from each other
(p < 0.05).
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Figure 3. Fluoride (F) ion release from composites (mean ± sd; n = 6) at pH 7.0. The incorporation of
nCaF2, DMAHDM, and MPC increased the release of F ions with time (p < 0.05). Different letters (a, b,
c, d, e) indicate significant differences between groups at day 70 (p < 0.05).
The calcium ion release is plotted in Figure 4. At 70 days, nCaF2+MPC had a Ca ion release
of (0.32 ± 0.005) mmol/L, and nCaF2+DMAHDM+MPC had a similar ion release at (0.35 ± 0.006)
mmol/L. Groups containing MPC had ion releases that were significantly higher when compared to
other groups (p < 0.05). nCaF2 had a Ca ion release of (0.11 ± 0.004) mmol/L. nCaF2+DMAHDM had
(0.18 ± 0.005) mmol/L, and Heliomolar control had close to zero Ca ion release.
Figure 4. Calcium (Ca) ion release from composite resins (mean± sd; n = 6) at pH 7.0. The incorporation
of nCaF2, DMAHDM, and MPC increased the release of Ca ions with time (p < 0.05). Different letters
(a, b, c, d) indicate significant differences between groups at day 70 (p < 0.05).
Two-day biofilm colony forming units CFU on composites are shown in Figure 5: (A) Total
microorganisms, (B) total streptococci and (C) mutans streptococci (mean ± SD; n = 9). CFU was
reduced by 6 logs from a mean of 2.51 × 108 counts for Heliomolar control to 1.00 × 102 counts for the
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new nCaF2+DMAHDM+MPC composite (p < 0.05). nCaF2+DMAHDM reduced the CFU by 4 logs
(p < 0.05). The combination of nCaF2+DMAHDM+MPC yielded the smallest CFU counts.
Figure 5. Colony-forming unit (CFU) counts of 2-day biofilm on composite discs (mean ± sd;
n = 9): (A) Total microorganisms, (B) total streptococci, and (C) mutans streptococci (mean
± sd; n = 9).The incorporation of nCaF2+DMAHDM+MPC had the lowest CFU, followed by
nCaF2+DMAHDM in the total microorganisms. The reduction of CFU in nCaF2+DMAHDM+MPC
and nCaF2+DMAHDM was similar in total streptococci and mutans streptococci (p < 0.05). In each
plot, different letters (a, b, c, d) indicate significant differences between groups (p < 0.05).
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The bacterial metabolic activity of 2 days biofilm on composites is shown in Figure 6A. Metabolic
activity was decreased from 0.18 (OD540/cm2) for commercial Heliomolar composite control, to 0.02 for
the nCaF2+DMAHDM+MPC composite (p < 0.05). Biofilm lactic acid production results can be seen
in Figure 6B. The lactic acid production was reduced from 0.72 mmol/L on commercial Heliomolar
control composite to 0.29 mmol/L in the nCaF2+DMAHDM+MPC composite.
Figure 6. (A) The total metabolic activity, and (B) Lactic acid production (mean ± sd; n = 9) of composite
specimens exposed to salivary biofilm. The incorporation of nCaF2+ DMAHDM had the best reduction
in the metabolic activity and lactic acid production (p < 0.05). In each plot, different letters (a, b, c, d)
indicate significant differences between groups (p < 0.05).
SEM results in Figure 7 indicate an extensive biofilm formation at 24 h, 48 h, and 96 h in all
groups except those containing the antimicrobial DMAHDM. Heliomolar (CC), experimental control
(EC), and nCaF2+MPC groups had the most biofilm formation at all time points, followed by the
nCaF2 group. Biofilm formation increased with time. However, in DMAHDM-containing groups there
was minimal attachment of biofilm observed. At 96 h, the DMAHDM-containing groups showed a
reduction in biofilm attachment compared with earlier time points.
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Figure 7. Scanning Electron Microscopy (SEM) images of biofilm formed on composite disc surfaces
at 24 h, 48 h, and 96 h. All images are at 3000×magnification. Arrows indicate presence of minimal
biofilm on DMAHDM-containing specimens. All other groups had full coverage of a substantial and
mature biofilm.
5. Discussion
The present study developed a new composite consisting of nCaF2, DMAHDM and MPC,
and investigated the mechanical, ion release and oral biofilm properties. The protein-repellant
nCaF2+DMAHDM+MPC had slightly lower mechanical properties when compared to all other
groups. However, nCaF2+DMAHDM had good mechanical properties matching those of a commercial
composite, while possessing high levels of F and Ca ion release and a strong antibacterial effect.
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The new bioactive composite nCaF2+DMAHDM decreased biofilm CFU by four orders of magnitude
over that of commercial control composite, and substantially reduced acid production to inhibit caries.
Critical to the development of any new composite restorative material are its mechanical properties.
The flexural strength of EC was around (170 ± 38) MPa. With the addition of 15% nCaF2, the strength
was reduced slightly to (157 ± 5) MPa. Those values are consistent with the results in a previous
study [32]. The composite in that study had 65% total fillers and 20% CaF2, similar to the 70% total
fillers and 15% nCaF2 composition in the present study. The flexural strength for the control group
containing no nCaF2 in the previous study was (145 ± 9) MPa, while the group which had 20% nCaF2
had a flexural strength of 121 MPa. The nCaF2+DMAHDM and nCaF2+MPC had similar strengths of
(95 ± 6), and (96 ± 5) MPa, respectively. Meanwhile, for nCaF2+DMAHDM+MPC, the flexural strength
was around (64 ±3) MPa. Those are similar to the results of a previous study using the same filler mass
fraction where the flexural strength was around 90 MPa when 3% MPC and 3% DMAHDM were added
to the BT resin [43]. The decreased strength in nCaF2+DMAHDM+MPC could be due to two reasons.
First, the BT base resin is composed of BisGMA and TEGDMA, which contain two reactive groups
each. However, both DMAHDM and MPC are monomethacrylates and contain one reactive group.
The addition of these monomethacrylates may substantially change the reaction kinetics and resulting
crosslinked network, which can result in inferior mechanical properties. Another possible explanation
for the decrease in mechanical properties is due to the hydrophilic nature of MPC. The specimens for
flexural strength were stored for 24 h in water at 37 ◦C. The hydrophilicity of MPC makes it more likely
that the composite would absorb water during the 24 h immersion prior to testing. This would likely
lead to the reduction in flexural strength compared with the non-MPC groups.
Fluoride releasing materials have been known to render teeth more resistant to decay [45]. However,
many available materials with fluoride-releasing properties, such as glass ionomer and resin modified
glass ionomers, have inferior mechanical properties that do not serve the high load requirements for
restorations in stress-bearing areas. Therefore, the incorporation of F ions into composite restorations
would have the dual benefit of fluoride release and improved mechanical properties [46–48]. The current
study synthesized nCaF2 through a spray-drying method, which produced nanoparticles of CaF2
with a median particle size of about 32 nm. The use of small amounts of nCaF2 fillers prevented the
mechanical properties to be compromised. As seen in previous studies, the use of fluoride fillers with
larger particle sizes require higher mass fractions of fillers to achieve significant fluoride ion release.
This would lead to a decrease in the composite mechanical properties [49].
The incorporation of nanoparticles with a high surface area resulted in the release of high levels of
F and Ca ions using a low nCaF2 filler level [33]. F ions foster remineralization by forming fluoroapatite
[Ca5(PO4)3F] [50]. Furthermore, it was shown that the lower the pH, the higher the release of ions.
In this study, the release of F ions was significantly increased with the integration of 15% nCaF2 at a pH
of 7, measuring (0.04 ± 0.01) mmol/L. This was comparable to the 0.03 mmol/L F release level in a study
that had a pH of 6, yet with an increased percentage of CaF2 (23%) [51]. Groups containing MPC had
the highest F ion release over time. The levels of release in nCaF2+MPC and nCaF2+DMAHDM+MPC
were (0.40 ± 0.02) mmol/L and (0.25 ± 0.03) mmol/L, respectively. This could be due to the hydrophilic
nature of MPC, resulting in a higher level of water uptake. As more water was absorbed by the
composite, the Ca and F ions were solubilized, leading to an increase in the initial ion release. However,
nCaF2+DMAHDM F ion release was (0.20 ± 0.03) mmol/L, which was superior to the control. While the
amount of nCaF2 was the same in the two groups, the lower level of initial release in nCaF2+DMAHDM,
when compared to MPC containing groups, could result in a more sustained level of F ion release
over a longer period. The releasing trend of F and Ca ions were the same for all groups. The groups
containing nCaF2 had a high F release initially, and subsequently were followed by a steady state
release. The higher release of Ca and F ions in all nCaF2 composites revealed that CaF2 nanoparticles
were fast released from the nCaF2 composites because of the hydrolytic breakdown of the interface
between the resin matrix and the CaF2 nanoparticles. A likely explanation for such a trend is that the
ions were released from the near-surface Ca and F reservoir of the nCaF2 composite, and the reservoir
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near the surface diminished with the increase in immersion time. However, in clinical situations,
the superficial layer of nCaF2 would experience repeated chewing forces and tooth-brushing, hence the
CaF2-depleted surface would be removed by wear. As a result, a fresh surface would be exposed
with the ability to further continue the calcium and fluoride release. Further studies are needed to
investigate the outcome of wear on Ca and F ion release, as well as whether these materials can be
made rechargeable to extend the lifetime of ion release.
Recurrent caries is considered a major drawback of composite restorations [1,52,53].
Studies proposed that the greater vulnerability to recurrent caries may be associated with the absence of
composites’ antibacterial capability when compared to other commonly used restorative materials such
as glass ionomers and amalgams [2,54]. Therefore, the improvement of composites by incorporating
antibacterial, protein repellent, and remineralizing properties is essential to lengthen the service life
of composite restorations. DMAHDM has demonstrated strong antibacterial effects on an extensive
antimicrobial spectrum through its contact-killing properties [26,55]. Since DMAHDM contains a
reactive methacrylate group, it is copolymerized within the resin matrix, rendering it immobilized
and preventing its release or loss over time [26,56]. Hence, its antibacterial capability is long-lasting.
However, the antibacterial ability of DMAHDM is limited to biofilms that contact the composite
surface [26], as biofilms that are not in contact with DMAHDM cannot be killed via DMAHDM’s
mechanism of action. Even with this limitation, the composite containing nCaF2+DMAHDM
substantially lowered the biofilm development and production of lactic acid, reducing the CFU
of biofilm by 4 logs.
It can be seen in Figure 6B that the experimental control group and the group containing nCaF2
and MPC exhibited a greater lactic acid production when compared with the other groups. DMAHDM
has been shown in previous work to have a strong antibacterial effect, as illustrated by the CFU data
in Figure 5. This antibacterial activity is reflected indirectly by the lactic acid production. When an
S mutans biofilm accumulates, the secretion of lactic acid occurs. In the absence of a viable biofilm,
the concentration of lactic acid is expected to be very low, as is the case in the DMAHDM-containing
groups. Interestingly, the nCaF2 and nCaF2+MPC groups did not have a significant reduction in CFU
(Figure 5), but the nCaF2 group showed a significant reduction in lactic acid production in contrast
to the nCaF2+MPC group. Previously, it has been shown that the inclusion of CaF2 in a composite
formulation has a moderating effect on the lactic acid production [57]. It has been speculated that the F
ion release helped reduce the acid production of the bacteria via the inhibition of metabolic pathways
such as the fermentation pathway for lactic acid production, biofilm plaque, and hydrodynamic effects
on mass transfer, fluoride delivery, and caries [58]. However, when MPC was added to the composite
containing nCaF2, there was no decrease in lactic acid production. This response may be related to
the interactions between the calcium and fluoride ions and the phosphorylcholine fragment of MPC.
The protein-repellent nature of MPC from the hydrogen bond network of water molecules surrounding
the phosphorylcholine fragment limited the ability of the protein to adsorb on the surface. It was
found, however, that the presence of halide ions (Cl−, Br−, I−) influenced the hydrogen bond network
and the diffusion through it [59]. It is possible that the presence of F− ions would have a similar result,
which may affect F ion diffusion and disrupt the creation of a protein-repellant coating, leading to
biofilm formation.
SEM images in Figure 7 confirm the presence of substantial biofilm on all groups except those
containing DMAHDM. At 24 h and 48 h, Heliomolar (CC), experimental control (EC), nCaF2,
and nCaF2+MPC groups exhibited the formation of microcolonies and early biofilm multilayers.
The biofilms on these groups at 96 h were fully mature, substantial, and dense. However,
in DMAHDM-containing groups there was minimal attachment of biofilm observed. At 96 h the
DMAHDM-containing groups showed a reduction in biofilm attachment compared to earlier time
points. It is possible that the antimicrobial effect of DMAHDM as a contact-killing agent had eliminated
the bacteria left on the samples over time. These results correlate very well with the CFU results.
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It is possible that the salivary proteins adsorption on composite resin surfaces might reduce the
effectiveness of this “contact-killing” mechanism. Therefore, a protein repellent agent was added.
MPC is a methacrylate that contains phospholipid polar groups. MPC is highly hydrophilic and has
been shown to decrease the adsorption of protein and reduce bacterial attachments [60]. Previous work
indicated that integrating MPC into the resin decreased the adsorption of proteins by approximately
one order of magnitude [43,61]. Additionally, it was shown that surfaces containing MPC were
resistant to brushing mechanical stresses [62]. In this study, MPC was incorporated into the resin,
and copolymerized into the composite resin. This is analogous to the process of incorporating
DMAHDM, with a similar result of a stable, covalently bonded, and non-releasing functionality.
In the current study, the antibacterial capability of the experimental composite was improved
with nCaF2 and was further substantially improved with the use of both nCaF2 and DMAHDM.
However, the nCaF2+MPC group showed no reduction in the CFU counts. The composite that
had nCaF2+DMAHDM+MPC displayed the most potent antibacterial effect with CFU 6 log biofilm
reduction. Therefore, these results confirmed that the addition of DMAHDM is vital to improving the
antibacterial effect. It is thought that DMAHDM serves to reduce the accumulation of biofilm and,
as a result, improves the efficacy of MPC in resisting protein adsorption. However, in the absence of
DMAHDM, the bacterial biofilm will accumulate and render MPC less effective.
The combination of nCaF2+DMAHDM promoted remineralization and had a significant
antibacterial effect. Another potential benefit of using nCaF2 is that the release of F ions could
act as a transmembrane proton carrier and an inhibitor to the glycolytic enzyme, thus preventing
oral microorganisms by stimulating acidification of the cytoplasm and providing antibacterial effect
at a long-distance to inhibit caries [10,63]. These properties would be highly valuable to inhibit
recurrent caries around the margins of the restoration, since this is the location that most dental
plaque tends to accumulate. In addition to its superior antibacterial and remineralization properties,
the nCaF2+DMAHDM composite exhibits excellent mechanical properties which make it suitable in a
variety of restoration applications. In comparison, the composite consisting of nCaF2+DMAHDM+MPC
exhibited lower mechanical properties. However, the strength and modulus achieved by this group
was still high enough to be used for restorations in low load areas such as class V restorations [37].
This is a critical area of utilization, since older patients tend to have exposed root surfaces that are
more prone to caries. Further studies are needed to investigate the nCaF2+DMAHDM combination in
dental cements, bonding agents, fissure sealants, and composites to remineralize tooth lesions and
suppress biofilm and plaque buildup, especially in patients with a high caries risk.
6. Conclusions
A novel composite with remineralization and antibacterial properties was established by combining
nCaF2+DMAHDM for the first time. Release of F and Ca ions from the composite was significantly
achieved through the incorporation of nCaF2. The new composite exhibited strong antibacterial and
ion release capabilities, prevented biofilm production of lactic acid, and decreased biofilm CFU by 4 log.
This bioactive nanocomposite is promising to protect tooth structures, inhibit demineralization,
and provide a reservoir for the release of calcium and fluoride ions. The combined effect of
nCaF2+DMAHDM shows promise in a variety of dental applications where remineralization and
prevention of recurrent caries is a priority.
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46. Kus-Liśkiewicz, M.; Rzeszutko, J.; Bobitski, Y.; Barylyak, A.; Nechyporenko, G.; Zinchenko, V.; Zebrowski, J.
Alternative Approach for Fighting Bacteria and Fungi: Use of Modified Fluorapatite. J. Biomed. Nanotechnol.
2019, 15, 848–855. [CrossRef] [PubMed]
47. Montazeri, N.; Jahandideh, R.; Biazar, E. Synthesis of fluorapatite–hydroxyapatite nanoparticles and toxicity
investigations. Int. J. Nanomed. 2011, 6, 197–201. [CrossRef]
48. Wiegand, A.; Buchalla, W.; Attin, T. Review on fluoride-releasing restorative materials—Fluoride release
and uptake characteristics, antibacterial activity and influence on caries formation. Dent. Mater. 2007, 23,
343–362. [CrossRef]
49. Balhaddad, A.A.; Kansara, A.A.; Hidan, D.; Weir, M.D.; Xu, H.H.K.; Melo, M.A.S. Toward dental caries:
Exploring nanoparticle-based platforms and calcium phosphate compounds for dental restorative materials.
Bioact. Mater. 2019, 4, 43–55. [CrossRef]
50. Lata, S.; Varghese, N.O.; Varughese, J.M. Remineralization potential of fluoride and amorphous calcium
phosphate-casein phospho peptide on enamel lesions: An in vitro comparative evaluation. J. Conserv. Dent.
2010, 13, 42–46. [CrossRef]
51. Anusavice, K.J.; Zhang, N.-Z.; Shen, C. Effect of CaF2 content on rate of fluoride release from filled resins.
J. Dent. Res. 2005, 84, 440–444. [CrossRef]
52. Sakaguchi, R.L. Review of the current status and challenges for dental posterior restorative composites:
Clinical, chemistry, and physical behavior considerations. Summary of discussion from the Portland
Composites Symposium (POCOS) June 17–19, 2004, Oregon Health and Science University, Portland, Oregon.
Dent. Mater. 2005, 21, 3–6. [CrossRef]
53. Demarco, F.F.; Corrêa, M.B.; Cenci, M.S.; Moraes, R.R.; Opdam, N.J.M. Longevity of posterior composite
restorations: Not only a matter of materials. Dent. Mater. 2012, 28, 87–101. [CrossRef]
54. Nedeljkovic, I.; Teughels, W.; De Munck, J.; Van Meerbeek, B.; Van Landuyt, K.L. Is secondary caries with
composites a material-based problem? Dent. Mater. 2015, 31, e247–e277. [CrossRef] [PubMed]
55. Imazato, S.; Ebi, N.; Takahashi, Y.; Kaneko, T.; Ebisu, S.; Russell, R.R.B. Antibacterial activity of
bactericide-immobilized filler for resin-based restoratives. Biomaterials 2003, 24, 3605–3609. [CrossRef]
56. Xu, X.; Wang, Y.; Liao, S.; Wen, Z.T.; Fan, Y. Synthesis and characterization of antibacterial dental monomers
and composites. J. Biomed. Mater. Res. Part B Appl. Biomater. 2012, 100B, 1151–1162. [CrossRef]
57. Cheng, L.; Weir, M.D.; Xu, H.H.K.; Kraigsley, A.M.; Lin, N.J.; Lin-Gibson, S.; Zhou, X. Antibacterial
and physical properties of calcium-phosphate and calcium-fluoride nanocomposites with chlorhexidine.
Dent. Mater. 2012, 28, 573–583. [CrossRef]
58. Stoodley, P.; Wefel, J.; Gieseke, A.; Debeer, D.; von Ohle, C. Biofilm plaque and hydrodynamic effects on
mass transfer, fluoride delivery and caries. J. Am. Dent. Assoc. 2008, 139, 1182–1190. [CrossRef]
59. Zhang, Z.J.; Madsen, J.; Warren, N.J.; Mears, M.; Leggett, G.J.; Lewis, A.L.; Geoghegan, M. Influence of salt
on the solution dynamics of a phosphorylcholine-based polyzwitterion. Eur. Polym. J. 2017, 87, 449–457.
[CrossRef]
60. Sibarani, J.; Takai, M.; Ishihara, K. Surface modification on microfluidic devices with 2-methacryloyloxyethyl
phosphorylcholine polymers for reducing unfavorable protein adsorption. Colloids Surf. B Biointerfaces 2007,
54, 88–93. [CrossRef]
61. Zhang, N.; Chen, C.; Melo, M.A.; Bai, Y.-X.; Cheng, L.; Xu, H.H. A novel protein-repellent dental composite
containing 2-methacryloyloxyethyl phosphorylcholine. Int. J. Oral Sci. 2015, 7, 103–109. [CrossRef]
62. Tateishi, T.; Kyomoto, M.; Kakinoki, S.; Yamaoka, T.; Ishihara, K. Reduced platelets and bacteria adhesion on
poly(ether ether ketone) by photoinduced and self-initiated graft polymerization of 2-methacryloyloxyethyl
phosphorylcholine. J. Biomed. Mater. Res. A 2014, 102, 1342–1349. [CrossRef]
63. Van Loveren, C. Antimicrobial activity of fluoride and its in vivo importance: Identification of research
questions. Caries Res. 2001, 35 (Suppl. S1), 65–70. [CrossRef]
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution







Early Polylysine Release from Dental Composites and
Its Effects on Planktonic Streptococcus mutans Growth
Nikos N. Lygidakis 1, Elaine Allan 2, Wendy Xia 3, Paul F. Ashley 1 and Anne M. Young 3,*
1 Unit of Paediatric Dentistry, Department of Craniofacial Growth and Development, UCL Eastman Dental
Institute, London WC1X 8LD, UK; nikos.lygidakis@gmail.com (N.N.L.); p.ashley@ucl.ac.uk (P.F.A.)
2 Division of Microbial Diseases, UCL Eastman Dental Institute, London WC1X 8LD, UK; e.allan@ucl.ac.uk
3 Department of Biomaterials and Tissue Engineering, UCL Eastman Dental Institute, London WC1X 8LD, UK;
wendy.xia2011@yahoo.co.uk
* Correspondence: anne.young@ucl.ac.uk
Received: 19 June 2020; Accepted: 24 July 2020; Published: 27 July 2020
Abstract: The study aim was to assess the effect of incorporating polylysine (PLS) filler at different mass
fractions (0.5, 1 and 2 wt%) on PLS release and Streptococcus mutans planktonic growth. Composite
containing PLS mass and volume change and PLS release upon water immersion were assessed
gravimetrically and via high-performance liquid chromatography (HPLC), respectively. Disc effects on
bacterial counts in broth initially containing 8× 105 versus 8× 106 CFU/mL Streptococcus mutans UA159
were determined after 24 h. Survival of sedimented bacteria after 72 h was determined following
LIVE/DEAD staining of composite surfaces using confocal microscopy. Water sorption-induced mass
change at two months increased from 0.7 to 1.7% with increasing PLS concentration. Average volume
increases were 2.3% at two months whilst polylysine release levelled at 4% at 3 weeks irrespective
of composite PLS level. Early percentage PLS release, however, was faster with higher composite
content. With 0.5, 1 and 2% polylysine initially in the composite filler phase, 24-h PLS release into
1 mL of water yielded 8, 25 and 93 ppm respectively. With initial bacterial counts of 8 × 105 CFU/mL,
this PLS release reduced 24-h bacterial counts from 109 down to 108, 107 and 102 CFU/mL respectively.
With a high initial inoculum, 24-h bacterial counts were 109 with 0, 0.5 or 1% PLS and 107 with 2%
PLS. As the PLS composite content was raised, the ratio of dead to live sedimented bacteria increased.
The antibacterial action of the experimental composites could reduce residual bacteria remaining
following minimally invasive tooth restorations.
Keywords: polylysine; antibacterial; dental composites
1. Introduction
Dental caries is one of the most common diseases affecting humans. Traditionally, treatment
involved the removal of all the affected tooth structure followed by replacement with amalgam. Silver
mercury amalgam is a highly effective restorative material due to both its good mechanical and
antibacterial properties. Following the Minamata agreement in 2013 on global mercury reduction
signed by 140 counties, amalgam is being phased out. In Europe, amalgam use in primary teeth was
banned in 2018 [1].
Modern dentistry advocates for the removal of highly infected surface dentine but not underlying
demineralized and less infected dentine that may be close to the pulp [2]. Effective cavity sealing with
Glass Ionomer Cement (GIC) restorations can reduce any underlying residual bacterial contamination.
It can also encourage remineralization but have insufficient strength for larger cavities.
Conversely, dental composites have greater strength, but their placement is complex and their
technique sensitive. Multiple adhesion-promoting steps are required, in addition to material placement
and light curing in several increments to reduce polymerization shrinkage consequences [3]. Composite
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failure is usually due to secondary caries at the restoration margins. This is attributed to a combination
of residual bacteria, shrinkage and enzyme-activated degradation of demineralized dentine, which
may compromise the bonding interface, enabling further bacterial penetration and growth [4]. A
composite material that could provide surface release of antibacterial and remineralizing agents upon
damage of the tooth/restoration interface might therefore be beneficial.
Antibacterial components such as chlorhexidine, fluoride, quaternary ammonium methacrylate,
silver and triclosan have previously been added to dental composites [5–9]. Polylysine (PLS) is an
alternative antibacterial agent that has been included in composites more recently. Polylysine-greater
eukaryotic cell-compatibility may address the limited biocompatibility of some other antibacterial
agents [10,11]. Studies suggest electrostatic adsorption of polylysine on bacterial surfaces, and its
abnormal distribution within their cytoplasm, leads to their cell damage [12,13]. Polylysine, however,
is generally recognized as safe (GRAS). It is a natural polypeptide that is biodegradable, water-soluble,
nontoxic and edible. Additionally, polylysine is extensively used in eukaryotic cell culture to promote
cell attachment and as a food preservative [12,14]. In the human body, polylysine degrades harmlessly
to give the essential amino acid, lysine [12,14]. Furthermore, polylysine addition into calcium
phosphate-containing composites can enhance apatite precipitation on their surfaces from simulated
body fluid. Polylysine may therefore also enhance composite remineralizing potential [10].
Whilst many properties of polylysine-containing dental composites have now been
investigated [10,11], publications on their actions against bacteria are limited. In this study, therefore,
the ability of composites with increasing levels of polylysine to affect bacterial growth was investigated.
Effects on planktonic bacteria are assessed to model the feasibility of surface polylysine release reducing
bacterial microleakage in gaps at the tooth restoration interface. Polylysine release kinetics are provided
to help explain the varying levels of antibacterial action. Potential polylysine addition and release
effects on set material stability are monitored through mass and volume changes in water.
2. Materials and Methods
2.1. Components
The resin matrix was prepared using Urethane Dimethacrylate (UDMA) (DMG, Hamburg,
Germany) as a base monomer and PolyPropylene Glycol Dimethacrylate (PPGDMA) (Polysciences,
Inc., Warrington, FL, USA) as a diluent monomer. 4-methacryloxyethyl trimellitate anhydride (4-META)
(Polysciences, Inc., Warrington, FL, USA) and Camphorquinone (CQ) (DMG, Hamburg, Germany)
were added at low level. The filler consisted of two different sizes of aluminosilicate glass of 7 μm
and 0.7 μm (DMG, Hamburg, Germany), fumed silica (Aerosil OX 50, Evonik, Essen, Germany),
monocalcium phosphate monohydrate (MCPM) (Himed, Old Bethpage, NY, USA) and polylysine
(PLS) (Handary, Brussels, Belgium).
UDMA is a common base monomer, that has been used as an alternative to bisphenol A-glycidyl
methacrylate (Bis-GMA) [15]. In previous studies, PPGDMA, a diluent monomer that can be used
instead of triethylene glycol dimethacrylate (TEGDMA), enhanced paste stability, increased light
activated polymerization and reduced associated shrinkage [11]. 4-META is an adhesion-promoting
monomer [16]. Monocalcium phosphate monohydrate (MCPM) particles added to composites can
promote water sorption and react to produce brushite crystals of greater volume thereby giving
expansion to compensate polymerisation shrinkage. Furthermore, release of its phosphate ions can
promote apatite precipitation from simulated dentinal fluid to remineralize dentine [17].
2.2. Paste Preparation
Four formulations with 1 variable (PLS) were prepared. The resin (liquid) phase consisted of
UDMA (72 wt%), PPGDMA (24 wt%), 4-META (3 wt%), and CQ (1 wt%) [11]. This was prepared by
mixing the components and stirring for 24 h at room temperature on a magnetic stirrer hot plate (Jeo
Tech) until a clear liquid was achieved. The filler phase contained glass of 7 μm, 0.7 μm and fumed
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silica in the ratio 6:3:1. 10 wt% MCPM was added to the filler as in F2 in previous work [11] but the
tricalcium phosphate was removed. Additionally, the filler PLS level was varied (0, 0.5, 1 or 2 wt%)
instead of being fixed at 2 wt%. Filler: resin were mixed in the weight ratio 5:1 for 45 s at 3500 rpm
using a centrifugal mixer (Speedmixer, Hauschild Engineering, Hamm, Germany). This high ratio
produced pastes with a consistency comparable with the commercial packable composite Filtek Z250
(3M, Bracknell, UK) used as an additional control in antibacterial studies.
2.3. Composite Discs Preparation
Disc-shaped specimens were formed by applying the composite pastes within metal circlips with
internal diameter 10 mm and thickness of 1 mm and pressing them between two sheets of acetate
(Figure 1). The specimens were then photopolymerized using a blue light-emitting diode curing unit
with a wavelength of 450–470 nm and power of 1100–1300 mW/cm2 (Demi Plus, Kerr Dental, Bioggio,
Switzerland) with the tip in contact with the acetate sheet. The curing duration was 40 s on each side
of each disc. This method gives 72% monomer conversion for the formulations [11]. The discs were
then removed from the circlip, any excesses were trimmed with a no.11 blade, and stored at room
temperature in the dark until required.
 
Figure 1. Preparation of composite disc and disc placed in well.
2.4. Mass and Volume Change
The mass and volume change of set discs versus time in deionised water (DW) were determined
using a density kit and four-figure digital balance (AG204, Mettler, Toledo, OH, USA) according to the
ISO 17304:2013. 1% sodium dodecyl sulphate (Sigma-Aldrich, Gillingham, UK) in DW was used as the
buoyancy medium.
Discs (n = 3), prepared as above, were immersed in 1 mL of DW in individual sterilin tubes at
23 ◦C. At 1, 3, 6 h, 1, 2, 5, 7 days, 2, 4 and 8 weeks, the discs were removed from the solution, their
surfaces blot dried using absorbent paper, weighed in air and in the buoyancy medium and then
placed into new tubes with fresh 1 mL of DW. Initial mass and volume were calculated by extrapolation
of early data versus square root of time to zero. Mass and volume change were then calculated as
percentages of original mass as shown in detail in previous publications [10,11].
2.5. Polylysine Release
High-performance liquid chromatography (HPLC) (Shimadzu corporation, Kyoto, Japan) was
used to measure polylysine release from composite discs. The composite discs (n = 3) were prepared
as above, weighed and then immersed in 1 mL deionized water (DW) in individual sterilin tubes. The
discs were removed from the DW and placed in a new tube with 1 mL of fresh DW at 1, 3, 6 h, 1, 2, 5,
7 days and 3 weeks. The storage solutions were stored at 23 ◦C prior to analysis.
A normal phase column in hydrophilic interaction liquid chromatography (HILIC) mode was
used. The mobile phase was 50 vol% acetonitrile in DW with 0.1 vol% of phosphoric acid (97%) added.
Flow rate, run time, temperature, and UV detection wavelength were 1.0 mL/min, 43 min, 30 ◦C and
210 nm respectively. PLS solutions of 10 to 100 ppm were used to generate a calibration curve which
was then employed to determine PLS concentrations in each storage solution. Cumulative PLS versus
time, as a percentage of that calculated to be in the original specimen, was then determined [10].
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2.6. Bacterial Growth Inhibition
A single colony of S. mutans UA159 was inoculated into brain heart infusion broth (BHI, Oxoid,
Basingstoke, UK) and incubated statically at 37 ◦C for 16 h in air enriched with 5% CO2. The culture
was diluted in BHI broth to generate an inoculum of 8 × 105 and 8 × 106 CFU/mL which was confirmed
by viable counting.
On the day of each experiment the discs (n = 3) were placed in a custom made ultraviolet light
box and irradiated for 30 min on each side to ensure sterility. Decontamination was verified by plating
on agar. The discs were then placed into a 24 well plate as seen in Figure 1. 1 mL of the S. mutans
inoculum was added to each well and the plates placed in the incubator on a shaking tray at 200 rpm
at 37 ◦C in air. At 24 h, the cultures were 10-fold serially diluted and plated out on BHI agar (Oxoid,
Basingstoke, UK). Bacterial colonies were counted after 3 days of incubation at 37 ◦C in 5% CO2.
2.7. Surface Bacteria Observations
To assess viability of attached bacteria on material surfaces, composite discs (n = 2) were immersed
in an S. mutans suspension with concentration of 5 × 106 CFU/mL and incubated statically for 72 h in air
at 37 ◦C. The discs were removed and gently immersed in fresh BHI broth to remove unattached bacteria
before placing in a clean well plate for staining using LIVE/DEAD Viability kit (Thermofisher Scientific,
Loughborough, UK). Confocal laser scanning microscopy (Radiance 2100, Biorad, Hercules, CA, USA)
with an objective lens of 10×–20×magnification was used to visualize bacteria. Images were saved and
processed using Lasersharp 2000 (Biorad, Hercules, CA, USA) and ImageJ (ImageJ Developers).
2.8. Statistical Analysis
Data analysis was undertaken for volumetric analysis, polylysine release and bacterial viable
counts using Analysis of Variance (ANOVA) and SPSS (IBM, Armonk, NY, USA) with p < 0.05
considered significant. To perform multiple comparisons of multiple formulations, the Bonferroni
adjustment was used.
3. Results
3.1. Mass and Volume
Mass and volume change both increased proportional to the square root of time. Final mass
change at 2 months increased linearly with polylysine content from 0.7 to 1.7 wt% (RSQ = 0.96). Final
volume change, however, was not significantly affected by PLS level (p > 0.05) and was between 2.2
and 2.5 vol% (Figure 2).
 
Figure 2. Graph of percentage change in mass and volume of the three formulations containing polylysine
after 2 months. Error bars = st. dev. (n = 3). * indicates significance between results (p < 0.05).
102
J. Funct. Biomater. 2020, 11, 53
3.2. Polylysine Release
Cumulative polylysine release was initially proportional to the square root of time but then
levelled between 2 and 3 weeks (Figure 3). Cumulative percentage release was higher with 2% PLS at 1
and 2 days at 2.4 and 2.7% but within experimental error independent of concentration and 4% by
3 weeks. In Figure 4, the percentage release is converted to provide a calculated total concentration per
disc that would have been released into 1 mL of storage solution by 6 h, 24 h and three weeks. At
3 weeks, the PLS release in grams was proportional to the level in the filler. At earlier time points,
however, doubling the filler PLS content more than doubled the release in grams (see Figure 4).
Figure 3. Cumulative percentage release of polylysine (PLS) versus the square root (SQRT) of time.
Error bars = st. dev (n = 3). * indicates that formulation with 2% PLS has significantly higher percentage
release at 24 and 48 h but not at early or later times.
Figure 4. Cumulative polylysine release after 6 h, 24 h and 3 weeks at 23 ◦C for formulations with 0.5, 1
or 2% PLS. Error bars = st. dev (n = 3). * indicates 2% PLS containing formulation has significantly
higher release at all time points compared with the other 2 formulations.
3.3. Determination of Antibacterial Activity
Colony forming units are shown in Figure 5, after 24 h incubation in air with different composite
formulations for two different initial inoculum bacterial levels. Irrespective of initial inoculum level,
CFU increased to 109 for all controls with no PLS. This was also observed with 0.5% and 1% PLS
with the higher initial inoculum. Conversely, 0.5 and 1% PLS in the composite filler caused a 90 and
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99% reduction in CFU with the lower initial inoculum concentration. With 2% PLS, the 24 h CFU
count was down to 107 and 102 with high versus low initial inoculum levels, respectively. The 2% PLS
formulations had statistically significantly less bacteria at 24 h when compared to all other composites
at both inoculum concentrations.
Figure 5. Bacterial growth after 24 h with two different inoculum concentrations of S. mutans, 8 × 105
and 8 × 106 CFU/mL. Four different formulations and a commercial composite were tested. Plates with
discs and inoculum were incubated in air for 24 h at 37 ◦C while being shaken. Error bars = st. dev
(n = 3), * indicates 2% is significantly different when compared to other formulations.
3.4. Confocal Laser Scanning Microscopy
Figure 6 shows confocal images of composite surfaces stained with live/dead stain. The bacteria do
not form a biofilm due to the lack of sucrose but are seen as individual bacteria on the material surface.
As the concentration of polylysine in the composite disc increases, an increase in the proportion of
dead bacteria is seen.
 
Figure 6. From top left to bottom right 0, 0.5, 1, 2% formulations. Inoculum: S. mutans 5 × 106 CFU/mL.
Plates with discs and inoculum were incubated for 72 h in air at 37 ◦C before staining. Stained with
Live/Dead staining. (n = 2).
104
J. Funct. Biomater. 2020, 11, 53
4. Discussion
4.1. Mass and Volume Change
Dental restorations are exposed to fluids from the oral cavity continuously. Any dental composite
will have micro voids after the setting reaction has taken place. When immersed in solution (i.e.,
deionized water), over time, the water will be absorbed by the voids in the composite as well as the
composite matrix phase and the mass and volume will increase. Excessive expansion can result in a
reduction in mechanical properties [18].
Mass and volume changes were undertaken for 2 months, as previous work has shown they
tend to level off after this time [19]. With low PLS, the volume change, approximately double the
mass change, suggests water is mostly expanding the matrix phase [19]. This is a consequence of the
composite density being double that of water. With higher PLS, the mass increase, more comparable
with the volume change, suggests there are more pores being filled by water which would cause
mass increase but no expansion. The porosity may be caused by poor wetting and dispersion of the
hydrophilic PLS particles by the monomer phase. The lack of change in the volume with increasing PLS
level suggests it has minimal effect on the surrounding matrix expansion. The final levels of mass and
volume change with 2% PLS (1.7 wt% and 2.3 vol%) are approximately two thirds of those seen with
an earlier similar formulation (F2) (2.5 wt% and 3.5 vol%) that had an additional 10 wt% tricalcium
phosphate [11]. This suggests the mass and volume changes are related to the total calcium phosphate
levels in these composites. A previous study has shown that the commercial composite Z250 shows an
increase in mass and volume after 7 weeks of 1.1 and 1.6% respectively [11]. The mass and volume
changes of the experimental composites were comparable or above those observed for Z250.
4.2. Antibacterial Activity and Polylysine Release
Polylysine has been added to dental composites in previous research [10,11], but reports on the
optimum concentration have not been carried out. This study attempts to replicate the conditions at the
interface between the composite and the sealed affected dentine in which sucrose will be excluded. In
this situation, the formation of biofilm on the discs was not observed. One recent study demonstrated
that polylysine had satisfactory antibacterial efficacy against S. mutans in a liquid culture medium
and as an application on biofilm–dentin surfaces. The study demonstrated that the susceptibility
of microorganisms to polylysine was dependent on polylysine concentrations [20]. Additionally, it
showed that polylysine can kill and inhibit the growth of the periodontal pathogen Porphyromonas
gingivalis [20].
Increased polylysine release from the composite can have a negative effect on the mechanical
properties of the material [11], so the minimum amount to cause bacterial kill would need to be
used. This is a common issue for formulations with a released soluble antibacterial agent [5,6]. Other
antibacterial agents, such as quaternary ammonium methacrylate, are non-released and their effect
on physical properties is less evident [8,21]. Additionally, their surface antibacterial properties could
be more stable over time. Surface antibacterial benefits, however, may be neutralized by a biofilm or
adhesive covering. Conversely, the benefit of high early polylysine release is a greater chance of an
effective reduction in residual bacteria deep within minimally excavated cavities. The above studies
suggest, however, that higher levels of polylysine release may be required for highly infected cavities.
Previous experiments have shown greater early burst release and a higher release over time from
a 2.5% PLS formulation with approximately 5.5% after 24 h and 9% at 3 weeks of being observed. As
this was not previously affected by monocalcium and tricalcium phosphate addition, the differences
may instead be due to the use of the more standard TEGDMA monomer. This can cause lower
conversions [10] than seen with PPGDMA [11]. In this new study, the composite formulation with
2% PLS released 2.4% of polylysine in the first 24 h and after 3 weeks this had increased to just 4%.
Initial polylysine release, proportional to the square root of time with no early burst release, is more in
agreement with a recent report using the same monomer system as this study [22]. The work showed
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that increasing the polylysine concentration from 4 to 6 and then 8 wt% of the filler caused final release
percentages to level at values of 13, 28 and 42% after 1, 2 and 3 months respectively [22]. This was
attributed to surface release from layers of 65, 140 and 210 micron thick. The PLS release levelling
between 1 and 3 weeks in this study fits with this trend. Given that the sample thickness is 100 microns,
a final release of 4% suggests the PLS release may be from surface layers of just 20 microns thick.
Due to the initially higher concentration of PLS, the release in grams is higher as the concentration
of polylysine in the formulations increased from 0.5 to 2%. The Minimum Inhibitory Concentration
of polylysine on S. mutans in air with inoculum density of 5 × 105 CFU/mL is 20 μg/mL [23]. After
24 h, the 0.5%, 1% and 2% formulations had an average (n = 3) of 8, 25 and 93 μg/mL of polylysine
released. This could explain why the 1% and 2% formulations inhibit growth in air conditions as
they release more than 20 μg/mL of polylysine. Conversely, the 0.5% formulations which released less
than 20 μg/mL did not inhibit growth. It is therefore expected that higher PLS concentrations will be
required to inhibit growth of higher inoculum concentrations. This was also demonstrated in a recent
study [20].
The aim of using Confocal was to visualize the live/dead state of bacteria sedimented on the
composite disc surfaces. In many other studies, additional sucrose is added to promote biofilm
formation [8,9]. The method chosen in this study with no additional sucrose, however, better replicates
the environment beneath the restoration after effective sealing. With these conditions, largely only
well-spaced individual bacteria were seen on the material surfaces and not biofilms. With the 0.5% and
1% PLS discs, some dead bacteria were present on disc surfaces at 72 h, whereas on the 2% PLS discs,
the majority were dead. At the high level of initial inoculum chosen for the confocal study, the 2%
PLS disc prevents any change in bacterial numbers in suspension at 24 h indicating bacterial increase
is exactly balanced by killing. It is possible, therefore, that dead bacteria on the composite surfaces
were killed when they made contact with remaining PLS on the composite surfaces or through more
prolonged and increasing contact with PLS in the suspension.
5. Conclusions
Increasing polylysine concentration from 0.5% to 2% in composite discs leads to an increase in
mass but not volume change over three weeks. Whilst the PLS-release percentage was faster in the
first 24 h with 2% in the filler, the final percentage release was not affected by increasing composite
PLS level. With 2% PLS, the amount released into 1 mL of broth in 24 h was sufficient to display
significantly reduced bacterial levels when the initial inoculum level was at 8 × 105, but their growth
in number was only inhibited when the initial bacterial counts were raised 10-fold. With an initial
inoculum of 5 × 106 bacteria, those detected on the composite surfaces after 72 h were mostly live with
1% or less PLS in the composite but dead with 2% PLS. Higher PLS may enable the greater killing of
residual bacteria when composites are used for minimally invasive tooth restorations. Considering
the limitations of this study and taking into account work completed in previous studies [24–26],
future research should include sucrose in the experiments to allow for biofilm growth on the discs to
determine the effectiveness of PLS against biofilms, test multispecies biofilms and assess long term
polylysine release and how this may affect the integrity of the restoration.
6. Patents
The work is covered by the following licensed patent families: Formulations and composites with
reactive fillers (US8252851 B2, EP2066703B1, US20100069469, WO2008037991A1), and Formulations
and materials with cationic polymers (PCT/GB2014/052349, WO2015015212 A1, EP3027164A1,
US20160184190).
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Abstract: Recently, silver (Ag) and copper (Cu) have been incorporated into a titanium (Ti) surface to
realize their antibacterial property. This study investigated both the durability of the antibacterial
effect and the surface change of the Ag- and Cu-incorporated porous titanium dioxide (TiO2) layer.
Ag- and Cu-incorporated TiO2 layers were formed by micro-arc oxidation (MAO) treatment using
the electrolyte with Ag and Cu ions. Ag- and Cu-incorporated specimens were incubated in saline
during a period of 0–28 days. The changes in both the concentrations and chemical states of the
Ag and Cu were characterized using X-ray photoelectron spectroscopy (XPS). The durability of the
antibacterial effects against Escherichia coli (E. coli) were evaluated by the international organization
for standardization (ISO) method. As a result, the Ag- and Cu-incorporated porous TiO2 layers were
formed on a Ti surface by MAO. The chemical state of Ag changed from Ag2O to metallic Ag, whilst
that of Cu did not change by incubation in saline for up to 28 days. Cu existed as a stable Cu2O
compound in the TiO2 layer during the 28 days of incubation in saline. The concentrations of Ag
and Cu were dramatically decreased by incubation for up to 7 days, and remained a slight amount
until 28 days. The antibacterial effect of Ag-incorporated specimens diminished, and that of Cu was
maintained even after incubation in saline. Our study suggests the importance of the time-transient
effects of Ag and Cu on develop their antibacterial effects.
Keywords: antibacterial; surface modification; coatings; implant; biofilm; silver; copper
1. Introduction
Prosthetic joint infection (PJI) is a devastating and threatening complication for patients and
orthopedists [1,2]. Biofilm, which is a main cause of PJI, is the final state of infections. Invaded bacteria
generally initiate the infection by adhering onto the implant surface, and grow through a specific
mechanism such as extracellular polysaccharide (EPS) production [3–5]. The removal of matured
biofilms from the implant is difficult because biofilms are resistant to antibiotics due to their bacterial
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diversity and the presence of the EPS [6–9]. Often, the only way to eradicate the infection and prevent
sepsis is to remove the contaminated device from the patient. To avoid this, biofilm formation must
be prevented by inhibiting the initial stage of biofilm formation, namely bacterial invasion, adhesion
and growth.
Antibacterial property, which can kill the bacteria, is a necessary and required bio-function on
implant surfaces. Silver (Ag) and copper (Cu) are major antibacterial elements, and their effects
on various bacteria have been examined by many studies. Ag and Cu potently inhibit various
pathogenic bacteria [10–14]. Various surface modification techniques have been used to incorporate
these elements on implant surfaces, and their efficacies have been shown by in vitro [15,16] and
in vivo [17,18] experiments.
Micro-arc oxidation (MAO), which is an anodic oxidation process with micro-discharges on the
specimen surface under high voltage, form a connective porous oxide layer with the incorporation of
elements from the electrolyte solution. MAO using the calcium (Ca)- and phosphorous (P)-containing
electrolyte improves the hard-tissue compatibility of titanium (Ti), owing to calcium phosphate
formation, the promotion of osteoblast adhesion and proliferation, as well as the acceleration of
calcification [19–26]. The widespread use of Ti in metallic biomaterials reflects the good mechanical
property and biocompatibility of these materials. In addition, some studies have focused on the
incorporation of antibacterial elements on Ti surfaces by MAO. Ag- and Cu-incorporated TiO2 coatings
reportedly exhibit antibacterial activity [27–35].
PJI comprises an early infection (within three weeks after surgery) and a late-onset infection
(approximately three to eight weeks after surgery), because the bacterial invasion can occur due to
implant surgery or the hematogenous spread of bacteria [36–38]. Thus, the long-term inhibition of
biofilm formation relies on the durability of antibacterial effects. The surface changes are key in the
development of antibacterial effect. Therefore, biodegradation behavior must be precisely characterized
to understand the antibacterial effect and its durability. However, little attention has been given
to the biodegradation behavior of antibacterial coatings. Therefore, the relationship between the
surface change and the durability of antibacterial property on Ag and Cu in an in vivo environment is
still unknown.
We investigated the long-term behaviors of Ag and Cu in the porous TiO2 layer formed by
MAO treatment. The changes in both the concentrations and chemical states of the Ag and Cu in
the oxide layer incubated for a prolonged period in physiological saline were characterized using
X-ray photoelectron spectroscopy (XPS). Moreover, the change of antibacterial property was evaluated
using the international organization for standardization (ISO) method with Escherichia coli (E. coli).
In other words, the aim was to clarify the time-transient effects of Ag and Cu in porous TiO2 layers on
antibacterial property.
2. Materials and Methods
2.1. Specimen Preparation
Ag- and Cu-incorporated porous titanium dioxide layers were prepared on a commercially pure
Ti (grade 2) surface. The ti disks were prepared from the rod of Ti, and each surface was mechanically
polished using #320, #320, #600 and #800 silicon carbide abrasive papers. After polishing, all the
specimens were washed by ultra-sonication in acetone and ethanol for 10 min.
The electrolyte compositions for MAO were 150 mM calcium acetate and 100 mM calcium
glycerophosphate solution, containing 2.5 mM silver nitrate or 2.5 mM copper chloride.
The electrochemical parameters were a voltage of 400 V and a current density of 251 Am−2, and the
treatment time was 10 min. The area in contact with the electrolyte was 39 mm2 using the working
electrode [39]. After the MAO treatment, all specimens were incubated in a saline during 0 to 28 days.
The specimens were fixed onto a polyethylene container to allow the release of metal ions from the
surface into the saline. Incubation was performed at 37 ◦C in a humidified chamber under constant
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shaking (100 rpm). Every seventh day, the pooled solution was changed with a fresh one. This process
simulated a simple biodegradation of Ag- and Cu-incorporated specimens in the body. The specimens
after incubation in saline for each period were used further for the surface characterization and
evaluation of antibacterial activity. After the MAO and incubation, the surfaces were thoroughly
washed in ultrapure water in order to remove any solution remaining in the porous oxide layer.
2.2. Surface Characterization
Surface morphologies on the specimens incubated during 0 and 28 days were observed by
scanning electron microscopy with energy dispersive X-ray spectrometry (SEM/EDS; S-3400NX, Hitachi
High-Technologies Corp., Tokyo, Japan). X-ray diffraction (D8 ADVANCE, Bruker, Billerica, MA,
USA) was performed to characterize the crystal structure of each specimen. X-ray photoelectron
spectroscopy (XPS; JPS-9010MC, JEOL, Tokyo, Japan) was used in this investigation. The detail of
the measurement condition was 10 kV of acceleration voltage, 10 mA of current, MgKα (energy:
1253.6 eV) of X-ray source, and was described in our previous study [40]. The calibration of the binding
energy was performed based on C 1s photoelectron energy region peak derived from contaminating
carbon (285.0 eV). The integrated intensity of each peak was calculated using Shirley’s method [41].
In addition, a modified Auger parameter (α’) of Ag and Cu, calculated from the Ag 3d5/2, Ag M4VV,
Cu 2p3/2 and Cu L3VV peaks, was used for the investigation of chemical state changes. According to a
method described previously [42], the surface composition on each specimen was calculated using a
photoionization cross-section of empirical data [43,44] and theoretically calculated data [45].
2.3. Evaluation of Antibacterial Activity
The antibacterial activity was evaluated using E. coli (NBRC3972). This evaluation was performed
according to the ISO 22196: 2007 method. This experiment was approved by the Pathogenic Organisms
Safety Management Committee in Tokyo Medical and Dental University (22012-025c). Luria–Bertani
(LB) broth (LB-Medium, MP Biomedicals, Irvine, CA, USA) was used as culture medium, and E. coli
was cultured in this at 37 ◦C for 24 h. After culturing, the bacterial density in the suspension of this
bacterium strain was measured by ultraviolet–visible spectrometer (UV–vis; V-550, JASCO, Tokyo,
Japan), and was adjusted by dilution to be 1.0 × 106 CFUs mL−1. The specimens, which were used
for this evaluation, were sterilized by immersion in 70% ethanol and washed with ultrapure water.
The prepared bacterial suspension was dropped on the surface of each specimen and cultured at
37 ◦C for 24 h using a sterilized cover plastic film. After 24 h culturing, the suspension of E. coli was
collected from the specimen surface, and transferred onto nutrient agar plates with dilution. The E. coli
in collected suspension was cultured on the nutrient agar plates at 37 ◦C during 24 h. The number
of viable bacteria was determined by counting the number of colonies formed on the plates. In this
evaluation, the specimen without Ag and Cu was used as the negative control and the specimens with
Ag or Cu before incubation were used as the positive control because our previous study revealed that
these specimens exhibited antibacterial effects for E. coli [27,28].
2.4. Statistical Analysis
All values are shown as the means ± standard deviation, and commercial statistical software
KaleidaGraph (Synergy Software, Reading, PA) was used for statistical analysis. One-way analysis of
variance was used following the multiple comparisons with the Student–Newman–Keuls method to
assess the data, and p < 0.05 was considered to indicate statistical significance.
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3. Results
3.1. Surface Characterization
Typical connective porous morphology after MAO were observed from Ag- and Cu-incorporated
TiO2 layers. This morphology on each specimen was maintained after incubation in saline during
28 days (Figure 1).
 
Figure 1. Scanning electron microscopy (SEM) images of (A) the Ag- and (B) the Cu-incorporated
TiO2 layers before and after incubation in saline during 28 days and the cross-sectional views of the
specimens before incubation.
The XRD spectra obtained from the control, the specimens before incubation, and the specimens
after incubation are presented in Figure 2, respectively, from the bottom to the top in each figure.
Peaks corresponding to α-Ti and anatase TiO2 were detected, and those of Ag were undetected in
the Ag-incorporated specimens before and after incubation. Peaks corresponding to α-Ti, anatase
TiO2, and rutile TiO2 were detected, while those of Cu were undetected. Furthermore, the chemical
structures of Ag- and Cu-incorporated specimens did not change by the incubation in saline during
28 days.
 
Figure 2. X-ray diffraction (XRD) spectra obtained from the (A) Ag- and (B) the Cu-incorporated
specimens before and after incubation in saline during 28 days. The spectra presented at the bottom in
each figure was obtained from the control.
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Figure 3 shows the XPS survey scan spectra obtained from Ag- and Cu-incorporated specimens
before and after incubation in saline during 28 days. The peaks originating from C, O, P, Ca, Ti, and Ag
or Cu were detected from the XPS spectra of the Ag- and Cu-incorporated specimens. In addition to
these elements, the peak originating from Na was detected in the specimens after incubation in saline
from 7 to 28 days. P existed as a phosphate species and calcium existed as Ca2+, because the binding
energies of the corresponding peaks of P 2p and Ca 2p3/2 were 133.7–134.1 eV and 347.6–347.9 eV,
respectively. The binding energy of the Ti 2p3/2 peak was 458.9–459.3 eV, indicating that Ti existed as
TiO2. The binding energies of the Na 1s peaks were 1071.7–1072.4 eV, indicating that Na exists as Na+.
Figure 3. X-ray photoelectron spectroscopy (XPS) survey scan spectra obtained from the (A) Ag- and
(B) the Cu-incorporated specimens before and after incubation in saline during 28 days.
Figure 4 depicts the Wagner plot of Ag and Cu obtained from this XPS characterization and
previous studies [46–48]. The chemical state change of Ag and Cu is determined by the comparison of
their binding energy with α′ values on the Wagner plot. According to the Wagner plot of Ag, the α′
value of the Ag-incorporated specimen before incubation (0 days) was 724.9 eV, indicating that Ag
mainly exists as Ag2O. The α′ values of Ag increased with incubation time. Since the α′ value finally
converged to 726.1 eV, it became clear that the chemical state of Ag incorporated in TiO2 by MAO
approached that of metallic Ag with increasing incubation times. On the other hand, the α′ values of
Cu from the specimens immersed in saline for 28 days were 1849.3–1849.7 eV, indicating that Cu exists
as Cu2O. The chemical state of Cu in the oxide layer did not change during the incubation in saline.
Figure 5 shows the changes in the concentrations of Ti, P, Ca and Ag or Cu detected from Figure 5A’s
Ag- and Figure 5B’s Cu-incorporated specimens with the incubation time. The concentrations of
Ag and Cu were relatively small (around 2.5 atom%), even before the incubation. Furthermore,
from the results of the EDS analysis of the cross-section shown in Figure 1, 0.1 atom% of Ag and
0.1 atom% of Cu were detected from the inside oxide layers, respectively. Thus, the amounts of Ag
and Cu incorporated during the MAO treatment were small. The amount of Ag and Cu dramatically
decreased to approximately Ag 0.4 atom% and Cu 0.8 atom% upon incubation in saline from 0 to 7 days,
respectively. These concentrations remained constant until 28 days. Moreover, the concentrations of
Ca and P decreased, and that of Ti increased with the incubation time.
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Figure 4. Wagner plot of (A) the Ag and (B) the Cu in the oxide layer incubated in saline for 28 days
based on the photoelectron peaks and the Auger peaks. Each parameter of the Ag and the Cu
compounds is plotted according to the previous studies [46–48].
Figure 5. Changes in the atomic concentrations in (A) the Ag- and (B) the Cu-incorporated TiO2 layers
with the incubation time.
3.2. Evaluation of Antibacterial Activity
The normalized bacterial number of E. coli on each specimen is shown in Figure 6. The vertical
axis represents the bacterial number normalized by the initial concentration of E. coli. The normalized
bacterial number smaller than 1 (shown as a dashed line in the figure) indicates that the tested
specimens exhibited an antibacterial effect. E. coli grew on the untreated Ti and control specimen,
because the number of E. coli on those specimens significantly increased compared with the initial
bacterial number. In contrast, Ag- and Cu-incorporated specimens developed antibacterial effects
against E. coli.
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Figure 6. Comparison of the antibacterial effects of the untreated Ti control specimen (micro-arc
oxidation (MAO)-treated Ti without antibacterial elements), the Ag- and the Cu-incorporated specimens.
Data are shown as the mean ± standard deviation. * Significant difference between specimens (p < 0.05).
Changes in the antibacterial effects of Ag- and Cu-incorporated specimens before and after
incubation in saline for 28 days are shown in Figure 7. The antibacterial effect of the Ag-incorporated
specimen after incubation was significantly weakened compared to that before incubation. This effect
was at the same level as that of Cu-incorporated specimens. On the other hand, the antibacterial effects
of Cu-incorporated specimens did not change upon incubation, and were maintained even after the
28-day incubation in saline.
Figure 7. Changes of the antibacterial effects of (A) the Ag- and (B) the Cu-incorporated specimens
before and after incubation in saline. Data are shown as the mean ± SD. * Significant difference between
the specimens before and after incubation (p < 0.05).
4. Discussion
The porous oxide layers formed by MAO did not change their surface morphology and crystal
structure during the incubation in saline (Figures 1 and 2). The lack of change is highly beneficial for
the development of antibacterial property on implant surfaces.
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The chemical states of P, Ca, and Ti in the Ag- and Cu-incorporated oxide layers were phosphate,
Ca2+, and TiO2, respectively. These chemical states did not change upon incubation in saline for
up to 28 days (Figure 3). The porous oxide layer consisted of TiO2 as well as incorporated Ca, P,
and antibacterial elements (Figures 3 and 5). The presence of Ca and P in the porous oxide layer makes
the hard-tissue compatibility of Ti better [27]. The peak originating from Na+ was detected from the
specimens after incubation in saline for 7 to 28 days. It is conceivable that compounds related to
Na+ were generated on the specimen surfaces, owing to the interfacial reactions between oxide layer
and saline.
Ag- and Cu-incorporated porous oxide layers were formed on Ti surfaces, and slight amounts of
Ag and Cu were incorporated by MAO using the electrolyte containing Ag and Cu (Figures 1 and 5).
These results indicate that the constituent elements in the electrolyte were incorporated into the porous
oxide layer during the MAO treatment. The incorporations of Ag and Cu by MAO is beneficial for
realizing the antibacterial property on the implant surface (Figure 6). In addition, our previous studies
revealed that specimens with Cu and a suitable amount of Ag did not affect the cellular adhesion,
proliferation, differentiation or the calcification of the osteoblast cells [27,28]. Therefore, MAO can be
imparting dual-function to the Ti surface, namely antibacterial property and hard-tissue compatibility.
The concentration of Ag in the oxide layer was dramatically decreased, and the chemical state
of Ag in the oxide layer was changed from Ag2O to metallic Ag during the incubation in saline
(Figures 4 and 5). These results indicate that Ag2O was converted into chemically stable metallic Ag in
saline, due to the release of Ag ions. A study that investigated the formation mechanism of Ag particles
in sodium citrate solution described the reduction of Ag on Ag particles via the radical-to-particle
electron transfer [49]. The α’ values of Ag in the oxide layer increased with incubation time, indicating
that the density of electrons increased. Therefore, like the reduction of Ag on Ag particles in the
solution containing sodium citrate, the change of the chemical state of Ag in the oxide layer incubated
in saline may be caused by radical-to-Ag electron transfer. Moreover, the antibacterial effects of
Ag-incorporated specimens changed upon incubation in saline (Figure 7). This finding implicates
changes of both the concentration and the chemical state of Ag in the oxide layer in the antibacterial
effect. However, it can be considered that Ag changes its chemical state more drastically depending on
components, such as sulfur, in the actual biological environment, since Ag changed its chemical state,
even in the simple simulated body fluid. Therefore, changes in the chemical state of Ag in the actual
biological environment could influence the antibacterial effect.
The concentration of Cu in the oxide layer was dramatically decreased, and the chemical state of
Cu in the oxide layer did not change upon incubation in saline (Figures 4 and 5). The chemical state
of Cu in the oxide layer was stabilized as Cu2O despite the difference in incubation time. This result
indicates that the Cu2O is a stable chemical state in the TiO2 layer. In addition, the antibacterial
effect of the Cu-incorporated specimen was maintained even after the 28 days of incubation in saline.
These results indicate that Cu2O in a stable chemical state has a more important role in the development
of an antibacterial effect, compared with the change of surface concentration of Cu. Previous studies
revealed a substantial difference in antibacterial effects between CuO and Cu2O. CuO inhibited the
development of an antibacterial effect compared to metallic Cu. In contrast, thermally generated Cu2O
was as effective as metallic Cu [50,51]. In other words, the presence of Cu2O and the slight amount of
Cu in the TiO2 layer are necessary to develop the antibacterial effect.
The results support the proposal that the concentrations of Ag and Cu in the oxide layer are
easily and dramatically changed by the incubation in saline. In addition, the chemical state of Ag
changed from Ag2O to metallic Ag, while that of Cu did not change. The antibacterial effect of an
Ag-incorporated specimen for Gram-negative bacteria changed by the 28-day incubation in saline,
while the activity of Cu was maintained. The collective findings indicate the importance of the
time-transient effects of Ag and Cu. This knowledge will be useful in the design of antibacterial
implants based on the surface changes of Ag and Cu in vivo. Further study will be necessary to reveal
the long-term effects of Ag and Cu for Gram-positive bacteria.
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5. Conclusions
Ag- and Cu-incorporated porous titanium dioxide layers were formed on Ti surfaces by MAO
treatment. The chemical states of P, Ca, and Ti in the Ag- and Cu-incorporated oxide layer were
phosphate, Ca2+, and TiO2, respectively. These chemical states did not change upon incubation in
saline for 28 days. Moreover, the chemical state of Ag changed from Ag2O to metallic Ag, and that of
Cu did not change by incubation in saline for up to 28 days. The concentrations of Ag and Cu were
dramatically decreased by incubation for up to 7 days, and remained a slight amount until 28 days.
The antibacterial effect of Ag-incorporated specimens changed, and the effect of Cu was maintained
even after incubation in saline. The findings highlight the importance of the time-transient effects of
antibacterial elements on their antibacterial properties.
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Abstract: The article presents an original way of getting porous and mechanically strong CaSiO3-HAp
ceramics, which is highly desirable for bone-ceramic implants in bone restoration surgery. The method
combines wet and solid-phase approaches of inorganic synthesis: sol-gel (template) technology
to produce the amorphous xonotlite (Ca6Si6O17·2OH) as the raw material, followed by its spark
plasma sintering–reactive synthesis (SPS-RS) into ceramics. Formation of both crystalline wollastonite
(CaSiO3) and hydroxyapatite (Ca10(PO4)6(OH)2) occurs “in situ” under SPS conditions, which is the
main novelty of the method, due to combining the solid-phase transitions of the amorphous xonotlite
with the chemical reaction within the powder mixture between CaO and CaHPO4. Formation of
pristine HAp and its composite derivative with wollastonite was studied by means of TGA and
XRD with the temperatures of the “in situ” interactions also determined. A facile route to tailor a
macroporous structure is suggested, with polymer (siloxane-acrylate latex) and carbon (fibers and
powder) fillers being used as the pore-forming templates. Microbial tests were carried out to reveal
the morphological features of the bacterial film Pseudomonas aeruginosa that formed on the surface of
the ceramics, depending on the content of HAp (0, 20, and 50 wt%).
Keywords: porous bioceramics; wollastonite; hydroxyapatite; sol-gel technology; spark plasma
sintering–reactive synthesis; bacterial test
1. Introduction
Sustainable development of modern biotechnology in the field of regenerative and reconstructive
bone surgery is governed by the quality of the available biomaterials, a specific class of systems with a
unique set of physico-chemical and mechanical characteristics (chemical inertness, microstructural
diversity, mechanical strength, fracture resistance, and durability), as well as biocompatibility
(non-toxicity, bio-inducivity, bio-conductivity, and bio-resistivity) [1,2]. The combination of such
properties in one product is a challenging scientific and technological problem in the search for
affordable raw materials and simple processing technologies to fabricate the final products.
Calcium monosilicate, β-wollastonite (CaSiO3), is actively studied at the moment due to its
applications in traumatology, orthopedics, dentistry, maxillofacial surgery, and other areas of medicine
for the recovery, replacement, and reconstruction of the damaged tissue in a living organism [1,3–14].
Owing to β-wollastonite’s ability to activate the growth of the apatite layer on its surface due to the
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pronounced osteoconduction and bio-resorption via exchange of Ca2+ and SiO32− with the bioorganic
medium, the material is promising as an artificial bone substitute [15,16]. In terms of chemical bonding,
wollastonite ceramic is close to the inorganic bone matrix and has no toxic effect on the body. In addition,
it is corrosion-resistant, thermally stable, and chemically inert or bioactive under long-term exposure in
bioorganic environments [17]. In order to achieve maximum similarity to the functional and structural
parameters of the bone tissue, β-wollastonite can be modified with hydroxyapatite (HAp), which is
a complete analogue of a living bone [14,18,19].
Chemical composition is an important, but not the only characteristic, of bioceramics implants.
Their uniqueness to a large extent is determined by a combination of structural and mechanical
characteristics. Porous and mechanically stable ceramics represents a model of cellular “spongiose”
material that serve as a matrix for ingrowth (implantation) of the bone tissue during osteointegration,
a process of recovering lost tissular structures in the living organism in the presence of the implant.
Osteointegration intensity depends on pores presented in the implant, particularly, on their size,
quantity, and interconnectivity. The bio-integration process, which is based on the reproduction of
osteogenic cells, requires large macropores, sized 100–135 μm, as well as on the thin submicron and
nanosized pores that are commensurate with blood plasma proteins for their effective adsorption.
Stability of such a matrix has to be optimal for the uniform distribution of mechanical load between
natural and artificial bone that avoids the possibility of excess decomposition of the bone tissue [20,21].
Thus, it is obvious that load-resistant ceramics with a hierarchical pore size distribution is necessary
for practical medicine.
From an implant manufacturing standpoint, fabrication of the β-wollastonite powder and its
composites with the HAp-required characteristics and properties is not difficult. This can be done
by sol-gel, hydrothermal, and precipitative synthesis technologies [6,22–30]. These approaches are
easy to implement and allow to vary the size and shape of the crystallites and to tailor the surface
morphology. On the contrary, to manufacture the bulk ceramics of the required geometry, characteristics,
and properties is far more challenging due to the rigid thermal conditions of the powder treatment
during consolidation into dense ceramics. During the fabrication of wollastonite ceramics, most of
the conventional sintering methods do not provide the preservation of the porous structure of the
wollastonite [31] due to the negative impact of the heat treatment on the composition and structure
of the final product. The reason lies in the phase instability of the HAp above 1000 ◦C, as well as
the destruction of the porous volume and the activation of grain growth, which leads to distortion
or destruction of the porous frame in the solid body and negatively affects the final properties of
the biocomposite [14,32,33].
The problems in the synthesis of porous ceramics described above are solved by using the
technology of spark plasma sintering (SPS) [34–38]. The unique mechanism of powder consolidation
in this technology is based on the spark plasma current flowing through the sample under pressure,
which provides a number of advantages over traditional methods, because in this case ceramic
wollastonite with a tailored microstructure and exceptional mechanical characteristics is rapidly
formed [39–41]. The structural strength of the SPS ceramics is achieved without the need for
additional reinforcement components that contaminate the final product. Our early studies have
identified the above-described prospects of SPS application for the synthesis of nanostructured
bioceramic wollastonite [42–45] with its bioactive properties being assessed “in vivo” [46]. Additionally,
these studies showed several original methods for developing a porous structure of the ceramics that is
similar to the texture of bone tissue by introducing various porous templates. However, the technology
of spark plasma sintering–reactive synthesis (SPS-RS) should be considered even more promising for
the production of innovative ceramics. SPS-RS is based on the chemical interaction between the starting
components of the sintering mixture under the influence of spark plasma, resulting in a new type of
the final product [47–49]. This approach allows one to directly obtain different materials with unique
properties based on multi-component ceramic systems. The literature substantiates the advantages
of SPS-RS compared to conventional SPS and hot pressing [41]. SPS-RS efficiency for bioceramic
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synthesis is based on the local character of the chemical interaction between the components of the
reaction mixture (resulting in biocomponents) under the spark plasma heating, taking place on the
interparticle contacts.
Such local heating favors the formation of the fine-crystal phases of the biocomponent, which will
be more biologically compatible or resorbed depending on its chemical composition. Additionally,
microlocal heating allows the reactions to proceed at lower temperatures; thus, not disrupting the
metastability of the substances and increasing the limit of their thermodestruction. We have recently
explored the feasibility of this approach for fabrication of ZrO2 ceramics containing the bioactive
phosphate compounds obtained “in situ” under SPS-RS conditions [50]. For the synthesis of ceramic
HAp-containing wollastonite, similar studies have not been conducted before.
In this regard, the work intends to study the way to obtain a crystalline ceramic HAp–wollastonite
composite via solid phase transformation of amorphous xonotlite and “in situ” interaction of the
reaction mixture (CaO and CaHPO4) under SPS conditions. Additionally, the way to tailor the porous
structure of the ceramics using pore-forming templates has been investigated. Microbial tests were
conducted to assess the possible risks of an infectious process caused by bacterial contamination of
the ceramics.
The proposed non-standard SPS-RS approach can pave the way to fabrication of biocompatible
ceramics for bone tissue engineering; thus, contributing another flexible strategy for the synthesis
of biomaterials.
2. Materials and Methods
2.1. Materials
Sodium metasilicate (Na2SiO3·5H2O) and calcium chloride (CaCl2·2H2O) have been used as the
main precursors for calcium silicate synthesis. Calcium oxide (CaO) and calcium hydro-orthophosphate
(CaHPO4) were used to synthesize HAp. All reagents are of 99.98% purity (Sigma-Aldrich, St. Louis,
MO, USA). Siloxane acrylate latex “KE 13–36” (LLC “Astrokhim”, Electrostal, Russia, solid phase
content 50%, average particle size 160 [51,52]), carbon fiber (CF) “AUT-M” (TS 1916-346-04838763-2009,
ENPO “Inorganica”, Electrostal, LTD Russia), and a graphite powder (GP) fraction 1–5 μm (GOST
7885-86, “Khazar”, Turkmenistan) were used as the pore-forming templates.
2.2. Synthesis Technique
The composite CaSiO3 (wollastonite)/HAp ceramics was prepared in three successive stages.
Initially, the method of sol-gel (template) synthesis yielded a composite material (xerogel) based on
hydrated calcium silica (xonotlite, Ca6Si6O17·2OH) mixed with polymer latex (pore-forming template).
Then, a sintering mixture (SM) was made by blending the obtained xerogel with the reaction mixture
components (RM) for the formation of HAp. Finally, the consolidation of SM using SPS technology
was carried out.
2.2.1. The Sol-Gel (Template) Synthesis of Amorphous Composite Powder Ca6Si6O17·2OH (Xonotlite)
A total of 50 mL of 1.0 M calcium chloride solution and 50 mL of 1.0 M sodium metasilicate
solution were added batchwise to 150 mL of a siloxane–acrylate water solution (latex:water ratio 1:30)
under intense stirring. Then, the solution was stirred for three hours at 100 ◦C until a dense gel was
formed, which after boiling was cooled to room temperature (25 ◦C). After that, 16.6 mL of a 1.0 M
calcium chloride solution and 10 mL of 1.0 M ammonium hydrophosphate were added to the obtained
gel and stirred for 1 h at room temperature (25 ◦C). The resulting gel was filtered and washed with
distilled water until a negative reaction to the chloride ions was obtained, and then dried for about
5 h at 90 ◦C.
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Fabrication of wollastonite proceeded according to the chemical reaction below:
CaCl2 + Na2SiO3 → CaSiO3 + 2NaCl (1)
2.2.2. Preparation of the Sintering Mixture Added with Reaction Mixture Additive
The composite xerogel obtained according to Section 2.2.1 was mixed with the components of the
reaction mixture (RM) CaO+CaHPO4 at the planetary mill at a rotation rate of 870 rpm for three cycles
for 15 min. Carbon fiber and powder graphite (Table 1) were added into this mixture as additional
pore-forming agents during ball milling.
Reaction of HAp formation:
CaO + CaHPO4 → Ca10(PO4)6(OH)2 + 2H2O (2)
Table 1. Wollastonite/HAp and the amounts of added templates.
# Sample Notation






1 CaSiO3-(50)Hap 50 50 - -
2 CaSiO3-(20)Hap 80 20 - -
3 CaSiO3-(20)Hap/5(CF) 80 20 5 -
4 CaSiO3-(20)Hap/10(CF) 80 20 10 -
5 CaSiO3-(20)Hap/5(CF)-10(GP) 80 20 5 10
6 CaSiO3-(20)Hap/10(CF)-10(GP) 80 20 10 10
Note: * Estimated amount of HAp according to the reaction Equation (2); ** weight amount in terms of the total
mass of the sintering mixture.
2.2.3. SPS-RS Fabrication of the Composite CaSiO3 (Wollastonite)/HAp Ceramics
The SM powder (fraction 0.1–0.5 mm), obtained via ball milling (see Section 2.2.2), was put into a
graphite die (outer diameter—30 mm, internal diameter—15.5 mm, and height—30 mm), prepressed
(20.7 MPa), and then the green body was put into a vacuum chamber (pressure 6 Pa) and sintered on a
LABOX-625 SPS machine “Sinter Land Incorporation, LTD” (Niigata, Japan). Sintering was executed at
900 ◦C at a heating rate of 100 ◦C/min and 5 min holding at maximal temperature. After sintering, the
samples were cooled down to room temperature (25 ◦C) for 40 min. Pressure loaded onto the sample
during sintering was 24.5 MPa and remained constant throughout the process. The frequency of the
low-voltage pulse generated in the On/Offmode was 12/2, with a pulse packet duration of 39.6 ms and
a 6.6 ms pause between the pulses. The maximum current and voltage during sintering were 500 A and
2 V, respectively. To prevent the consolidated powder from being sintered to the die walls and plungers,
as well as to easily extract the resulting compound, 200 μm thick graphite paper was used. The die
was wrapped in a thermal insulating fabric to reduce the heat loss when heated. The temperature of
the process was controlled by an optical pyrometer focused on a hole (5.5 mm deep) located in the
middle of the die’s outer wall. In order to remove the templates, the samples were annealed in air at
800 ◦C for 1 h at a heating rate of 5 ◦C/min, in the “Nabertherm GmbH” furnace (Lilienthal, Germany).
2.3. Microbiological Test
Microbiological studies were done to assess the formation of Pseudomonas aeruginosa biofilms on
the obtained samples of ceramic wollastonite. The samples were placed on the surface of the solid
medium and pre-seeded with the reference strain Pseudomonas aeruginosa. Cultivation was carried
out at 37 ◦C for 48 h. The biofilm was fixed on the sample by rinsing with 4% formaldehyde in a 1%
solution of the phosphate buffer followed by exposure of 1% of the osmium tetroxide solution for 1 h.
Dehydration was carried out with consistent treatment in ethanol of varying concentrations and at
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appropriate exposures (30%—10 min; 50%—10 min; 70%—10 min; and 96%—20 min), and then in
acetone for 20 min. The morphology of the biofilms was studied using electron microscopy.
2.4. Characterization Methods
The identification of crystalline phases in the original powders and the ceramics derived from
them was carried out using X-ray diffraction (XRD) with CuKα-radiation (Ni-filter, average wavelength
(λ) 1.5418 Å, range of angles of 10–80◦, scan step 0.02◦, and spectrum registration speed—5◦/min) on a
multipurpose X-ray diffractometer D8 Advance “Bruker AXS” (Karlsruhe, Germany). XRD patterns
were taken from the Powder Diffraction File™ (PDF, Soorya N Kabekkodu, 2007). The reference
numbers from the PDF database are as follows: Wollastonite—01-084-0654 (C) Wollastonite 1A—CaSiO3;
hydroxyapatite: 01-074-0566 (C) Hydroxyapatite—Ca10(PO4)6(OH)2. Thermogravimetric analysis
(TGA) was carried out on the derivativograph Q-1500 of the F. Paulik, J. Paulik, L. Erdey (Hungary)
system in air in a platinum crucible at a heating rate of 10◦/min to a maximum temperature of 1000 ◦C.
Low-temperature nitrogen sorption was employed to determine the specific surface area (Sspec.) on
an automated physisorption analyzer, Autosorb IQ “Quantachrome” (Boynton Beach, FL, USA),
using the Brunauer–Emmett–Teller (BET) model. The pore size distribution was analyzed on a mercury
porosimeter AutoPore IV “Micromeritics GmbH” (Norcross, GA, USA). The material’s structure and
biofilm’s morphology were studied by the method of scanning electron microscopy (SEM) on an Ultra
55 “Carl Zeiss” (Oberkochen, Germany) with a field-emission cathode and Oxford X-Max detector for
Energy-dispersive X-ray (EDX) spectroscopy. The composite ceramic samples were covered by 5 nm of
platinum and were investigated at the fracture sites at accelerating voltages of 5 kV and at 20 kV for
EDX analysis. To minimize irradiation and to exclude the samples charging, biofilms were investigated
at an accelerating voltage of 1 kV after fixing on the samples (see Section 2.3). The beam current was I
≈ 100 pA. Vickers hardness (HV) was measured at a HV0.5 load on a hardness tester, the HMV-G-FA-D
“Shimadzu” (Kyoto, Japan) micro-solid. Prior to microhardness tests, the ceramic surface was polished
on an automated polishing machine MECATECH 234 (Grenoble, France). Compressive strength (σcs) of
the cylindrically shaped samples (diameter 15.3 mm and 3–6 mm high) was determined by squeezing
at a rate of 0.5 mm/min on the tensile machine Autograph AG-X plus 100 kN “Shimadzu” (Kyoto,
Japan). The experimental density (ED) of the samples was determined by hydrostatic weighing on the
balance Adventurer™ “OHAUS Corporation” (Parsippany, NJ, USA)




S× (l2 − l1)
where F—load applied onto the sample (N); h—sample’s height (mm); S—sample’s surface area (mm2);
and l1 and l2—starting and final height of the material (mm) in the range of applied loads.
Sample deformation along the height under applied pressure spanning 3000–5000 N was evaluated
via the formula:






where l1 and l2 is the starting and final sample height (mm) in the range of applied loads.







where ω—mass content of component; and ρ—theoretical density of the component.
To calculate the porosity of the samples the formula was used:
Porosity(%)= 100−(ED/RD×100)
ED—experimental density, RD—relative density.
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The experimental density and Vickers microhardness were obtained as the mean values out of three
measurements for each sample. Determination of the compressive strength is a destructive method of
analysis, so only a single measurement was done on each sample. Young’s modulus was calculated in
the range of 3000–5000 N from the trends, obtained from the compressive strength measurements.
3. Results and Discussion
Primarily, the chemical interaction between the components of the reaction mixture (RM) was
studied to reveal the HAp formation according to Reaction (2) in air as well as to simulate the conditions
of SPS consolidation in the presence of the hydrated calcium silicate xerogel (xonotlite). The temperature
when the RM components started to react (Reaction (2)) was determined by thermogravimetric analysis
(Figure 1).
 
Figure 1. Thermogram of the reaction mixture (RM) sample heated in air.
According to the results of the TGA (Figure 1), a slight mass loss of 1.7 wt% is observed till
200 ◦C on the TG and DTG curves, while an endo-effect associated with it lasts till 250 ◦C on DTA.
A further increase in temperature leads to the 8 wt% weight loss by 490 ◦C on TG due to the solid-phase
interaction of the RM components yielding HAp and water by Reaction (2) with the onset of the
endo-effect being observed from 400 to 550 ◦C on the DTA curve. Moreover, at these temperatures the
non-reacted calcium hydrophosphate is likely to decompose according to Reaction (3).
2CaHPO4 = Ca2P2O7 + H2O (3)
There is a 0.5% weight loss at 700 ◦C on the TG curve with a minimum at 670 ◦C on DTG, which can
be caused by the partial decomposition of calcium carbonate according to Reaction (4).
CaCO3 = CaO + CO2↑ (4)
To confirm the results of the TGA, XRD was performed for the RM samples before and after
annealing in air at different temperatures (Figure 2).
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Figure 2. The XRD patterns of the RM powder in its original form (1) and after its heat treatment in air
at the following temperatures: (2) 500–700 ◦C, (3) 900 ◦C, and (4) 1000 ◦C.
The RM composition consists of the CaO and CaHPO4 crystalline phases (Figure 2, Pattern 1).
Thermo-oxidative annealing initiates a solid phase reaction of the RM with the formation of HAp at
the temperature ranging from 500 to 700 ◦C (Figure 2, Pattern 2) according to Reaction (2), which was
also noted on TGA (Figure 1). An impurity of calcium pyrophosphate (Ca2P2O7), which can be formed
according to Reaction (3), has been identified in this sample.
An increased annealing temperature leads to partial (at 900 ◦C) and complete (at 1000 ◦C)
decomposition of HAp with the formation of calcium orthophosphate (Ca3(PO4)2) (Figure 2, Pattern 3)
according to Reaction (5):
Ca10(PO4)6(OH)2 = 3Ca3(PO4)2 + CaO + H2O. (5)
Then, we investigated formation of wollastonite combined with HAp from the sintering mixture
(SM), which consists of a xerogel (Ca6Si6O17·2OH (xonotlite)) obtained via sol-gel and an RM along
with the pore-forming templates (latex, carbon fiber, and graphite powder). To do this, the TGA was
implemented and the corresponding thermograms (Figures 3 and 4) were obtained. According to
them, the mass loss of 5.6 wt% in the samples by 250 ◦C on TG is mainly due to partial dehydration
of xonotlite (Figure 3). When the temperature rises, the pore-forming agent, organo-silicon latex,
gets oxidized and decomposed. This process results in a loss of sample’s mass of 13.3 wt% and
characterized by an exo-effect within 240–450 ◦C on DTA and a minimum at 360 ◦C on the DTG.
Up to 450 ◦C, the dehydration of the xonotlite is complete and the latex becomes partially burnt out
from the bulk. There is also a solid-phase interaction between the RM components in this temperature
range, yielding HAp as it was studied above (Figure 1) according to Reaction (2). The remaining latex
part is burnt out by 750 ◦C on the DTA along with the associated minima observed at 590 and 730 ◦C on
DTG, resulting in a mass loss of 11.2 wt%. Partial HAp decomposition may also take place according
to Reaction (4). The total weight loss was 30.1 wt%. The exo-effect with an inflection point at 790 ◦C on
DTA is caused by the crystallization of the wollastonite.
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Figure 3. Thermograms of sintering mixture (SM) sample containing 20 wt% of the RM.
 
Figure 4. Thermograms of the SM sample containing 20 wt% of the RM as well as 10 wt% of carbon
fiber and 10 wt% of graphite powder.
The initial stage of the SM sample annealing in the presence of carbon pore-formers manifests
water removal with a mass loss of about 6 wt% by 310 ◦C on the TG curve (Figure 4), which is similar
to the above sample. However, further heating of the sample has a significant difference associated
with the imposed templates. Along with latex burnout from the xonotlite’s bulk, the exo-effect at
315–450 ◦C on DTA merges with the exo-effect coming from the graphite powder burning within
410–531 ◦C. Decomposition of another template, carbon fiber, takes place in the range 550–764 ◦C
on DTA. These effects correspond to the minima on the DTG at 360, 430, and 665 ◦C, related to the
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decomposition of latex, graphite powder, and carbon fibers, respectively. Besides, that region also
encompasses latex burnout by 750 ◦C on TG, as was shown earlier on Figure 3. The decomposition
processes of the carbon fiber and graphite powder occur simultaneously, causing a large area of
exo-effect on the DTA curve in the range 531–764 ◦C. The formation of crystalline wollastonite is
in this case similar to the above-described pattern without carbon additives, which occurs with the
onset of heat at 800 ◦C on the DTA. It is worth noticing the continuous nature of the mass loss in this
sample reaching 42.4 wt% by 790 ◦C on the TG curve, which is significantly higher in comparison
with the sample without the carbon additives discussed above. This difference is caused by the
thermo-oxidative destruction of the carbon pore-forming agents.
According to the XRD, the composition of the original SM sample includes the phases of the RM
components (CaO and CaHPO4), while the silicate phase cannot be found, evidencing its amorphous
structure (Figure 5, Pattern 1). After annealing at 500 ◦C, the phase of calcium orthosilicate Ca2SiO4
is observed, which indicates the intermediate stage of crystalline wollastonite formation (Figure 5,
Pattern 2). The presence of calcium silicate in this mixture slows down the interaction between the RM
components at this temperature, as there is no HAp phase in the material. Annealing at 900 ◦C leads
to the formation of crystalline wollastonite as well as HAp as a result of the interaction between the
RM components (Figure 5, Pattern 3). In addition, there is an impurity of calcium orthophosphate
Ca3(PO4)2 caused by the HAp decomposition according to Reaction (5). Annealing of the SM sample
containing carbon pore-forming agents at the same temperature (900 ◦C) also yields wollastonite and
HAp (Figure 5, Pattern 4) without formation of calcium orthophosphate, which is likely caused by
HAp phase stabilization during templates oxidation.
 
Figure 5. Thermograms of the original SM sample containing 20 wt% of the RM (1), as well as its
derivatives annealed at different temperatures: (2)—500 ◦C; (3)—900 ◦C; (4)—900 ◦C, the sample
containing pore-forming agents (10 wt% CF and 10 wt% GP); and (5)—1000 ◦C.
According to the described results, the optimal temperature to obtain crystalline wollastonite and
to initiate an “in situ” reaction between the RM components for the formation of the HAp phase is
found to be 900 ◦C. In addition, the temperature of SPS below 900 ◦C is not enough for sintering of
wollastonite, because the required mechanical characteristics are not achieved as was shown in our
previous study [44].
XRD patterns of the SPS ceramic samples obtained from the SM (Figure 6) shows the phase
composition corresponding to a composite based on crystalline wollastonite and HAp. For all samples,
the composition is identical regardless of the HAp content and the type of pore-forming template used.
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Figure 6. XRD patterns of the composite ceramics obtained by SPS-RS at 900 ◦C and their
subsequent thermo-oxidative treatment at 800 ◦C: (1)—CaSiO3-(50)HAp; (2)—CaSiO3-(20)HAp;
(3)—CaSiO3-(20)Hap/5(Cw); (4)—CaSiO3-(20)HAp/10(Cw); (5)—CaSiO3-(20)HAp/5(Cw)-10(Cp);
and (6)—CaSiO3-(20)HAp/10(Cw)-10(Cp). The sample description is presented in Table 1.
The results of porosimetry and structural analysis revealed the effect of the templates on the
structure of the obtained ceramics samples. Differential mercury intrusion analysis shows the average
size of the macropores provided by the polymer latex is about 100 nm (Figure 7). Changing the amount
of HAp in the ceramics from 20 to 50 wt% does not lead to significant structural changes, with the
pore size distribution being maintained in the specified interval (samples CaSiO3—(20)HAp and
CaSiO3—(50)HAp). The surface area for these samples, calculated by BET, lies in the same range of 2.6
and 2.8 m2·g−1 (Table 2).
The introduction of carbon fiber (5 and 10 wt%) into the synthesis and its subsequent removal
changes the range of the pore sizes in the resulting ceramics. When 5 wt% CF are added, the average
pore size is approximately 100 nm but the base of the intrusion curve has extended, indicating the
formation of larger pores sized above 100 nm (sample CaSiO3-(20)HAp/5(CF)). The number of these
pores increases with the amount of the additive. At 10 wt% of CF, there emerges a peak at about
the 1–5 μm range on the differential intrusion curve (CaSiO3-(20)HAp/10(CF) sample). At the same
time, Sspec. decreases from 2.9 to 1.9 m2·g−1 (Table 2), which is probably due to the exclusion of the
micro and mesopores (less than 50 nm) from the sample’s structure at the moment of carbon template
oxidation and macropores formation. There is an extended base of the intrusion curve observed for the
sample containing 5 wt% of powder graphite (CaSiO3-(20)HAp/5(CF)-10(GP) sample) with a separate
maximum appearing in the range above 5 μm (CaSiO3-(20)HAp/10(CF)-10(GP) sample). Sspec. increases
for the samples under consideration to 4.9 and 4 m2·g−1, respectively (Table 2). The general trend
observed for all samples is the increase in the macropores’ volume from 0.18 to 0.43 mL/g, depending
on the type and quantity of the used template as well as the growth of the total porosity in the system
from 8.3 to 27.7% (Table 2).
Changes in the structure of samples are confirmed by microscopic studies. SEM images (Figure 8)
show that the samples synthesized with a different HAp content in the presence of a polymer latex
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(CaSiO3-(20)HAp and CaSiO3-(50)HAp) samples) are characterized by the presence of pores sized
below 200 nm, which is commensurate to the template’s size. Additional carbon pore-forming agents
produce larger pores of 1 μm and above, the shape and size of which are commensurate to that of
carbon fiber as, e.g., for the CaSiO3-(20)HAp/10(CF) sample. The introduction of graphite powder
into the synthesis leads to a distorted arrangement of the pores derived from CF with the structure
becoming looser (CaSiO3-(20)HAp/10(CF)-10(GP)) (Figure 8). In both samples, when the large pores
(larger than 1 μm) are forming, the presence of the small pores (less than 200 nm) is maintained.
 
Figure 7. Differential mercury intrusion curves obtained for the porous SPS composite ceramics.
Sample denotation is presented in Table 1, the structural characteristics are in Table 2. The indexes
(GP, CF, and L) show the pore size ranges tailored by certain types of pore-forming agents (templates):
L—siloxane-acrylate latex, CF—carbon fiber, and GP—graphite powder.
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Table 2. Structural characteristics of the composite ceramics samples.
# Sample Sspec., m
2·g−1 Vpore, mL/g Porosity, %
1 CaSiO3-(50)HAp 2.8 ± 0.1 0.18 ± 0.01 8.3
2 CaSiO3-(20)HAp 2.6 ± 0.1 0.13 ± 0.01 9.7
3 CaSiO3-(20)HAp/5(CF) 2.9 ± 0.1 0.21 ± 0.01 18.5
4 CaSiO3-(20)HAp/10(CF) 1.9 ± 0.1 0.26 ± 0.01 19.7
5 CaSiO3-(20)HAp/5(CF)-10(GP) 4.9 ± 0.1 0.28 ± 0.01 25.4
6 CaSiO3-(20)HAp/10(CF)-10(GP) 4 ± 0.1 0.43 ± 0.01 27.7
 
Figure 8. SEM images of the spark plasma sintering–reactive synthesis (SPS-RS) composite ceramics
surface. The sample descriptions are presented in Table 1.
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Based on the EDX data, the presence of phosphorus on the surface of the samples is found, which
indicates the presence of HAp in the ceramic wollastonites. The uniform distribution of phosphorus in
the samples can be observed on the map of the elements, which reflects the difference when the number
of HAp increases from 20 to 50 wt% (Figure 9, Table 3). According to the quantitative EDX analysis,
there is also a difference in the phosphorus content of the ceramics. Analysis of arbitrary surface areas
of the samples with a different HAp content (Figure 9, Spectra 1 and 2) indicates a phosphorus content
of 2.15 and 4.78 wt% (Table 3). A 2.2-fold difference in phosphorous content corresponds well to the
amounts of introduced RM components into the sintering mixture within the error of the method.
 
Figure 9. Elements mapping (EDX analysis) on the surface of the composite ceramic samples containing
20 wt% (the CaSiO3-(20)HAp sample) and 50 wt% HAp (the CaSiO3-(20)HAp sample).
Table 3. The quantitative surface elemental composition (EDX analysis) of the composite ceramic
samples presented in Figure 9 (wt%).
Samples Spectra C O Si P Ca
CaSiO3-(20)HAp Spectrum 1 6.31 ± 0.03 67.49 ± 0.03 11.84 ± 0.03 2.15 ± 0.03 12.21 ± 0.03
CaSiO3-(50)HAp Spectrum 2 6.96 ± 0.03 68.81 ± 0.03 8.09 ± 0.03 4.78 ± 0.03 11.36 ± 0.03
The physical and mechanical characteristics of the biocomposite ceramics (Table 4) were determined.
The relative density (RD) of the samples with a different HAp content ranges between 90.2 and 91.7%
under certain conditions of SPS consolidation. The increase in the HAp content from 20 to 50 wt% in
the ceramic composite leads to an increase in compressive strength (σcs.) from 302 to 362 MPa and in
microhardness (HV) from 134 to 146 (Table 4, Samples 1 and 2). The total porosity of the ceramics
formed by polymer latex is reduced from 9.7 to 8.3% (Table 2) due to the fact that the amount of HAp
in the sample is in direct relation to the original silicate raw material (xonotlite), which contains the
latex template. When the ratio of xonotlite to HAp changes, the amount of latex responsible for porous
structure formation thereby alters the strength characteristics of the final ceramics.
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Table 4. Physical and mechanical characteristics of the composite ceramics samples.






1 CaSiO3-(50)HAp 2.723 ± 0.005 91.7 146 362 2564 5.3
2 CaSiO3-(20)HAp 2.586 ± 0.005 90.2 134 302 2224 4.1
3 CaSiO3-(20)HAp/5(CF) 2.334 ± 0.005 81.4 64 176 1997 5.2
4 CaSiO3-(20)HAp/10(CF) 2.301 ± 0.005 80 34 111 1421 6.3
5 CaSiO3-(20)HAp/5(CF)-10(GP) 2.137 ± 0.005 74.6 26 75 1379 8.7
6 CaSiO3-(20)HAp/10(CF)-10(GP) 2.069 ± 0.005 72.2 1< 35 1358 9.2
The total porosity of the system was enhanced in this work by means of additional carbon
pore-forming agents (Table 2), although it significantly reduces the density and affects the mechanical
characteristics of the samples (Table 4). Adding 10 wt% carbon fiber into the synthesis is found
to be optimal as it yields porous (19.7%) and dense (RD 80%) biocomposite ceramics, with the
mechanical strength (σcs. 111 MPa) lying within the values of the normal strength of natural bone
(110–120 MPa) [53–55]. Introducing powder carbon as an additional pore-forming agent is also useful
for increasing the overall porosity of the ceramics, but its quantity should be clearly defined with the
other characteristics achieved.
The work carried out a microbiological test to study the formation and morphological features of
bacterial film (biofilm) based on Pseudomonas aeruginosa on the surface of composite ceramic samples
with different HAp contents. In addition, a sample of pristine ceramic wollastonite without the
HAp additive, which was obtained in our earlier studies, was used for comparison [42]. The type
of bacteria implemented here lives in the external environment (water and soil) and is one of the
leading pathogens that cause post-surgery infections requiring medical care [56]. According to the
SEM images (Figure 10), all the samples clearly show that a mature biofilm had formed. On the sample
of ceramic wollastonite without HAp, the biofilm is distributed in a denser, uniform layer (Figure 10a).
On the contrary, in the case of composite ceramics, the monolithic agglomerates of the HAp phase
are less intensely populated by bacteria with the latter occupying mostly places of porous and loose
formations (Figure 10b,c). All samples between the cells clearly show cytoplasmic bridges, which is a
sign of an actively developing biofilm. The main point to be noted is that the bacteria grown on the
samples containing HAp are covered with a thick layer of alginate, which indicates the inclusion of a
protective reaction of the bacteria under the negative impact of the environment caused by the presence
of HAp in the ceramics and the completion of the biofilm formation (Figure 10b*,c*). The formation
of an alginate layer indicates that the presence of HAp in the ceramic prevented the formation of a
dense uniform (continuous) biofilm layer. In this regard, in terms of the risk of infection, the composite
HAp-containing ceramics contained is more attractive for biomedical applications.
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Figure 10. SEM images of bacterial film on ceramic samples with different HAp content obtained by
SPS-RS: (a,a*) 0 wt% HAp—continuous layer of bacterial cells without an alginate layer; (b,b*) 20 wt%
HAp—less dense layer of bacterial cells coated with an alginate layer; (c,c*) 50 wt% HAp—rarefied
layer of bacterial cells coated with a dense layer of alginate.
4. Conclusions
The work provides an original way to obtain CaSiO3-HAp porous ceramics with the wet and
solid-phase synthesis strategies being combined. The method involves sol-gel synthesis (template) of
the starting raw material in the form of an amorphous composite material based on xonotlite and its
subsequent spark plasma sintering yielding ceramic wollastonite. TGA, XRD, and EDX showed that
the HAp phase formation in the resulting ceramics can be initiated by the solid-phase interaction of the
reaction mixture (CaO and CaHPO4) in the spark plasma heating by the “in situ” reaction directly at the
moment of sintering of the amorphous xonotlite. It has been determined that the optimal temperature
for the SPS-RS to obtain crystalline wollastonite from the amorphous xonotlite, as well as to initiate the
reaction “in situ” with the formation of HAp, is 900 ◦C.
Nitrogen physisorption and mercury porosimetry allowed to reveal that the pore size and volume
depend on the type and quantity of the template introduced at the different stages of the synthesis,
leaving pores after the thermal-oxidative treatment of the ceramics. It is shown that latex introduced
in the sol-gel synthesis allows to form pores of about 100 nm, while carbon pore-forming agents
added prior to SPS-RS contribute to the formation of macropores of 1 μm and larger. We determined
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that the use of latex and 10 wt% carbon fiber is considered the optima, as porous (19.7%) and dense
(RD 80%) biocomposite ceramics is formed that exhibit the required mechanical strength (σcs. 111 MPa),
which is within the values of the normal strength of natural bone (110–120 MPa). The use of graphite
powder should be carefully adjusted due to its impact on the other important physical and mechanical
characteristics of ceramics.
The results of the microbiological test revealed that the (20 and 50 wt%) HAp-containing ceramic
samples show the bacteria Pseudomonas aeruginosa being covered with a thick layer of alginate, with
the latter not being observed on pristine wollastonite. Alginate appearance indicates the protective
response of the bacteria to a negative environmental impact. In this regard, in terms of the risk of
infection, composite HAp-containing ceramics is more attractive for biomedical applications.
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Abstract: Bioactive mineral-based dentin desensitizers that can quickly and effectively seal dentinal
tubules and promote dentin mineralization are desired. This in vitro study evaluated a novel
nanohydroxyapatite-based desensitizer, Predicta (PBD, Parkell), and its effect on bond strength of
dental adhesives. Human dentin discs (2-mm thick) were subjected to 0.5 M EDTA to remove the
smear layer and expose tubules, treated with PBD, and processed for surface and cross-sectional SEM
examination before and after immersion in simulated body fluid (SBF) for four weeks (ISO 23317-2014).
The effects of two dental desensitizers on the microshear bond strength of a universal adhesive and a
two-step self-etch system were compared. SEM showed coverage and penetration of nanoparticles
in wide tubules on the PBD-treated dentin at the baseline. After four weeks in SBF, untreated
dentin showed amorphous mineral deposits while PBD-treated dentin disclosed a highly mineralized
structure integrated with dentin. Desensitizers significantly reduced microshear bond strength test
(MSBS) of adhesives by 15–20% on average, depending on the bonding protocol. In conclusion,
PBD demonstrated effective immediate tubules sealing capability and promoted mineral crystal
growth over dentin and into the tubules during SBF-storage. For bonding to desensitizer-treated
dentin, a two-step self-etching adhesive or universal bond with phosphoric acid pretreatment
are recommended.
Keywords: bioactive desensitizer; hypersensitivity; SEM; nanoparticle; nanohydroxyapatite;
microshear bond strength; phosphoric acid; self-etch
1. Introduction
Dentin hypersensitivity (DH) has become a more frequently encountered issue in diagnostic
and therapeutic clinical situations. DH is identified by a typical short sharp pain on the exposed
dentin because of the thermal, evaporative, tactile, osmotic, or chemical stimuli. The common clinical
manifestations of DH include exposed dentin from abrasion, erosion or exposed root surface. Although
the mechanism of pain transmission and sensitivity in dentin is still under speculation, the most
accepted theory is the hydrodynamic mechanism of sensitivity. It is postulated that the sudden flow of
tubular fluid within the tubules in the presence of irritating stimulus results in the activation of sensory
nerve ending thereby inducing pain or sensitivity [? ? ]. The density and size of patent dentinal tubules
are critical factors to the severity of DH in patients.
A standard treatment for DH has not yet been established [? ]. Two main methods utilized for
the treatment of DH are occlusion of the dentin tubules and interference with the sensitivity of the
mechanoreceptor. A plethora of products have been developed with the aim to reduce the discomfort
from DH. Dentin desensitizers have been introduced for DH treatment mainly through tubular
occlusion [? ? ? ? ]. Calcium phosphate mineral-based desensitizers have attracted considerable
interest in recent years thanks to their biocompatible properties yielding an effective dentinal tubule
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occlusion and reduction in dentin permeability. They also possess the possibility of mineral crystal
growth in the oral environment [? ? ? ]. The composition of calcium and phosphate in a material
may exhibit the ability to form hydroxyapatite (HA; Ca10(PO4)6(OH)2) as a final product. HA and its
variations are the main mineral component in human tooth and their biocompatibility have rendered
them as clinically practical choices [? ].
Dental adhesives have been utilized in the treatment of restoring teeth in combination with
DH. The component in the bonding agent provides the simultaneous conditioning and priming
for the underlying dentin, resulting in superior bond strength and reduced DH [? ? ]. However,
the sealing ability of adhesives on the dentin surface could be affected by an incomplete micro-emulsion
polymerization of the hydrophilic primer and hydrophobic bonding [? ]. Therefore, in order to increase
the effectiveness of treatment, it would be necessary to desensitize dentin exhibiting DH prior to the
placement of a restoration. It was reported that one-step self-etching adhesives and dentin desensitizers
could significantly relieve DH immediately and over a month after treatment [? ]. The usage of dentin
desensitizer in the combination with the bonding agent can alleviate the postoperative sensitivity
with the composite restoration [? ]. Nevertheless, its effect on bonding performance using different
bonding systems remains to be evaluated, as the desensitized treated dentin may be unfavorable for
bonding [? ? ]. The objective of this in vitro study was to evaluate the morphological characteristic of
the new nanohydroxyapatite-based desensitizer with the proprietary composition of calcium, sodium,
phosphate, and silica when applied on the tooth surface and the effect of this material on the bond
strength. The null hypotheses were that the novel desensitizer could modify the morphological
characteristic of the dentin of the extracted teeth and did not interfere with the bonding performance
of the tested adhesives.
2. Materials and Methods
The extracted human teeth were used in this study in accordance with the guideline of the
Ethics Committee of the University of Washington Human Subject Division and the Declaration of
Helsinki, which allow the use of extracted deidentified human teeth. Forty molars were collected
during treatment plan and patient care and stored at 4 ◦C in water with 0.02% thymol.
The occlusal cusps were removed by cutting perpendicularly to the long axis of the tooth 2–3 mm
from the tip of the cusp to expose superficial midcoronal dentin using a low-speed water-cooled
diamond saw (Isomet; Buehler, Lake Bluff, IL, USA). The roots were then sectioned at the cement-enamel
junction to obtain 2-mm-thick dentin slices. The occlusal side of each disc was polished under running
water by 600-grit paper (3M, St. Paul, MN, USA) for 30 s in circular motion to create a standardized
smear layer. The surfaces were observed under the digital stereomicroscope (MU1000, AmScope,
Irvine, CA, USA) to eliminate the cracks, residual enamel, coarseness and pollutants.
The composition and application of desensitizers and adhesives according to the manufacturer’s
instruction were listed in Table ??.
Table 1. Materials used in the study.
Materials Composition Application
Teethmate Desensitizer (TMD)
(Kuraray Noritake Dental Inc,
Tokyo, Japan)
Powder: tetracalcium phosphate (TTCP)
and dicalcium phosphate anhydrous
(DCPA)
Liquid: water
Mix powder and water within 30 s,
apply slurry with microapplicator
15 s, rub 60 s rinse with
water spray.
Predicta Bioactive Desensitizer gel
(PBD, Parkell, Edgewood, NY, USA)
Calcium, phosphate,
nanohydroxyapatite
Rinse surface with warm water,
dry with absorbent cotton. Paint a
coat and rub gently the liquid in
10–20 s using an applicator. Wipe
the product off using a cotton
pledget before air blowing.
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Table 1. Cont.
Materials Composition Application
Parkell Etching (Parkell, Edgewood, NY,
USA) 32% PA Gel (H3PO4) 10–15 s etch then rinse.
Parkell Universal Adhesive PBOND
(Parkell, Edgewood, NY, USA)
Acetone, Ethyl Alcohol, 10-MDP,
2-Hydroxylethyl methacrylate,
2-Propenoic acid
Mix well, dispense 1–3 drops. Rub
the liquid using an applicator,
keep moist for 20 s. Blow gently
for 10 s and light cure for 10 s.
Clearfil SE 2
(Kuraray Noritake Dental, Japan)
Primer: MDP, HEMA, camphorquinone,
hydrophilic dimethacrylate,
N,N-diethanol p-toludine, water.
Bond: MDP, Bis-GMA, HEMA,
camphorquinone, hydrophobic
dimethacrylate, N,N-diethanol
p-toludine, silanated colloidal silica.
With the applicator, prime for 20 s.
Apply bond and light cure for 10 s
Z100 Restorative (3M ESPE,
St. Paul, MN, USA)
Bis-GMA, TEDGMA,
Zirconium/Silica filler
Build the resin cylinder then light
cure for 40 s.
2.1. Morphological Observation
Ten dentin discs were pretreated with 0.5 M EDTA (pH 7.4) for 2 min to completely remove
the smear layer and widely open the dentinal tubules before applying the deionized water. Half of
the disc surfaces were subjected to the Predicta Bioactive Desensitizer (PBD, Parkell, Edgewood, NY,
USA) whereas the other half served as control (no PBD). Five discs were immediately processed for
SEM examination while the other five were stored for four weeks in simulated body fluid (SBF) for
bioactivity test (specified by the ISO 23317:2014) (Figure ??A).
 
Figure 1. Methodology: Dentin discs were produced from human molar for morphological observation
(A) and microshear bond strength test (B). For (A): Ten dentin discs were pretreated with EDTA (pH 7.4) to
remove the smear layer and open dentinal tubules before rinsing. Half of the disc surfaces were subjected
to Predicta Bioactive Desensitizer (PBD) and the other half served as control (no PBD). Five discs were
immediately processed for SEM examination while the other five were stored for four weeks in simulated
body fluid (SBF) for bioactivity test (specified by the ISO 23317:2014). For (B): Thirty dentin discs were
allocated into three groups (n = 10): Teethmate Desensitizer (TMD) treatment, PBD treatment and no
desensitizer as control. The universal adhesive (PUB) in self-etch (SE) or with phosphoric acid etching
(PA)) and two-step self-etch adhesive Clearfil SE Bond 2 (CSE) were used. Small cylinders of the hybrid
composite were bonded on the dentin surface and the wire loop bond test was performed at a crosshead
speed of 1 mm/min.
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2.2. Observation after Application of PBD
The specimens were dried in a desiccator without heating for 24 h. The discs were then superficially
scored using a diamond bur and delicately fractured by finger pressure revealing the cross-section
of dentinal tubules without creating an additional smear layer. The boundary between applied and
non-applied dentin surface was targeted for visualization under SEM (JEOL JSM-6010LA, Tokyo,
Japan). After gold-sputter coating, the micromorphology was examined at magnifications of 1000×,
4000×, 5000×, and 10,000×. Furthermore, in order to anticipate the bioactivity of PBD-treated dentin in
the oral environment, the dentin discs were further placed in dust-free SBF solution incubated at 37 ◦C
for four weeks in a transparent bottle.
2.3. Microshear Bond Strength Test
Thirty dentin discs were randomly distributed into three groups (n = 10): Teethmate Desensitizer
(TMD, Kuraray Noritake Dental Inc, Tokyo, Japan) treatment, Predicta Bioactive Desensitizer (PBD)
treatment and no treatment (control). The universal adhesive PBOND (PUB, Parkell, Edgewood, NY,
USA) in self-etch (SE) or with phosphoric acid etching (PA, Parkell Etching Gel, Parkell, Edgewood,
NY, USA) and two-step self-etch adhesive Clearfil SE Bond 2 (CSE, Kuraray Noritake Dental) were
used in the experiment of microshear bond strength test (MSBS). Figure ?? represented the method of
the study.
Prior to the irradiation, three pieces of Tygon tubes (Saint-Gobain Performance Plastic, Nagano,
Japan) with an internal diameter of 0.8 mm and 1.0 mm in height were fixed on the dentin surface of
each slice. The adhesive was light-cured for 10 s at 600 mW/cm2 (Yoshida Light Curing Unit, Japan).
The hybrid composite Z100 (A2 Shade, 3M ESPE, St. Paul, MN, USA) was carefully placed inside the
tubing lumens before irradiation for 40 s. After 1 h-storage at room temperature (25 ◦C), the tygon
tubes were removed using a sharp blade to obtain the cylinders of resin with the size of 0.8 mm in
diameter and 1.0 mm in height bonded to the dentin surface. The specimens were then stored in
distilled water in an incubator at 37 ◦C.
After storage, an MSBS test was conducted. The dentin slice was attached to the testing apparatus
(Mecmesin, Compact Force Gauge, CFG+, UK) with a thin layer of cyanoacrylate glue (Model Repair II
Blue, Dentsply-Sankin, Tochigi, Japan) and tested in a microshear tester (Bisco, Inc., Schaumburg, IL,
USA). A 0.2 mm-diameter steel wire was looped at the bottom of the resin cylinder, in contact with the
lower half-circle of the cylinder and the dentin surface. The wire loop was maintained according to
the shear stress orientation at the bonding interface. The force was applied at a crosshead speed of
1 mm/min until failure then the MSBS data were recorded (Figure ??B).
2.4. Evaluation of Failure Mode
After the MSBS test, the mode of failure was determined for each specimen under the digital
stereomicroscope. The fractured surfaces were classified as followed: adhesive failures between resin
and dentin, mixed failures that were partially adhesive and partially cohesive, and cohesive failures
that occurred entirely within the bonding resin or entirely in dentin.
2.5. Statistical Analysis
The distribution of data in each group was normal (Kolmogorov–Smirnov p > 0.05), parametric
tests were performed. The MSBS values were statistically analyzed using two-way ANOVA with
application mode and desensitizer treatment as factors. The statistical procedures were analyzed at
0.05 significance level using IBM SPSS Statistics 23 Software.
3. Results
Immediately after the application of PBD, SEM micrographs showed good coverage by PBD of
the widely open dentinal tubule in EDTA-demineralized dentin as clearly observed in the comparison
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of the untreated and treated side (Figure ??). The cross-sectional images showed that the nanoparticles
form PBD have penetrated into the dentinal tubules and further sealed the nanospaces exposed through
the collagen network and lateral branches in the tubule walls of demineralized dentin. Intratubular
dentin seemed to be densely penetrated on the treated side. The depth of penetration was estimated to
be 5–10 μm from the dentin surface. The thickness of the formed layer as a result of the PBD application
was approximately 1 μm.
 
Figure 2. Cross-sectional SEM images immediately after application of PBD. The patency of dentinal
tubules and open lateral branch orifice (arrow) have been well sealed on the treated side.
After four weeks of SBF immersion, SEM images of dentin treated with EDTA and PBD disclosed
a highly dense and homogenous structure of dentin measuring at least 20 μm in thickness. In this
structure, a surface layer was not easily distinguished from the bulk of subsurface dentin, indicating
integrated mineralization of the surface zone through both mineral deposition on the surface and into
the demineralized dentin, forming a highly mineralized unified structure whereas there was no such
unification on untreated sides (Figure ??).
The results of MSBS of each experimental group (mean and SD) were listed in Table ?? and
Figure ??. Two-way ANOVA indicated that both the use of desensitizers and application mode were
significant factors in MSBS and their interaction was significant (p < 0.05). Generally, both PBD
and TMD significantly reduced bond strength to dentin by 15–20% on average; however, the effect
was adhesive dependent. For PUB, the groups using phosphoric acid etching (PUB-PA) consistently
showed higher bond strength compared to the ones using self-etch (PUB). Bonding to PBD and TMD
with either PUB-PA and CSE were comparable (p > 0.05).
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Figure 3. SEM images four weeks after application of PBD and immersion in SBF. PBD-treated dentin
demonstrates a solid layer of mineral formation while no coverage is distinguished in the untreated
dentin away from the PBD-treated dentin.
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Table 2. Mean microshear bond strength of the experimental groups (MPa).
Mean ± SD. TMD PBD Control
PUB-SE 25.5 ± 4.7 19.5 ± 3.7 24.9 ± 4.0
PUB-PA 31.8 ± 5.8 30.2 ± 5.9 37.9 ± 5.0
CSE 29.2 ± 5.7 34.2 ± 3.7 40.3 ± 4.3
Figure 4. Bond strength of the experiment group in MPa. Bars indicate no significant difference
(p < 0.05). Two-way ANOVA indicated that both the use of desensitizers and application mode were
significant factors in MSBS and their interaction was significant (p < 0.05). Predicta (PBD) and Teethmate
(TMD) significantly reduced bond strength to dentin by 15%–20% on average; however, the effect
depended on the adhesives. For Universal Adhesive (PUB), the groups using phosphoric acid etching
(PUB-PA) consistently showed higher bond strength compared to the ones using self-etch (PUB).
Bonding to PBD and TMD with either PUB-PA and Clearfil SE 2 (CSE) were comparable (p > 0.05).
4. Discussion
Desensitizing agents occlude the dentinal tubules at the tubular orifice or within the dentinal
tubules to prevent the fluid flow and therefore decrease the pain sensation by counteracting the
hydrodynamic mechanism of DH. The effectiveness of various desensitizing agent to mitigate the DH
has been reported in previous studies. The clinical efficacy has been reported in the application on
vital abutment teeth prepared to receive full coverage or porcelain fused to metal restoration [? ? ].
The pre-impression sealing of the dentin was recommended for tooth preparation on vital teeth to
reduce the pressure transmitted to the pulp chamber during the crown cementation [? ].
In this study, immediately after the application of PBD, the untreated dentin showed patent
dentinal tubules. At the area adjacent to the PBD-treated dentin, random mineral deposits were
observed on the untreated dentin. It is assumed that these deposits have formed as a result of free PBD
nanoparticles adjacent to the PBD-treated dentin (Figure ??).
For evaluation of the mineral forming ability of PBD-treated dentin, SBF immersion proceeded for
four weeks. The SBF was used to simulate the clinical situation where dentin interacts with body fluids,
such as saliva from the oral environment and dentinal fluid and plasma from the pulpal side. The SBF
is an acellular and protein-free simulated fluid with ion concentration nearly equal to those of human
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blood plasma. SBF was preferred over artificial saliva formulations for the bioactivity experiment in this
study since the ISO test has standardized the SBF for bioactivity test and apatite formation ability, while
there is not a comparable standard established for artificial saliva formulations. Due to the similarity
between bone and dentin in terms of mineral composition and structure, the bioactivity test for bone
implant devices would be applicable to a desensitizer material applied to dentin. The bioactive material
is expected to form a layer of apatite on their surface [? ]. In this study, PBD demonstrated bioactivity
as defined by the ISO 23317-2014 document. Considering the composition of SBF, the forming mineral
in the ISO experiment is expected to be apatite.
The SEM micrographs confirmed that the dentin regions exposed for the experiment were rich
in open dentin tubules, and tubular sealing was achieved immediately by PBD. The mineral growth
matured through the SBF-storage period. Fine precipitates are observed inside the tubules close to the
surface whereas the group without PBD, there were patent tubules. The principal mineral content in
PBD (calcium and phosphate, as disclosed by the manufacturer) could stimulate the mineralization
of the dentine tubules. During immersion in SBF, different processes occur resulting in structural
and chemical change at the surface of dentin: leaching, degradation, and precipitation. Calcium ions
dissolve from the bioactive substance into the body fluid. The nucleation of hydroxyapatite is possible
because the surrounding fluid is supersaturated with respect to hydroxyapatite due to the dissolution
of the calcium ions. The process of formation and growth of the hydroxyapatite layer continues by
the reactions of calcium, phosphate and hydroxide ions [? ]. In the oral cavity, the supersaturated
calcium phosphate salts contained in the saliva could precipitate to form a less soluble compound HA
continuously [? ].
The study compared the bond strength of adhesives to dentin treated with PBD and TMD.
The main components of TMD are TTCP and DCPA, which are eventually converted to hydroxyapatite
in an aqueous environment. This conversion is predicated upon the dissolution-precipitation reaction
mechanism [? ]. TTCP and DCPA dissolve and supply Ca2+ and PO43−. The supersaturation of the
apatite-contained solution prompted the precipitation of HA crystals. TMD has been investigated
previously in vitro with a superior tubule occlusion rate compared to silver diamine fluoride and
resin-containing oxalate [? ? ? ]. SEM images of TMD showed all tubules occluded with crystalline
precipitates, with similar precipitation on the intertubular surface [? ]. The application of TMD
occluded dentinal tubules and reduced dentin permeability by 92% regardless of the exposed collagen
network [? ]. A comparable tubule occlusion was found in the novel PBD, therefore its sealing ability
for treatment DH is promising.
As far as bonding performance is concerned, dentin desensitizers significantly decreased the
bond strength of bonding agents. These findings are in alignment with the results of previous work [?
? ? ]. The application of desensitizers before the bonding system significantly reduced shear bond
strengths to sound dentin. In the three-step bonding system, the protocol included acid etching,
rinsing, and drying of dentin before applying the primer. Self-etching primers succeeded in eliminating
the dentin-conditioning steps before priming. Nevertheless, the majority of self-etching primers
have a milder acidity. Therefore, the lower bond strengths to sound dentin might be accounted for
the desensitizer deposition blocking the dentin tubule orifices and intertubular diffusion channels.
The nanoparticles layer of the desensitizer dispersed on the dentin could hinder the adhesives to
interact with the demineralized substrate, resulting in reducing the bond strength [? ].
The literature has reported that the dentin treated with mineral-based desensitizers did not show
a reduction in the bond strength when treated with a two-step self-etching adhesive material [? ].
The reason for this phenomenon was explained by the interaction created between the desensitizer,
the smear layer, and dentin. This was in contrast with the result in this present study where bond
strength in PUB-SE mode after application of PBD and TMD was reduced compared to the control group.
The functional monomer in self-etch adhesives could contribute to the superficial micromechanical
interlocking through hybridization of dentin substrate. The exposed HA crystal that remains around
collagen is expected to be beneficial, as a substrate for chemical bonding. A mineral-rich substrate
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allow a more substantial chemical interaction with the functional monomer and protect the collagen
against hydrolysis thus prevent from premature degradation [? ? ].
It was of interest to compare the bond strength characteristics of two products PBD and TMD
in a combination of adhesives. The result indicated that bonding to PBD with PUB-PA and CSE is
comparable to that to TMD. The bonding performance of the PBD-treated specimen was corroborated
with SEM images obtained by the application of PUB on dentin. PUB with acid etching exhibited
resin tag formation, which could explain higher values in groups bonded in PA mode. Nonetheless,
it was reported that the sequence of application of etching and desensitizer affected the bonding
performance [? ? ]. When dentin was acid-etched before the application of oxalate desensitizer [? ] or
Novamin [? ], the bonding performance was not compromised. However, in this application sequence,
the formation of resin tags might be affected by tubule occlusion with calcium-containing desensitizer
pastes [? ]. The clinical decision of whether to etch dentin or not after desensitizer application should
be made considering the potential increase in permeability of dentin following etching. The interaction
of PBD and phosphoric acid etched dentin, as application of the acid prior to treatment with PBD and
the universal bond, warrants further investigation.
Successful bonding to dentin may further reduce the effects of hydraulic pressure for the treatment
of the post-operative DH [? ? ]. The use of the universal bonding system with acid phosphoric etching
or the two-step self-etching is recommended following the usage of mineral-based desensitizer to
achieve a high bond strength.
The study highlights the biomimetic remineralization shown by desensitizing agent PBD. It could
be of interest to compare investigate the characteristics of PBD in vivo. The present laboratory test
could be to some extent a predictive tool for the clinical efficacy of desensitizing materials, while the
effect of adhesive systems on the survival rate of restorations following desensitizing treatment should
be further studied.
5. Conclusions
In this in vitro study, the newly developed dentin desensitizer demonstrated effective dentinal
tubules sealing capability and promoted mineral crystal growth over dentin and into the tubules
during simulated body fluid storage. For bonding to the desensitizer-treated dentin, dentin treatment
by two-step self-etching system or universal bond with phosphoric acid is recommended.
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Abstract: This communication reports preliminary data towards the development of a live ex vivo
model of persistent infection that is based on the chick embryo chorioallantoic membrane (CAM),
which can be used for pre-screening biomaterials with antimicrobial properties for their antimicrobial
and angiogenic potential. Our results showed that it was possible to infect chicken embryos with
Staphylococcus aureus, one of the main types of bacteria found in the persistent infection associated
with chronic wounds, and maintain the embryos’ survival for up to 48 h. Survival of the embryos
varied with the dose of bacteria inoculum and with the use and time of streptomycin application after
infection. In infected yet viable embryos, the blood vessels network of the CAM was maintained
with minimal disruption. Microbiological tests could confirm embryo infection, but quantification
was difficult. By publishing these preliminary results, we hope that not only our group but others
within the scientific community further this research towards the establishment of biomimetic and
reproducible ex vivo models of persistent infection.
Keywords: chronic wounds; infection; chick embryo CAM; ex ovo; biomaterials
1. Introduction
Chronic wounds are described as severe non-healing wounds that constitute a significant burden
to healthcare systems [1]. According to a retrospective health economics study, in the U.K. the National
Health System (NHS) treated 2.2 million wounds in the year 2012/2013, with an estimated cost of GBP
5 billion. In the USA, about 6.5 million patients are affected by chronic wounds and an estimated
USD 25 billion is spent annually on treating these wounds [1]. Predictably, these figures will rise
with an ageing population and the increasing prevalence of long-term conditions such as diabetes [1].
Chronic wounds do not progress through the overlapping healing stages of haemostasis, inflammation,
proliferation, and remodelling, as these wounds are often infected and lack the angiogenic supply for
the healing process to begin [1,2]. Current treatments include surgery, dressings, drugs, and devices,
among others, and often a combination of them is necessary to achieve healing [1]. Therefore,
there is a clinical need for new effective treatments with the ultimate goal of regeneration rather than
repair. Tissue engineering is a rapidly progressing field that offers exciting potential to find new and
regenerative treatments for chronic wounds.
With the advent of tissue engineering, biomedical engineers, material scientists, and cell biologists
are researching novel systems for management of these difficult wounds. The research strategies for
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treating chronic wounds vary from stem cell-based therapies and gene therapies to tissue-engineered
biomaterial scaffolds [3,4]. The rationale for using tissue-engineered scaffolds is to control the infection,
restore the angiogenic response, and allow new tissue formation to take place while providing a
temporary extracellular matrix (ECM). To develop biomaterials that can treat the underlying infection
and promote angiogenesis, the candidate materials need to go through rigorous in vitro and in vivo
testing. In the particular case of chronic wounds, currently there is not a chronic wound model in
existence that can mimic the in vivo scenario for pre-screening biomaterials. Such a model should
mimic the persistent infection associated with chronic wounds. Furthermore, this model should allow
testing of the angiogenesis potential of the candidate biomaterials.
The extraembryonic chorioallantoic membrane (CAM) of the chick embryo is easily accessible,
highly vascularised, and presents an immunodeficient environment [5]. Therefore, it has been widely
used in various aspects of research such as biology, pharmacy, oncology, and tissue regeneration [5,6].
It has also been used as an ex vivo model to study pathogenesis and the invasion capacity of different
bacteria such as Klebsiella pneumoniae, fungi such as Cryptococcus gatii or Candida albicans, and viruses
such as the fowlpox-causing viruses [7–10]. In these studies, the CAM was inoculated with the pathogen
of interest, and after subsequent infection, the researchers assessed the survival and morphological
features of the CAM and embryo. Thus far, only in ovo systems have been used. However, ex ovo
systems may offer advantages over in ovo systems. Although in ovo CAM assays are very popular,
a significant variation exists in in ovo techniques as a result of a lack of standardisation. Furthermore,
in ovo systems often develop contamination from the eggshell dust, and therefore are inefficient
in maintaining sterility of the embryo [6]. Recently, research into ex ovo techniques has seen the
development of efficient, reproducible, and cost-effective CAM assays that are becoming increasingly
popular in the fields of biomaterials and tissue engineering [6].
We are currently developing a novel ex vivo model of persistent infection using ex ovo chick
embryo CAM for testing the antimicrobial potential of tissue-engineered materials followed by their
subsequent angiogenesis potential. In the present preliminary study, we try to answer the initial
question of whether it is possible to infect chick embryos/CAM with bacteria and maintain their
survival ex ovo for up to 48 h. For this purpose, we used Staphylococcus aureus, one of the main types
of bacteria found in the persistent infection associated with chronic wounds [11], and antibiotics
(i.e., streptomycin) to maintain and/or enhance embryo survival.
2. Materials and Methods
2.1. S. aureus Strains
A clinical strain and a control antibiotic-susceptible strain (ATCC 29213) of S. aureus were kindly
donated by The Hillingdon Hospitals NHS Foundation Trust (Uxbridge, UK). Donated S. aureus
samples were in mannitol salt agar (MSA) plates.
2.2. Luria-Bertani (LB) Agar Plates
LB agar powder (17.5 g, 22700025, Thermo Fisher Scientific, Loughborough, UK) was dissolved
in 500 mL of deionised water, autoclaved, and cooled down to approximately 50 ◦C. Working in a
biosafety cabinet, the agar was poured into Petri dishes (around 25 mL of agar per dish). Plates were
partially covered with the lids and allowed to cool down and dry. Finally, the lids were closed, and the
plates stored with the agar side up at 4 ◦C until used (for a maximum of 4 weeks).
2.3. S. aureus Culture/Colony Isolation
The agar plate(s) were taken out of the fridge to warm up to room temperature. Using a sterile
swab, a single colony of S. aureus from the sample MSA plate (clinical or control strain) was picked and
streaked onto a fresh LB agar plate, which was incubated for up to 24 h at 37 ◦C. The same procedure
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was carried out to maintain culture of S. aureus in LB agar plates but transferring individual colonies
from LB agar plates to fresh ones.
2.4. Streptomycin Sensitivity Assay
Filter paper (Whatman, WHA1001150, Sigma-Aldrich, Dorset, UK) was cut into 6 mm discs and
autoclaved prior to use. Streptomycin solutions (streptomycin sulfate salt, S6501, Merck, Feltham, UK)
ranging from 100 mg/mL to 5 μg/mL were prepared and stored at 4 ◦C under sterile conditions.
A standard EUCAST (European Committee on Antimicrobial Susceptibility Testing) disc diffusion
method [12] was used as follows. Agar plates were taken out of the fridge several minutes before
the procedure. Isolated colonies of S. aureus were picked from an LB plate (see Section 2.3) using a
sterile swab, transferred into a sterile tube containing 1 mL of sterile water, and vortexed to suspend
the bacteria in the water. The Optical Density (OD) at 600 nm of the prepared bacterial suspension
was measured. If required, the suspension was diluted to obtain 4 × 108 cfu/mL. A sterile swab was
dipped in the final suspension, and excess fluid was removed and swabbed onto a fresh LB agar plate
to obtain confluent bacterial growth. Bacteria were let to set for a few minutes before applying the
streptomycin-soaked discs onto the plate; using sterile tweezers, filter paper discs were dipped in the
required streptomycin solution, excess fluid was removed, and then the soaked discs were placed onto
the plates, which were incubated for 24 h at 37 ◦C. Finally, the diameters of the zones of inhibition
were measured using a ruler.
2.5. Ex Ovo Culture System
The use of chicken embryos in our study did not require ethical approval as per the guidelines
of The Institutional Animal Care and Use Committee (IACUC) and the National Institutes of Health,
USA, and the Animals Scientific Procedures Act (ASPA), U.K., which state that a chicken embryo that
has not reached the 14th day of its gestation period would not experience pain and can therefore be
used for experimentation without any ethical restrictions or prior protocol approval [6].
Fertilized chicken eggs obtained from a local producer in Middlesex (Quedgeley, UK) were kept
in a specialized incubator at 38 ◦C and ≈45% relative humidity for 3 days, when the embryos were
transferred to a shell-less culture system consisting of a glass–cling film set-up routinely used in our
laboratory [6]. Briefly, Pyrex glasses of 8 cm diameter were autoclaved and filled up to three-quarters
with sterile water, and then a clean cling film layer (pre-sterilised with 70% Industrial Methylated
Spirit (IMS) and dried) was placed inside the glasses with the bottom of the cling film touching the
water. Rubber bands secured the cling film on the glasses. After 3 days in the specialized incubator,
eggs were wiped with cytosol wipes, cracked open against the sharp edge of a triangular block, and the
contents were immediately transferred to the glass-cling film set up. The yolk sac and the embryo
were identified and assessed for viability by looking for a beating heart. The glasses were then covered
with a Petri dish, transferred to the incubator, and grown for 6 days at 38 ◦C and 80%–90% humidity.
2.6. Ex Ovo CAM Infection with S. aureus
At day 9, the CAMs were infected using 2 doses of 50 μL of S. aureus bacterial inoculum, applied
topically avoiding dispersing the inoculum very close to the embryo (Figure 1A). The inoculation
spots were marked on the cover Petri dish lid (Figure 1). Control CAMs were inoculated with two
doses of 50 μL of deionised water. The ex ovo cultures were covered with the corresponding Petri
dish lid and incubated at 38 ◦C and 80%–90% humidity. Viability of the embryos was monitored daily.
Macroscopic and microscopic images (using a GT vision stereo microscope, GXM-XTL3T101, GT Vision
Ltd, Stansfield, UK) of the embryos were taken regularly. Allantoic fluid samples were taken either
from embryos that died during the experiment or that were sacrificed if still viable. The allantoic fluid
was collected (≈1 mL) at relevant time points, diluted 5–6-fold, plated, and incubated at 37 ◦C for 24 h
to examine the presence of infection.
155
J. Funct. Biomater. 2020, 11, 37
 
Figure 1. Photos taken during the experimental procedure of this study showing (A) application of
Staphylococcus aureus bacterial inoculum on the chorioallantoic membrane (CAM) of a viable embryo
contained in a glass–cling film set-up and inoculation spots marked on the cover Petri dish lids, and (B)
application of streptomycin-infused 6 mm diameter filter paper discs on the CAM using sterile tweezers.
2.7. Preparation and Application of Streptomycin-Infused Discs on CAM
A solution of 5 mg/mL of streptomycin in sterile water was prepared, and 6 mm diameter
filter paper discs were dipped into it. Streptomycin-infused discs (×4) were gently applied onto the
CAM using sterile tweezers (Figure 1B). The ex ovo cultures were immediately covered with the
corresponding Petri dish lid and incubated at 38 ◦C and 80%–90% humidity.
A control for streptomycin activity was run alongside the ex ovo cultures by using the standard
EUCAST method described before. Four streptomycin-infused discs were applied onto the LB agar
plate, which was incubated at 37 ◦C for up to 24 h.
3. Results and Discussion
3.1. Streptomycin Sensitivity Assay
An assay to determine the streptomycin concentration that yielded the desired level of bactericidal
effect was carried out, where S. aureus was tested against several concentrations of streptomycin
using the standard EUCAST disc diffusion method [12]. S. aureus from both a clinical strain and
a control antibiotic susceptible strain were used. Results showed that the minimum streptomycin
concentration necessary to yield a noticeable bactericidal effect on both strains tested was 5 mg/mL.
Below this concentration, the bactericidal effect was faint, whereas above it the effect was hardly
enhanced (Figure 2). Therefore, 5 mg/mL was chosen to carry out our study.
3.2. Embryo Survival after Infection of CAM in the Absence of Streptomycin
According to the literature, an inoculum of 108 cfu/mL or higher would result in embryo death [7,8].
A quick test confirmed this previous finding, where our embryos died within 24 h following CAM
inoculation with 108–109 cfu/mL inoculum (results not shown). A study by Gow et al. using an
inoculum of 105 cfu/mL showed embryo death within 24 h. However, in the cited study, the infecting
pathogen was the fungus Candida albicans [10]. In our study, we lowered the bacterial load in the
inoculum to 105 cfu/mL for investigating embryo survival following CAM infection.
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Figure 2. Results from the streptomycin sensitivity assay. Graphs show average ± standard deviation
(n = 3 per streptomycin concentration).
Results showed that embryo survival decreased to 50% 24 h after inoculation and continued to
decrease following another 24 h of incubation (Figure 3A). By day 3 (72 h), infected embryos were
dead. Our control embryos (non-inoculated CAM) survived over the 72 h experiment (Figure 3A).
On examining the allantoic fluid, the presence of bacterial colonies was observed in infected embryos,
suggesting the presence of infection within the CAM as well (Figure 3B,C).
 
Figure 3. (A) Percentage of embryo survival after CAM infection (infected CAM) with 105 cfu/mL
inoculum compared to non-infected CAMs (control CAM). Results show average (n = 3 for control and
n = 6 for infected CAM at the beginning of the experiment). (B) S. aureus load in allantoic fluid samples
of infected CAMs. X means that there were too many colonies and a count could not be performed.
(C) Representative images of Luria-Bertani (LB) plates showing S. aureus colony formation after plating
samples of the allantoic fluid from control and infected CAMs.
These results suggest that it is possible to infect chick embryos/CAM with S. aureus (105 cfu/mL
inoculum) and maintain their survival for up to 48 h. However, the percentage of embryo survival
under these conditions is approximately 30%. Therefore, the next question to answer is whether
survival rate could be increased with the use of antibiotics, the aminoglycoside streptomycin in
our study.
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3.3. Embryo Survival after Infection of CAM in the Presence of Streptomycin
An increase in embryo survival was observed in the presence of the antibiotic streptomycin when
applied at the time of inoculation (0 h) (Figure 4A). On injecting the CAMs with the antibiotic 24 h
after inoculation, survival increased after 24 h incubation; however, after further 24 h of incubation,
the embryos died. Examination of the allantoic fluid showed clear presence of infection in the
embryos/CAM when the antibiotic was applied 24 h after inoculation, whereas no infection could be
seen in the control group or when streptomycin was applied at the time of inoculation (Figure 4B).
Figure 4. (A) Percentage of embryo survival after CAM infection (infected CAM) with 105 cfu/mL
inoculum compared to non-infected CAMs (control CAM). Streptomycin was applied either at the
time of inoculation (0 h) or 24 h after inoculation (24 h). Results show average (n = 2 per group).
(B) Representative images of LB plates showing S. aureus colony formation after plating allantoic fluid
samples (105 dilution). No colonies were observed in the control group plates. As can be observed,
there were too many colonies to perform a count and subsequent quantification, which could only be
done using a higher dilution.
These results suggest that embryo survival depends on the inoculum dose, the use of antibiotics,
and the time of their application on the infected CAM. Further work on this project intends to look
into a higher range for these variables to find optimum conditions. Nevertheless, the answer to the
initial question of whether it is possible to infect chick embryos/CAM with bacteria and maintain their
survival for up to 48 h was affirmative, which sets the ground for developing an ex vivo model of
persistent infection.
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3.4. CAM Morphology of Infected Embryos
Another aim of this study was to investigate CAM morphology of infected embryos to understand
how infection with S. aureus affects the CAM blood vessel network, which could have an effect when
studying the angiogenic potential of candidate materials. The CAM is highly vascularised with both
mature vessels and capillaries and is easily accessible for orthotopic implantation of biomaterials
without initiating an embryo immune reaction [6]. If this network of vessels and capillaries was badly
disrupted due to infection, testing of biomaterials on it would not be possible.
Non-infected CAMs showed a well-defined network of blood vessels with no obvious pathological
features (Figure 5A,G). On the other hand, CAMs with signs of infection showed various degrees of
blood vessel damage, which was mainly observed on the periphery of the CAM, as well as throughout
the network (Figure 5B,E). In some instances, the blood vessel network appeared quite disrupted,
making it not suitable for further biomaterial testing (Figure 5E). However, some infected embryos
showed minimal blood vessel network disruption (Figure 5B). Microscopic analysis showed a cloudy
background for infected CAMs (Figure 5H) compared to non-infected CAMs (Figure 5G). Application
of streptomycin at the time of inoculation seemed to clear infection because no evident signs of it could
be observed for the majority of these CAMs (Figure 5C,D) compared to applying the antibiotic 24 h
after inoculation (Figure 5E). When embryo death occurred, the CAM blood vessel network appeared
completely destroyed (Figure 5F).
These results suggest that under certain conditions it is possible to infect CAMs with S. aureus and
keep the embryo viable while maintaining the network of CAM blood vessels with minimal disruption.
In the future, it would be useful to investigate the way in which to quantify blood vessel damage to
establish a threshold of viability for biomaterial testing.
We acknowledge that the system presented here is, at the moment, fragile, where we only managed
to keep a low percentage of infected embryos alive for up to 48 h. We also acknowledge variation
of outcomes and reproducibility. The CAM model in itself is a highly biological variable, even in
non-infected eggs [6]. Therefore, the differences observed in our study may stem from this intrinsic
feature of the CAM model, rather than inappropriate methodology. Further experiments with increased
biological replicates may improve reproducibility.
It is worth mentioning that extraction of allantoic fluid was technically difficult and invasive to
the embryo. Although information on the dynamics of infection spread would be useful, manipulation
of the embryo during the experiment could introduce additional contamination and stress, increasing
the chances of death due to the experimental procedure versus the infection itself. However, this can be
resolved by extracting the allantoic fluid after sacrificing the embryo, as we did in our study, at given
time intervals. The analysis of allantoic fluid in this preliminary study was largely exploratory and
we could not anticipate the final bacterial concentration in the embryo because no reports of similar
experiments exist. In future work, we do intend to take into account this study’s observations when
quantifying bacterial burden. Notwithstanding, the results presented still allow comparison of bacterial
burden between CAMs with different survival outcomes.
In addition, more research and optimisation are needed to test a wider range of conditions,
such as the ones mentioned earlier (i.e., inoculum dose, the use of antibiotics, and the time of their
application on the infected CAM), in order to find the optimum conditions to achieve consistent
and reproducible viability of infected embryos. Nevertheless, this system is more representative of
the biological situation in chronic wounds where living tissues are ridden with bacterial infection.
Moreover, it is very cost-effective.
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Figure 5. Macroscopic images of the CAM with and without bacterial infection, where black arrows
point at vessel damage due to the bacterial invasion. (A) Non-infected CAM incubated for 48 h.
(B) CAM infected with 105 bacterial inoculum and incubated for 48 h. (C) CAM infected with
105 bacterial inoculum with antibiotic applied at the time of infection (0 h) and incubated for 24 h.
(D) Same embryo as C after 48 h incubation. (E) CAM infected with 105 bacterial inoculum with
antibiotic applied 24 h post-infection and incubated for 24 h. (F) Same embryo as (E) after 48 h incubation
(embryo is dead and network of blood vessels is completely destroyed). (G) Stereomicroscopy image
of non-infected CAM at 24 h showing a mostly clear background and well-defined blood vessels.
(H) Stereomicroscopy image of infected CAM at 24 h post-infection showing a cloudy background
(white arrows point at yellowish cloudy spots) and in some areas blood vessels appear less well-defined
and fainter than in non-infected CAM. Please note that with the purpose of protecting the live ex vivo
cultures, photos were taken with the Petri dish lid on, but the lid might have been taken off if the
embryos were already dead or sacrificed. Additionally, the lid might have been moved (without
opening) to capture the morphological changes in the CAM/embryo.
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4. Conclusions
The main conclusions from this study are (1) it was possible to infect chicken embryos with
S. aureus, one of the main types of bacteria found in the persistent infection associated with chronic
wounds, and maintain the embryos’ survival for up to 48 h; (2) survival of the embryos varied with
the dose of bacteria inoculum and with the use and time of application after infection of an antibiotic
(streptomycin in this study); (3) in infected yet viable embryos, the blood vessels network of the CAM
was maintained with minimal disruption; and (4) microbiological tests can confirm infection of the
embryo, but quantification is difficult.
In summary, we report here preliminary data towards the development of a live ex vivo model
of persistent infection that can be used for pre-screening biomaterials intended for treating chronic
wounds for their antimicrobial and angiogenic potential. This model is relatively simple, quick,
and low-cost, and mimics the in vivo situation more closely than traditionally used antimicrobial tests
using agar plates and dilution assays. In addition, keeping in accordance with the principles of the
National Centre for the Replacement Refinement and Reduction of Animals in Research (NC3R’s),
this model does not require administrative procedures for obtaining ethics committee approval for
animal experimentation. Nevertheless, we do acknowledge that further work is still needed towards
further optimisation to study the interaction of biomaterials with two different strains of bacteria
commonly found in chronic wounds, in order to assess their antimicrobial and angiogenic properties.
By publishing these preliminary results, we hope that not only our group but others within the scientific
community further this research towards the establishment of biomimetic and reproducible ex vivo
models of persistent infection. Such models would not only be useful in the research of treatments
for chronic wounds, but also in those applications where infection is an important factor to take into
account when investigating new therapies.
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Abstract: Background: Toothpastes containing nano-hydroxyapatite (n-HAp) substituted with metal
ions provide calcium and phosphate ions to dental hard tissues, reducing demineralization,
and promoting remineralization. Few data are available about the effect of these bioactive compounds
on oral microbiota. Methods: This in vitro study evaluated the influence of two commercially-available
substituted n-HAp-based toothpastes (α: Zn-carbonate substituted n-HAp; β: F, Mg, Sr-carbonate
substituted n-HAp) on early colonization (EC, 12 h) and biofilm formation (BF, 24 h) by oral microbiota.
Controls were brushed with distilled water. Artificial oral microcosm and Streptococcus mutans biofilms
were developed using human enamel and a resin-based composite (RBC) as adherence surfaces.
Two test setups, a shaking multiwell plate and a modified drip-flow reactor (MDFR), were used
to simulate clinical conditions during the night (low salivary flow and clearance) and daytime,
respectively. Energy-dispersive X-ray spectrometry (EDS) was used to evaluate specimens’ surfaces
after toothpaste treatment. Fluoride release from β toothpaste was evaluated. Viable adherent biomass
was quantified by MTT assay, and biofilms’ morphology was highlighted using confocal microscopy.
Results: EDS showed the presence of remnants from the tested toothpastes on both adherence surfaces.
β toothpaste showed significantly lower EC and BF compared to control using the artificial oral
microcosm model, while α toothpaste showed lower EC and BF compared to control, but higher
EC and BF compared to β toothpaste. The effect shown by β toothpaste was, to a minimal extent,
due to fluoride release. Interestingly, this result was seen on both adherence surfaces, meaning that the
tested toothpastes significantly influenced EC and BF even on RBC surfaces. Furthermore, the effect
of toothpaste treatments was higher after 12 h than 24 h, suggesting that toothbrushing twice a
day is more effective than brushing once. Conclusions: The efficacy of these treatments in reducing
microbial colonization of RBC surfaces may represent a promising possibility in the prevention of
secondary caries.
Keywords: fluoride(s); biofilm(s); Streptococcus mutans; bioreactor(s); enamel; composite materials;
biomaterials; hydroxyapatite; nanostructured materials; dental
1. Introduction
Biofilms colonizing dental surfaces represent the habitat of a wide range of microorganisms.
In healthy conditions, this microbial community provides fundamental benefits to host surfaces,
including homeostasis of critical environmental parameters such as pH, as well as protection against
J. Funct. Biomater. 2020, 11, 36; doi:10.3390/jfb11020036 www.mdpi.com/journal/jfb163
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colonization by exogenous species. However, loss of this equilibrium can result in dysbiosis, leading to
the onset of oral diseases, including dental caries [1,2].
Mechanical biofilm control can be beneficially associated with the use of active compounds to
reduce biofilm formation, positively affecting the biological equilibrium of the ecosystem [3]. The search
for new bioactive compounds to prevent dental caries development and progression has led researchers
to focus their attention on the use of nanotechnologies, especially hydroxyapatite (HAp), metals, and
metal oxide nanoparticles [4–6]. Nanotechnology applications offer the opportunity to modulate the
formation of dental biofilms using nanoparticles with bioactive effects. Indeed, their possible use in
biofilm control is related to some peculiar characteristics that materials acquire when nano-sized:
shape, surface-to-volume ratio, chemical reactivity, and ability to interact with the bacterial cell
wall directly [6–8]. Considerable efforts have been made to clarify the transfer mechanisms of such
nanoparticles through biofilms, indicating that nanoparticles can diffuse through water channels inside
biofilms, interacting both with the microbial cells and with the hard tissue surface.
Toothpastes containing nano-hydroxyapatite (n-HAp) and its precursors can provide calcium and
phosphate ions to dental hard tissues, reducing demineralization, and promoting remineralization.
N-HAp may also form a protective layer on dental hard tissues with chemical characteristics
very close to natural tissues, showing biomimetic properties [9,10]. Biomimetic n-HAp or other
calcium phosphate-based nanosystems have been shown to actively shift the ionic balance toward
remineralization [11,12]. Recently, n-HAp-based toothpastes containing metal ions such as Zn, F, Mg,
and Sr have been introduced to improve the remineralization processes. The small quantity of metal
ions with which nHAp is doped modulates the properties of the compound already from its deposition,
influencing crystal growth and length, and influencing its solubility and strength. They are firmly
embedded inside the lattice and are not supposed to be released. Most studies, therefore, provide data
about the remineralization potential of these compounds on surface lesions, with few reporting their
influence on early microbial colonization (EC) and biofilm formation (BF) [13–16].
Resin-based composites (RBCs) provide an example of artificial surfaces intensely colonized
by cariogenic biofilms due to their lack of buffering effect [17]. This characteristic has been put into
relation with the high occurrence of secondary caries in the sound dental tissues surrounding an RBC
restoration [17]. The possibility of influencing microbial colonization of RBCs, therefore, can be seen
as a means to prevent the occurrence of such lesions. For this reason, RBCs are a potential target
of preventive measures exploiting the potential of nanotechnologies in order to reduce secondary
caries occurrence.
The aim of this study was to evaluate the in vitro effect of two n-Hap-based toothpastes on
early colonization (EC) (12 h) and biofilm formation (BF) (24 h) of human enamel and RBC surfaces.
The study was performed by aerobically culturing the monospecies Streptococcus mutans and an artificial
oral microcosm using both a static and a continuous flow setup. The aim of the two models was to
assess the effect of the tested toothpastes under environments simulating clinical conditions during the
night (low salivary flow and clearance) and day (high salivary flow and clearance). The null hypothesis
was that toothpaste treatment would not influence EC and BF on sound enamel surfaces in the tested
models. An additional null hypothesis was that toothpaste treatment would not influence EC and BF
on RBC surfaces in the tested models.
2. Materials and Methods
2.1. Preparation of Specimens
Reagents, culture media, and disposables used in this study were obtained from E. Merck AG
(Darmstadt, Germany). A total of 110 human teeth extracted for clinical reasons were obtained and
stored at −20 ◦C until use. The Institutional Review Board of the University of Milan approved the
protocol (codename: SALTiBO-2017). Enamel disks 6.0 mm in diameter and 1.5 mm thick were cut from
the teeth surfaces by means of custom-made water-cooled diamond trephine burs (Indiam, Carrara,
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Italy). A total of 213 enamel disks were prepared for the study, using this procedure to obtain more
than one disk from each tooth.
A total of 213 disks (6.0 mm diameter and 1.5 mm thickness) of a nanohybrid resin-based composite
(RBC, Clearfil Majesty ES-2, shade A2, Kuraray Europe GmbH, Hattersheim am Main, Germany)
were obtained by packing an excess of uncured material into a custom-made PTFE mold. The top
and bottom surfaces of the RBC were covered with a cellulose acetate strip (Mylar) and condensed
against a glass plate by applying a load of 1 kg for 20 s. The specimens were then irradiated for
40 s by placing the tip of a light-curing unit (MiniLED, Satelec, Acteon Group, Merignac, France,
420–480 nm emission, 1250 mW/cm2 irradiance) into direct contact with the acetate strip. To remove
most of leachates, RBC specimens were then stored under light-proof conditions in phosphate-buffered
saline (PBS) for 6 days at 37 ◦C, with the buffer replaced twice a day.
Both enamel and RBC disks were polished using grinding paper (1000, 2000, and 4000 grit) to
obtain a surface roughness with Ra < 0.2 μm. They were then randomly divided into three groups
(α, β, and control, n = 71/group, Figure 1).
Figure 1. Diagram of specimens processing for the present study. After brushing with the tested
toothpastes or with distilled water, enamel and RBC specimens were rinsed, sterilized, then subjected
to microbiological analysis and surface imaging (SEM, CLSM) and analysis (EDS). The microbiological
analysis included two test setups, two microbiological models, and two incubation times.
2.2. Toothpastes
Two toothpastes containing n-HAp were tested (Table 1). The toothpastes were inserted into
test tubes coded by the Greek letter corresponding to the first two groups (α, β). In this way,
the experimenters performing microbiological procedures were blinded regarding their composition.
Each toothpaste was mixed to a slurry using one part of toothpaste and two parts of distilled water.
Then, enamel and RBC disks of groups α and β were manually brushed by a single operator with
the corresponding toothpaste for 2 min and rinsed with distilled water for 1 min. Disks belonging to
the control group were brushed with distilled water for 2 min, then rinsed for 1 min with distilled
water. All disks were then sterilized using a chemical peroxide-ion plasma sterilizer (STERRAD, ASP,
Irvine, CA, USA).
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Table 1. Label, manufacturer and composition of the tested substituted n-Hap-containing toothpastes.
Label Name Company Composition
Toothpaste α Biorepair TotalProtection Plus
Coswell
Funo (BO), Italy
Purified water, zinc carbonate
hydroxyapatite, glycerin, sorbitol, hydrated
silica, silica, aroma, cellulose gum,
tetrapotassium pyrophosphate, sodium
myristoyl sarcosinate, sodium methyl
cocoyl taurate, sodium saccharin, citric acid,









Purified water, glycerin, hydrated silica,
fluoride-hydroxyapatite, Mg-Sr-carbonate
hydroxyapatite conjugated with chitosan,
cellulose gum, xylitol, cocamidopropyl
betaine, xantham gum, aroma, acesulfame
K, ethylhexylglycerin, phenoxyethanol,
sodium benzoate, citric acid.
2.3. Surface Imaging and Analysis
Scanning electron microscopy (SEM) and energy-dispersive X-ray spectroscopy (EDS) analysis
were performed (n = 4/group, Figure 1) using a TM4000Plus Tabletop scanning electron microscope
(Hitachi, Schaumburg, IL, USA) equipped with an EDS probe (Q75, Bruker, Berlin, Germany) to
investigate the presence of toothpaste residues on the specimen surface. Dry specimens were observed
in surface-charge reduction mode without sputter-coating, using an accelerating voltage of 15 KV.
Three randomly selected fields were acquired for each specimen at 500× magnification and were
analyzed using the EDS probe in full-frame mode using an acquisition time of 150 s. SEM micrographs
(backscattered electrons mode) and EDS elemental maps of the surfaces at 5000×magnification were
also obtained. The acquired data represent the elemental composition of the ≈1 μm superficial layer.
2.4. Saliva Collection
Whole saliva was collected from five healthy volunteers, according to a previously described
protocol [18]. They refrained from oral hygiene for 24 h, did not have any active dental disease,
and did not have antibiotic therapy for at least three months prior to the experiment. Chilled test tubes
were used for saliva collection. Saliva was then pooled, heated to 60 ◦C for 30 min and centrifuged
(27,000× g, 4 ◦C, 30 min). The sterile supernatant was collected into sterile tubes and stored at −20 ◦C.
Saliva was thawed at 37 ◦C for 1 h before use. The Institutional Review Board of the University of
Milan approved the use of saliva (codename: SALTiBO-2017), and written, informed consent was
obtained from all volunteers.
2.5. Microbiological Procedures
Two microbiological models were used in this study: a monospecific S. mutans culture and an
artificial oral microcosm based on mixed oral flora (Figure 1).
A pure suspension of S. mutans strain ATCC 35668 was obtained as described elsewhere [19].
Briefly, Mitis Salivarius Bacitracin agar (MSB agar) plates were inoculated with the S. mutans strain
and incubated aerobically in a 5% CO2-supplemented atmosphere at 37 ◦C for 48 h. After transferring
an inoculum in Brain Heart Infusion (BHI) broth and further incubating in a 5% CO2-supplemented
atmosphere at 37 ◦C for 12 h, a pure culture of the microorganism was obtained. Cells were harvested
by centrifugation (2200× g, 19 ◦C, 5 min), washed twice with sterile phosphate-buffered saline (PBS),
and resuspended in the same buffer., The suspension was sonicated using low-energy output (7W for
30 s, B-150 Sonifier, Branson, Danbury, CT, USA) to disperse bacterial chains. Finally, the suspension
was adjusted to an optical density of 1.0 on the McFarland scale, corresponding to a concentration of
approximately 6.0 × 108 cells/mL.
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A mixed oral flora inoculum was obtained from fresh, pooled saliva expectorated from the same
five donors previously described, filtered through sterile glass wool, vigorously stirred for 2 min,
and immediately used. Two test setups were used in this study: a shaking multiwell plate and a
modified drip-flow reactor (MDFR).
2.5.1. Shaking Multiwell Plate
Disks were placed in 48-well sterile plates and incubated at 37 ◦C for 24 h in sterile saliva; then,
the saliva was removed by gentle aspiration. Each well was inoculated with 100 μl of either S. mutans
suspension or mixed oral flora, and 900 μl of sterile modified artificial saliva medium. The medium
composition was the following: 10.0 g/L sucrose, 2.5 g/L mucin (type II, porcine gastric), 2.0 g/L
bacteriological peptone, 2.0 g/L tryptone, 1.0 g/L yeast extract, 0.35 g/L NaCl, 0.2 g/L KCl, 0.2 g/L
CaCl2, 0.1 g/L cysteine hydrochloride, 0.001 g/L hemin, and 0.0002 g/L vitamin K1 [20]. Plates were
then incubated aerobically in an orbital shaker at 37 ◦C and 100 rpm. After either 12 h (colonization) or
24 h (biofilm formation), adherent viable biomass assessment was performed.
2.5.2. MDFR
The bioreactor used in the present study was a modification of a commercially available drip-flow
reactor (DFR 110, BioSurface Technologies; Bozeman, MT, USA) according to previously described [21].
The modified design (MDFR) allowed the placement of customized PTFE trays on the bottom of the
flow cells to submerge the specimen surfaces in the flowing medium. Specimens from each group were
randomly divided into the eight flow cells of two identical MDFRs. After sterilization (STERRAD),
the MDFR was assembled inside a sterile hood, and a salivary pellicle was obtained on the specimen
surface after incubation with sterile saliva at 37 ◦C for 24 h. Saliva was then removed, each flow-cell
was inoculated with 10 mL of either S. mutans suspension or mixed oral flora suspension to allow
bacterial adherence. After 4 h, a peristaltic pump (RP-1k; Rainin, Emeryville, CA, USA) provided the
constant flow of sterile modified artificial saliva medium through the flow cells (9.6 mL/h). For each
microbiological inoculum, the amount of viable adherent biomass was evaluated after either 12 h or
24 h of further incubation in aerobic conditions (Figure 1).
2.6. Viable Biomass Assessment
Viable and metabolically active biomass adherent to the specimen surface was assessed using
a tetrazolium-based assay as described previously [21]. In brief, a tetrazolium salt stock solution
was prepared by dissolving 5 mg/mL 3-(4,5)-dimethylthiazol-2-yl-2,5-diphenyltetrazolium bromide
(MTT) in sterile PBS; a phenazinium salt stock solution was prepared by dissolving 0.3 mg/mL of
N-methylphenazinium methyl sulphate (PMS) in sterile PBS. The solutions were stored at 2 ◦C in
light-proof vials until the day of the experiment when a fresh measurement solution (FMS) was
prepared by diluting 1:10 v/v of MTT stock solution and 1:10 v/v of PMS stock solution in sterile PBS.
A lysing solution (LS) was prepared by dissolving 10% v/v of sodium dodecyl sulphate (SDS) and
50% v/v dimethylformamide in distilled water and stored at 2 ◦C until the day of the experiment
when it was warmed at 37 ◦C for 2 h before use. After the specified incubation times, the orbital
shaker and the MDFR medium flow was halted, flow cells and plates were opened, the specimens
were carefully removed and immediately placed into Petri plates containing sterile PBS at 37 ◦C.
They were gently washed three times with sterile PBS to remove non-adherent cells and finally placed
inside the wells of 48-well plates containing 300 μL of FMS each. The plates were incubated at 37 ◦C
under light-proof conditions for 3 h. During incubation, electron transport across the microbial plasma
membrane and, to a lesser extent, microbial redox systems, converted the yellow salt to insoluble
purple formazan crystals. The conversion at the cell membrane level was facilitated by the intermediate
electron acceptor (PMS). The unreacted FMS was gently removed by aspiration, and the formazan
crystals were dissolved by adding 300 μL of LS to each well. The plates were stored for an additional
1 h under light-proof conditions at room temperature; 100 μL of the solution was then transferred into
167
J. Funct. Biomater. 2020, 11, 36
96-well plates. The absorbance of the solution was measured using a spectrophotometer (Genesys
10-S, Thermo Spectronic, Rochester, NY, USA) at a wavelength of 550 nm; results were expressed as
relative absorbance in optical density (OD) units corresponding to the amount of adherent, viable and
metabolically active biomass.
2.7. Confocal Laser-Scanning Microscopy (CLSM)
A total of three specimens for each material and treatment group (Figure 1) were prepared for
CLSM analysis. They were incubated using the MDFR test setup with the artificial oral microcosm
model for 12 h. Then, they were gently removed from the flow cells, rinsed twice with sterile
PBS, stained using the FilmTracer™ LIVE/DEAD® Biofilm Viability Kit (Invitrogen Ltd., Paisley, UK),
and analyzed using confocal laser-scanning microscopy (CLSM; Eclipse Ti2 inverted CLSM, Nikon, Tokyo,
Japan). Three randomly selected image stack sections were recorded for each specimen. Confocal images
were obtained using a dry objective (20×; NA = 0.5) at a resolution of 2048 × 2048 pixels, with a
zoom factor of 1.0 and a scan speed of 400 Hz, and digitalized using the Nikon Imaging Software
(NIS)—Elements Viewer, v. 4.50. Three channels were acquired in parallel scanning; the first used an
excitation at 405 nm and emission at 420–470 nm in order to subtract potential autofluorescence digitally.
The other two channels had an excitation wavelength of 488 nm, and emission was acquired at 500–570 nm
(green channel, live bacteria) and 610–760 nm (red channel, dead bacteria). For each image stack section,
3D-rendering reconstructions were obtained using Drishti (Ajay Limaye, Australian National University,
CAN, AUS, http://sf.anu.edu.au/Vizlab/drishti/).
2.8. Fluoride Release Measurements
Measurements of fluoride release from the fluoride-hydroxyapatite-containing toothpaste (β)
were performed to correlate it with the hypothesized antimicrobial activity of the toothpaste. A total of
48 enamel disks and 48 RBC disks were additionally prepared and brushed as previously specified
(cf. Sections 2.1 and 2.2): one half (n = 24) was brushed with slurry from toothpaste β, and the other half
was brushed with distilled water. Immediate fluoride release (t = 0) was evaluated from eight disks for
each toothpaste. These disks were placed in 48-well plates containing 300 μL of sterile saliva in each
well for 24 h. Disks were then discarded, 1:50 dilution of total ionic strength solution adjustment buffer,
TISAB III (Orion Research Inc, Boston, MA, USA) was added, and the solution adjusted to pH = 5.5.
The fluoride content of the solution was determined using the ion-selective electrode micro-method.
The remaining disks were weighted with an analytical balance, then sterilized, and a monospecies
S. mutans biofilm was allowed to develop on their surfaces after salivary pellicle formation using the
MDFR as described in Section 2.5.2 for the same incubation times (12 h and 24 h). A total of eight disks
for each toothpaste and time group were weighed again, and the weight of the adherent wet biomass
was calculated. After that, each disk was inserted into one well of 48-well plates containing 300 μL of
10 vol% SDS in distilled water and 1:50 TISAB III (pH = 5.5), and the plates were sonicated for 5 min to
allow dispersion of the biomass. Then, disks were discarded, and the fluoride content of the solution
was determined.
The amount of released fluoride was calculated and displayed in parts per billion (ppb) after
normalizing the fluoride readings by the disks’ surfaces. The amount of fluoride incorporated in the
biofilm structures was calculated and displayed in parts per million (ppm) after normalizing the fluoride
readings by the amount of adherent biomass. All analyses were performed using the ion-selective
electrode micro-method, as described previously [22]. In brief, a stock solution with a fluoride
concentration of 1000 ppm was appropriately diluted with 10 vol% SDS in distilled water at pH = 5.5
to obtain fluoride standards with fluoride concentrations ranging from 0.0019 to 64 ppm. A calibration
curve was obtained using a digital pH/mV meter (SA-720, Orion Research Inc, Boston, MA, USA). A
1:50 final dilution of TISAB III as an ionic strength adjustor was added to each standard before the
analyses. A negative reference standard (0 ppm fluoride) was prepared by adding 1:50 TISAB III to the
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solution containing 10 vol% SDS in distilled water; this solution was also used to rinse the electrodes
between measurements.
2.9. Statistical Analysis
All statistical analyses were performed using statistical software (JMP 12.0, SAS Institute, Inc.,
Cary, NC, USA). The OD and F data were reported as means and standard errors calculated from
the natural values. The normality of distributions was preliminarily checked using Shapiro-Wilk test,
and homogeneity of variances was preliminarily checked using Bartlett’s test. A multi-way ANOVA
model was used on OD dataset considering the factors: toothpaste (α, β, control), adherence surface
(enamel, RBC), test setup (shaking multiwell plate, MDFR), microbiological model (S. mutans, oral
microcosm), and incubation time (12 h, 24 h). A multi-way ANOVA model was used on fluoride dataset
considering the factors: toothpaste (β, control), adherence surface (enamel, RBC), and incubation
time (12 h, 24 h). Student-Newman-Keuls post-hoc test was used to highlight significant differences
(p < 0.05).
3. Results
3.1. Surface Imaging and Analysis
To investigate the presence of toothpaste residues on enamel and RBC surfaces as well as the
composition of the tested toothpastes, specimens were observed using SEM-EDS in surface-charge
reduction mode without sputter-coating, using an accelerating voltage of 15 KV (Figure 2). EDS results
showed that the elemental composition of both toothpastes was very similar, except that α toothpaste
contained zinc, while β toothpaste contained strontium, magnesium, and fluoride (Figure 3).
Enamel specimens showed a significant increase in surface zinc content after treatment with α
toothpaste, and a significant increase in strontium and magnesium content after treatment with β
toothpaste (Table 2). Very interestingly, EDS detected the presence of calcium and phosphate on the
surfaces of RBC specimens treated with both toothpastes, as well as traces of zinc on specimens treated
with α toothpaste and magnesium on specimens treated with β toothpaste (Figure 2, Table 2).
 
Figure 2. The panel, to be read horizontally, depicts the SEM backscattered electrons micrographs (500×
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and 5000×, respectively) and EDS elemental maps (5000×) of the specimen surfaces. The EDS maps are
additionally presented as single-channel maps to better identify the topographical presence of each
element. The first two rows of the panel display the surfaces of the vacuum-dried toothpastes tested in
this study: α toothpaste (containing Zn-carbonate substituted n-HAp) and β toothpaste (containing
F, Mg, Sr-carbonate substituted n-HAp). Their aspect is very similar, showing silica microparticles
(identified by Si signal) and clusters of n-HAp (identified by Ca and P signals). Zn and Sr signals were
below the detection limits in mapping mode and were not displayed. The last two rows of the panel
represent the surfaces of the tested restorative material after treatment with the toothpastes: RBC +
α toothpaste and RBC + β toothpaste. The RBC composition included silica particles (identified by
Si signal), and alumina and barium glass micro and nanoparticles (identified by Al and Ba signals).
Ca signal was displayed as a marker of toothpaste remnants. It is noteworthy that toothpaste remnants
could be associated with alumina and barium glass fillers rather than silica particles.
Figure 3. EDS spectra acquired from vacuum-dried tested toothpastes surfaces (α toothpaste containing
Zn-carbonate substituted n-HAp, and β toothpaste containing F, Mg, Sr-carbonate substituted n-HAp).
Strong Ca and P signals are identified belonging to the n-HAp, as well as the signals corresponding to
the corresponding doping elements (Zn in α toothpaste and F, Mg, Sr, in β toothpaste). High counts
of Si were also detected in both toothpastes, together with relatively low counts of Al and other
elements. The relative amounts of n-HAp doping elements and other elements such as Al and S are
below the conventionally considered detection limit of EDS (about 1 wt%). However, the presence of
such elements is shown by peaks that were clearly identifiable on all acquired spectra. In this sense,
the acquisition of several spectra over the surfaces of many specimens, and the use of statistical analysis
on acquired data demonstrating low variability in signals among the different acquisitions (cf. Table 2)
allows overcoming, to some extent, this detection limit, improving the performances of EDS analysis.
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3.2. Microbiological Results
The effect of the tested toothpastes on EC and BF, expressed as mean OD values ± 1 standard error,
according to test setup are shown in Figures 4 and 5. ANOVA results showed an overall significant
influence of the tested toothpastes on both EC and BF, with a significant interaction between the factors,
toothpaste, and microbiological model (p = 0.017). No significant interactions were found between
toothpaste and incubation time, adherence surface, or test setup, meaning that the toothpastes had the
same effect on microbial viability both in EC and BF, independently from the type of bioreactor used.
Most importantly, the tested toothpastes had the same effect on microbial viability, both on enamel
and RBC surfaces. On the contrary, ANOVA highlighted a significant interaction (p < 0.0001) among
adherence surface, test setup, microbiological model, and incubation time.
Figure 4. Biofilm formation on the surface of the tested specimens using the shaking multiwell plate
test setup, according to the microbiological model (S. mutans monospecific biofilm or artificial oral
microcosm, aerobically grown) and to the incubation time (12 h or 24 h). Sucrose-enriched sterile
modified artificial saliva medium was used in all experiments. Low shear stress on specimens’ surfaces
was obtained by an orbital incubator, to simulate oral conditions during the night. Moreover, the closed
system setup allows a progressive increase in microorganism catabolites and antimicrobial agents
released from the surfaces. Results of viable biomass assay are expressed as mean OD ± SE. Different
superscript letters indicate significant differences between groups (student’s test, p < 0.05). α toothpaste
contains Zn-carbonate substituted n-HAp; β toothpaste contains F, Mg, Sr-carbonate substituted
n-HAp while Ctrl group was brushed with distilled water. β toothpaste significantly reduced the early
colonization of the artificial oral microcosm on enamel surfaces when compared to the control.
Considering the results of the post-hoc test on the toothpaste factor, the artificial oral microcosm
model showed significantly lower EC and BF on group β disks compared to the control, with group α
disks showing lower EC and BF compared to control, but higher EC and BF compared to β toothpaste.
Surprisingly, this pattern was found on both tested adherence surfaces, demonstrating an influence of
toothpastes on EC and BF even over RBC surfaces. In the monospecific S. mutans model, the toothpastes
did not significantly influence EC and BF.
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Figure 5. Biofilm formation on the surface of the tested specimens using the MDFR bioreactor test setup,
according to the microbiological model (S. mutans monospecific biofilm or artificial oral microcosm,
aerobically grown) and to the incubation time (12 h or 24 h). Sucrose-enriched sterile modified artificial
saliva medium was used in all experiments, being pumped through the flow-cells of the bioreactor. High
hydrodynamic stress conditions that occur during the daytime can thus be simulated. An elution of
microorganism catabolites and antimicrobial agents released from the surfaces can also occur. Results of
viable biomass assay are expressed as mean OD ± SE. Different superscript letters indicate significant
differences between groups (student’s test, p < 0.05). α toothpaste contains Zn-carbonate substituted
n-HAp; β toothpaste contains F, Mg, Sr-carbonate substituted n-HAp while Ctrl group was brushed
with distilled water. β toothpaste significantly reduced early colonization (enamel and RBC) and
biofilm formation (RBC) of the artificial oral microcosm when compared to the control. Interestingly,
the adherence surface showed a more considerable influence than toothpaste treatment on early
colonization and biofilm formation, independent of the microbiological model or test setup applied.
The effect of the toothpaste on RBC surfaces was not expected and opens the possibility to control
microbial colonization on RBCs, and, ultimately, secondary caries prevention, by such treatments.
Considering the role of the adherence surface, the oral microcosm model showed significantly
higher EC and BF on enamel than on the tested RBC in both test setups (shaking multiwell plate and
MDFR). S. mutans showed significantly higher EC and BF on the tested RBC than on enamel in the
shaking multiwell plate test setup and significantly higher BF on the tested RBC than on enamel in
the MDFR.
Regarding incubation time, as expected, there was an overall significant increase in biomass over
time. The artificial oral microcosm grown in the MDFR on enamel surfaces showed no significant
difference in viable adherent biomass between 12 and 24 h incubation (p = 0.0711). Likewise, S. mutans
grown in the MDFR on both adherence surfaces showed no significant difference in viable adherent
biomass between 12 and 24 h incubation (p = 0.5665 and p = 0.7691 for enamel and RBC, respectively).
From the test setup point of view, MDFR showed an overall significantly higher EC and BF than
the shaking multiwell plate, except for BF of artificial oral microcosm on enamel surfaces.
Considering the microbiological model, the artificial oral microcosm showed higher EC and BF
than S. mutans on enamel surfaces in both test setups, whereas S. mutans showed higher EC and BF
than the artificial oral microcosm in the shaking multiwell plate on RBC surfaces.
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A set of additional enamel and RBC specimens were made and treated with the toothpastes
or with the control, as described in the Methods section, to provide a morphological view of the
microbial colonization. The most biologically meaningful result was found to be the one obtained
using the MDFR test setup and the artificial oral microcosm model for 12 h (EC, Figure 5). Therefore,
this particular situation was furtherly investigated using confocal laser-scanning microscopy and
live/dead staining. The results are illustrated in Figure 6. Enamel specimens showed a uniform
microbial layer colonizing all surfaces, with multilayered structures starting to develop. The aspect is
in keeping with the viable biomass results, showing early colonization of β toothpaste < α toothpaste
= control. On enamel specimens treated with β toothpaste, a slightly higher amount of dead cells and
microcolonies can be seen. RBC specimens showed much lower colonization than enamel, showing
early colonization of β toothpaste < α toothpaste < control. The surfaces of the specimens provided an
intense red fluorescence that was not wholly subtracted by parallel scanning in the near-UV 405 nm
channel. This artifact was not due to dead cells, but rather to autofluorescence coming from the RBC,
and also to an affinity of the propidium iodide dye with RBC surfaces, as previously shown [22].
 
Figure 6. CLSM results of the adherence surfaces treated with the control and the tested toothpastes
using the MDFR test setup and the artificial oral microcosm model for 12 h. Scans were analyzed
3D reconstructions obtained using Drishti software. Enamel surfaces provided a much higher early
colonization than RBC surfaces. In the background of the enamel control specimen, a central microcolony
shows a long tail detached from the surface and oriented horizontally downstream (to the right).
This feature is typical of biofilms that develop on surfaces in the presence of relatively high shear
stress and is also a means to colonize downstream surfaces rapidly. This feature demonstrates the good
morphological resemblance of bioreactor-grown biofilms with in vivo ones. Enamel specimens treated
with β toothpaste showed a higher amount of dead cells compared to the other groups. RBC specimens
treated with β toothpaste showed the lowest early colonization overall, consistently with viable
biomass results.
3.3. Fluoride Release Results
The fluoride release from the disks treated with the fluoride-hydroxyapatite containing toothpaste,
and the fluoride content of the biofilms after 12 and 24 h are displayed in Figure 7. A significant albeit
shallow release of fluoride was seen from enamel specimens treated with β toothpaste. Contrary to
RBC specimens, enamel specimens showed biofilms containing significant amounts of fluoride at both
incubation times. After 12 h, treatment with β toothpaste significantly decreased fluoride presence in
the overlying biofilm compared to the control (p < 0.001).
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Figure 7. Immediate fluoride release (ppb/mm2 ± SE) after disks’ brushing and fluoride presence
(ppm ± SE) in the biofilms grown over the disks’ surfaces after 12 and 24 h. Different superscript letters
indicate significant differences between groups (Student’s test, p < 0.05). β toothpaste contains F, Mg,
Sr-carbonate substituted n-HAp while Ctrl group was brushed with distilled water. β toothpaste did
not increase the baseline fluoride presence in biofilms grown over enamel surfaces despite showing
a low but significant immediate fluoride release. The reduction in fluoride presence seen in enamel
specimens after 12 h of incubation when compared to the control may be due to an uptake of fluoride
by the tested toothpaste.
4. Discussion
Nano-hydroxyapatite is considered one of the most promising bioactive materials with a
broad spectrum of applications in preventive and restorative dentistry. N-HAp particles have been
demonstrated to have a similar structure to natural enamel apatite crystals and can remineralize
dental hard tissues [15,23–25]. Non-substituted n-HAp is also used for desensitizing and anti-erosion
purposes [26,27]. The synthesis of nano-scaled zinc carbonate or magnesium-strontium carbonate
hydroxyapatite (ZnCO3/n-HAp, Mg-SrCO3/n-HAp) represented significant progress in this field,
allowing the introduction of n-HAp-based toothpastes with remineralization and antibacterial
potential [28]. Different substituted n-Hap, coupled to other compounds with antibacterial activity,
such as Zn PCA, chitosan, and fluoride, have been developed to achieve the goal of the remineralization
of dental hard tissues [4,29–32]. Nevertheless, very few data are available in the literature about the
antibacterial activity of these compounds, which is important in caries prevention because of the
impact of oral biofilms in the dynamics of carious lesion formation.
Biofilms produce organic acids that cause the demineralization of the hard tissues. Moreover,
biofilms can act as a reservoir of calcium and phosphate for remineralization, but also as a
diffusion barrier for other compounds, such as fluoride, thus reducing the efficacy of some
caries-preventive agents [16]. From a microbiological point of view, n-HAp-containing products
might allow adsorbed nanoparticles to interact with bacterial cells, reducing adherence to hard tissue
surfaces, thereby reducing biofilm formation.
The current in vitro study compared the effect of two substituted n-HAp-based toothpastes on
early colonization and biofilm formation. Teeth specimens treated with the α toothpaste showed no
significant differences in EC and BF compared to the control and β group, whereas specimens treated
with β toothpaste showed a significantly lower EC and BF compared to the control (Figures 4 and 5).
Both toothpaste formulations contained doping agents having antibacterial activity, namely zinc
in α toothpaste and fluoride and strontium in β toothpaste, suggesting that n-HAp doping agents,
rather than n-HAp itself, play a crucial role in determining the antibacterial properties of these
compounds. Furthermore, fluoride and strontium have been shown to exhibit synergistic antibacterial
performance [33,34]. EDS data (Table 2) showed that the zinc and fluoride concentrations were in the
same range, while strontium in the β toothpaste was four times higher. A possible explanation of these
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results could be that the association of fluoride and strontium was more effective in reducing EC and BF
than zinc alone at the tested concentrations. Nevertheless, fluoride release (Figure 7), which was only
found on brushed enamel surfaces, did not help in explaining the reduced EC and BF by β toothpaste
on RBC surfaces. Furthermore, despite a significant initial release of fluoride, the amount of this ion
was not increased in biofilms grown over enamel and RBC surfaces treated with the β toothpaste,
confirming the fact that biofilms do not tend to accumulate fluoride [16].
EDS data also showed the presence of calcium and phosphate on the surfaces of RBC specimens
treated with both toothpastes, as well as traces of zinc on specimens treated with α toothpaste and
magnesium on specimens treated with β toothpaste (Figure 2 and Table 1). It is noteworthy that
toothpaste remnants could be associated with alumina and barium glass fillers rather than silica particles.
This observation, needing further confirmation, opens the possibility for such compounds to actively
interact with RBC surfaces with the effect of reducing or preventing secondary caries occurrence.
Regarding the influence of the adherence surface on the antibacterial activity of substituted n-HAp,
as the surface features can deeply influence biological behavior, the roughness of all specimens was
reduced below 0.2 μm Ra [35] to exclude the possible influence of this parameter on EC and BF. The two
tested surfaces were selected considering their buffering capacity: a buffering surface (enamel) and a
non-buffering one (RBC). The non-buffering surface was selected because it has been demonstrated
to promote the growth of biofilms with a high concentration of cariogenic bacteria [17]. Our data
showed that the adherence surfaces did not influence the effect of the tested toothpastes on EC and BF.
This result was observed for both S. mutans and the oral microcosm, indicating that, unexpectedly,
both substituted n-HAps had the same effect on buffering and non-buffering surfaces independent
of their chemical composition, suggesting a similar interaction of the active components with the
specimen surface. EDS results confirm the presence of active compounds from both toothpastes on both
adherence surfaces. This presence was seen to a larger extent on enamel compared to RBC. However,
the presence of such active compounds on the tested RBC surface, as seen in the present study, is very
interesting from the perspective of controlling EC and BF on these surfaces, with the final aim of
reducing secondary caries occurrence. Indeed, small but accumulative effects can prevent dysbiotic
changes in dental biofilms and help maintain a beneficial oral microbiome [36]. In this sense, the use of
this kind of active principles might be an efficient means of reducing secondary caries occurrence by
actively promoting our natural microbiota and reducing the impact of the drivers of dysbiosis, such as,
for instance, the presence of a non-buffering surface.
Two test setups were used, shaking multiwell plates and a drip-flow bioreactor to simulate
clinical situations as close as possible, avoiding the variabilities that characterize in vivo studies.
The first test setup was designed to evaluate EC and BF under low hydrodynamic stress conditions,
for instance, during the night. Moreover, the first setup favors a progressive increase in microorganism
catabolites and antimicrobial agents released from the surfaces. The second one simulated relatively
high hydrodynamic stress conditions that occur during the daytime. S. mutans showed lower EC and
BF in the first test setup compared to the second one, probably due to the limited amount of nutrients
available and the accumulation of metabolic acids in the culture medium.
From the microbiological model point of view, the approach simulated as much as possible
the clinical situation by testing an oral microcosm in addition to a monospecific S. mutans biofilm.
The oral microcosm was used to evaluate the mixed oral flora developing on hard tissues, while the
monospecific S. mutans model was used to assess the behavior of the cariogenic part of flora when
treated with the tested compounds. In our study, S. mutans showed a higher affinity for RBC surfaces
than for enamel, which is probably related to the buffering capacity of the tested surfaces being a
crucial factor for both EC and BF.
Still, the microbiological models and incubation conditions may not be an accurate replica of
all the complex interactions taking place in the oral environment. However, in vitro simulations are
useful since they can push microenvironmental conditions to levels that might be difficult to control, or
even unethical if replicated in vivo. The culture medium was made to have a high content in sucrose,
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therefore promoting the growth of fermentative Streptococcus as well as the acidogenic species in the
mixed inoculum. The aim was to provide a shift in microbial composition towards a pathogenic biofilm,
to test the activity of the toothpastes in a harsh environment. An active principle such as substituted
n-HAp is especially useful if it can provide a controlled release of ions over time and, especially,
in response to defined environmental conditions. A fermentative biofilm can reach pH values lower
than 4.0, promoting the demineralization of enamel (critical pH ≈ 5.5). n-HAp is known to be very
stable at neutral pH. Therefore, an acidogenic microbial challenge as the one produced in the present
setups helped in understanding the effect of the toothpastes when challenged by pathogenic biofilms.
Considering incubation time, 12 h was selected as toothbrushing twice a day is the most frequently
advised routine, while a 24 h incubation can provide a sufficient amount of time to evaluate BF.
The results showed that the most relevant differences between the tested toothpaste groups were found
on S. mutans EC, which means after 12 h of incubation. In a translational sense, this may suggest that
the tested toothpastes provided the best effect when used twice a day, rather than a single time.
5. Conclusions
A toothpaste treatment based on substituted n-HAp showed an in vitro antibacterial effect both
on natural and RBC surfaces, which was more pronounced after 12 h than after 24 h. On RBC surfaces,
toothpaste remnants seemed to show selective affinity with some particles, such as alumina and
barium glass fillers, rather than silica particles. This observation is worthy of future investigations
aimed at clarifying the interactions between substituted n-HAp and RBC fillers from the perspective of
secondary caries prevention. This phenomenon provides a basis to design clinical studies aimed to
confirm in vivo the preventive efficacy of these active principles.
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Abstract: A 200 nm plasma-enhanced chemical vapor-deposited SiC was used as a coating on dental
ceramics to improve anti-bacterial properties for the applications of dental prosthesis. A thin SiO2
(20 nm) in the same system was deposited first, prior to SiC deposition, to improve the adhesion
between SiC to dental ceramic. Silane and methane were the precursors for SiC deposition, and the
SiO2 deposition employed silane and nitrous oxide as the precursors. SiC antimicrobial activity was
evaluated on the proliferation of biofilm, Streptococcus sanguinis, and Streptococcus mutans on SiC-coated
and uncoated dental ceramics for 24 h. The ceramic coating with SiC exhibited a biofilm coverage
of 16.9%, whereas uncoated samples demonstrated a significantly higher biofilm coverage of 91.8%,
measured with fluorescence and scanning electron microscopic images. The cytotoxicity of the SiC
coating was evaluated using human periodontal ligament fibroblasts (HPdLF) by CellTiter-BlueCell
viability assay. After 24 h of HPdLF cultivation, no obvious cytotoxicity was observed on the SiC
coating and control group; both sets of samples exhibited similar cell adhesion and proliferation.
SiC coating on a ceramic demonstrated antimicrobial activity without inducing cytotoxic effects.
Keywords: antimicrobial; ceramic; coating; silicon carbide; cytotoxicity
1. Introduction
Improving the dental restoration’s lifetime through careful selection of materials has been the
focus of many previous studies, where traditionally different alloys and metal systems have been
evaluated for biocompatibility and antibacterial properties [1–10]. Although the majority of these
approaches have used methods involving the bulk system, use of thin films can offer an easier avenue
to maintaining the integrity of the restoration while grafting unique properties to selective areas where
the film is applied. One of the novel thin films of interest is silicon carbide due to the ease of deposition,
lack of reactivity to the oral environment, and high strength [11–15] of this material. Silicon carbide
has found significant success in two major areas: semiconductors and ceramics. Silicon carbide can
easily be deposited by plasma deposition systems to form conformal films with tight control over
thickness from nanometers to micrometers [16–20]. Silicon carbide may present a biosafe path to
protect restorative surfaces from bacterial adhesion and degradation without compromising the bulk
properties of traditional dental material technology.
In recent reports, the development and optimization of SiC-based coatings to minimize surface
corrosion and wear on glass ceramic veneers has been demonstrated [14,21]. Hsu et al. [21] reported that
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SiC-coated dental ceramics demonstrated a significant reduction in corrosion when placed in caustic
environments that represent the extreme conditions of the oral cavity. Chen et al. [22] demonstrated
that the thickness of the SiC coating can also be optimized to match any tooth shade required within
the dental field.
As new dental materials such as SiC are developed, analyzing their anti-bacterial and
biocompatibility properties is imperative. The biofilms that adhere to dental materials can be
described as a micro-ecosystem formed by various species of microorganisms, surrounded by a protein
extracellular matrix and polysaccharides generated by them [23]. These biofilms are responsible
for plaque formation, leading to dental caries, periodontal disease, peri-implantitis, and enamel
demineralization. They can adhere to both biotic and abiotic surfaces, such as prostheses, implants,
or host tissues [24]. Bacterial adhesion to a substrate is a multifactorial process that involves surface
properties inherent to both the bacteria and the biomaterial [25,26]. Bacteria present in the oral
cavity naturally tend to adhere to ceramic materials and also to the interface between tooth and
restoration [27,28]. They adhere on the cervical third of the proximal surface, and along the gingival
margin where they are protected from mechanical action, creating a well-structured biofilm [29].
Understanding how these biofilms adhere to surfaces is crucial in qualifying new dental materials. On
solid surfaces such as enamel, the ability to aggregate, the order of appearance of the microorganisms [30,31],
and the environment [23] are essential factors in oral biofilm formation. The composition of the material,
as well as the surface structure, can influence the initial bacterial adhesion and compromise dental
health. Poor oral hygiene or a compromised immune system can also be contributing factors that aid
colonization [32]. SiC coating provides a smoother surface after corrosion, which could minimize plaque
accumulation, secondary caries, and periodontal inflammation from occurring [21].
Although SiC has been studied and applied as a viable biomaterial in the literature [15–18],
no work to date has studied the feasibility of SiC as a dental material. One of the precluding tasks to
determine if SiC can be utilized as a dental material is to quantify how the coating affects monomicrobial
and polymicrobial biofilm adhesion, as well as the cytotoxicity for human cells.
The objective of this study was to evaluate the effect of SiC coating on monomicrobial and
polymicrobial biofilm adhesion, as well as determine the viability of human cells in contact with the
coating surface. Understanding the biological and mechanical behavior of dental materials in the oral
environment is crucial to developing predictable restorations, and thus we proposed the hypotheses
that SiC coatings on ceramic will (1) decrease monomicrobial and polymicrobial biofilm adhesion on
the surface of the ceramic, and (2) exhibit biocompatibility without signs of cytotoxicity.
2. Material and Methods
2.1. Ceramic Sample Preparation
Fluorapatite glass-ceramic disks (Ivoclar Vivadent AG, Schaan, Liechtenstein, 12.6 × 2 ± 0.2 mm)
were polished using silicon carbide abrasive paper (Carbimet, Buehler, Lake Bluff, IL, USA) and
subsequently cleaned using the following procedure: (1) acetone cleaning in an ultrasonic bath,
(2) isopropyl alcohol rinse followed by a compressed nitrogen drying step, and (3) ozone treatment to
remove surface carbon contamination.
2.2. SiC Coating
After the ceramic disks were polished and cleaned, half of the disks (40/80) were coated with
silicon dioxide (SiO2) and silicon carbide (SiC) on both sides. These depositions were done within a
plasma-enhanced chemical vapor deposition system (PECVD, PlasmaTherm 790, Saint Petersburg, FL,
USA). The corresponding thicknesses of the deposited SiO2 and SiC films were 20 nm and 200 nm,
respectively. The SiO2 film was utilized as an adhesion layer between the ceramic and SiC, and was
optimized in a previous report [21]. The precursors for the SiO2 film were silane (SiH4) and nitrous
oxide (N2O). Following the SiO2 deposition, methane (CH4) and silane (SiH4 ) were the precursors
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used for silicon carbide deposition. The deposition temperature for both films was 300 ◦C, and the
deposition rates for SiO2 was 330 Å/min and for SiC was 170 Å/min [14].
2.3. Bacteria Growth
To study the antimicrobial properties of the coated and uncoated disks, monomicrobial and
polymicrobial strains (ATCC—American Type Culture Collection) of Streptococcus mutans (ATCC 35688)
and Streptococcus sanguinis (ATCC BAA-1455) were utilized. S. mutans and S. sanguinis were used for
this study because these bacteria are the early colonizers of initial supragingival biofilm in the first
8 h and are present in greater quantities in the oral biofilm. The strains were grown onto agar plates
with brain heart infusion broth (BHI, Himedia) for 24 h at 37 ◦C. After the growth, each microbial
suspension was centrifuged at 4700 rpm for 10 min (Centrifuge model MPW-350, Beckman Coulter,
Indianapolis, IN, USA) to separate the supernatant and microbial suspension. The centrifuge process
was performed twice to minimize the quantity of debris. After separation, the microbial suspension
adjusted to 107 colony-forming units (CFU)/mL and was ready to be placed onto the coated and
uncoated glass-ceramic disks.
2.4. Experimental Design
The two groups in this study were (i) non-coated fluorapatite glass-ceramic disks as the reference
group, and (ii) SiO2/SiC-coated fluorapatite glass-ceramic disks (SiC-disks). Twenty-four ceramic
specimens of each group were sterilized in an autoclave (121 ◦C, 60 min) and then placed into individual
sterile plates. A total of 12 samples from each group were used to study the effects of monomicrobial
suspensions, and the remaining 12 samples were used to study polymicrobial suspensions (S. sanguinis
and S. mutans). For all samples, 100 uL of mono- or polymicrobial suspension was added to each plate
containing a coated or uncoated disk, along with 1 mL of BHI broth to adequately cover the full disk.
To study the biocompatibility and cytotoxicity of the SiC coating, human periodontal ligament
fibroblasts (HPdLF, Lonza, Basel, Switzerland) were cultured and subsequently placed onto coated
and uncoated samples. The HPdLF were cultured at 37 ◦C in a growth media consisting of Dulbecco’s
modified Eagle’s medium (DMEM) with 10% fetal bovine serum and 1% penicillin/streptomycin.
After the cells were cultured, they were seeded onto 16 sterilized ceramic disks from each group,
each within its own sterilized well plate. The approximate concentration of cells after seeding was
20,000 cells per well.
The quantitative data were presented as the means± standard deviations. The statistical differences
were compared using one-way ANOVA and Tukey’s test (Graph Prism 6.0, GraphPad Software Inc.,
San Diego, CA, USA). For all analyses, statistical significance was pre-set at α = 0.05.
2.5. Characterization Techniques
2.5.1. Scanning Electron Microscopy
Non-coated, SiC-coated, and glazed disks were examined under scanning electron microscopy
using a MAICE system (JEOL JSM-6400 Scanning Electron Microscope, JEOL LTD, Tokyo, Japan)
to characterize surface roughness. After the coated and non-coated disks were incubated for 24 h,
the culture medium was removed, and the polymicrobial biofilm adhered to the samples was fixed
in a solution of 3% glutaraldehyde, 0.1 mol/L sodium cacodylate, and 0.1 mol/L sucrose for 45 min.
Samples were soaked for 10 min in a buffer solution of 0.1 mol/L sodium cacodylate and 0.1 mol/L
sucrose. Sample surfaces and cells were processed in serial ethanol dehydrations for 10 min each and
dehydrated in hexamethyldisilazane (HDMS) before being stored in a desiccator until SEM imaging.
The samples were then sputter-coated with a palladium–gold alloy (Polaron SC 7620 Sputter Coater,
Quorum Technologies, Laughton, East Sussex, United Kingdom) with a thickness of 10 nm to reduce
charging effects during SEM analysis (10–15 mA, under a vacuum of 130 mTorr). After this, the SEM
was operated at 5 kV, spot 3 to 6 (FEI NOVA 430, Hillsboro, OR, USA).
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2.5.2. Atomic Force Microscopy (AFM)
Topographies of non-coated and coated with SiC samples were evaluated using an atomic force
microscopy system (Bruker/Veeco/Digital Instruments NanoScope V, Billerica, MA, USA). The AFM
was operated in tapping mode, using a silicon AFM probe (RTESP-300, Bruker, Billerica, MA, USA),
with radius less than 10 nm, and resonance frequency between 200 and 400 kHz.
2.5.3. Water Contact Angle Measurements
The contact angle is described as the angle between the liquid–solid interface. The water contact
angle (WCA) measurements were performed on the neutralized non-coated and coated SiC surfaces
(neutralized up to pH 6.0). Static contact angles were assessed by the sessile drop method with a contact
angle goniometer (Krüss DSA 10, Matthews, NC, USA), equipped with video capture. The automatic
dosing feature of the DSA 10 dispensed a water drop on the non-coated and coated SiC surfaces,
and the needle was manually withdrawn. Images were captured after contact of a droplet with the
surface by a camera leveled with the surface. Contact angle measurements were analyzed by the circle
fitting profile available with the DSA 10 imaging software. Three separate measurements were made
on each sample at different locations.
2.5.4. Cytotoxicity Test
Cell viability were determined by a CellTiter-BlueCell Viability Assay (Promega G808A), which was
used according to the manufacturer’s instructions. After 24 h, 50 μL of CellTiter-Blue dye was added
to ceramic specimens for every 500 μL of culture media, and samples were incubated for 6 h at 37 ◦C
and 5% CO2. Sample fluorescence was analyzed using a spectrophotometer (SmartSpec Plus, Bio-Rad,
Hercules, CA, USA) at a wavelength of 600 nm, which generated density optic values.
2.5.5. Colony-Forming Units
After 24 h of incubation, the ceramic samples were removed and placed inside an Eppendorf tube
with Ringer’s solution (Sigma-Aldrich). The monomicrobial biofilm of S. sanguinis and S. mutans was
disaggregated by an ultrasonic homogenizer (Sonopuls HD 2200–Bandelin Electronic, Berlin, Germany)
for 30 s. The generated microbial suspension was serially diluted (1:10), and 100 μL was seeded on
BHI agar for each respective sample. After 48 h of incubation, the concentration of colony-forming
units (CFU) per milliliter was determined by visual counting.
2.5.6. Fluorescence Assay
After the incubation period, bacteria adhered to the samples were stained with SYTO 9 dye
(Live/Dead BacLight Bacterial Viability Kit, ThermoFisher Scientific, Waltham, MA, USA) according
to the manufacturer’s instructions. Fluorescence images of the live bacteria were recorded in a
fluorescence microscope (Zeiss Imager-A2, Jena, Germany) and analyzed by ImageJ software. Bacteria
coverage percentages were averaged over five random areas on each filter specimen (n = 8).
The quantitative data are presented as the means ± standard deviations. The statistical differences
were compared using one-way ANOVA and Tukey’s test (Graph Prism 6.0, GraphPad Software Inc.,
San Diego, CA, USA). For all analyses, statistical significance was pre-set at α = 0.05.
3. Results
3.1. Atomic Force Microscopy (AFM) and Scanning Electron Microscopy (SEM)
According to Figure 1, the AFM analysis showed an irregular surface topography in non-coated
samples with roughness Rq 9.58. In contrast, SiC-coated samples were slightly smoother with Rq 7.98
(p > 0.05). Non-coated, SiC-coated, and glazed disks demonstrated significant qualitative differences
in surface roughness (Figure 2A–F).
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Figure 1. Roughness means values and standard deviation in non-coated (reference) and coated (ref
SiC) samples (A). Atomic force microscopy (AFM) images of surface topography of non-coated (B) and
coated SiC (C), with amplifications of 10 μm.
 
Figure 2. SEM images of roughness of non-coated and coated samples. (A,D) Non-coated fluorapatite
disk, (B,E) glazed fluorapatite disk, and (C,F) SiC-coated fluorapatite disk.
3.2. Water Contact Angle Measurements (WCAs)
The outcomes indicate different WCAs between the non-coated and coated surfaces (Table 1).
The coated SiC surface presented higher contact angles than the non-coated surface (p > 0.05).
Table 1. Mean of contact angle measurements on non-coated and coated SiC surfaces.
Ceramic Samples Contact Angle (±SD)
Non-coated 46◦ ± 2◦
Coated SiC 60◦ ± 1◦
3.3. Bacterial Growth
After 24 h, the amount of polymicrobial biofilm (S. mutans and S. sanguinis) was less on the
SiC-coated disks. The biofilm coverage on these disks was 16.9%, whereas uncoated reference samples
showed a significantly higher biofilm coverage of 91.8% (p < 0.0001) (Figure 3).
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Figure 3. Live coverage of Streptococcus mutans and Streptococcus sanguinis after 24 h of culture on the
non-coated (control) and coated surfaces.
The fluorescence images in Figure 4 demonstrate higher polymicrobial biofilm (S. mutans and
S. sanguinis) formation on the control group than on the coated group. The SEM images confirmed the
results from the live assays, showing a reduction in the number of adherent biofilms on the coated
group for S. mutans and S. sanguinis after 24 h of culture (Figure 5).
 
Figure 4. Live fluorescence images of S. mutans and S. sanguinis cultured for 24 h on the non-coated
(A,B) and coated (C,D) surfaces. The cultures were stained with SYTO 9 to dye the living bacteria green.
There was a significant reduction in the number of CFU/mL after 24 h contact with ceramic SiC
coating compared to the control group (Figure 6), showing p = 0.0003 for S. sanguinis and p ≤ 0.0001 for
S. mutans. The reduction of the monomicrobial biofilm of S. sanguinis and S. mutans were also similar
(p = 0.2528).
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Figure 5. SEM adhesion of polymicrobial biofilm of S. mutans and S. sanguinis after 24 h of cultivation
on non-coated (A,B) and coated (C,D) ceramic disks.
 
A B 
Figure 6. Mean (±SD) of colony-forming units (CFU)/mL of monomicrobial biofilms of S. mutans (A)
and S. sanguinis (B) presented in the non-coated (control) and coated groups.
3.4. Biocompatibility Testing
In order to determine whether the SiC coating presented biocompatibility, the cytotoxicity was
evaluated by the CellTiter-Blue assay. After 24 h of HPdLF cultivation on the samples, no obvious
cytotoxicity was observed, as evidenced by the absorbance of the cells cultured on SiC coating being
comparable to the control group (p = 0.3904) (Figure 7).
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Figure 7. Cytotoxicity of the non-coated (control) and coated groups after 24 h of human periodontal
ligament fibroblasts (HPdLF) culture assessed by CellTiter-Blue absorbance.
The SEM images showed the interaction of cell extensions with the SiC-coated and non-coated
surfaces. SEM results demonstrated that cells adhered and covered the full surface of the disk after
24 h in culture. Additionally, the cell morphology was similar for cells cultured on SiC-coated and
non-coated samples, where HPdLFs appeared oval-shaped and flattened on the surface (Figure 8).
 
Figure 8. SEM images showing the adhesion of HPdLF on non-coated (A,B) and coated (C,D) surfaces
after 24 h of incubation.
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4. Discussion
The adhesion of streptococci to solid surfaces has been described as a two-step process, where the
first step is influenced predominantly by macroscopic substratum properties such as surface roughness
and surface free energy [33]. High substratum surface roughness has been shown to induce increased
plaque formation in vivo [34,35], as the initial adhesion of microorganisms preferably starts at locations
that provide shelter against shear forces. The surface roughness of differently prepared lithia disilicate
ceramic restorations (pressed (Press), milled (CAD), fluorapatite layered (ZirPress/Ceram), and glazed
(Ceram Glaze)) is closely related to the adherence of S. mutans [27]. The application of a SiC coating on
the surfaces of ceramic significantly minimized biofilm adhesion on the surface. A possible explanation
is that SiC altered the surface roughness of the ceramic. SEM 3D analysis of ceramic surfaces before
and after coating with SiC (Figure 2A–F) revealed a distinct difference in surface roughness between
the two surfaces. The SiC coating achieved planarization of the ceramic surface, essentially minimizing
surface roughness that bacteria can adhere to. Even when compared to a glazed ceramic surface,
the SiC coating produced a smoother surface (Figure 2B,C). This change in surface roughness was
further confirmed by a difference in surface topography of coated and non-coated surfaces, as observed
by AFM (Figure 1).
Numerous studies have also demonstrated that surfaces with high surface free energy foster
microbial adherence in vitro and in vivo [35–38]. In addition, bacteria with high cell surface free energy
appear to adhere preferentially to surfaces with high surface free energy.
Bacterial adhesion to a substrate and the initial biofilm composition is also related to surface
hydrophobicity, and communication between existing microorganisms [28,37,38]. Although the
literature shows that bacteria adhere better to hydrophobic surfaces, biofilm formation depends not
only on the surface topography but also on the bacteria species involved. Evidence suggests that
the presence of polysaccharides on the cell surface of Gram-positive bacteria, such as S. mutans and
S. sanguinis, tends to make the bacterial cell more hydrophilic [35,38]. Additionally, the cell shape and
size, including surface characteristics such as extracellular substances such as flagella and fimbriae,
as well as the production of proteins, are believed to have a significant influence on the process of
bacterial adhesion [33,34].
On the basis of contact angle measurements conducted in this study, we found that coated
SiC surfaces were more hydrophobic than non-coated surfaces; however, we found lower colonized
bacteria. This might suggest that SiC-coated samples can cause the detachment of bacteria from the
biofilm after 24 h.
In vitro studies have been performed on bacterial adhesion to various ceramic materials [28,39–43].
In the present study, we verified the adhesion of streptococcal species and the accumulation of complex
biofilms, which are of critical importance to predict the effect of biofilms on the surface ceramics.
Streptococcus mutans and Streptococcus sanguinis were used for this study because these bacteria are
predominant members in dental plaque, which is often described as a dual-species biofilm model [36,44].
The association of these microorganisms can interfere in the development of each other and promote
different results between polymicrobial and monomicrobial biofilms.
Lower adhesion of polymicrobial biofilm of S. mutans and S. sanguinis on the surface of fluorapatite
glass-ceramic coated with SiC was demonstrated. Additionally, we found a significant reduction
in their monomicrobial biofilm. Two studies found significant differences in adhesion of different
streptococcal species among different ceramic materials. These differences were observed in the
bacterial surface coverage, as well as in the thickness of the biofilm between the tested ceramic
materials. The lowest surface coverage (19.0%) and biofilm thickness (1.9 mm) were determined on the
HIP Y-TZP ceramic; the highest mean values were identified with the lithium disilicate glass-ceramic
(46.8%, 12.6 mm) [41,42]. On the other hand, Meier et al. [40] did not observe any significance.
Our study showed that the percentage of polymicrobial biofilm coverage was five times less for the
ceramic coated with SiC (16.9%) compared with the uncoated group (91.8%). Ceramic coating also
presented significant reductions of CFU/mL in monomicrobial biofilms of S. mutans and S. sanguinis.
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This may be related to the alteration of the surface energy and slightly smoother surface of coated SiC
surfaces, which can decrease the bacteria adhesion.
Because significant differences in bacteria adhesion were identified among the groups,
the hypothesis that SiC coatings on ceramic will decrease monomicrobial and polymicrobial biofilm
adhesion on the surface of the ceramic has to be accepted.
Furthermore, a study by Auschill et al. [45] found that biofilms form a very thin layer on ceramic,
but demonstrated the highest viability compared with biofilms on amalgam, gold, and composite resin.
Dal Piva et al. [28] found a lower value of bacterial adhesion for zirconia reinforced lithium silicate
(ZLS) ceramic compared to zirconia partially stabilized by yttrium (YZHT) ceramic. Lithium disilicate
glass-ceramics (LDS) have lower S. mutans adhesion than fully stabilized zirconia (FSZ) and partially
stabilized zirconia (PSZ), but the difference was not reflected in early biofilm formation [46]. Polished
feldspathic ceramics showed less Candida albicans adherence, whereas the adherence of streptococci
was greater than C. albicans in all conditions [39].
Ceramic materials may exhibit positive or negative results in terms of cell viability, according
to the ceramic composition [37,38]. Studies have demonstrated a significant decrease in cell viability
for computer-assisted design (CAD) block feldspathic ceramics [47]. Feldspathic ceramic glass and
glass-ceramics based on the 3CaO·P2O5-SiO2-MgO system were considered not cytotoxic by MTT
((3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) [39] and neutral red analysis [48],
respectively. Additionally, lithia–silica glass-ceramic was biocompatible, promoting cell adhesion and
proliferation after 21 days [38]. However, zirconia-reinforced lithium silicate (ZLS) ceramic showed
severe initial cytotoxicity when in contact with fibroblasts for 24 h [28]. This study demonstrated that
fluorapatite glass-ceramic with or without SiC coating presented no cytotoxicity on human periodontal
ligament cells by CellTiter-Blue. SiC-coated surfaces seeded with HPdLF cells may foster cell survival
similar to surfaces that were not coated with SiC. Additionally, cells appeared elongated and intimately
attached to both ceramic surfaces by SEM images. Some cell-to-cell interaction on the surface of
ceramics was observed (Figure 8). Because the biocompatibility of the materials can be evaluated
by the direct interaction between the ceramic surface and the cells, we can affirm that SiC coating
is biocompatible.
This study confirmed that SiC coating can decrease bacterial adhesion on the surface of ceramic
veneers while maintaining biocompatibility with other cells. SiC recently demonstrated optimized
color properties and corrosion resistance [21,22]. This coating can be applied to dental materials to
improve their clinical performance.
5. Conclusions
A SiC coating on ceramic demonstrated enhanced bactericidal ability without inducing cytotoxic
effects. The SiC coating presented bactericidal activity against S. mutans and S. sanguinis after 24 h of
culture. In addition, the coating did not induce cytotoxic effects on periodontal ligament fibroblasts.
These results indicate that a SiC coating can be used as a tool to prevent bacterial adhesion and improve
the clinical performance of ceramic restorations. Further studies will include in vivo validation of
coating performance.
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Abstract: The insufficient radiopacity of dental adhesives applied under composite restorations makes
the radiographic diagnosis of recurrent caries challenging. Consequently, the misdiagnosis may lead
to unnecessary replacement of restorations. The aims of this study were to formulate experimental
dental adhesives containing cerium dioxide (CeO2) and investigate the effects of different loadings of
CeO2 on their radiopacity and degree of conversion for the first time. CeO2 was characterized by
X-ray diffraction analysis, Fourier transforms infrared spectroscopy, and laser diffraction for particle
size analysis. Experimental dental adhesives were formulated with CeO2 as the inorganic filler with
loadings ranging from 0.36 to 5.76 vol.%. The unfilled adhesive was used as a control. The studied
adhesives were evaluated for dispersion of CeO2 in the polymerized samples, degree of conversion,
and radiopacity. CeO2 presented a monoclinic crystalline phase, peaks related to Ce-O bonding, and
an average particle size of around 16 μm. CeO2 was dispersed in the adhesive, and the addition of
these particles increased the adhesives’ radiopacity (p < 0.05). There was a significant decrease in the
degree of conversion with CeO2 loadings higher than 1.44 vol.%. However, all materials showed
a similar degree of conversion in comparison to commercially available adhesives. CeO2 particles
were investigated for the first time as a promising compound to improve the radiopacity of the
dental adhesives.
Keywords: dental materials; dentistry; adhesives; light-curing of dental adhesives; composite resins;
methylmethacrylate; oxides; cerium; polymers; dentine bonding agents
1. Introduction
Currently, resin composites and dental adhesive systems are used in restorative dentistry as
primary direct restorative materials [1]. The failure of resin composites is mainly due to recurrent
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caries and fractures [2]. The diagnosis of recurrent caries underneath resin composite is a challenge for
dentists [3]. Recurrent carious lesions may not always be seen during a clinical examination at the
interface between the resin composite, and it requires radiographic evaluation for diagnosis [4,5].
Further, the application of adhesive systems can be seen radiographically as a radiolucent area,
which mimics the radiographic appearance of carious lesions [6]. The radiolucency of dental adhesives
can contribute to the misinterpretation of radiographic images [4,7,8]. Based on it, dentists may
intervene surgically in existing composite restorations, replacing the resin [9].
A previous report has assessed and demonstrated the lack of radiopacity on many restorative
dental materials [10]. In their results, all assessed materials were radiolucent and required alterations
to their composition to facilitate their detection using radiographic images. The radiopacity of dental
adhesives depends on their filler content, and it can be enhanced by incorporating elements with a
high atomic weight as inorganic fillers [11].
Cerium dioxide (CeO2), a rare-earth oxide found in the lanthanide series of the periodic table, has
been increasingly used as a nanotherapeutic material [12]. The numerous commercial applications
for CeO2 also called ceria, include glass and glass polishing, phosphors, ceramics, catalysts, and
metallurgy [13]. Cerium is found in various minerals, and its primary deposits are located in the
United States (Florida and Idaho) and Brazil [14]. Interesting biological properties have been observed
for both nanometric and micrometric CeO2 [15]. Thus, as further advancement in CeO2′s applications,
this compound has gained substantial interest in several innovative applications, mainly due to its
redox property and catalytic activity [15,16]. In the dental field, CeO2 was primarily used for dental
ceramics since this compound stimulates the natural fluorescence found in human dental enamel [11].
The high atomic number 58 of cerium suggests that it can promote considerable attenuation of a dental
X-ray beam [17,18]. The incorporation of CeO2 in adhesives can be a valuable strategy to promote
radiopacity and improve the detection of dental adhesives underneath resin composites. Therefore, the
aims of this study were to formulate experimental dental adhesives containing CeO2 and investigate
the effects of different loadings of CeO2 on their radiopacity and degree of conversion for the first time.
2. Results
Figure 1 shows the results of CeO2 particles’ characterization. In Figure 1A, the X-ray diffraction
analysis of the powder shows the crystallinity pattern of a monoclinic phase of CeO2 (powder diffraction
file, ICDD-PDF 37-1468). In Figure 1B, the chemical composition analyzed by Fourier Transform
Infrared Spectroscopy (FTIR) displays the peaks related to Ce–O bonds at 400 cm−1. Figure 1C,D
presents the results of size distribution analysis. The histogram shows a non-normal distribution
of size (Figure 1C). The 10th percentile showed a particle diameter of 1.15 μm. The median (50th
percentile) was 14.98 μm, the 90th percentile was 31.32 μm, and the mean particle size was around
16 μm (Figure 1D).
Figure 2 presents the qualitative assessment via micro-Raman of the materials’ surfaces containing
0.36 (A) and 0.76 (B) vol.% of CeO2. The image consists of a 2-D array of measured spectra, which means
that the distribution of the chemical composition can be investigated. After mapping the polymer’s
surfaces, the integration of the corresponding CeO2 peak (464 cm−1) was used for analysis and graphs
generation. In the graphs, from blue to yellow, more CeO2 is identified. It was observed that the higher
the load of CeO2 in the resin, the larger the area under the curve (peak) in micro-Raman spectra for
this oxide, generating more yellow regions in the graph. In these analyses, more areas in yellow were
presented in the adhesive with 0.76 vol.% of CeO2 in comparison to the group with 0.36 vol.%.
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Figure 1. CeO2 particles’ characterization: (A) X-ray diffraction analysis shows the pattern of the
monoclinic phase of crystallinity for CeO2; (B) FTIR analysis displays the peaks related to Ce-O bonds at
400 cm−1; (C) and (D) show the non-normal distribution size of CeO2 and the values of size distribution.
Figure 2. Micro-Raman analysis of the dental adhesive surfaces containing 0.36 (A) and 0.76 (B) vol.%
of CeO2. Both images display the intensity of the CeO2 peak at 464 cm−1. The higher the load of CeO2
in the dental adhesive, the more areas in yellow are observed.
Figure 3 indicates the results of the radiopacity of each experimental adhesive resin containing a
different percentage of volume fraction of CeO2. In Figure 3A, an illustrative radiograph displays the
location of the dental adhesive layer underneath the composite restorative material. The arrows indicate
the radiolucent areas corresponding to the adhesive layer. The difference of radiopacity between the
composite resin and the adhesive layer can be clearly observed. In Figure 2B, the mean and standard
deviation of radiopacity is expressed in mm of aluminum. The control group, which is an unfilled
adhesive, showed the lower mean value of radiopacity, without statistical difference for the groups
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with 0.36 vol.% and 0.72 vol.% of CeO2. From the addition of 1.44 vol.% of CeO2, there was increased
radiopacity of the adhesive in comparison to the control group (p < 0.05). The group with 5.76 vol.%
of CeO2 showed the highest value of radiopacity among all groups (p < 0.05). The incorporation of
4.32 vol.% and 5.76 vol.% presented values of more than 1 mm of aluminum.
 
 
Figure 3. The dental radiograph displays the layer of dental adhesive applied under the composite
resin (A) The arrows guide the visualization of the radiolucent adhesive layer. (B) The radiopacity
of the experimental dental adhesives according the to the increasing concentration of cerium oxide.
Different letters indicate statistical differences among groups (p < 0.05).
Figure 4 shows the results of the degree of conversion analysis of the experimental dental adhesives.
The uncured adhesive samples were directly dispensed on the attenuated total reflection (ATR) device
of FTIR to analyze the conversion of carbon-carbon double bonds in the aliphatic chain. The values
ranged from 61.52 (±0.33) % for the control group to 47.90 (±1.64) % for 5.76 vol.% of CeO2. From the
incorporation of 2.88 vol.% of CeO2, the degree of conversion reduced in comparison to the control
group (p < 0.05). The lowest value of the degree of conversion was found for the highest load of CeO2
incorporated in the adhesive (p < 0.05).
Figure 4. Degree of conversion of the experimental dental adhesives containing CeO2. Different letters
indicate statistical differences among groups (p < 0.05).
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3. Discussion
In this in vitro study, CeO2 particles were explored as potential radiopacifier for dental adhesives
since high atomic weight and density can provide a suitable level of radiopacity. CeO2 was first
chemically characterized by XRD, Raman, and FTIR to be incorporated for the first time in a dental
adhesive resin. In the current investigation, CeO2 successfully increased the radiopacity of the adhesive,
maintaining a suitable degree of monomer conversion.
CeO2 particles used in this study presented a monoclinic crystalline phase with particular
chemical groups and the average particle size of around 16 μm. This oxide was incorporated in an
experimental adhesive resin formulated as previously reported, with conventional dental methacrylate
monomers [19,20]. The presence of a radiopacifying agent is essential to enable the identification of
restorative materials and dissimilarity from pathological processes in the adjacent areas [21]. Recurrent
caries and marginal gaps are very often the reasons for the replacement of composite restorations [22].
The misdiagnosis and treatment decision for unnecessary replacement of restorations lead to additional
loss of sound tooth tissue, with an increased cost and discomfort for the patient [23]. Therefore, the
restorative materials should have optimal radiopacity for accurate radiographic differentiation for
existing restorations and recurrent dental caries, supporting clinical follow-ups. Substantial changes in
radiopacity are compulsory by the International Organization for Standardization (ISO) for dental
restorative materials [24]. The compliance with the ISO 4049 requires a minimum radiopacity of
restorative materials higher than that of dentin and greater or equivalent thickness of aluminum
(with ≥98% purity) [24]. In the present study, the increased load of CeO2, by the percentage of
volume, was added to an experimental dental adhesive, providing a material with proper radiopacity.
Our results have shown that CeO2 at 4.32 vol.% had radiopacity higher than 1 mm of Al.
Besides the increase of radiopacity, the addition of inorganic fillers in monomeric blends may
improve polymers properties, such as the elastic modulus, tensile strength, fracture toughness, Knoop
hardness, and stability against solvents [25]. However, the higher filler addition can also decrease
the degree of monomer’s conversion [19]. The degree of conversion is a valuable chemical property
for polymers, and it may be associated with the stability of the restoration over time [20]. Therefore,
a reliable polymerization is desired for adhesive resins to reduce hydrolytic degradation in the clinical
setting [26,27]. Here, we observed that the incorporation of CeO2 at a load that reaches the high
radiopacity level reduced the degree of conversion of the dental polymer. Previous studies have
reported similar outcomes in the investigations of radiopacifying agents containing different kinds of
heavy metals [28]. Marins et al. [29] evaluated the addition of niobium pentoxide (Nb2O5) nanoparticles
to the dental adhesive as radiopacifiers and observed that the degree of conversion decreased with the
addition of particles at percentage mass fraction equal or greater than 10%. In other studies, Nb2O5
and Ta2O5 showed a decrease in the degree of conversion up to 5 wt.% [19,20]. Our results are also in
agreement with those of Amirouche-Korichi et al. [28], where progressive decreases of the degree of
conversion were linearly related to the filler contents.
The outcome observed for the degree of conversion may be attributed to the high refractive index
of CeO2 (approx. ղ = 2.2 to 2.8) [30], which may have decreased the accessibility of light energy inside
the polymer. The limited mobility of monomer chains by the incorporation of the opaque fillers has also
been considered as a contributing factor for the decrease in the monomer’s conversion [31]. Another
consideration for observed decay in the degree of conversion with regard to the dental adhesive with
loadings higher than 2.88 vol.% relies on particle size. The fillers used in our study are micro fillers
with an average size of around 16 μm. Previous reports support the effect of particle size in microns
and highlight that the volume occupied by the particles may compromise the polymerization rates
of the material [32–34]. Further evaluation of the polymerization behavior of nanosized CeO2 could
be interesting to address this subject. Moreover, it would be noteworthy to evaluate the effect of
micro-sized CeO2 in the adhesive with thinner samples or in situ in dentin.
Moreover, we suggest further biological studies on dental adhesives containing CeO2 in micro
and nanoscale, since this oxide has emerged as a noteworthy agent for bioactive (such as scaffolds and
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bioglasses) and antimicrobial materials [35–37]. In this context, a dental adhesive with such properties
could be a promising strategy to assist in decreasing the incidence of recurrent caries and improving the
remineralization process after selective removal of carious dentin. In this study, despite the decreased
degree of conversion observed by increasing CeO2 addition, all groups showed values around 50%,
which is in accordance with commercial dental adhesives [38]. Therefore, CeO2 may be a promising
alternative filler for biopolymers.
4. Materials and Methods
4.1. X-ray Diffraction Analysis of CeO2
CeO2 particles purchased were analyzed via X-ray diffraction to detect the crystalline phases of
the powder. diffractometer (PW 1730/1 model, Philips, Santa Clara, CA, USA) was operated at 40 kV
and 40 mA with CuKa radiation. The scanning rate used was 0.058/min, with 2 s of time-steps at 0.02◦
each, from 5◦ to 60◦ [18].
4.2. FTIR Analysis of CeO2
Fourier Transform Infrared Spectroscopy (FTIR) was used to chemically characterize the powder
of CeO2. The analysis was performed using the spectrophotometer Vertex 70 (Bruker Optics, Ettlingen,
Germany) with an attenuated total reflectance device (ATR). CeO2 powder was placed on the ATR,
and the analysis performed using 20 scans, 4 cm−1 of resolution in 5000 to 400 cm−1, and Opus 6.5
software (Bruker Optics, Ettlingen, Germany).
4.3. Particle Size Distribution of CeO2
CeO2 particles were dispersed in water with sonication for 60 s. Then, particle size was analyzed
via laser diffraction particle size analyzer (CILAS 1180, Cilas, Orleans, France) according to a previous
study [18].
4.4. Preparation of Dental Adhesives
The adhesive resins were formulated by mixing 50 wt.% bisphenol A glycol dimethacrylate (BisGMA),
25 wt.% triethylene glycol dimethacrylate (TEGDMA), and 25 wt.% 2-hydroxyethyl methacrylate
(HEMA). As a photoinitiator system, camphorquinone and ethyl 4-dimethylaminobenzoate were
added at 1 mol%, each one in the base resin. As polymerization inhibition, 0.01 wt.% of butylated
hydroxytoluene was incorporated. CeO2 was added at 0.36, 0.72, 1.44, 2.88, 4.32, and 5.76 vol.%.
The resins adhesives were hand-mixed for 5 min, sonicated during 180 s, and hand-mixed again for
5 min. One group without CeO2 was used as control.
4.5. Qualitative Analysis of CeO2 into Dental Adhesives
To identify the presence of CeO2 in dental adhesives, two groups containing this filler were
evaluated via micro-Raman Spectroscopy (Senterra, Bruker Optics, Ettlingen, Germany). One sample
from the group with 0.36 vol.% and another from the group with 5.76 vol.% were prepared using a
polyvinylsiloxane mold. The samples were photoactivated for 20 s on each side using a light-emitting
diode dental curing unit (Radii Cal, SDI, Melbourne, Australia) with 1200 mW/cm2. An area of
110 μm × 110 μm of the surfaces was analyzed via Opus 7.5 software (Opus 7.5, Bruker Optics,
Ettlingen, Germany). The analyses were performed with a wavelength of 785 nm, with 5 s and two
co-additions. The peak correspondent to CeO2 (464 cm−1) was used for integration.
4.6. Radiopacity Evaluation
The adhesive resins were evaluated for their radiopacity, according to the International
Organization of Standardization (ISO) 4049/2009 guidelines [24]. Five samples per group (n = 5)
with disc-shaped were prepared with 10.0 mm (±0.5 mm) in diameter and 1.0 mm (±0.1 mm) in
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thickness with photoactivation for 20 s on each side. The images were made using a phosphor plate for
the digital system (VistaScan; Dürr Dental GmbH & Co. KG, Bietigheim-Bissingen, Germany) at 70 kV,
8 mA, and 0.4 s of exposure time. A focus-film distance of 400 mm was used in the assays. One specimen
per group was positioned on the film for each X-ray exposition. An aluminum step-wedge (99.12 wt.%
of aluminum, thickness from 0.5 mm to 5.0 mm, in increments of 0.5 mm) was exposed with the
samples for each image specimens in all images. The images were saved in TIFF, analyzed using
Photoshop software (Adobe Systems Incorporated, San Jose, CA, USA), and the mean and standard
deviation of the grey levels (pixel density) were measured.
4.7. Degree of Conversion
To analyze the degree of conversion of the adhesives, FTIR-ATR was used according to a previous
study [39]. Three drops per group (n = 3, 3 μL each one) were directly dispensed on ATR diamond
crystal. An adjustable holder stand was used to fix the light-curing unit and to standardize the
distance between its tip and the top of the samples. Two spectra were acquired per group from 4000 to
400 cm−1 with a resolution of 4 cm−1. The first spectrum was obtained before the photoactivation. Then,
the samples were photoactivated for 20 s and analyzed again. To calculate the monomer conversion,
the peak related to the carbon-carbon (C=C) double bond in the aromatic ring of BisGMA (1610 cm−1)
was used as an internal standard. The peak related to C=C in the aliphatic chains (1640 cm−1) was
used along with the C=C at 1610 cm−1 according to the following equation:
Degree of conversion (%) = 100×
(
I_ 1640− cured/I_ 1610− cured
I_ 1640− uncured/I_1610− uncured
)
4.8. Statistical Analysis
CeO2 characterization was descriptively analyzed, as well as the identification of CeO2 in the
polymerized adhesives. Shapiro-Wilk test was used to evaluate the data normality. The data of
radiopacity was evaluated via ANOVA on ranks and Dunn’s test. The data of the degree of conversion
was analyzed via one-way ANOVA and Tukey’s post-hoc test. Both analyses were performed at 0.05
level of significance (p < 0.05).
5. Conclusions
CeO2 was investigated for the first time as a promising filler to improve the radiopacity of
dental adhesives. The particles were chemically analyzed and then used in experimental adhesives
formulation. Through of incorporation of CeO2 particles at 1.44 vol.%, the dental adhesives were
able to show increased radiopacity and a proper degree of conversion. The restorative materials here
proposed could be a reliable strategy to assist clinicians diagnose recurrent caries.
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Abstract: The aims of this study were to evaluate the physicochemical and
mechanical properties, antimicrobial (AM) functionality, and cytotoxic potential of novel
dental polymers containing quaternary ammonium and trimethoxysilyl functionalities
(e.g., N-(2-(methacryloyloxy)ethyl)-N,N-dimethyl-3-(trimethoxysilyl)propan-1-aminium iodide
(AMsil1) and N-(2-(methacryloyloxy)ethyl)-N,N-dimethyl-11-(trimethoxysilyl)undecan-1-aminium
bromide (AMsil2)). AMsil1 or AMsil2 were incorporated into light-cured (camphorquinone
+ ethyl-4-N,N-dimethylamino benzoate) urethane dimethacrylate (UDMA)/polyethylene
glycol-extended UDMA/ethyl 2-(hydroxymethyl)acrylate (EHMA) resins (hereafter, UPE resin)
at 10 or 20 mass %. Cytotoxic potential was assessed by measuring viability and metabolic activity
of immortalized mouse connective tissue and human gingival fibroblasts in direct contact with
monomers. AMsil–UPE resins were evaluated for wettability by contact angle measurements and
degree of vinyl conversion (DVC) by near infra-red spectroscopy analyses. Mechanical property
evaluations entailed flexural strength (FS) and elastic modulus (E) testing of copolymer specimens.
The AM properties were assessed using Streptococcus mutans (planktonic and biofilm forms) and
Porphyromonas gingivalis biofilm. Neither AMsil exhibited significant toxicity in direct contact with cells
at biologically relevant concentrations. Addition of AMsils made the UPE resin more hydrophilic. DVC
values for the AMsil–UPE copolymers were 2–31% lower than that attained in the UPE resin control.
The mechanical properties (FS and E) of AMsil–UPE specimens were reduced (11–57%) compared to
the control. Compared to UPE resin, AMsil1–UPE and AMsil2–UPE (10% mass) copolymers reduced
S. mutans biofilm 4.7- and 1.7-fold, respectively (p ≤ 0.005). Although not statistically different, P.
gingivalis biofilm biomass on AMsil1–UPE and AM AMsil2–UPE copolymer disks were lower (71%
and 85%, respectively) than that observed with a commercial AM dental material. In conclusion,
the AM function of new monomers is not inundated by their toxicity towards cells. Despite the
reduction in mechanical properties of the AMsil–UPE copolymers, AMsil2 is a good candidate for
incorporation into multifunctional composites due to the favorable overall hydrophilicity of the
resins and the satisfactory DVC values attained upon light polymerization of AMsil-containing
UDMA/PEG-U/EHMA copolymers.
Keywords: antimicrobial effect; biofilms; cytotoxicity; dental resins; physicochemical properties;
mechanical properties; quaternary ammonium methacrylates
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1. Introduction
As people live longer and retain more of their own teeth, the incidence of dental caries, especially
root caries, increases. Currently, the prevalence of root caries in older adults ranges from 29% to
89% [1]. The expected aging of the population will further increase root caries occurrences. Therefore,
implementing more effective prevention strategies and/or developing new treatments for root caries is
prudent. Often, compromised integrity of the conventional restorative/tooth interface [2,3] ultimately
results in bacterial microleakage and secondary caries. Class V restoratives may release fluoride
ions which, at adequate concentrations, protect teeth from demineralization and possibly contribute
to regeneration of mineral lost to caries. Fluoride release, however, does not provide an effective
antimicrobial (AM) protection, although fluoride can have some AM properties [4,5]. The majority
of the contemporary dental restoratives do not possess substantial AM properties [6] verifiable in
clinical trials [7]. To improve the longevity of repair, the restorative material should be AM. Adding
AM function to dental materials typically focuses on release/slow release of various low molecular
weight AM agents [5,8–15]. However, mechanism(s) of their actions are elusive, and there are concerns
about their toxicity to human cells, the development of tolerances (in the case of antibiotics), and
long-term efficacies. Moreover, the release of these agents can compromise mechanical performance of
the restoratives and, if the dose or release kinetics are not properly controlled, can induce toxicity to
the surrounding tissues [16].
Antimicrobial polymeric materials with quaternary ammonium (QA) salts have been widely
applied to a variety of antimicrobial-relevant areas (reviewed by [17,18]). QA methacrylates are known
for their AM action against both Gram-positive and Gram-negative bacteria. Studies have indicated
that QA compounds destroy bacterial cell membrane integrity and eventually lead to cell death [19–21].
The proposed mechanism of action is the electrostatic interaction between positively charged molecules
and negatively charged microbial cell membranes. So far, QA methacrylates have not been successfully
incorporated into dental restorative(s) to yield a sustained AM function [22]. Historically, the most
attention has been given to methacryloyloxydodecyl pyrimidinium bromide (MDPB) and its acrylamide
copolymer [6,23]. MDBP has been commercialized and suggested to be potentially applicable to
various restoratives. However, due to their poor color stability, MDBP-based materials can only be
used for aesthetically inferior restorations. To widen the utility of QAs in restorative dentistry, various
QAs have been formulated into bonding agents and dental resin composites [20,24–26]. Successful
incorporation of these new AM QAs into polymeric phases of composite materials would be a major
step in creating new Class V restoratives that are clinically effective against secondary caries. We are
advancing the development of Class V restorative materials by introducing bioactive amorphous
calcium phosphate (ACP) filler into polymer-based restorative in parallel to the AM monomer, thus
creating a multifunctional AM and remineralizing materials (hereafter AMRE). ACP has been indicated
as a precursor to hydroxyapatite formation both in vitro and in vivo [27–33]. ACP also exhibited
favorable in vivo osteoconductivity compared to hydroxyapatite [34]. Based on our group’s knowledge
of ACP chemistry and our understanding of structure/composition/property relationships existing in
ACP polymeric systems [35–39], we have undertaken a task to formulate AMRE polymeric composites
that maintain a desired state of supersaturation with respect to hydroxyapatite and efficiently restore
mineral-depleted tooth structures while providing sustained AM protection. Prior to formulating
AMRE composites, it is essential to evaluate the AM-containing resins (no ACP filler) to establish the
effect of AM monomers on basic biological, physicochemical, and mechanical properties of copolymers.
AMsil syntheses and subsequent validation protocols of novel dental monomers containing QA
and trimethoxysilyl functionalities are described in detail by Okeke et al. (2019) [40]. The motivation for
synthesizing AMsil1 and AMsil2 was to develop coupling agents capable of conferring the AM properties
and coupling with both ACP phase and polymer phase of Class V resin-based composites. This study
reports on the incorporation of these two polymerizable QA monomers with different alkyl chain
lengths (e.g., N-(2-(methacryloyloxy)ethyl)-N,N-dimethyl-3-(trimethoxysilyl)propan-1-aminium iodide
(AMsil1) and N-(2-(methacryloyloxy)ethyl)-N,N-dimethyl-11-(trimethoxysilyl)undecan-1-aminium
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bromide (AMsil2)) (Figure 1) into UDMA/poly(ethylene glycol)-extended UDMA (PEG-U)/ethyl
2-(hydroxymethyl) acrylate (EHMA) resins (hereafter UPE resin) and the biological, physicochemical,
and mechanical screening of AM–UPE copolymers. Working hypotheses were that AMsil monomers
will show minimal or no toxicity towards immortalized mouse subcutaneous connective tissue
fibroblasts (CCL1) or human gingival fibroblasts (HGF) and that AMsil–UPE copolymers will have
similar physicochemical and mechanical properties compared to the parent UPE copolymers. AMsil1–
and AMsil2–UPE copolymers were assessed for their AM activity against Streptococcus mutans and
Porphyromonas gingivalis, which are model microorganisms for dental caries [41,42] and periodontal
disease [43,44], respectively.
 
Figure 1. Skeletal structural formulas of AMsil1 (a) and AMsil2 (b) monomers.
2. Results
2.1. Structural Verification of AMsils
The AMsil structures were verified by 1H and 13C NMR (Tables 1 and 2). In brief, both 1H
and 13C NMR spectra of AMsils confirmed the successful quaternization of 2-(dimethylamino)ethyl
methacrylate (DMAEMA) precursor. By performing the syntheses in chloroform, methoxy groups of
(3-iodopropyl)trimethoxy silane (IPTMS) and (11-bromoundecyl)trimethoxy silane (BrUDTMS) were
protected from hydrolysis to which they are prone in aqueous environment.
Table 1. Assignments of 13C and 1H NMR chemical shifts of AMsil1.
Atom # 13C Chemical Shift, ppm 1H Chemical Shift, ppm # of H’s Signal Splitting
1 126.6 (CH2) 5.77, 6.09 1, 1 singlets
2 135.3 (C) 0
3 17.8 (CH3) 1.92 3 singlet
4 165.8 (C) 0
5 58.0 (CH2) 4.52 2 multiplet
6 61.7 (CH2) 3.70 2 multiplet
7, 8 50.6 (CH3) 3.09 6 singlet
9 65.9 (CH2) 3.34 2 multiplet
10 15.6 (CH2) 1.72 2 multiplet
11 5.2 (CH2) 0.54 2 multiplet
12, 13, 14 50.1 (CH3) 3.51 9 singlet
Atom numbering is illustrated in Figure 1.
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Table 2. Assignments of 13C and 1H NMR chemical shifts of AMsil2.
Atom # 13C Chemical Shift, ppm 1H Chemical Shift, ppm # of H’s Signal Splitting
1 126.5 (CH2) 5.76, 6.08 1, 1 singlets
2 135.3 (C) 0
3 17.8 (CH3) 1.91 3 singlet
4 165.8 (C) 0
5 58.1 (CH2) 4.52 2 multiplet
6 61.6 (CH2) 3.70 2 multiplet
7, 8 50.4 (CH3) 3.09 6 singlet
9 63.8 (CH2) 3.36 2 multiplet
10 21.7 (CH2) 1.67 2 multiplet
11–18 22.1, 25.7, 28.4, 28.6, 28.7,28.8, 28.9, 32.3 (CH2)
1.25 16 multiplet
19 8.6 (CH2) 0.57 2 multiplet
20, 21, 22 49.9 (CH3) 3.46 9 singlet
Atom numbering is illustrated in Figure 1.
2.2. Biocompatibility Testing
2.2.1. AMsil1
AMsil1 concentration did not exert a statistically significant effect on the viability of CCL1 cells
(Figure 2). However, the exposure time reduced the number (1.2-fold difference of mean, p ≤ 0.002) of
live cells. Similarly, AMsil1 concentration did not affect the metabolic activity of CCL1 cells. Time of
exposure had a modest effect (p ≤ 0.02) on CCL1 metabolic activity, although no significant paired
comparisons (within each concentration) were observed.
 
Figure 2. Percent control value of viability (a) and metabolic activity (b) of CCL1 cells exposed to 2-fold
serial dilutions of AMsil1 (≤8.34 mmol/L) for 24 or 72 h. Data represent mean ± standard error for five
independent replicates tested in triplicate.
Independent of time, AMsil1 concentration exerted a main effect (p ≤ 0.001) on the number of viable
HGFs (Figure 3). Paired comparisons indicated that at lower AMsil1 concentrations (≤0.13 mmol/L),
the number of live HGFs decreased. Independent of AMsil1 concentration, exposure time reduced
(19.73 difference of means, p ≤ 0.001) HGF viability. Monomer concentration or time of exposure did
not statistically affect the metabolic activity of HGF cells (data not shown).
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Figure 3. Percent control value of viability of human gingival fibroblast (HGF) cells exposed to 2-fold
serial dilutions of AMsil1 (≤8.34 mmol/L) for (a) 24 h or (b) 72 h. Data represent mean ± standard error
for five independent replicates tested in triplicate.
2.2.2. AMsil2
Regardless of time, AMsil2 concentration exerted a main effect (p ≤ 0.001) on the number of
viable CCL1s (Figure 4). Paired comparisons indicated that at 24 h exposure, CCL1 cells exposed to
≥3.64 mmol/L were lower (p ≤ 0.05) than the number of live cells exposed to all lower concentrations.
At 72 h exposure, the percentage of live CCL1 cells exposed to ≥1.82 mmol/L AMsil2 was at least 3- to
4-fold lower (p ≤ 0.001) compared to all concentrations ≤ 0.91 mmol/L.
Like cell viability, AMsil2 concentration exerted an effect (p ≤ 0.001) on CCL1 metabolic activity.
Viability and metabolic activity of CCL1 cells exposed to AMsil2 showed a strong positive linear
correlation at 24 h (R2 = 0.91, p ≤ 0.0005) and 72 h (R2 = 0.93, p ≤ 0.0005) (data not shown).
AMsil2 exhibited a concentration effect (p ≤ 0.001) on HGF cell viability (Figure 5). Paired
comparisons indicated that exposure to ≥1.82 mmol/L AMsil2 reduced the number of live HGFs by
more than 3-fold (p ≤ 0.05) compared to the control group. When considering the effect of time
regardless of AMsil2 concentration, the number of live cells was consistently lower (~23% difference of
means). Like viability, AMsil2 concentration exhibited an effect (p ≤ 0.001) on HGF metabolic activity.
At 24 and 72 h, viability and metabolic activity of HGF cells exposed to AMsil2 showed a positive linear
correlation (R2 = 0.94; (p ≤ 0.0005) and R2 = 0.77; (p ≤ 0.001), respectively) (data not shown).
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Figure 4. Percent control value of viability of CCL1 cells exposed to 2-fold serial dilutions of AMsil2
(≤7.28 mmol/L) for 24 or 72 h. Data represent mean ± SEM for five independent replicates tested in
triplicate. * indicates p ≤ 0.05 when compared to concentrations ≤ 0.91 mmol/L within the same time
period. + indicates p ≤ 0.05 when compared to 0.455, 0.228, or 0.114 mmol/L concentrations within
same time period.
 
Figure 5. Percent control value of viability of HGF cells exposed to 2-fold serial dilutions of AMsil2
(≤7.28 mmol/L) for 24 h or 72 h. Data represent mean ± SEM for five independent replicates tested in
triplicate. + indicates p ≤ 0.05 when compared to concentrations ≤ 0.455 mmol/L within same time
period. * indicates p ≤ 0.05 when compared to concentrations ≤ 0.91 mmol/L within same time period.
ˆ indicates p ≤ 0.05 when compared to concentrations ≤ 0.114 mmol/L within same time period. $
indicates p ≤ 0.05 when compared to concentrations ≤ 0.228 mmol/L within same time period.
For both AMsils, control wells (with or without cells) in which the tetrazolium salt reagent was
omitted resulted in negligible optical density values. Positive control wells containing unexposed cells
(i.e., no AMsils) that were given an equal volume of culture medium were not significantly different
from cells that were previously treated with the viability stain (data not shown).
2.3. Hydrophobicity/Hydrophilicity of the Resins
Copolymers comprised of UPE resin with added AMsils generally exhibited lower contact angles
(CAs) (Figure 6), suggesting change in their hydrophilic/hydrophobic balance toward more hydrophilic
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surfaces. At 10 mass % monomer in the resin, CAs of both AMsil1–UPE and AMsil2–UPE copolymers
(46.9 ± 5.9◦ and 37.4 ± 9.2◦, respectively) were significantly lower (23% and 38% reduction, respectively;
p ≤ 0.01) than the CA of the UPE control 60.8 ± 5.1◦. The apparent increase in the CA in going
from 10% to 20% AMsil in the resin was significant only for AMsil2 (p ≤ 0.035). The overall order
of the decreasing relative hydrophilicity (evidenced by the increasing CA values) of the examined
UPE-based copolymers was as follows: (10% AMsil2–UPE ≥ 10% AMsil1–UPE) > (20% AMsil2–UPE =
20% AMsil1–UPE) > UPE control.
Figure 6. The contact angle (CA) values of AMsil–UPE and UPE control indicative of the changes in
resin’s overall hydrophilicity/hydrophobicity upon introduction of AMsil monomers at 10 and 20 mass
% relative to UPE. Shown are mean values + standard deviation of four repetitive measurements in
each experimental group.
2.4. Effect of AMsils on Degree of Vinyl Conversion (DVC)
Introduction of 10% and 20% AMsil1 into UPE reduced (p ≤ 0.05) the mean vinyl moiety conversion
upon photopolymerization by 31% and 20%, respectively (Figure 7). No significant effect was observed
with the increasing levels of AMsil1 in the resin. Although reduced, the DVC observed amongst the
AMsil2 groups was not statistically different from one another or the UPE control group.
Figure 7. The values for degree of vinyl conversion (DVC) attained 24 h post-cure in AMsil–UPE
copolymers compared to no-AM UPE control. Shown are mean values + standard deviation of three
repetitive measurements.
2.5. Mechanical Properties of AMsil–UPE Copolymers
The FS and E of AMsil–UPE copolymers were, generally, diminished compared to the UPE resin
control (Figure 8). The extent of reduction in FS and E varied with the type and the concentration
of AMsil. In all AMsil–UPE formulations, the FS values were significantly (p ≤ 0.05) lower than the
UPE control counterparts. In both 10 mass % AMsil formulations, the E was reduced, although not
statistically significant. At 20 mass %, the E of both AMsil formulations were notably lower (p ≤ 0.0008)
than the UPE resin control. Both FS and E reductions ranged from moderate (11–13%) for 10 mass %
AMsil formulations to substantial (25–57%) for 20 mass % AMsil formulations.
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Figure 8. (a) Flexural strength and (b) tensile elasticity of AMsil–UPE copolymers in comparison with
the UPE control. Indicated are mean values + standard deviation of three specimens.
2.6. Bacterial Testing
For planktonic bacterial testing, the number of S. mutans colony-forming units/mL observed
amongst the AMsil groups were not statistically different from one another or the control groups
(UPE only and commercial control). However, compared to UPE resin, AMsil1–UPE and AMsil2–UPE
(10% mass) copolymers reduced the colonization of S. mutans biofilm 4.7- and 1.7-fold, respectively
(p ≤ 0.002) (Figure 9). S. mutans biofilms exposed to AMsil1–UPE were at least 2.8-fold lower (p ≤ 0.005)
than that observed with AMsil2–UPE.
Figure 9. Streptococcus mutans biofilm growth inhibition by the experimental AMsils–UPE (10 mass
%) copolymers compared to UPE control resin. Bar height indicates mean + standard deviation of 5
specimens/group.
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P. gingivalis biofilm biomass on copolymer disks exposed to AMsil1–UPE and AMsil2–UPE were
lower (71% and 85%, respectively) than that observed with the commercial control, albeit not statistically
different (p ≤ 0.07) (Figure 10).
Figure 10. Porphyromonas gingivalis biofilm growth inhibition by the experimental AMsils–UPE (10
mass %) copolymers compared to UPE control resin. Bar height indicates mean + standard deviation of
5 specimens/group.
3. Discussion
We considered cytotoxicity of any AM monomer to be a major determinant of whether the materials
that incorporate the monomer in their resin phase are worthy of further study. We believe that direct
contact cellular testing of the new agent must be done at biologically relevant eluent concentrations. In
this study, we employed conditions that reflect the accelerated leachability of UPH resins and included
AMsil concentrations that significantly exceed the upper thresholds established experimentally in the
previous work [45]. The direct toxicity of AMsils towards CCL1 cells and/or HGFs was demonstrated to
be marginal or undetectable, except at the higher concentrations of monomers tested. These high AMsil
levels correspond to unrealistically high levels of the unreacted monomers and are highly unlikely to
ever be registered clinically. Our cytotoxicity results support the basic hypothesis of the study and
suggest that, from a biotoxicity viewpoint, AMsils can be safely utilized in design of AM new materials.
Leachability studies of AM–UPE formulations employing high-performance liquid chromatography
are currently underway in our laboratory, and are expected to confirm the conclusions derived from
the tests based on the accelerated UPH leachability study.
Upon introduction of AMsil into the UPE resin, a shift towards lower CA values, consistent
with the moderate increase in the overall hydrophilicity, was seen in all AMsil–UPE formulations.
The detected range of CAs in AMsil–UPE resins (37.4–53.3◦) correlates very well with the range of
CAs typical for the commercial resin composites (37.4–53.3◦) [46]. The lowest CAs detected in 10%
AMsil2–UPE formulation make this resin a good candidate for the incorporation of the ACP filler
in future design of AMRE composites. ACP-filled composite requires sufficient water absorption
to initiate water-catalyzed transformation of ACP during which the remineralizing calcium and
phosphate ions are released, by diffusion, into surrounding mineral-deficient tooth structures. There,
they regenerate these mineral-depleted structures via redeposition of hydroxyapatite [47]. Taken
together, the enhanced wettability should ease a diffusion of water into AMRE composite and result in
the subsequent release of calcium and phosphate ions from the composite needed for demineralization
prevention and/or active remineralization at the restoration site.
The range of DVC values attained in AMsil–UPE copolymers (60.7–86.7%), dependent on both
the monomer type and its quantity in the resin, were higher or equal to the DVC reported for
2,2-bis[p-(2-hydroxy-3-methacryloxypropoxy)phenyl]propane (bis-GMA)-based resins/composites
with incorporated QA ionic dimethacrylate (67.9–70.7%) [25]. AMsil2 copolymers reached significantly
higher DVC values (75.2–86.7%) compared to their AMsil1 counterparts (60.7–70.9%). In AMsil2–UPE
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formulations, the inclusion of AM monomer apparently did not affect the high levels of DVC typically
seen in UDMA-based resins [35,36]. This phenomenon has been attributed to the chain transfer
reactions caused by UDMA’s –NH– groups, resulting in increased mobility of the resin network’s
radical sites [48]. The DVCs attained in AMsil2–UPE copolymers suggest limited mobility of cross-linked
polymer matrix, thus reducing the likelihood of unreacted monomers leaching out to a minimum.
The observed DVC decrease in AMsil1–UPE formulations compared to those of AMsil2–UPE is yet to
be explained.
The results of FS and E tests indicated a reduction of the copolymers’ mechanical properties
in going from the UPE control to 10% AMsil–UPE to 20% AMsil–UPE. The reduction was far more
pronounced in AMsil1 series (50%) compared to the AMsil2 series (15%). This overall reduction in
mechanical properties, particularly in AMsil2–UPE copolymers, should not disqualify this monomer
from further exploration, as AM agent in multifunctional AMRE composites. To compensate for the
reduction in the mechanical properties, incorporation into composites of the reinforcing fillers in
addition to ACP should be considered.
AMsils integrated into UPE resin were effective in reducing (p ≤ 0.002) S. mutans biofilms.
Compared to the commercial control, P. gingivalis biofilm biomass was notably lower (71–85%) on
AMsils–UPE copolymer disks, however, not statistically different. As Gram-positive bacteria have
peptidoglycan with long anionic polymers, called teichoic acids [49] (i.e., yielding a higher cell
surface net negative charge than Gram-negative organisms), one could anticipate S. mutans to be more
susceptible to AMsils. Notwithstanding, quaternary ammonium compound AM functionality can also
be affected by the type of counter-ion [50], pendant active groups [51], molecular weight, and length of
the alkyl chains [52].
AMsils show promise, as S. mutans planktonic and biofilm forms were reduced. Nonetheless,
this reduction was only significant (p ≤ 0.002) for biofilms. When comparing planktonic and biofilm
responses, similar trends were observed with an endodontic sealer. For example, bacteria tested with a
resin-based root canal sealer did not statistically reduce the planktonic forms, while notably decreasing
bacteria in monospecies biofilms [53]. These authors attributed this to the release of substances during
the setting process. This attribute is unlikely applicable to our material, as DVC was high and aqueous
extraction was conducted for 72 h. In another report, Staphylococcus aureus biofilms were demonstrated
to be more susceptible to killing than the planktonic form of the same strain [54].
Although AM functionality is observed, we believe that the full potential of the AMsil monomers
has not yet been realized. As reported for other quaternary ammonium compounds [47], the current
AMsil–UPE copolymer formulations are likely to have N+ charges randomly distributed throughout
the material. As the mechanism of AM action is contingent on contact, it would be advantageous
to develop fabrication methods that would favor charge density at the materials surface. Further,
others have demonstrated that proteins can diminish the AM capability of quaternary ammonium
methacrylates (reviewed by [6]). Currently, there is insufficient information concerning the interaction
of proteins with quaternary ammonium methacrylates. Elucidation of the protein–material interactions
would yield valuable information to develop strategies to maximize AM efficacy of materials with a
charge-based AM mechanism of action.
In conclusion, our novel AM dental monomers (AMsil1 and AMsil2) exhibited minimal or no
toxicity upon direct contact with biologically relevant concentrations, while reducing S. mutans and P.
gingivalis biofilm forms. AMsils made the UDMA/PEG-U/EHMA resin more hydrophilic. This would be
an advantageous feature in AMRE composites that require water to induce their remineralizing effects.
At 10 mass % level of AMsil monomer, DVC of the ensuing AMsil–UPE copolymers was only marginally
lower than in UPE control and still exceeded DVCs typically seen in the commercial composites
based on bis-GMA/triethyleneglycol dimethacryalate (TEGDMA) resins. The mechanical properties of
AMsil–UPE copolymers were reduced (11–57%) compared with the UPE control. The extent of reduction
depended on both the type and the concentration of AMsil monomer in the resin. This finding should
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not disqualify the AMsil–UPE resins from use in AMRE composites intended for Class V restorations
where the mechanical stability is not a critical factor.
4. Materials and Methods
4.1. Monomer Synthesis
The synthesis and validation protocols for the AMsils are described in detail by Okeke et al.
(2019) [40]. In brief, AMsil1 and AMsil2 were synthesized at 50–55 ◦C by reacting equimolar amounts of
tertiary amine, DMAEMA, with IPTMS and BrUDTMS, respectively, in the presence of chloroform and
butylated hydroxytoluene. DMAEMA, IPTMS, and butylated hydroxytoluene were purchased from
Sigma, St. Louis, MO, USA. BrUDTMS was purchased from Gelest Inc., Morrisville, PA, USA. Reactants
and solvents (chloroform, diethyl ether, hexane; Sigma, St. Louis, MO, USA) used during synthesis
and the subsequent purification were used as received, without further purification. The reaction
yields were 94.8% and 36.0% for AMsil1 and AMsil2, respectively. Due to the generally hygroscopic
nature of QA monomers, the AMsils were stored under vacuum (25 mm Hg) before being used for
resin formulation and/or copolymer disk specimen preparation.
4.2. Structural Verification
Purified monomers were characterized by 1H and 13C NMR spectroscopy as described [40]. Briefly,
spectra were obtained using a Bruker Advance II (600 MHz) spectrometer equipped with a Broadband
Observe room temperature probe (Bruker, Corp., Billerica, MA, USA). Monomers were dissolved in
deuterated dimethyl sulfoxide containing tetramethylsilane.
4.3. Experimental Resin Formulation
UPE resin was formulated from the commercially available monomers UDMA, PEG-U, and
EHMA at 2.8:1.0:1.7 mass ratio (corresponds to the average mass ratio of the ternary UDMA-based
formulations explored by our group so far). A conventional visible light initiator system comprised of
camphorquinone and ethyl-4-N,N-dimethylamino benzoate (4EDMAB) was introduced to the resin at
concentrations of 0.2 mass % camphorquinone and 0.8 mass % 4EDMAB. AMsils were blended into
UPE resin to yield (AMsil1 or AMsil2)–UPE resin with 10 or 20 mass % of AM component. Addition of
AMsil1 or AMsil2 to the light-activated UPE resin took place in the absence of blue light. The rationale
for the chosen levels of AM monomers is based on the previously reported AM activities of similar
QA methacrylates in camphorquinone /4EDMAB-activated bis-GMA/TEGDMA resins [25]. Once all
components were introduced, the mixture was stirred magnetically (38 rad/s) at 22 ◦C until a uniform
consistency was achieved. CLEARFIL SE Protect BOND (Kurary America, Inc., New York, NY, USA)
was used as a comparative commercial AM material. This resin was prepared using equal quantities of
primer (containing MDPB) and bonding (containing bis-GMA-HEMA) agent.
4.4. Biocompatibility Tests
Direct contact cytotoxicity of AMsils was determined following described protocols [55,56].
Briefly, immortalized mouse subcutaneous connective tissue fibroblasts (NCTC clone 929 [L-cell,
L-929, Strain L derivative]; American Type Culture Collection (ATCC), Manassas, VA, USA) (CCL1)
or HGF (Applied Biological Materials, Inc., Richmond, BC, Canada) were exposed to 2-fold serial
dilutions (AMsil1: ≤8.34 mmol/L; AMsil2: ≤7.28 mmol/L). Chosen concentrations corresponded to
approx. 7% mass fraction of AMsil1 or AMsil2 in the copolymer resin and a maximum of 2% leaching.
To allow for the possibility of restoration multiplicity and variable size, a 2-fold greater dilution was
also included in the testing. These calculations are based on the accelerated leachability study of
UDMA/PEG-U/2-hydroxyethyl methacrylate (HEMA) resin (abbreviated UPH; a close analog to UPE
resin used in this study) and ACP-UPH composites [57]. After 24 and 72 h incubation, cells were
assessed for cell viability (LIVE/DEAD® Viability/Cytotoxicity kit, Life Technologies, Corp., Grand
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Island, NY, USA) and metabolic activity (CellTiter® AQueous One Solution Reagent; Promega, Corp.,
Madison, WI, USA). Controls were without the AMsils and/or cells. The CCL1 cells and HGFs were
maintained, at 37 ◦C and 5% CO2, in 10% serum-supplemented Eagle’s minimum essential medium
(ATCC) and PriGrow III medium (Applied Biological Materials, Inc.), respectively. For experiments,
cells were obtained from a subconfluent stock culture. Means were obtained from 5 independent
replicates tested in duplicate.
4.5. Contact Angle (CA)
Changes in hydrophilicity/hydrophobicity of UPE resins due to the introduction of AMsils were
assessed by CA measurements (drop shape analyzer DSA100, Krüss GmbH, Hamburg, Germany).
Following the deposition of the sessile droplets of the resin on the substrate, they were imaged after
1 min resting time with a charge-coupled device camera at the points of intersection (three-phase
contact points) between the drop contour and the projection of the surface (baseline). The CA water
values were calculated employing the Krüss Advance software. Four repetitive measurements were
performed in each group.
4.6. Copolymer Specimen Preparation
For biotesting, UPE and AMsil1–UPE and AMsil2–UPE copolymer specimens were fabricated by
filling circular openings of a flat stainless-steel molds (6 mm diameter, 0.5 mm thickness) with the
resins. Each side of the mold was covered with Mylar film and a glass slide, firmly clamped, and then
cured (2 min/side: Triad 2000; Dentsply International, York, PA, USA).
Specimens were subjected to extraction in Dulbecco’s phosphate-buffered saline lacking both
calcium and magnesium (Life Technologies, Grand Island, NY, USA) for 72 h, at 37 ◦C and 6.3 rad/s
using an orbital shaker. After extraction, the disks were dried under vacuum (desiccator; ~22 ◦C) for
7 days. Specimens were sterilized for 12 h using an Anprolene gas sterilization chamber (Andersen
Products, Inc., Haw River, NC, USA). Prior to bacterial testing, specimens were degassed for ≥5 days
under vacuum (desiccator; ~22 ◦C).
4.7. Degree of Vinyl Conversion (DVC)
DVC of UPE and (AMsil1 or AMsil2)–UPE resins was determined by collecting the near-IR (NIR)
spectra (Nexus; ThermoFisher, Madison, WI, USA) before and 24 h after the light cure and calculating
the reduction in =C–H absorption band at 6165 cm−1 in the overtone region in going from monomers
to polymers. By maintaining a constant specimen thickness, a need for an invariant internal standard
was eliminated. The DVC was calculated as
DVC (%) = [(areamonomer − areapolymer)/areamonomer] × 100 (1)
where areapolymer and areamonomer correspond to the areas under 6165−1 absorption peak after and
before the polymerization, respectively.
4.8. Mechanical Properties of Copolymers
Test specimens (2 mm × 2 mm × 25 mm) for flexural strength (FS) and elastic modulus (E)
determinations were photopolymerized in the same manner as the copolymer disks for biological
testing. Polymerized specimens did not undergo any additional treatment. The FS and E of UPE
and (AMsil1 or AMsil2) UPE copolymer specimens was tested employing the Universal Testing
Machine (Instron 5500R, Instron Corp., Canton, MA, USA). The load was applied (crosshead speed
of 1 mm/min) to the center of a specimen positioned on a test device with supports 20 mm apart.
The FS and E of the specimens (three replicates/experimental group) were calculated as instructed in
the ISO4049:2009 document.
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4.9. Bacterial Testing
4.9.1. Planktonic
Testing of Streptococcus mutans UA-159 (ATCC® 700610) planktonic forms was according to
described methods [47,58]. Briefly, bacterial cultures with an optical density of 1.2–1.3 at 600 nm
(Unico® 1200 Spectrophotometer, United Products & Instruments, Inc., Dayton, NJ, USA) were diluted
and seeded onto copolymer disks at a density of ~3 × 107 CFU/disk. Another disk was placed atop
to maximize contact. After a 2 h incubation (37 ◦C, 5% CO2) the samples were placed in 1 mL of
Todd Hewitt broth, rigorously mixed, and utilized to prepare a 10-fold dilution series. A 100 μL
aliquot of the resulting suspensions were spread onto the surface of THB agar plates. After incubation
(~20 h at 37 ◦C, 5% CO2), colony-forming units were enumerated using an IncuCount Colony Counter
(Revolutionary Science, Shafer, MN, USA). UPE resin disks and HemCon® Dental Dressing (HemCon
Medical Technologies, Inc., Portland, OR, USA) were used as negative and positive controls, respectively.
Around 30 to 300 CFU per spread plate was the range considered countable. Notwithstanding, agar
plates streaked with neat solutions of some groups yielded less than the lower limit of detection. Such
data were reported as less than the limit of quantification. The number of CFU/mL was calculated as
CFU number/(volume plated × dilution factor). Mean counts were obtained from five independently
tested copolymer disk sandwiches.
4.9.2. Biofilm
A bioluminescent S. mutans strain JM 10 (derivative of wild type UA159 [59] was used to assess
the AM properties of AMsils. Methods of the real-time bioluminescence assay were as described [41,58].
Porphyromonas gingivalis, strain FDC 381 (ATCC® BAA-1703) was propagated in Becton Dickinson
BBL chopped meat carbohydrate, pre-reduced II broth, using a shaking incubator (37 ◦C, anaerobic
conditions). Three-day cultures were diluted in broth to approximate 5 × 106 CFU/mL. Copolymer
disks, vertically supported in a 24-well plate, were immersed in 1.6 mL of the bacterial suspension.
In anaerobic conditions, the plate was incubated at 37 ◦C for 4 days. The copolymer disks were washed
thrice in sterile 0.89% NaCl solution. Thereafter, the biofilm was displaced from the copolymer disks by
transferring them to a sterile glass tube containing 1 mL of saline, vortexed (1 min), sonicated (10 min),
and vortexed (1 min). Each disk was visually examined to ensure that the biomass was removed.
The resulting suspensions were used to make 10-fold serial dilutions and subsequently spread onto
the surface of Brucella agar with hemin and vitamin K1 (Sigma-Aldrich, St. Louis, MO, USA) plates.
After incubation (3 days at 37 ◦C, anaerobic conditions), colony-forming units were enumerated.
4.10. Statistical Analyses
Analysis of variance and multiple paired comparisons (two-sided, 95% confidence interval) were
used to analyze the experimental data as a function of material makeup and/or exposure/incubation
time and establish a statistical significance of differences between the experimental groups. Correlation
coefficient (r) was calculated to determine the functional dependence between cellular metabolic
activity and viability. (SigmaPlot™, Systat Software, San Jose, CA, USA and/or Microsoft Office Excel
2016; Microsoft, Redmond, WA, USA). Graphics were created using Microsoft Office Excel 2016 and/or
DeltaGraph6 for Windows® (Red Rock Software, Inc., Salt Lake City, UT, USA).
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Abstract: In this study, we have prepared a series of 4- and 6-arm star-shaped polymers with varying
molecular weight and hydrophobicity in order to provide insight into the role and relationship that
shape and composition have on the binding and protecting of oral relevant surfaces (hydroxyapatite,
HAP) from bacteria colonization. Star-shaped acrylic acid polymers were prepared by free-radical
polymerization in the presence of chain transfer agents with thiol groups, and their binding to the HAP
surfaces and subsequent bacteria repulsion was measured. We observed that binding was dependent
on both polymer shape and hydrophobicity (star vs. linear), but their relative efficacy to reduce oral
bacteria attachment from surfaces was dependent on their hydrophobicity only. We further measured
the macroscopic effects of these materials to modify the mucin-coated HAP surfaces through contact
angle experiments; the degree of angle change was dependent on the relative hydrophobicity of the
materials suggesting future in vivo efficacy. The results from this study highlight that star-shaped
polymers represent a new material platform for the development of dental applications to control
bacterial adhesion which can lead to tooth decay, with various compositional and structural aspects
of materials being vital to effectively design oral care products.
Keywords: polymer; dental; antibacterial; antifouling; hydroxyapatite; star-shaped; hydrophobicity;
acrylic acid; oral; composition
1. Introduction
The control and reduction of oral biofilm formation [1], initiated by bacterial species living in
polymicrobial, pathogenic colonies at or below the gingival margin [2], are critical steps toward the
prevention of dental caries and periodontal diseases [3–5]. While many methods have been proposed to
prevent or treat these biofilms [6–10], one promising strategy is the use of synthetic polymer additives
that bind to the tooth surface to act as a barrier or deterrent to the deposition of planktonic bacteria
through either lethal [11–13] or non-lethal [14,15] mechanisms. Dental materials, especially those
delivered from common over the counter products such as toothpaste or mouthwash, must effectively
be multifunctional materials in that they must (1) deposit and stick to a tooth surface, (2) act as a
barrier against bacteria attachment, (3) be robust against external challenges such as food and drink in
order to not require constant reapplication, and (4) perform steps 1–3 in the presence of the salivary
pellicle. Conventional polymers used for this strategy include poly (methyl vinyl ether/maleic acid)
(Gantrez) and cross-linked micron-sized polyacrylic acid particles (carbopol). Additional polymers
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such as polyaspartate adhered to hydroxyapatite (HAP) and reduced the attachment of Streptococcus
sanguinis [16]. While these materials do show the ability to reduce bacterial attachment to the tooth
surface, the relationship between a polymer’s structure and composition to maximize efficacy, i.e., to
bind to an enamel surface and provide anti-attachment properties, remains disconnected.
We have previously shown that star-shaped polymers with pre-assembled poly(hydroxyethyl
methacrylate) (HEMA) chains formed stable polymer coatings on polyethylene terephthalate
surfaces [17]. Consistent with similar reports [18–32], these star-shaped architectures provided
brush-like structures of highly packed polymer chains that could physically repel bacteria to result in a
significant reduction of attached bacteria. While this approach using water-insoluble polymers was
suitable for hydrophobic resin surfaces, those potentially delivered from common oral care products
are required to have significant water solubility. Materials, such as poly(acrylic acid) (PAA) are indeed
water soluble, and have been known to bind to the tooth or HAP surfaces through interactions between
the anionic carboxylate (COO-) groups in the polymer side chains and cationic calcium ions at the
enamel surface [33–35].
As illustrated in Figure 1, we have prepared a small library of linear and star-shaped water-soluble
polymers comprising of acrylic acid (AA) and methyl acrylate (MA) in order to draw a relationship
between polymer structure (linear vs. 4-arm vs. 6-arm) and polymer composition (variable
hydrophobicity) with their ability to bind to oral-relevant surfaces and provide bacterial anti-attachment
in model systems. The specific goal of this report is to increase fundamental understanding of
polymer-tooth surface interactions toward the development of new polymer platforms and products
for anti-bacterial attachment activity.
 
Figure 1. Star-shaped and linear poly(acrylic acid)s used in this study. The chemical structures of linear
poly(acrylic acid) polymers (Lin), 4-arm (4Star) and 6-arm (6Star) star-shaped poly(acrylic acid), and
4-arm star-shaped copolymers with methyl acrylate (4StarMA).
2. Results and Discussion
2.1. Synthesis of 4- and 6-Arm Star-Shaped Polymers and Characterization
We wanted to test the free-radical polymerization in the presence of chain transfer agents (CTAs)
as a facile synthetic strategy to prepare star-shaped polymers (Figure 2A) (See Tables S1–S6 in
Supplementary Materials for polymerization conditions). In this polymerization, the thiol of a CTA
reacts (R-SH) with the radical at the polymer chain and terminates the chain propagation by transferring
the hydrogen atom (Figure S1). At the same time, the thiyl radical (R-S•) is generated and initiates
new polymerization with the remaining monomers. This chain transfer cycle continues to consume all
the remaining monomers, and the molecular weight of polymers can be determined by the relative
reactivity of the radicals to CTAs compared to the monomers (chain transfer coefficient, Ctr in Equation
(2)) (See Section 3.5. Analysis of Polymerization Process in Materials and Methods for Equation (2))
and the molar ratio of CTA to monomers ([SH]/[monomer]). We have previously prepared star-shape
polymers with 10–12 polymer chain arms by crosslinking the end groups of pre-existing polyHEMA
polymer chains [17]. However, this preparation method required multiple synthesis and purification
steps. To that end, we synthesized a series of polymers with a range of molecular weights by altering
the ratio of CTA to monomers to determine if this synthetic method can provide star-shaped polymers
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with sufficient size control. In general, star-shaped polymers have been synthesized by living radical
polymerization methods, which provided well-defined polymers [36]. However, we chose free-radical
polymerization with thiol CTAs because we are interested in a facile approach, potentially capable of
large-scale production.
Figure 2. Synthesis of star-shaped polymers. (A) Synthesis of 4-arm star-shaped polymers, (B) Chemical
structures of chain transfer agents. MMP: methyl 3-mercaptopropionate, PETMP: pentaerythritol
tetrakis(3-mercaptopropionate), DPEHMP: dipentaerythritol hexakis(3-mercaptopropionate). (C) Mayo
plots. The broken lines present the results of line fitting. Ctr was determined from the slope of the line.
[SH]/[monomer] = (The number of thiol groups in a CTA) × [CTA]/[monomer].
The CTAs are small compounds with 4 or 6 thiol groups (PETMP and DPEHMP) (Figure 2B),
which serve as core molecules to initiate propagation of polymer chains and yield star-shaped polymer
structures. The mono-thiol chain transfer agent MMP provided linear polymers. We used tert-butyl
acrylate (tBuA) as a protecting group of acrylic acid to facilitate polymer synthesis, and characterization
through GPC and NMR spectroscopy. The average degree of polymerization of each arm (DParm) was
determined by comparing the integrated peak area from the polymer backbone to that of CTAs in the
1H NMR spectrum (See Experimental for details). As the ratio of CTA to monomers was increased, the
molecular weight of polymers decreased, giving a series of star-shaped and linear polymers with Mn
of ~2000 to 200,000 g/mole (See Table S7 for the molecular weight of polymers). It should be noted
that the molecular weights of polymers were further measured by size exclusion chromatography
(SEC), which separates materials of various masses by the hydrodynamic volume of polymer chains.
In general, the hydrodynamic volume of star-shaped polymer is smaller than that of linear polymer
with same absolute molecular weight [37]. Therefore, the comparison of molecular weights between
the linear and star-shaped polymers by SEC alone would not be sufficient.
To probe the chain transfer polymerization, we examined the relationship between the ratio of
the thiol groups to monomers and the polymer chain length. The Mayo plots (1/DP or 1/Mn (GPC)
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vs. [SH]/[monomer] based on Equation (2) for linear, 4-arm, and 6-arm star-shaped polymers showed
linear correlations (Figure 2C), and the Ctr value of each CTA was determined as the slope of fitted lines
in the Mayo plots (Ctr = 0.91 (Lin), 1.06 (4Star), 0.97, (6Star)). In addition, the plots of 1/Mn (determined
by GPC) against [SH]/[Monomer] also showed linear correlations (Figure 2C). These results suggested
that the polymerization was driven by independent chain transfer processes initiated by each thiol
group of the CTAs. This further suggested that a polymer chain grew from each CTA arm (formation
of star-shaped polymers), and the average polymer chain arm length could be controlled by varying
the ratio of CTA to monomers.
The protected t-BuA polymers were treated with TFA to yield acrylic acid polymers (Figures 1
and 2). Because the resultant acrylic acid polymers were no longer soluble in GPC solvent (THF), the
molecular weights and distribution of polymers were not determined. The DP of resultant acrylic
acid polymers could also not be relatively determined by 1H NMR analysis because the signals from
the CTA agents were very small or not detected, which is likely due to low solubility of polymers in
solvent. The linear, 4-arm, and 6 arm star-shaped polymers are denoted as Lin-X, 4Star-X, and 6Star-X,
respectively, where X indicates the DP of each arm determined for the protected t-BuA polymers.
We also extended the synthetic approach to the preparation of hydrophobic random copolymers.
tert-Bu acrylate (tBuA) was co-polymerized with methyl acrylate (MA) to give random copolymers
with acidic carboxylic and methyl (ester) groups in the side chains (4StarMA) (Table S8). The mole
percentages of MA in the polymers were close to the initial feed ratios, indicating that the MA monomers
were quantitatively incorporated to the polymer chains. The copolymers are denoted as 4StarMAY-X,
where X and Y indicates the DP of each arm and mole percentage of MA in a polymer, respectively.
2.2. Binding of Star-Shaped Polymers to HAP
We first investigated the binding behaviors of star-shaped polymers onto HAP as a tooth surface
model as it has a similar chemical composition to enamel [38,39]. The intrinsic binding properties of
polymers can provide useful insights into the relationship between polymer structure and surface
activity. Specifically, the binding constant of the polymers and the maximum amount of binding sites
on hydroxyapatite surfaces would represent the polymers binding properties. Such information would
be helpful to predict polymer activity and design new polymers for subsequent improvements.
We synthesized rhodamine-labeled polymers (Figure 3A and Table S9) for the fluorescence-based
binding assay described below. The assay used HAP powder dispersed in an aqueous solution as a
model for HAP surfaces for polymer binding [40,41]. This assay provided a facile high-throughput
method to determine the amounts of polymers that remained free in supernatant at equilibrium (Ceq)
and adsorbed onto the HAP surface (q) (Figure 3B). The amount of polymers adsorbed onto the HAP
surface was increased as the polymer concentration was increased and appears to level off at high
concentrations (Figure 3B). The adsorption isotherms may be represented by the following equation










where qmax and Kd are the maximum amount of adsorbed polymers and dissociation constant,
respectively [42–44]. The data were well fitted by Equation (1) (Figure 3C). The qmax and Kd values were
calculated from the slope and intercept of each plot (Table S10). To compare the molecular behaviors of
the star-shaped and linear polymers with different molecular sizes, we use the qmax and Kd values given
in molar concentrations (μmol/g HAP and μM) for discussion, which present the binding behaviors of
each polymer molecule. It should be noted that we used the DP of protected tBu polymers to calculate
the Mn values of de-protected polymers because of the difficulty to determine the DP of de-protected
polymers by 1H NMR as described above. The Mn values were used to convert the qmax and Kd values
given in weight-based concentrations to molar concentrations.
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Figure 3. Synthesis of fluorescent dye-labeled polymers and their adsorption on hydroxyapatite powder
(HAP). (A) Synthesis of rhodamine-labeled 4-arm star-shaped polymers. The rhodamine monomer (0.1
mol.% to the total number of monomers) was polymerized with t-Bu methacrylate. (B) Adsorption of
4-arm star-shaped polymer F-4Star-192 on HAP surfaces. Fluorescence intensities from supernatants
of polymer assay solutions with and without HAP. (C) Adsorption isotherm and linear Langmuir
plot. q: the amounts of polymers adsorbed onto the HAP surface. Ceq: the polymer concentration of
supernatant at equilibrium.
First, we examined the binding properties of star-shaped and linear polymers which have a range
of DPs of each polymer arm in order to evaluate the effects of assembly of polymer chains on their HAP
binding as well as the effect of polymer arm length (DP) on their binding behavior. In general, the qmax
values for 4- and 6-arm star-shaped polymers were smaller than that of the linear polymer (Figure 4A).
This is likely because of the larger molecular sizes of star-shaped polymers, which occupy larger areas
on the hydroxyapatite surface than the linear polymer, such that fewer star-shaped polymers could
be bound to the hydroxyapatite surface. On the other hand, the dissociation constant Kd values of
star-shaped polymers were smaller than that of the linear polymer (Figure 4B), indicating that the
star-shaped polymers adsorbed on the hydroxyapatite surface more strongly than the linear polymer.
This can be explained by the large polymer sizes of star-shaped polymers which have more contact
points on the hydroxyapatite surface for binding. The 4- and 6-arm star-shaped polymers with DP~120
showed the similar qmax and Kd, indicating that these polymers occupy similar areas on the HAP
surfaces and have similar binding.
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Figure 4. HAP adsorption of linear and 4-ram star-shaped polymers. (A) qmax and (B) Kd were
determined by the Langmuir plot.
Regarding the effect of polymer arm length (DP) on their binding behavior, the qmax and Kd
value of 4-arm star-shaped polymers decreased as the DP of arms increased and leveled off at large
DPs (Figure 4A). On the other hand, the Kd value also leveled off for the polymers with large DPs
(Figure 4B). The qmax and Kd values of linear polymers also decreased and appeared to level off at large
DPs. These results suggest that the maximum number of adhered polymers and their binding affinity
did not increase once the size of polymers became sufficiently large. This leveling-off of HAP binding
behavior of the polymers may be explained by the following model. The anionic carboxylic groups
of the polymer side chains are the binding ligand to HAP surfaces through electrostatic interactions.
Therefore, as the polymer chains become longer, having more carboxylic side chains, the binding
affinity of polymers for HAP would increase. However, the binding of carboxylic side chains to HAP
surfaces requires the polymer chains to be flattened and/or stretched on the HAP surface, which is
not favorable because of the large entropic penalty. Therefore, the binding of polymers would be
determined by the balance between the two driving forces to maximize the number of binding sites
by carboxylic groups on the HAP surface (enthalpy gain) and minimize the strain on polymer chains
(entropic penalty). As the DP of the polymers increase, the number of carboxylic side chain groups
increase, thus increasing their binding. However, once the polymers are long enough, the polymer
chains would be difficult to be constrained on the HAP surface because of the entropic penalty, resulting
in the leveling of qmax and Kd.
The effect of hydrophobic side chains on polymers binding to HAP surfaces was also examined.
The random copolymers with hydrophobic monomer MA showed maximum points in the qmax and Kd
values as the composition of MA was increased (Figure 5). This binding behavior with maximum points
may be explained by the interplay between the electrostatic binding of carboxylate groups to HAP and
the intramolecular and intermolecular associations of MA groups. Increasing the MA composition
reduces the number of carboxylic side chains, which may in turn reduce the binding affinity of polymers
(higher Kd). On the other hand, the hydrophobic groups may associate intramolecularly (within the
same star-shaped polymer), which may prevent the extension of polymer chains for binding, resulting
in low binding affinity (higher Kd). Based on this model, the increase in the Kd values for the low
percentage of MA may indicate that the intramolecular association and/or reduced number of acidic
groups are dominant, but low Kd value for the polymer with 55% MA indicates the intermolecular
hydrophobic association between star-shaped polymers may play an important role to stabilize the
polymer layer. On the other hand, the qmax also slightly increased, indicating the conformation of bound
polymer chains are more compact (smaller occupied surface area). The polymers with 55% MA showed
lower qmax, indicating the polymer chains are more expanded likely because of increased intermolecular
associations of MA groups between the star-shaped polymers, which is in good agreement with the
low Kd value. These results suggest that the binding behaviors of polymers to HAP surfaces can be
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controlled by their hydrophobicity, but is a less contributing factor than the overall shape (linear vs.
star) of the polymer.
Figure 5. Effect of hydrophobic monomer composition on HAP adsorption of 4-arm
star-shaped polymers.
2.3. Anti-Bacterial Attachment Activity of Linear and Star-Shaped Polymers
We have shown that shape significantly impacts the binding constant of polymers to HAP surfaces
and that higher DPs are required for linear polymers than star-shaped in order to reach minimum
Kd values. As such, we selected a subset of linear, star-shaped, and hydrophobic polymers based on
their respective DP values that were similar to their tightly-binding fluorescent counterparts (DP =
100–200) in order to choose those materials with the strongest affinity to the HAP surface (Figure 6 and
Table 1). In this way, we have effectively normalized to the polymers’ Kd such that any differences in
anti-attachment or contact angle measurements could be ascribed to the shape and composition of the
polymers rather than simply their lack of presence through dissociation from the HAP surface. Table 1
lists the non-fluorescent polymers chosen for further evaluation. Additionally, we have intentionally
chosen materials that do not kill bacteria but instead repel. Surface modifications that reduce bacteria
deposition and colonization through contact kill or simple cell repulsion will ultimately appear the
same, i.e., both surfaces will have a sufficiently reduced amount of living bacteria. We acknowledge
that a combination of mechanisms, that is, kill + repel, would likely have the greatest efficacy, however
by using materials known to not kill, but rather repel, we can isolate the mechanism to a single mode,
subsequently making for more easily understood results. Consumer product constraints surrounding
materials that reduce bacteria population through bactericidal mechanisms will inherently certain
elicit regulatory restrictions. It is therefore important to have an understanding on materials that act as
a non-lethal, almost mechanical, barrier only.
HAP-coated substrates were used as an enamel surface model to test the attachment of a mixture of
oral bacteria Actinomyces viscosus and Streptococcus oralis. These bacteria are known as early colonizers
of the oral biofilm formation [45,46], so significant reductions of these species are suggestive of efficacy
on full healthy oral biofilms. In general, all of the polymers reduced the attachment of the bacteria
onto the HAP surfaces by 17–54% relative to untreated control. However, what is immediately clear
is that the six samples separated into two distinct groupings based on their relative hydrophobicity
(Figure 6). Among the acrylic acid homopolymers, the linear (Lin-211) and 6-arm (6Star-129) star-shaped
polymers showed a 30–32% reduction, while the 4-arm star (4Star-165) had only a 17% reduction.
In contrast, all hydrophobic random copolymers gave higher percent reductions regardless of their
shape. The linear copolymer (LinMA48-194), and 4-arm star-shaped copolymers (4StarMA56-215
and 4StarMA34-171) showed percent reductions of 43–54%, and were statistically superior to their
homopolymer counterparts.
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Figure 6. Anti-bacterial attachment activity of linear and star-shaped polymers. The activity of
polymers was assessed by the percent reduction in bacterial attachment relative to control (untreated
HAP surface). The data and error bars represent the average of 12 replicates with 95% confidence limits.
The alphabetical letters on the bars present statistical grouping.
Table 1. Polymers selected for anti-bacterial adhesion assay and contact angle experiments and
analogue polymers for HAP-binding assay.
Polymers Selected for Anti-Bacterial Adhesion and
Contact Angle Experiments








Lin-211 211 15,300 31.7 ± 4.2 F-Lin-189 189 13,700 1.05 ± 0.14 14.8 ± 5.5
4Star-165 165 48,000 17.6 ± 5.0 F-4Star-192 192 55,800 0.33 ± 0.06 1.4 ± 0.4
6Star-129 129 56,600 29.9 ± 2.5 F-6Star-121 121 53,100 0.38 ± 0.07 2.1 ± 0.6
LinMA48-194 194 b 15,400 46.3 ± 4.3 F-LinMA51-189 189 b 15,100 2.83 ± 0.11 14.0 ± 2.0
4StarMA34-171 171 53,000 43.2 ± 4.2 F-4StarMA37-185 185 57,700 0.33 ± 0.03 4.6 ± 0.8
4StarMA56-215 215 69,200 53.5 ± 5.5 F-4StarMA55-149 149 48,000 0.28 ± 0.02 1.6 ± 0.6
a The Mn (the number average molecular weight) of the polymers was calculated based on the DP of protected tBu
polymers and molecular weights of chain transfer agent and acrylic acrylate; b The theoretical DP calculated based
on the Mayo equation using the Ctr value and [SH]/[monomer].
This data is suggestive of several points in regard to the material characteristics required for
anti-attachment properties. First, while there may be small differences between the efficacies of
various shapes within the homo vs. copolymer families, their effect is diminished by the presence of
hydrophobic monomers within the random polymer chain. This is to say that bacteria are less able
to attach themselves to the HAP surface when that surface is coated with a hydrophobic polymer,
regardless of whether that polymer is linear or star-shaped. Second, the statistical groupings of the
star-shaped hydrophobic polymers were near equivalent, with 34 and 56 mol.% of methyl acrylate
providing similar effects. This implies that a “hydrophobic” polymer provides better anti-attachment,
but no significant increases in this effect were observed over the ranges evaluated. In the future, we
will explore this facet more closely as it may be possible to draw a true correlation here. In addition, the
maximum amount of adsorbed polymers qmax and dissociation constant Kd of the homopolymer and
hydrophobic copolymer with the same shape (linear, 4-, 6-arm star-shape) are very similar (Table 1).
This suggests that the enhanced effect of anti-bacterial adhesion by the hydrophobicity of copolymers is
not due to the difference in their inherent binding properties (the amount of polymers adhered) to HAP
surfaces, but it could be related to the physicochemical properties of polymers or polymer conformations
on the surface. It has been previously reported that random, block, cross-linked amphiphilic copolymers
effectively prevent protein adhesion and bacterial adhesion [47–54]. The proposed mechanism is
that these polymers form phase separated nano-scale domains, which reduce protein adsorption and
subsequent bacterial attachment [48]. These domains are smaller than the hydrophobic/hydrophilic
domains of proteins so that it is difficult for proteins to adopt their conformations to match with the
surface domains. While it is not clear at this point, we speculate that the copolymers in our study may
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also form such segregated microdomains by association of hydrophobic side chains, which may be a
more dominant factor for bacterial attachment than polymer shapes.
The ability for a polymer to provide anti-attachment effects to an oral surface can only happen if
the material sufficiently first binds to the surface. The data above has demonstrated that the chemistries
needed to bind and repel are not the same. A multi-arm star-shaped polymer had significantly better
binding to HAP, but in contrast composition played no such dominant role. Hydrophobicity did not
dramatically decrease Kd, however its presence significantly decreased bacteria attachment. Taken
together, a hydrophobic star-shaped material would be the ideal polymer system to both bind to
enamel and repel bacteria in our model systems.
2.4. Water Contact Angle
The polymer binding isotherms combined with bacteria anti-attachment clearly indicate the
tunability and functionality of these polymer systems. However, these materials would need to perform
in the presence of the salivary pellicle that coats all oral surfaces in order to provide sufficient effects
in-vivo. The pellicle is a complex mixture of proteins, deposited to the surface of enamel by salivary
flow [52], and fundamentally examining and predicting the interactions of star-shaped polymers
with a pellicle surface is a sufficient and ongoing challenge for our group. Polymers will interact
with a pellicle layer in different ways, depending on the dominate chemistry. For example, a recent
publication [55] showed that polyanions and polycations interacted differently with the pellicle, which
included their penetration depth relative to the HAP-pellicle interface. Another described changes
in pellicle thickness as well as antimicrobial functionality as a function of polymer deposition and
interaction with pellicle-coated HAP surfaces [12]. This effect can be rationally extended to variations
in hydrophobicity and shape. While the presence of a pellicle would add significant complexity, and is
outside of the scope of our current study, we did choose to examine how these polymers affected the
macroscopic properties of HAP through contact angle measurements after pre-treatment with artificial
saliva in order to demonstrate a small facet of in-vivo activity. Mucin-based artificial saliva has been a
substitute for human saliva in dental research [56], and we found that HAP discs first treated with
artificial saliva produced sufficient surfaces allowing for consistent measurements. Significant changes
in surface energies, exhibited by major differences in water droplet contact angle, would indicate
positive interactions between polymers and mucin-coated surfaces. This experiment represents our
first bridging data between fundamental studies and practical applications.
We generally observed that following treatment with polymer solutions, an increase in CA was
observed for most samples by >7◦, indicating that the polymer-treated surfaces were more hydrophobic
than the untreated control (Figure 7). The magnitude of this difference also reflected the compositional
changes within the polymers themselves. 4StarMA56-171, for example, had the highest contact angle
of 87.6◦, an effect attributed to the 56% MA concentration within the star shaped material. Example
images of the droplets can be seen in Figure 7, illustrating that these materials are effective at altering
the surface characteristics of HAP.
Within this series, however, the linear hydrophobic polymer LinMA48-194, exhibited a lower CA
than the untreated control, even though the polymer contains 48% methyl acrylate. The hydrophobic
side chains might stabilize the polymer coatings on the HAP surface by the hydrophobic interactions
with HAP and/or between the polymer chains. Such polymer network anchored on the HAP surface
might retain more water and therefore exhibit higher hydrophilicity, as compared to homopolymer
Lin-211 which increased CA. On the other hand, the hydrophobic star-shaped polymers exhibited
larger contact angles than LinMA48-194. It may be possible that linear polymer chains can adopt
a conformation on the surface such that the hydrophobic side chains face down toward the HAP,
and the hydrophilic (carboxylate) face up. The formation of such amphiphilic polymer conformation
would be more efficient than the star-shaped polymers which have denser polymer chains, giving
more constraints to conformational change. Because of the difference in the HAP pre-treatment
(mucin-coated or non-coated), we cannot directly compare these results to those of binding and
231
J. Funct. Biomater. 2019, 10, 56
anti-bacterial attachment. However, the results suggest that the polymers are capable of altering the
surface properties of HAP even in the presence of a protein layer.
Figure 7. Water contact angle of polymer treated HAP surfaces pre-treated with artificial saliva. Example
contact angle images of treated HAP surfaces: (A) untreated; (B) 4StarMA34-171; (C) 4StarMA56-215.
3. Materials and Methods
3.1. Materials
2,2’-azobisisobutyronitrile (AIBN) and pentaerythritol tetrakis(3-mercaptopropionate) (PETMP)
was purchased from Sigma-Aldrich Co. LLC. (St. Louis, MO, USA). Dipentaerythritol
hexakis(3-mercaptopropionate) (DPEHMP) was purchased from TCI America (Montgomeryville, PA,
USA). Methacryloxyethyl thiocarbamoyl rhodamine B was purchased from Polysciences (Warrington,
PA, USA). Trifluoroacetic acid (TFA) and solvents were purchased from Thermo Fisher Scientific, Inc.
(Waltham, MA, USA). tert-Butyl acrylate, methyl acrylate, and methyl mercaptopropionate (MMP)
were purchased from Acros Organics (Morris County, NJ, USA). The inhibitors of these monomers
were removed by passing through alumina before use. Other chemicals and solvents were used
without further purification. 1H NMR was performed using a Varian MR400 (400 MHz, Agilent
Scientific Instruments, Santa Clara, CA, USA) and analyzed using VNMRJ 3.2 (Agilent Scientific
Instruments, Santa Clara, CA, USA) and MestReNova. Gel permeation chromatography (GPC) analysis
was performed using a Waters 1515 HPLC instrument (Milford, MA, USA) using THF as an eluent,
equipped with Waters Styragel (7.8 × 300 mm) HR 0.5, HR 1, and HR 4 columns in sequence and
detected by a differential refractometer (RI). Sintered HAP discs (0.5 cm in diameter) were purchased
from Himed, Inc. (Old Bethpage, NY, USA).
3.2. Synthesis of tBu PAA Homopolymers
tert-Butyl acrylate (t-BuA), AIBN, and chain transfer agent (CTA) (MMP, PETMP, or DPEHMP)
in acetonitrile were mixed in a flask (See Table S1 for the polymerization conditions). The oxygen of
the reaction mixture was removed by bubbling nitrogen gas for 10 min, and the reaction solution was
stirred at 70 ◦C for 16 h. The reaction was cooled to room temperature. The solvent was removed
by evaporation under reduced pressure. The resultant residue was dissolved in diethyl ether, and
the polymer was isolated by precipitation in a methanol:water [50:50 (v/v)] mixture. The yield of
purification was >90% for most cases. The polymer arm length (DP) was calculated by comparing the
integrated peaks of -OCH2- group of chain transfer agent to the -CH- polymer backbone. The number
average molecular weight (Mn) was calculated using the DP and molecular weights of monomers and
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CTAs. Gel permeation chromatography molecular mass results were determined using a calibration
curve based on the standard samples of polystyrene. 1H NMR (CDCl3, 400 MHz) δ: 4.21–4.06 (s, 2H,
–OCH2– of PETMP), 2.85–2.51 (brs, 4H, –SCH2CH2–), 2.37-2.07 (brs, 1H, –CH–,), 1.97–1.14 (brs, 11H,
–CH3 and –CH2–).
The tBu groups of polymers were then removed by the addition of trifluoroacetic acid (TFA) (5
mL to 1 g of polymer). After stirring for 30 min, TFA was removed by blowing with nitrogen gas in a
closed container, and the gas was passed through a base (NaOH) aqueous solution to trap TFA. The
residue was dissolved in methanol, and deprotected polymers were isolated by precipitating in excess
diethyl ether. Subsequently, the precipitate was dissolved in distilled water and lyophilized to yield a
powdery product. 1H NMR (DMSO, 400 MHz) 2.4-2.0 (brs, 1H, –CH–,), 1.8-1.2 (brs, 2H, –CH2–).
3.3. Synthesis of Random Copolymers with MA
The PAA random copolymers with methacrylate (MA) were synthesized by the same method
with the tBu PAA homopolymers as described above. See Table S2 in Supporting Information for the
monomer feed compositions and reaction conditions.
3.4. Synthesis of Rhodamine B-Labeled Polymers
The rhodamine B-labeled copolymers were synthesized using methacryloxyethyl thiocarbamoyl
rhodamine B (0.1 mol.% to the total amount of monomers) by the same method as described above with
the tBu PAA homopolymers. See Supporting Information for the detailed procedure, polymerization
conditions, and monomer feed compositions (Tables S3–S6). The Mayo plots showed linear correlations,
and the Ctr values of each thiol group of linear and 4-arm polymers are 0.91 and 0.97 (Figure S2 and
Table S11).
3.5. Analysis of Polymerization Process
In general, DParm of polymer prepared in the presence of thiol groups as a CTA may be presented










where DP0, Ctr, [CTA] and [Monomer] represent the DP of each polymer arm in the absence of
CTA, chain transfer coefficient, initial mole concentration of thiol groups, and mole concentration of
monomers, respectively. According to the Mayo equation, the plot of 1/DP would be proportional to
[SH]/[Monomer], and the slop presents Ctr.
3.6. HAP Binding Assay
Fluorescence spectroscopy was used to evaluate the binding capacity of rhodamine-labeled
polymers onto HAP powder. The polymer solutions in 10 mM phosphate buffer with 150 mM NaCl
with different concentrations (pH = 7, adjusted by NaOH aq., 0.5 mL, 0.04, 0.08, 0.16, 0.31, 0.63, and
1.25 g/L) were mixed with HAP (30 mg/mL) in a 1.5 mL tube. The solution was gently shaken using a
mechanical shaker for 2 h at room temperature and then centrifuged at 10,000 rpm for 10 min. The
fluorescence emission intensities of the supernatant were measured (excitation wavelength = 553 nm,
emission wavelength = 627 nm) and compared with those for samples with same concentration of
polymers without HAP.
3.7. Anti-Bacterial Adhesion Assay
HAP coated MBECTM lids were treated by polymer solutions in MilliQ water (1 wt.%, pH 6.5
adjusted with NaOH or HCl) and allowed to shake in the incubator at 37 ◦C for 1 h. Following treatment,
excess polymer solution was removed from the MBECTM lids by submerging in Trypticase soy broth
(TSB) for 10–15 s for three cycles, replacing the TSB broth for each new cycle. The MBECTM lids were
233
J. Funct. Biomater. 2019, 10, 56
then incubated with freshly prepared overnight cultures of mixed Actinomyces viscosus (ATCC#43146,
American Type Culture Collection, Manassas, VA, USA) and Streptococcus oralis (ATCC#35037, American
Type Culture Collection, Manassas, VA, USA) for 3 h at 37 ◦C. After incubation the MBECTM lids were
submerged in TSB and sonicated two times for 2 min each time in order to detach the HAP-bound
bacteria into the TSB. The BacTiter-Glo Microbial Cell Viability Assay was utilized on the re-suspended
TSB to determine the percent reduction in the cell viability. The percent reduction was calculated by
the following equation based on the luminescent output of bacteria removed from untreated surfaces
and polymer-treated surfaces: % reduction = 100 × (bacteria attached on untreated surface—bacteria
attached on polymer-treated surface)/bacteria on untreated surface.
Bartlett’s test (p = 0.265) suggested that any variations are not significant, and the samples have
equal variances. Therefore one-way analysis of variance (ANOVA) was used to assess the treatment
effect and determine the statistical differences between the various sets. A Tukey multiple comparison
test was used to assess pairwise treatment differences. A p < 0.05 was used to indicate significant
statistical differences.
3.8. Contact Angle Measurements
Contact angle was performed on an Attension Theta instrument from Biolin Scientific (Stockholm,
Sweden). Data was analyzed using One Attension software v 2.9. Briefly, 1.0 wt.% polymer solutions in
MilliQ water were prepared, and their pH adjusted to 6.5 with concentrated NaOH or HCl. Because of
the immediate absorption of solution droplets into hydroxyapatite, surface modification was required
prior to treatment with polymer solutions in order to obtain stable droplets for comparison. Sintered
HAP was first treated with modified artificial saliva [39] for 1 h (see Supporting Information). After
this time, the discs were soaked in 2 mL of polymer solution for three hours on an orbital shaker. The
discs were removed and rinsed slightly to remove excess or loosely bound material, and then dried
overnight. Contact angle measurements of a 3 μL droplet on four separate HAP discs were collected
and averaged to provide statistical significance.
4. Conclusions
In summary of the present study, we synthesized linear, 4- and 6-arm star-shaped polymers based
on acrylic acid using chain transfer agents with corresponding thiol groups in order to provide insight
into the types of polymers that could both bind to HAP and repel bacteria from the surface. We have
found that polymer shape was more important to HAP surface binding than polymer composition
(hydrophobicity). However, polymer composition played a larger role than polymer shape (linear vs.
star-shape) when providing anti-bacterial protection. This information will be important for targeted
properties (binding, anti-bacterial attachment, wettability, etc.,) and further design polymers for dental
applications. In this study, our focus was the synthesis of star-shaped polymers and initial evaluation of
their physical and biological properties in order to test new polymer platforms for dental applications.
The oral environment is quite dynamic and subject to continuously changing environments due
to salivary flow, food and drink intake, and the resulting fluctuating pH. Therefore, the efficiency
of dental materials to provide benefits, as delivered through common oral care products, must be
investigated through delivery, substantivity, and efficacy. While limited to very simple systems here,
this approach is critical to build an understanding of dental materials as it can more effectively isolate
and identify specific modes of action in addition to chemical or physical barriers to the effectiveness of
these materials. Our future research will focus on further developing an understanding of star-shaped
polymers in reference to artificial-saliva and human-saliva-coated HAP surfaces, including binding
activity and bacterial anti-attachment properties.
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